source_doi,total_citations,policy_document_id,source_title,document_title,published_on,document_url,type,subtype,country,topics,classifications
https://dx.doi.org/10.1371/journal.pone.0152248,1.0,govie-a1e8443484e67a7cd19ca223b871179e,GOV.IE,Infection Prevention and Control (IPC),2023-05-16,https://www.gov.ie/en/publication/a057e-infection-prevention-and-control-ipc/,government,,Ireland,Hospital-acquired infection; Systematic review; Randomized controlled trial,health; science and technology; health>health treatment>medicine
https://dx.doi.org/10.1080/09540120500159334,3.0,who-5ff8925f283e676e408ee88d0679652c,World Health Organization,"Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa.",2018-03-26,https://apps.who.int/iris/handle/10665/269698,igo,healthcare agency,IGO,HIV/AIDS; Tuberculosis; Sexually transmitted infection,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1080/09540120500159334,3.0,worldbank-73b7e12270be50ebdebadfbd5a4a2fda,World Bank,The Global HIV Epidemics among Men Who Have Sex with Men,2011-05-27,https://hdl.handle.net/10986/2308,igo,development bank,IGO,Men who have sex with men; Epidemiology of HIV/AIDS; Sexually transmitted infection,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1080/09540120500159334,3.0,worldbank-8f3a5ebf1c9996a90cb260b36a12e8da,World Bank,The Global HIV Epidemics among Men Who Have Sex with Men,2012-03-19,https://openknowledge.worldbank.org/handle/10986/2308,igo,development bank,IGO,IPrEx; Men who have sex with men; HIV/AIDS,health; health>diseases and conditions>communicable disease>virus disease; society
https://dx.doi.org/10.1093/cid/civ514,2.0,hcspfr-12a539f763f1205a711b3b467f8478e9,Haut Conseil de la santé publique,Conduite à tenir autour d’un ou plusieurs cas de coqueluche,2022-11-18,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=1265,government,agency,France,Epidemiology; Pertussis vaccine; Polymerase chain reaction,health>diseases and conditions; health>diseases and conditions>illness; science and technology>natural science>biology
https://dx.doi.org/10.1093/cid/civ514,2.0,stateofwisconsin-418aea7aa07b5578a08ea69fdbee2944,State of Wisconsin,Pertussis Case Reporting and Investigation Protocol,2018-11-05,https://www.dhs.wisconsin.gov/publications/p01108.pdf,government,,USA,Diseases and disorders; Infectious diseases; Medical specialties,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/0035-9203(90)90290-u,7.0,who-329eab11fc377aa0841de0e3fe1dc80d,World Health Organization,Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan.,2018-03-26,https://apps.who.int/iris/handle/10665/268205,igo,healthcare agency,IGO,Injection (medicine); Hepatitis B; Hepatitis,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1016/0035-9203(90)90290-u,7.0,who-3ba89f209450e33b2ec6f66ed485370d,World Health Organization,Eastern Mediterranean Health Journal,2019-08-29,https://apps.who.int/iris/handle/10665/326736,igo,healthcare agency,IGO,Hepatocellular carcinoma; Institutional review board; Hepatitis C,health>diseases and conditions; health; education
https://dx.doi.org/10.1016/0035-9203(90)90290-u,7.0,who-3e2d2d7e8a364e10a76893e779a433a5,World Health Organization,"Prevalence of hepatitis B and C infections and associated factors among blood donors in Aden city, Yemen",2014-06-17,https://apps.who.int/iris/handle/10665/118167,igo,healthcare agency,IGO,Hepatitis B; Hepatitis; Hepatitis C,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1016/0035-9203(90)90290-u,7.0,who-78f74a9716e3f8dc846569dcbb1e53e2,World Health Organization,The global prevalence of hepatitis A virus infection and susceptibility : a systematic review,2012-06-17,https://apps.who.int/iris/handle/10665/70180,igo,healthcare agency,IGO,Chūbu region; Jaundice; Hepatitis,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1016/0035-9203(90)90290-u,7.0,who-992a673bbb1054baacc8e9fcbf91b57e,World Health Organization,Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan / Aamir J. Khan ... [‎et al.]‎,2012-06-16,https://apps.who.int/iris/handle/10665/57250,igo,healthcare agency,IGO,Hypodermic needle; Hepatitis C; Injection (medicine),health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1016/0035-9203(90)90290-u,7.0,who-c48d21018ea5d207772c737713436de2,World Health Organization,Hepatocellular carcinoma in Yemeni patients: a single centre experience over an 8-year period,2014-06-17,https://apps.who.int/iris/handle/10665/118170,igo,healthcare agency,IGO,Health; Hepatocellular carcinoma; Hepatitis C,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/0035-9203(90)90290-u,7.0,who-e48a1ed30f57e13e023cd29aba84561c,World Health Organization,Eastern Mediterranean Health Journal,2019-08-29,https://apps.who.int/iris/handle/10665/326737,igo,healthcare agency,IGO,Health; Public health; Medicine,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1016/j.jval.2020.10.013,1.0,rivmnl-5ddbb7d30eaf24856f469d5859ecfbbd,Rijksinstituut voor Volksgezondheid en Milieu,Prevention of respiratory syncytial virus (RSV) disease in infants. Background information for the Health Council of the Netherlands,2023-07-13,https://www.rivm.nl/publicaties/prevention-of-respiratory-syncytial-virus-rsv-disease-in-infants-background-information,government,research center,Netherlands,Palivizumab; Nirsevimab; Respiratory syncytial virus,health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.jsat.2020.108158,3.0,gaogov-fb35f344f5dbc654fb12088da4c3b0b0,U.S. Government Accountability Office,Older Workers: Opioid Misuse and Employment Outcomes,2022-02-17,https://www.gao.gov/products/gao-22-104491,government,,USA,Sampling (statistics); Unemployment; Employment,labour; labour; labour>employment
https://dx.doi.org/10.1016/j.jsat.2020.108158,3.0,gpogov-00dd79dbfa0bf609c2a47405db8b6516,Government Publishing Office (GPO),Older workers: opioid misuse and employment outcomes : report to congressional requesters.,2022-02-17,https://purl.fdlp.gov/GPO/gpo177674,government,,USA,Substance abuse; Sampling (statistics); Unemployment,labour; labour>employment; health
https://dx.doi.org/10.1016/j.jsat.2020.108158,3.0,nationalacademymedicine-f5f083627cce3bb8bdda622094ad1f68,National Academy of Medicine,Guide for Future Directions for the Addiction and OUD Treatment Ecosystem,2021-04-05,https://nam.edu/guide-for-future-directions-for-the-addiction-and-oud-treatment-ecosystem/,government,academy,USA,Naloxone; Substance use disorder; Telehealth,society>social problem>addiction; health>health treatment; health>diseases and conditions
https://dx.doi.org/10.1016/j.onehlt.2021.100330,1.0,europa-c4fb397a42b610ce3c5b2d6c5f2428d5,Publications Office of the European Union,One Health Governance in the European Union - Publications Office of the EU,2024-11-15,https://op.europa.eu/en/publication-detail/-/publication/56b65e58-a309-11ef-85f0-01aa75ed71a1/language-en,government,,EU,One Health; Health; European Union,health; environment; health>diseases and conditions
https://dx.doi.org/10.1046/j.1537-2995.1997.37197176950.x,2.0,federalregister-b5aef942f968513836866d93d1522267,Federal Register,Requirements for Testing Human Blood Donors for Evidence of Infection Due to Communicable Disease Agents,1999-08-19,https://www.federalregister.gov/documents/1999/08/19/99-21296/requirements-for-testing-human-blood-donors-for-evidence-of-infection-due-to-communicable-disease,government,,USA,Diseases and disorders; Hematopoietic stem cell transplantation; Plasmapheresis,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1046/j.1537-2995.1997.37197176950.x,2.0,hitap-bdd03fdc159cbce266e2bfb28afa796c,Health Intervention and Technology Assessment Program,Research report: Identifying information regarding effectiveness and cost-effectiveness of policy and strategies to mitigate the impact of HIV/AIDS in Thailand,2009-05-29,https://www.hitap.net/download/?fileid=20727&pid=166897,government,agency,Thailand,HIV/AIDS; Preventive healthcare; Prevention of HIV/AIDS,health>diseases and conditions; health; education
https://dx.doi.org/10.1073/pnas.1504964112,36.0,aspehhsgovus-1e82d2ed81c0ed9544fc25161a57a38f,ASPE,To Big Data or Not: Determining the Use of Big Data,2019-09-13,https://aspe.hhs.gov/reports/big-data-or-not-determining-use-big-data,government,,USA,Data; Research; Big data,"economy, business and finance>economic sector>computing and information technology; economy, business and finance>economic sector>computing and information technology>software; science and technology>social sciences>information science"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,cgiar-af4e17b4b66fb5a6f6a218781dbef039,CGIAR,Can call detail records provide insights into women’s empowerment? A case study from Uganda,2021-01-01,https://cgspace.cgiar.org/handle/10568/111023,think tank,research center,France,Sensitivity and specificity; Hyperparameter optimization; Support vector machine,"science and technology; labour; economy, business and finance>economic sector>agriculture"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,datapopalliance-4bf1c6167bf7e7a737620d07fd71c5e7,Data-Pop Alliance,Mobile phone data and COVID-19: Missing an opportunity?,2020-03-27,https://datapopalliance.org/publications/mobile-phone-data-and-covid-19-missing-an-opportunity/,think tank,,USA,COVID-19 pandemic; Information privacy; Pandemic,"health>diseases and conditions; health; economy, business and finance>economic sector>computing and information technology"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,datapopalliance-5f924d2a91c5156cede6d8fdfbd13ab6,Data-Pop Alliance,Understanding the Relationship Between Short and Long Term Mobility,2018-06-21,https://datapopalliance.org/publications/understanding-the-relationship-between-short-and-long-term-mobility/,think tank,,USA,Human migration; SIM card; Census,science and technology; health; science and technology>social sciences>economics
https://dx.doi.org/10.1073/pnas.1504964112,36.0,datapopalliance-9eb7eae03ccc8b17c2a0942e975ec6a9,Data-Pop Alliance,Mobile phone data for informing public health actions across the COVID-19 pandemic life cycle,2020-06-30,https://datapopalliance.org/publications/mobile-phone-data-for-informing-public-health-actions-across-the-covid-19-pandemic-life-cycle/,think tank,,USA,COVID-19 pandemic; Contact tracing; Privacy,"health>diseases and conditions; economy, business and finance>economic sector>computing and information technology; health"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,datapopalliance-fce2af77d4b4efef207e3dc9e5242aef,Data-Pop Alliance,Big Data to Address Global Development Challenges - Paper Series,2019-03-21,https://datapopalliance.org/publications/big-data-to-address-global-development-challenges-paper-series/,think tank,,USA,"Social vulnerability; Climate resilience; Training, validation, and test sets","disaster, accident and emergency incident>disaster; economy, business and finance>economic sector>computing and information technology; science and technology"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,europa-69dd5d921a4f34440d23231a1cec6597,Publications Office of the European Union,How human mobility explains the initial spread of COVID-19 : a European regional analysis.,2020-07-13,https://op.europa.eu/en/publication-detail/-/publication/dbc785b7-c7dc-11ea-adf7-01aa75ed71a1/language-en/format-PDF,government,,EU,Correlation and dependence; Regression analysis; Time series,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1073/pnas.1504964112,36.0,governmentofegypt-eb10cf0656fd1b1ed170f361be66d39d,Government of Egypt,The State Of Broadband 2018: Broadband Catalyzing Sustainable Development,2018-09-10,http://www.mcit.gov.eg/Upcont/Documents/Reports%20and%20Documents_4102018000_State_of_Broadband_2018_Broadband_Catalyzing_Sustainable_Development.pdf,government,,Egypt,5G; Internet of things; Internet access,"science and technology; economy, business and finance>economic sector>computing and information technology; education"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,governmentofsouthafrica-21c168cd7edc829916de6bbe914a2cd2,Government of South Africa,"Climate Change 2022 : Impacts, Adaptation and Vulnerability",2022-07-29,https://soer.environment.gov.za/soer/UploadLibraryImages/UploadDocuments/180123124621_IPPC%20working%20group%20ii.pdf,government,,South Africa,Environment; Nature; Global environmental issues,environment; environment>natural resources>water; health
https://dx.doi.org/10.1073/pnas.1504964112,36.0,idrc-41b1bcda7df4a86c9b8f53c38f0931b2,International Development Research Centre,Civil registration and vital statistics (CRVS) systems in the face of the COVID-19 pandemic : a literature review,2021-06-03,https://idl-bnc-idrc.dspacedirect.org/handle/10625/60206,think tank,,Canada,Coronavirus disease 2019; COVID-19 pandemic; Civil registration,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.1504964112,36.0,idrc-4af63965ae67b2656ff30d45d52db5d8,International Development Research Centre,Mapping big data solutions for the sustainable development goals : draft,2018-03-20,https://idl-bnc-idrc.dspacedirect.org/handle/10625/56906,think tank,,Canada,Sustainable Development Goals; Sustainability; Data analysis,"economy, business and finance>economic sector>computing and information technology; science and technology; environment"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,idrc-7b316b912f4c963911634d64c9d83adb,International Development Research Centre,Systèmes d’enregistrement et de statistiques de l’état civil (ESEC) à l’épreuve de la pandémie de COVID-19 : une revue de littérature,2021-06-03,https://idl-bnc-idrc.dspacedirect.org/handle/10625/60205,think tank,,Canada,COVID-19 pandemic; Coronavirus disease 2019; Health,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.1504964112,36.0,idrc-a9cea6c4f16790a90553a132eb399cb6,International Development Research Centre,Annex 19 : predictive model for the dengue incidences in Sri Lanka using mobile network big data.,2019-09-23,https://idl-bnc-idrc.dspacedirect.org/handle/10625/58136,think tank,,Canada,Artificial neural network; Machine learning; Deep learning,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.1504964112,36.0,idrc-ea49aa21ba1be30551bfd1bda729e73e,International Development Research Centre,Annex 19 : predicting population-level socio-economic characteristics using Call Detail Records (CDRs) in Sri Lanka,2019-09-26,https://idl-bnc-idrc.dspacedirect.org/handle/10625/58172,think tank,,Canada,Linear regression; Regression analysis; Roof,science and technology; society>social condition>poverty; science and technology>social sciences>economics
https://dx.doi.org/10.1073/pnas.1504964112,36.0,ipcc-959214f74a911cd6004e4833b4646f58,IPCC,"AR6 Climate Change 2022: Impacts, Adaptation and Vulnerability",2022-02-01,https://www.ipcc.ch/report/sixth-assessment-report-working-group-ii/,igo,,IGO,Climate change; IPCC Sixth Assessment Report; Climate resilience,environment; environment>natural resources>water; health
https://dx.doi.org/10.1073/pnas.1504964112,36.0,jointresearcheu-049edb9b67edcdc601c993769ad5781b,Joint Research Centre,How human mobility explains the initial spread of COVID-19,2020-07-13,https://publications.jrc.ec.europa.eu/repository/handle/JRC121300,government,agency,EU,Correlation and dependence; Regression analysis; Time series,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1073/pnas.1504964112,36.0,nber-7f68b28e0a4479fc84f64c0e8a5f130b,NBER,Mandated and Voluntary Social Distancing During The COVID-19 Epidemic: A Review,2020-11-30,https://www.nber.org/papers/w28139,think tank,,USA,Social distancing; Unemployment; Effect size,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.1504964112,36.0,opcwint-6d9690999426abb789ac7844592493bd,Organisation for the Prohibition of Chemical Weapons,Summary of the Second Meeting of the Scientific Advisory Board Temporary Working Group on Investigative Science and Technology,2019-01-21,https://www.opcw.org/sites/default/files/documents/2019/01/sab28wp02%28e%29.pdf,igo,,IGO,Art forgery; Douma chemical attack; TRPA1,science and technology; environment; science and technology>natural science>chemistry
https://dx.doi.org/10.1073/pnas.1504964112,36.0,unenvironment-9641807193493ee2abbb2917e2bd2dd9,United Nations Environment Programme,Shock Waves - Managing the Impacts of Climate Change on Poverty,2016-10-11,https://wedocs.unep.org/20.500.11822/7456,igo,,IGO,Economy; Natural environment; Risk,"environment; disaster, accident and emergency incident>disaster; economy, business and finance>economic sector>transport"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,unesco-35f86b196df1e4c1c86249528cf9aa2a,UNESCO,The State of broadband 2018: broadband catalyzing sustainable development,2018-01-01,https://unesdoc.unesco.org/notice?id=p::usmarcdef_0000374381,igo,,IGO,Internet of things; 5G; Internet access,"science and technology; economy, business and finance>economic sector>computing and information technology; education"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,unfccc-b2ec5c7d7c6061e4b6748cef785fe8a6,United Nations Framework Convention on Climate Change,National Adaptation plan of Ecuador,2023-03-22,https://unfccc.int/documents/627465,igo,,IGO,Earth sciences; Natural environment; Nature,environment; environment>nature; environment>natural resources>water
https://dx.doi.org/10.1073/pnas.1504964112,36.0,unicef_innocenti-8d2bc77bb06e0e67727e903a3dcf0a9c,UNICEF Office of Research - Innocenti,Ethical Considerations When Using Social Media for Evidence Generation,2018-06-13,https://www.unicef-irc.org/publications/967-ethical-considerations-when-using-social-media-for-evidence-generation-discussion.html,igo,,IGO,Social media; Privacy; U-Report,"economy, business and finance>economic sector>computing and information technology; science and technology; health"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,unitednations-2cbe9126b208b7a388b380a8039fe167,United Nations,World Development Report 2021 : data for better lives,2021-01-01,https://digitallibrary.un.org/record/3963929?ln=en,igo,,IGO,Governance; Infrastructure; Institution,"economy, business and finance>economic sector>computing and information technology; science and technology; economy, business and finance>economy"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,worldbank-0706632d98e8c17bdd772cb0a7f38c62,World Bank,Toward Successful Development Policies : Insights from Research in Development Economics,2020-02-06,https://openknowledge.worldbank.org/handle/10986/33289,igo,development bank,IGO,Poverty; Climate change adaptation; Tariff,education; science and technology; education>school
https://dx.doi.org/10.1073/pnas.1504964112,36.0,worldbank-0c003a20bec7148a6ab247aeba985e87,World Bank,Shock Waves : Managing the Impacts of Climate Change on Poverty,2015-10-21,https://openknowledge.worldbank.org/handle/10986/22787,igo,development bank,IGO,Poverty; Climate change mitigation; Climate change adaptation,"environment; environment>climate change; economy, business and finance>economic sector>transport"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,worldbank-0fc12248638a415910119876b4a283ec,World Bank,Shock Waves,2016-01-01,https://hdl.handle.net/10986/22787,igo,development bank,IGO,Climate change mitigation; Poverty; Climate change adaptation,"environment; disaster, accident and emergency incident>disaster; economy, business and finance>economic sector>transport"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,worldbank-265be945df13978db79db75fa3e33505,World Bank,Assessing Bias in Smartphone Mobility Estimates in Low Income Countries,2021-11-19,https://openknowledge.worldbank.org/handle/10986/36611,igo,development bank,IGO,Smartphone; Mobile app; Feature phone,"science and technology; economy, business and finance>economic sector>computing and information technology; health"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,worldbank-3dd2068b11beaedf488ae2fcca419ad2,World Bank,World Development Report 2021,2021-03-24,https://hdl.handle.net/10986/35218,igo,development bank,IGO,Tax; Official statistics; Data governance,"economy, business and finance>economic sector>computing and information technology; economy, business and finance>economy; economy, business and finance>economy"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,worldbank-78abc5d3311818037890a8bfb6837226,World Bank,Information and Communications for Development 2018,2018-10-15,https://hdl.handle.net/10986/30437,igo,development bank,IGO,Cost of living; Internet; DE-CIX,"economy, business and finance>economic sector>computing and information technology; economy, business and finance>economic sector>computing and information technology>software; science and technology"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,worldbank-84a0c78fbbadb7d94fabcc5b6bc53cca,World Bank,Using Mobile Phone Data to Reduce Spread of Disease,2020-03-01,https://hdl.handle.net/10986/33520,igo,development bank,IGO,Malaria; Infection; Tropical medicine,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.1504964112,36.0,worldbank-935998f6340561c05350fc0e52be3a83,World Bank,World Development Report 2021 : Data for Better Lives,2021-03-08,https://openknowledge.worldbank.org/handle/10986/35218,igo,development bank,IGO,Governance; Tax; Census,"economy, business and finance>economic sector>computing and information technology; science and technology; economy, business and finance>economic sector>computing and information technology>software"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,worldbank-99efdc24ef4babb3fe91867d9a035aeb,World Bank,Toward Successful Development Policies,2020-01-01,https://hdl.handle.net/10986/33289,igo,development bank,IGO,Economy; Free trade; Stunted growth,"education; economy, business and finance>economy; science and technology"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,worldbank-c02c02ff0f823c5d45e3d237a5a3a5b2,World Bank,Shock Waves: Managing the Impacts of Climate Change on Poverty,2015-10-31,http://hdl.handle.net/10986/22787,igo,development bank,IGO,Climate change mitigation; Poverty; Climate change adaptation,"environment; disaster, accident and emergency incident>disaster; economy, business and finance>economic sector>transport"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,worldbank-d16a5b6c833528b3ed5fcb78103eaa49,World Bank,Information and Communications for Development 2018 : Data-Driven Development,2018-09-25,https://openknowledge.worldbank.org/handle/10986/30437,igo,development bank,IGO,Internet access; Internet of things; Machine to machine,"economy, business and finance>economic sector>computing and information technology; economy, business and finance>economic sector>media; economy, business and finance>economic sector"
https://dx.doi.org/10.1073/pnas.1504964112,36.0,worldbank-e0b3f7ae972f569bd465ce698df286b7,World Bank,Using Mobile Phone Data to Reduce Spread of Disease,2020-04-02,https://openknowledge.worldbank.org/handle/10986/33520,igo,development bank,IGO,Malaria; Infection; Tropical medicine,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.1504964112,36.0,worldbank-e81b87e2db7fe093cdfb5f2f098fbb4e,World Bank,Assessing Bias in Smartphone Mobility Estimates in Low Income Countries,2021-06-28,https://hdl.handle.net/10986/36611,igo,development bank,IGO,Technology; Landline; Developing country,"science and technology; economy, business and finance>economic sector>computing and information technology; health"
https://dx.doi.org/10.1093/jac/dkw247,1.0,stateofqueensland-c0d60b75df39c5288f93cad37bfa21fc,State of Queensland,2016,2017-08-18,https://metronorth.health.qld.gov.au/wp-content/uploads/2018/01/rbwh-research-report-2016-full.pdf,government,,Australia,Physical therapy; Telehealth; Health care,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.5588/ijtld.13.0571,1.0,who-301ab53d4232d7505842274971743620,World Health Organization,2015 update,2015-06-04,https://apps.who.int/iris/handle/10665/174052,igo,healthcare agency,IGO,Tuberculosis; HIV/AIDS; World Health Organization,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment
https://dx.doi.org/10.1001/archpedi.1995.02170240035005,4.0,governmentofcanada-1314dcd583baaad553cf19d5fa8af37a,Government of Canada,Relevé des maladies transmissibles au Canada. Une dèclaration d'un comitè consultatif (DCC) : H12-21-2/29-8-PDF Publications - Canada.ca,2003-01-01,http://publications.gc.ca/site/eng/9.582254/publication.html,government,,Canada,Respiratory syncytial virus; Bronchiolitis; Epidemiology,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1001/archpedi.1995.02170240035005,4.0,governmentofcanada-3a4189b974ef27c91956c41df376e095,Government of Canada,Canada communicable disease report. An advisory committee statement (ACS) : H12-21-2/29-7-PDF Publications - Canada.ca,2003-01-01,http://publications.gc.ca/site/eng/9.582255/publication.html,government,,Canada,Palivizumab; Respiratory syncytial virus; Bronchiolitis,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1001/archpedi.1995.02170240035005,4.0,governmentofcanada-6cee3a3b9c8fe1a468b30f3d3300f030,Government of Canada,Relevé des maladies transmissibles au Canada. Une dèclaration d'un comitè consultatif (DCC) : H12-21-2/29-7-PDF Publications - Canada.ca,2003-01-01,http://publications.gc.ca/site/eng/9.582256/publication.html,government,,Canada,Palivizumab; Respiratory syncytial virus; Bronchiolitis,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1001/archpedi.1995.02170240035005,4.0,governmentofcanada-71d790b963348487aa7272765d1dffcd,Government of Canada,Canada communicable disease report. An advisory committee statement (ACS) : H12-21-2/29-8-PDF Publications - Canada.ca,2003-01-01,http://publications.gc.ca/site/eng/9.582253/publication.html,government,,Canada,Health; Medicine; Clinical medicine,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1097/00042560-199804150-00012,2.0,unaids-68c0b96b8f1789b3f40012609a5bb304,UNAIDS,Migrant Populations and HIV/AIDS,2000-08-11,https://www.unaids.org/en/resources/documents/2000/20000811_jc397-migrantpop_en.pdf,igo,,IGO,HIV/AIDS; Evaluation; Health,education; health>diseases and conditions; health
https://dx.doi.org/10.1097/00042560-199804150-00012,2.0,unitednations-5343ca0a97ca5a72a58a088bd6449040,United Nations,"Migrant populations and HIV/AIDS :the development and implementation of programmes: theory, methodology and practice",2000-06-01,https://digitallibrary.un.org/record/3957178?ln=en,igo,,IGO,Information; Self-report study; Sexually transmitted infection,health; science and technology; politics
https://dx.doi.org/10.21037/jtd.2020.02.64,6.0,governmentofindonesia-83472b61d34d2a59f622aa85c0407d9e,Government of Indonesia,An analysis of Covid-19 transmission in Indonesia and Saudi Arabia,2020-06-03,http://download.garuda.kemdikbud.go.id/article.php?article=1726565&val=12227&title=AN%20ANALYSIS%20OF%20COVID-19%20TRANSMISSION%20IN%20INDONESIA%20AND%20SAUDI%20ARABIA,government,,Indonesia,Compartmental models in epidemiology; Medical statistics; Clinical medicine,science and technology>mathematics; science and technology; health>diseases and conditions
https://dx.doi.org/10.21037/jtd.2020.02.64,6.0,nber-4f01abf470311b5eb1d24b48476b812a,NBER,Bayesian Adaptive Clinical Trials for Anti‐Infective Therapeutics during Epidemic Outbreaks,2020-05-14,https://www.nber.org/papers/w27175,think tank,,USA,Compartmental models in epidemiology; Type I and type II errors; Infection,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.21037/jtd.2020.02.64,6.0,oecddiscovery-73994c4e34072288606d75f49deb3de7,OECD,Études économiques de l'OCDE : Chine 2022 (version abrégée),2022-08-12,https://dx.doi.org/https://doi.org/10.1787/567b8724-fr,igo,,IGO,Bank; Funding; Debt,"economy, business and finance>economic sector>financial and business service>banking; economy, business and finance>economy; economy, business and finance>economy>macro economics>credit and debt"
https://dx.doi.org/10.21037/jtd.2020.02.64,6.0,oecddiscovery-ff706a34f858548a416b97c0dd6773db,OECD,OECD Economic Surveys: China 2022,2022-03-18,https://dx.doi.org/10.1787/b0e499cf-en,igo,,IGO,Economy; Government debt; OECD,"economy, business and finance>economy; economy, business and finance>economic sector>financial and business service>personal income; economy, business and finance>economy>macro economics>credit and debt"
https://dx.doi.org/10.21037/jtd.2020.02.64,6.0,worldbank-4e4424f82b15923ff55b9805721b4858,World Bank,Modeling and Predicting the Spread of Covid-19,2020-10-01,https://hdl.handle.net/10986/34590,igo,development bank,IGO,Econometrics; Coronavirus disease 2019; Logarithm,health>diseases and conditions; science and technology; science and technology>mathematics
https://dx.doi.org/10.21037/jtd.2020.02.64,6.0,worldbank-d443e4524d34193786a3b6a88804cb40,World Bank,"Modeling and Predicting the Spread of Covid-19 : Comparative Results for the United States, the Philippines, and South Africa",2020-10-08,https://openknowledge.worldbank.org/handle/10986/34590,igo,development bank,IGO,Econometrics; Coronavirus disease 2019; Logarithm,health>diseases and conditions; science and technology; science and technology>mathematics
https://dx.doi.org/10.1002/psp4.12591,1.0,who-d420f491ae94a36cf0a1ccd6acc463e4,World Health Organization,WHO operational handbook on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection: web annex B: critical concentrations for pretomanid and cycloserine: WHO policy statement,2024-01-01,https://apps.who.int/iris/handle/10665/376285,igo,healthcare agency,IGO,Minimum inhibitory concentration; Multidrug-resistant tuberculosis; Tuberculosis,science and technology>biomedical science>pharmacology; science and technology; health>diseases and conditions
https://dx.doi.org/10.1086/597305,1.0,adminch-786e860838cf1fef456edb3537d34b27,Government of Switzerland,Human Immunodeficiency Virus Drug Resistance : 2018 Recommendations of the International Antiviral Society – USA Panel,2018-12-28,https://www.bag.admin.ch/dam/bag/it/dokumente/kuv-leistungen/referenzdokument-klv-anhang-3/hiv-drug-resistance-recommendations.pdf.download.pdf/HIV_Drug_Resistance_recommendations.pdf,government,,Switzerland,Management of HIV/AIDS; HIV/AIDS; HIV,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1089/apc.2013.0105,2.0,nygov-107f59c7c042d0177f48713c3cffb5ba,New York State,"Jurisdiction Level Differences in HIV Diagnosis, Retention",2013-12-31,https://www.health.ny.gov/diseases/aids/ending_the_epidemic/docs/key_resources/care_committee/linkage_retention_and_vls/jurisdiction_level_differences.pdf,government,,USA,Animal viral diseases; HIV/AIDS; Management of HIV/AIDS,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1089/apc.2013.0105,2.0,who-c310c366e1f988b815e01bf4ab1e55fa,World Health Organization,Monitoring of HIV treatment in seven countries in the WHO Region of the Americas,2018-03-26,https://apps.who.int/iris/handle/10665/271761,igo,healthcare agency,IGO,Management of HIV/AIDS; HIV/AIDS; CD4,health; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1098/rspb.2000.0961,2.0,who-3e191cbc8df8853ced090aeb4ee8cd24,World Health Organization,"WHO manual for surveillance of human transmissible spongiform encephalopathies, including variant Creutzfeldt-Jakob disease",2012-06-16,http://apps.who.int/iris/handle/10665/42656,igo,healthcare agency,IGO,Health; Transmissible spongiform encephalopathy; Creutzfeldt–Jakob disease,health; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1098/rspb.2000.0961,2.0,who-6e8181dab0edd76f4c18c8da57cadcfe,World Health Organization,"The revision of the surveillance case definition for Variant Creutzfeldt-Jakob disease (‎vCJD)‎ : report of a WHO consultation, Edinburgh, United Kingdom 17 May 2001",2012-06-17,https://apps.who.int/iris/handle/10665/67341,igo,healthcare agency,IGO,Creutzfeldt–Jakob disease; Transmissible spongiform encephalopathy; Variant Creutzfeldt–Jakob disease,health; science and technology>natural science>biology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1038/s41598-018-19757-5,1.0,who-6a530cf5ca0b28db255e709069c83b45,World Health Organization,Optimizing active case-finding for tuberculosis: Implementation lessons from South-East Asia,2021-07-22,https://apps.who.int/iris/handle/10665/343105,igo,healthcare agency,IGO,Tuberculosis; GeneXpert MTB/RIF; Screening (medicine),health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/srep18585,2.0,sciensano-0c646fa4354cc6c6f786da6f4630fc6c,Sciensano,"Infectieziekten bij kinderen, die voorkomen kunnen worden door vaccinatie. Jaarrapport 2015",2017-01-13,https://www.sciensano.be/en/biblio/infectieziekten-bij-kinderen-die-voorkomen-kunnen-worden-door-vaccinatie-jaarrapport-2015,government,healthcare agency,Belgium,Vaccine-preventable diseases; Hepatitis B; Measles,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1038/srep18585,2.0,sciensano-d6fc83708b423e933c265491508635f2,Sciensano,Maladies infectieuses pédiatriques à prévention vaccinale. Rapport annuel 2015,2017-01-13,https://www.sciensano.be/en/biblio/maladies-infectieuses-pediatriques-a-prevention-vaccinale-rapport-annuel-2015,government,healthcare agency,Belgium,Polio eradication; Whooping cough; Medical humanities,health>diseases and conditions>communicable disease>virus disease; health; health>diseases and conditions
https://dx.doi.org/10.1089/aid.2006.22.240,1.0,nice-eca1723ed17559ddf0d6be29d6507833,NICE,Cabotegravir with rilpivirine for treating HIV-1,2022-01-05,https://www.nice.org.uk/guidance/ta757,government,healthcare agency,UK,Rilpivirine; Management of HIV/AIDS; Cabotegravir,science and technology>biomedical science>pharmacology; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1016/j.vaccine.2008.12.032,2.0,worldbank-2ba628c5c128c30be7fa70a621de6759,World Bank,"A Cost–Benefit Analysis of Cholera Vaccination Programs in Beira, Mozambique",2012-03-30,https://openknowledge.worldbank.org/handle/10986/4502,igo,development bank,IGO,Cost–benefit analysis; Externality; Vaccine,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1016/j.vaccine.2008.12.032,2.0,worldbank-4d9aec5bc938f99e8a59c5c51dbb7ae5,World Bank,"A Cost–Benefit Analysis of Cholera Vaccination Programs in Beira, Mozambique",2009-06-30,https://hdl.handle.net/10986/4502,igo,development bank,IGO,Cost–benefit analysis; Externality; Vaccine,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1016/j.watres.2013.06.001,8.0,cityofminneapolis-d3351d9c13e4328c1c8597506f760590,City of Minneapolis,Minneapolis Stormwater Pathogen Toolbox,2022-10-19,https://www2.minneapolismn.gov/media/content-assets/www2-documents/departments/Minneapolis-Pathogen-Toolbox_508-compliant.pdf,government,city,USA,Indicator bacteria; Combined sewer; Storm drain,environment>natural resources>water; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.watres.2013.06.001,8.0,environmentnz-a05287caeb016c650339362e7c64afe5,Ministry for the Environment,Issues in setting secondary contact recreation guidelines for New Zealand freshwaters (E.Coli),2013-10-24,https://environment.govt.nz/publications/issues-in-setting-secondary-contact-recreation-guidelines-for-new-zealand-freshwaters-e-coli/,government,,New Zealand,Campylobacteriosis; Campylobacter; Sampling (statistics),environment>natural resources>water; environment; health
https://dx.doi.org/10.1016/j.watres.2013.06.001,8.0,epagov-e58852c2ffc642958001de766b0da56b,EPA,2017 5-Year Review of the 2012 Recreational Water Quality criteria,2018-05-01,https://www.epa.gov/sites/default/files/2018-05/documents/2017-5year-review-rwqc.pdf,government,agency,USA,Antimicrobial resistance; Clean Water Act; Water quality,science and technology>natural science>biology; environment>natural resources>water; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1016/j.watres.2013.06.001,8.0,foodgovuk-030e143c99753f13c460fdb9a734c3f9,Food Standards Agency,Review of approaches for establishing exclusion zones for shellfish harvesting around sewage discharge points | Food Standards Agency,2015-05-01,https://www.food.gov.uk/research/foodborne-disease/review-of-approaches-for-establishing-exclusion-zones-for-shellfish-harvesting-around-sewage-discharge-points,government,food and drug safety,UK,Sewage treatment; Membrane bioreactor; Secondary treatment,environment>natural resources>water; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.watres.2013.06.001,8.0,governmentofcanada-2fb63c18db8d578e7e027339b1b7578e,Government of Canada,Guidelines for Canadian drinking water quality : microbiological pathogens and biological hazards : guideline technical document.: H144-118/2023E-PDF Publications - Canada.ca,2023-01-01,http://publications.gc.ca/site/eng/9.927511/publication.html,government,,Canada,Shigatoxigenic and verotoxigenic Escherichia coli; Enterovirus; Naegleria fowleri,health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.watres.2013.06.001,8.0,governmentofcanada-ded1639b0fd2ab6038d4952dd8c8b4c0,Government of Canada,Guidelines for Canadian recreational water quality : understanding and managing risks in recreational waters : guideline technical document.: H144-116/2023E-PDF Publications - Canada.ca,2023-02-01,http://publications.gc.ca/site/eng/9.918699/publication.html,government,,Canada,Water quality; Indicator bacteria; Environmental monitoring,environment>natural resources>water; environment>environmental pollution; environment
https://dx.doi.org/10.1016/j.watres.2013.06.001,8.0,gpogov-15f5258261ce008032012c9d1709dbb8,Government Publishing Office (GPO),The impacts of climate change on human health in the United States : a scientific assessment /,2016-04-22,https://purl.fdlp.gov/GPO/gpo68498,government,,USA,Effects of global warming; Disease; Mental disorder,health; environment; weather
https://dx.doi.org/10.1016/j.watres.2013.06.001,8.0,randcorporation-88594db4de0b7c397a09b3c50570c361,RAND Corporation,The Health Risks of Bathing in Recreational Waters,2014-08-14,https://www.rand.org/pubs/research_reports/RR698.html,think tank,research center,USA,Meta-analysis; Water; Water pollution,health; environment; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.vaccine.2008.07.098,2.0,aspehhsgovus-294f727aefe7c3d31b6feab2bba013f9,ASPE,A Review and Analysis of Economic Models of Prevention Benefits,2012-09-20,https://aspe.hhs.gov/reports/review-analysis-economic-models-prevention-benefits-0,government,,USA,Congressional Budget Office; Disability-adjusted life year; Quality-adjusted life year,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1016/j.vaccine.2008.07.098,2.0,kce-beafcfa334bd7c891491a9a540e34f3a,Belgian Health Care Knowledge Centre,Cost-effectiveness analysis of HPV vaccination of boys in Belgium,2019-01-01,https://kce.fgov.be/en/cost-effectiveness-analysis-of-hpv-vaccination-of-boys-in-belgium,government,healthcare agency,Belgium,Gardasil; Human papillomavirus infection; Genital wart,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment>preventative medicine
https://dx.doi.org/10.1093/oxfordjournals.aje.a114747,1.0,who-849bae7f07590715d421d39160298b44,World Health Organization,Human monkeypox: secondary attack rates,2018-03-25,https://apps.who.int/iris/handle/10665/264589,igo,healthcare agency,IGO,Monkeypox; Infection; Transmission (medicine),health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1086/319604,3.0,cdc-8ae666c8f8ba52f3e0a6062aaa64ac9e,Centers for Disease Control and Prevention (CDC),"Impact of the Pneumococcal Conjugate Vaccine and Antibiotic Use on Nasopharyngeal Colonization by Antibiotic Nonsusceptible Streptococcus pneumoniae — Alaska, 2000–2010",2015-11-01,https://stacks.cdc.gov/view/cdc/34949,government,healthcare agency,USA,Pneumococcal conjugate vaccine; Streptococcus pneumoniae; Minimum inhibitory concentration,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1086/319604,3.0,cdc-b76b41eb3d0dd7dde7470e0aa92e37f4,Centers for Disease Control and Prevention (CDC),"Effect of the 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization by Streptococcus pneumoniae — Alaska, 2008–2012",2013-11-23,https://stacks.cdc.gov/view/cdc/34136,government,healthcare agency,USA,Health; Vaccination; Public health,health>diseases and conditions; health; health>health treatment>preventative medicine>vaccines
https://dx.doi.org/10.1086/319604,3.0,resourcesforthefuture-bf3baf27b4b9355b068d6cdae54fed75,Resources for the Future,Extending the Cure: Policy responses to the growing threat of antibiotic resistance,2007-03-23,https://www.rff.org/publications/reports/extending-the-cure-policy-responses-to-the-growing-threat-of-antibiotic-resistance/,think tank,,USA,Antimicrobial resistance; Antibiotic; Methicillin-resistant Staphylococcus aureus,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1097/00001648-199507000-00009,2.0,ntphhs-5e2425a9d1674e24ead499b207fe816c,National Toxicology Program,Human Immunodeficiency Virus Type 1 (HIV-1),2016-08-05,https://ntp.niehs.nih.gov/ntp/roc/monographs/hiv_final201608_508.pdf,think tank,,USA,Structure and genome of HIV; HIV; Virus,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1097/00001648-199507000-00009,2.0,whoiarc-58fa41cc589e03bacb7a13679c9d49dc,IARC,Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses,2008-10-28,https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Human-Immunodeficiency-Viruses-And-Human-T-Cell-Lymphotropic-Viruses-1996,igo,healthcare agency,IGO,Structure and genome of HIV; Simian immunodeficiency virus; Retrovirus,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1007/s12561-011-9040-7,2.0,govdeptsspain-c9eed2cc9eff77998a0df11dfa5086c8,Government of Spain,Revisión De Beneficios Fiscales 2021,2022-03-30,https://www.hacienda.gob.es/Documentacion/Publico/GabineteMinistro/Varios/31-03-22-Informe-Revision-Beneficios-Fiscales-2021.pdf,government,,Spain,Foundation (nonprofit); Tax; Corporate tax,"education; economy, business and finance>economy; education>school>further education"
https://dx.doi.org/10.1007/s12561-011-9040-7,2.0,who-94167745bcfc5f13880a542f2aa8593b,World Health Organization,"Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV, web supplement: annex 2: evidence to decision-making tables and supporting evidence",2015-10-21,https://apps.who.int/iris/handle/10665/189977,igo,healthcare agency,IGO,HIV/AIDS; Management of HIV/AIDS; Breastfeeding and HIV,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment
https://dx.doi.org/10.4161/hv.23888,14.0,ecdc-3506ce47af346351d8a5a2a77a4b97e4,European Centre for Disease Prevention and Control,Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA,2017-12-06,https://www.ecdc.europa.eu/en/publications-data/expert-opinion-introduction-meningococcal-b-4cmenb-vaccine-eueea,government,agency,EU,Vaccination schedule; European Centre for Disease Prevention and Control; European Medicines Agency,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.4161/hv.23888,14.0,europa-772b95fee57b066e2aaa0033355b439d,Publications Office of the European Union,Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA.,2018-12-10,https://op.europa.eu/en/publication-detail/-/publication/4c663b6e-fcf7-11e8-a96d-01aa75ed71a1/language-en/format-PDF,government,,EU,Meningococcal vaccine; Vaccine; Neisseria meningitidis,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment>preventative medicine
https://dx.doi.org/10.4161/hv.23888,14.0,gezondheidsraad-92c5b4053a44fdf14d5fdaf34eda25f9,Gezondheidsraad,Vaccinatie tegen meningokokken,2018-12-19,https://www.gezondheidsraad.nl/documenten/adviezen/2018/12/19/vaccinatie-tegen-meningokokken,government,healthcare agency,Netherlands,Vaccination schedule; Vaccination; Meningitis,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease>epidemic
https://dx.doi.org/10.4161/hv.23888,14.0,governmentofcanada-0150c125efeb184bb3ab35257eaa56a0,Government of Canada,The use of bivalent factor H binding protein Meningococcal Serogroup B (MenB-fHBP) vaccine for the prevention of meningococcal B disease.,2019-01-01,http://publications.gc.ca/site/eng/9.881875/publication.html,government,,Canada,Neisseria meningitidis; DPT vaccine; Meningococcal vaccine,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.4161/hv.23888,14.0,governmentofcanada-2827d930785bef37c033ae61c1f20914,Government of Canada,The recommended use of the multicomponent meningococcal B (4CMenB) vaccine in Canada : common guidance statement / prepared by: Meningococcal B Pilot Project Task Group. : HP40-103/2014E-PDF Publications - Canada.ca,2014-03-26,http://publications.gc.ca/site/eng/9.699194/publication.html,government,,Canada,Neisseria meningitidis; Vaccine; Pneumococcal conjugate vaccine,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.4161/hv.23888,14.0,has-2d0db88873a764a14504958fdfe87059,Haute Autorité de Santé,Stratégie de vaccination pour la prévention des infections invasives à méningocoques : Le sérogroupe B et la place de BEXSERO®,2021-06-18,https://www.has-sante.fr/jcms/p_3066921/fr/strategie-de-vaccination-pour-la-prevention-des-infections-invasives-a-meningocoques-le-serogroupe-b-et-la-place-de-bexsero,government,healthcare agency,France,Vaccination; Vaccine; Neisseria meningitidis,health>diseases and conditions; science and technology>natural science>biology; health
https://dx.doi.org/10.4161/hv.23888,14.0,has-a5b9c5612a76393e3b843a7db0177449,Haute Autorité de Santé,Stratégie de vaccination pour la prévention des infections invasives à méningocoques : Le sérogroupe B et la place de TRUMENBA®,2021-06-22,https://www.has-sante.fr/jcms/p_3066917/fr/strategie-de-vaccination-pour-la-prevention-des-infections-invasives-a-meningocoques-le-serogroupe-b-et-la-place-de-trumenba,government,healthcare agency,France,Vaccination; Vaccine; Neisseria meningitidis,science and technology>natural science>biology; health>diseases and conditions; science and technology>natural science>biology>genetics
https://dx.doi.org/10.4161/hv.23888,14.0,hcspfr-1e4931101b62d5c7d49fb706d4cae591,Haut Conseil de la santé publique,Vaccination contre les infections invasives à méningocoque B. Place du vaccin Bexsero®,2013-10-25,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=386,government,agency,France,Vaccination; Vaccine; Herd immunity,science and technology>natural science>biology; health; health
https://dx.doi.org/10.4161/hv.23888,14.0,hcspfr-2732c5193b7f491ad0ec0a4828fd8831,Haut Conseil de la santé publique,Vaccination contre les infections invasives à méningocoque B. Place du vaccin Bexsero®,2013-10-25,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=388,government,agency,France,Vaccination; Vaccine; Herd immunity,science and technology>natural science>biology; health; health
https://dx.doi.org/10.4161/hv.23888,14.0,hcspfr-644510a66f3ccd04b3e2336168448f99,Haut Conseil de la santé publique,Vaccination contre les infections invasives à méningocoque B. Place du vaccin Bexsero®,2013-10-25,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=399,government,agency,France,Herd immunity; Models of deafness; Vaccination,science and technology>natural science>biology; health; education
https://dx.doi.org/10.4161/hv.23888,14.0,hcspfr-97f10462f7baf1dcde0ac9215c65b97f,Haut Conseil de la santé publique,Vaccination contre les infections invasives à méningocoque B. Place du vaccin Bexsero®,2013-10-25,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=387,government,agency,France,Medical specialties; Clinical medicine; Medicine,science and technology>natural science>biology; health; health
https://dx.doi.org/10.4161/hv.23888,14.0,inspq_canada-5a14f0c2a8d900d8342763716523a97c,Institut national de santé publique du Québec,Avis sur la pertinence d’un programme de vaccination universelle avec le vaccin méningococcique protéinique à quatre composantes au Québec,2016-10-12,https://www.inspq.qc.ca/publications/2169,government,healthcare agency,Canada,Immunology; Medical specialties; Health sciences,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.4161/hv.23888,14.0,kce-fced2e0f2152a45b7f987dc90f81486c,Belgian Health Care Knowledge Centre,A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study,2014-01-01,https://kce.fgov.be/en/a-quadrivalent-vaccine-against-serogroup-b-meningococcal-disease-a-cost-effectiveness-study,government,healthcare agency,Belgium,Medical specialties; Health; Public health,health; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.4161/hv.23888,14.0,rivmnl-48e9f66c90fe1f12b8bf17373806bdce,Rijksinstituut voor Volksgezondheid en Milieu,Meningococcal disease serogroup B. Updated information for the Dutch Health Council,2022-04-11,https://www.rivm.nl/publicaties/meningococcal-disease-serogroup-b,government,research center,Netherlands,Health care; Clinical medicine; Immunology,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.4269/ajtmh.2010.09-0735,4.0,fao-a14cd2cf2a6b4633fcdf60719580ecdb,Food and Agriculture Organization of the United Nations,Programme de lutte contre la trypanosomose africaine,2011-06-30,http://www.fao.org/3/a-i2245f.pdf,igo,,IGO,African trypanosomiasis; Medical specialties; Tsetse fly,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health>diseases and conditions
https://dx.doi.org/10.4269/ajtmh.2010.09-0735,4.0,fao-bba34ccbbc4bc561500016c602771058,Food and Agriculture Organization of the United Nations,Tsetse and Trypanosomiasis Information Numbers 15404-15614,2011-06-30,http://www.fao.org/3/a-i2245e.pdf,igo,,IGO,Medical specialties; Apolipoprotein L1; Tsetse fly,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.4269/ajtmh.2010.09-0735,4.0,who-ae87635dc7c4ed4671b95453f0b4625d,World Health Organization,Control and surveillance of human African trypanosomiasis: report of a WHO expert committee,2013-11-27,https://apps.who.int/iris/handle/10665/95732,igo,healthcare agency,IGO,Transmission (medicine); Life sciences; Biology,science and technology>natural science>biology; health; science and technology>natural science>biology>genetics
https://dx.doi.org/10.4269/ajtmh.2010.09-0735,4.0,who-f0385565be0a0300eab5eb1b10e6ff2b,World Health Organization,Trypanosomiase humaine africaine : lutte et surveillance : rapport d’un comité d’experts de l’OMS,2015-01-14,https://apps.who.int/iris/handle/10665/148113,igo,healthcare agency,IGO,Medical specialties; Organisms; Biology,health; science and technology>natural science>biology; science and technology
https://dx.doi.org/10.1111/tri.12586,1.0,stateofvalencia-8ecd400c373416e14c523678b130b4e3,Generalitat Valenciana,Memoria Científica 2015,2016-12-20,https://fisabio.san.gva.es/media/upload/arxius/investigacion/memoria-cientifica/memoria-cientifica-fisabio-2015.pdf,government,,Spain,Biobank; Metagenomics; Virus,science and technology>natural science>biology; science and technology>natural science>biology>genetics; science and technology
https://dx.doi.org/10.1016/j.ijid.2020.10.046,2.0,oecddiscovery-83a98243740dea871d22cb962e616e73,OECD,Études économiques de l'OCDE : Canada 2021,2021-03-11,https://dx.doi.org/10.1787/55949ebb-fr,igo,,IGO,Comprehensive Economic and Trade Agreement; Government debt; Value-added tax,"science and technology; economy, business and finance>economy>macro economics>inflation; economy, business and finance>economy"
https://dx.doi.org/10.1016/j.ijid.2020.10.046,2.0,pubmedcentral-5ea128ce4c1cabb2fb9d87c30cbc36a4,Guidelines in PubMed Central,International travel‐related control measures to contain the COVID‐19 pandemic: a rapid review,2021-03-25,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406796/pdf,other,aggregator,USA,Systematic review; COVID-19 pandemic; Screening (medicine),health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.1821298116,10.0,ahrq-81483526743f096862bc29140ffd3f43,AHRQ,Resource Allocation and Pandemic Response: An Evidence Synthesis To Inform Decision Making,2020-09-28,https://effectivehealthcare.ahrq.gov/products/allocation-scarce-resources/rapid-review,government,healthcare agency,USA,Influenza pandemic; Coronavirus disease 2019; Influenza,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1073/pnas.1821298116,10.0,europa-a65b7fd6dcd3d3d20034e53d9befbee4,Publications Office of the European Union,Eurosurveillance : special edition : children and COVID-19. November 2020.,2021-10-12,https://op.europa.eu/en/publication-detail/-/publication/38da351b-2c21-11ec-bd8e-01aa75ed71a1/language-en/format-PDF,government,,EU,Multisystem inflammatory syndrome in children; COVID-19 pandemic; Non-pharmaceutical intervention (epidemiology),health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1073/pnas.1821298116,10.0,izade-651d4be06322845cb64242dac270bac9,IZA Institute of Labor Economics,Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses,2020-08-24,https://www.iza.org/publications/dp/13625/modern-infectious-diseases-macroeconomic-impacts-and-policy-responses,think tank,,Germany,Poverty; Disease; Preventive healthcare,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1073/pnas.1821298116,10.0,izade-c9a9f6662550e4bb8f6c8957f00bf0ee,IZA Institute of Labor Economics,Impacts of Social and Economic Factors on the Transmission of Coronavirus Disease 2019 (COVID-19) in China,2020-04-06,https://www.iza.org/publications/dp/13165/impacts-of-social-and-economic-factors-on-the-transmission-of-coronavirus-disease-2019-covid-19-in-china,think tank,,Germany,Infection; Coronavirus disease 2019; Instrumental variables estimation,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.1821298116,10.0,nber-9d9f611ab52e71b5a074b507c1a8a2d7,NBER,Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses,2020-08-27,https://www.nber.org/papers/w27757,think tank,,USA,Poverty; Preventive healthcare; Economic growth,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1073/pnas.1821298116,10.0,oecddiscovery-9571e85678f3fc60abcbdfe83656bda5,OECD,Strengthening Pandemic Preparedness and Response Through Integrated Modelling,2024-05-07,https://dx.doi.org/https://doi.org/10.1787/5f046115-en,igo,,IGO,Pandemic; Policy; Epidemiology,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.1821298116,10.0,who-ce54cc0ae7b995108ea0dc4195cb7259,World Health Organization,Strengthening pandemic preparedness and response through integrated modelling,2024-01-01,https://apps.who.int/iris/handle/10665/376712,igo,healthcare agency,IGO,Pandemic; Policy; Epidemiology,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.1821298116,10.0,worldbank-60bea88e68eafc9d794ba9bad0c76daf,World Bank,"Europe and Central Asia Economic Update, Fall 2020 : COVID-19 and Human Capital",2020-09-25,https://openknowledge.worldbank.org/handle/10986/34518,igo,development bank,IGO,Recession; Economic growth; Fiscal policy,"economy, business and finance>economy; economy, business and finance>economy>macro economics>recession; economy, business and finance>economy>macro economics>inflation"
https://dx.doi.org/10.1073/pnas.1821298116,10.0,worldbank-89d9f609b20b738da98c5c3def706aa3,World Bank,"Europe and Central Asia Economic Update, Fall 2020",2020-10-07,https://hdl.handle.net/10986/34518,igo,development bank,IGO,Recession; COVID-19 pandemic; COVID-19 lockdowns,"economy, business and finance>economy; economy, business and finance>economy; economy, business and finance>economy>macro economics>recession"
https://dx.doi.org/10.1073/pnas.1821298116,10.0,worldbank-d09db66c3c9a5a3c8d35f652c8bc2627,World Bank,Strengthening Pandemic Preparedness and Response through Integrated Modelling,2024-05-30,https://hdl.handle.net/10986/41630,igo,development bank,IGO,Pandemic; Policy; Epidemiology,health>diseases and conditions; health; science and technology>social sciences
https://dx.doi.org/10.1086/313498,3.0,pubmedcentral-2157629af1c605bea201e748eccffaa0,Guidelines in PubMed Central,Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America,2016-02-15,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725385/pdf,other,aggregator,USA,Invasive candidiasis; Echinocandin; Caspofungin,science and technology>biomedical science>pharmacology; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1086/313498,3.0,pubmedcentral-340c8f55c759889994650679b9c2ff4c,Guidelines in PubMed Central,Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO),2013-09-12,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889633/pdf,other,aggregator,USA,Echinocandin; Caspofungin; Aspergillosis,health>diseases and conditions; health; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1086/313498,3.0,pubmedcentral-b09be2fc5973c8e8e7f38056ea5304eb,Guidelines in PubMed Central,Treatment of candidemia in adult patients without neutropenia - an inconvenient truth,2011-01-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222043/pdf,other,aggregator,USA,Caspofungin; Fluconazole; Candidiasis,science and technology>biomedical science>pharmacology; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1111/j.1750-2659.2011.00277.x,7.0,ecdc-4b23de648b44067aa3452a63db4ef1ca,European Centre for Disease Prevention and Control,Molecular surveillance strategy for human influenza in Europe,2012-04-20,https://www.ecdc.europa.eu/en/publications-data/molecular-surveillance-strategy-human-influenza-europe,government,agency,EU,GISAID; Influenza; Antiviral drug,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; health
https://dx.doi.org/10.1111/j.1750-2659.2011.00277.x,7.0,fao-0b8debf81d7c8de13bbcb644e8c5fa84,Food and Agriculture Organization of the United Nations,Santé animale,2014-02-12,http://www.fao.org/3/i3470f/i3470f.pdf,igo,,IGO,Avian influenza; Influenza A virus subtype H7N9; Influenza A virus subtype H5N1,health; health>diseases and conditions>communicable disease>epidemic; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1111/j.1750-2659.2011.00277.x,7.0,fao-4efb74e38e901c5dd174ea72df56138a,Food and Agriculture Organization of the United Nations,EMPRES Bulletin des maladies animales transfrontières: Fascicule No. 42 - 2013,2013-01-01,http://www.fao.org/3/a-i3470f.pdf,igo,,IGO,Avian influenza; Influenza A virus subtype H7N9; Influenza A virus subtype H5N1,health; health>diseases and conditions>communicable disease>epidemic; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1111/j.1750-2659.2011.00277.x,7.0,thlfi-2a4bd2070b285e6423e372c618acc9b4,Terveyden ja hyvinvoinnin laitos,Laboratory diagnosis and surveillance of acute respiratory tract infections caused by certain common viruses and Mycoplasma pneumoniae,2013-10-09,http://www.julkari.fi/handle/10024/110666,government,healthcare agency,Finland,Influenza A virus subtype H3N2; Infection; Influenza,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; health
https://dx.doi.org/10.1111/j.1750-2659.2011.00277.x,7.0,who-7f397d212a204ce4f283650249c591ad,World Health Organization,"Launching the Tool for Influenza Pandemic Risk Assessment (‎TIPRA)‎ meeting report: 4-5 May 2016, Geneva, Switzerland",2016-09-16,https://apps.who.int/iris/handle/10665/250126,igo,healthcare agency,IGO,Influenza pandemic; Influenza; Risk,health; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1111/j.1750-2659.2011.00277.x,7.0,who-adb7a9470979b19d6d1a92fd0f35171a,World Health Organization,2017 update,2018-01-23,https://apps.who.int/iris/handle/10665/259894,igo,healthcare agency,IGO,Influenza pandemic; Influenza; Vaccine,health; health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology
https://dx.doi.org/10.1111/j.1750-2659.2011.00277.x,7.0,who-cba242d7e44b5a65c892cb03d1698b0d,World Health Organization,The immunological basis for immunization series: module 23: influenza vaccines,2017-10-10,https://apps.who.int/iris/handle/10665/259211,igo,healthcare agency,IGO,Influenza; Orthomyxoviridae; Influenza pandemic,health>diseases and conditions>communicable disease>virus disease; health; science and technology>natural science>biology
https://dx.doi.org/10.1016/j.jhin.2006.12.020,11.0,adminch-17c79b8da316018a7b36dfbfdc045fb9,Government of Switzerland,Requisiti strutturali minimi,2022-06-02,https://www.bag.admin.ch/dam/bag/it/dokumente/mt/i-und-i/noso/mindestanforderungen-fuer-spitaeler.pdf.download.pdf/Requisiti%20strutturali%20minimi%20per%20la%20prevenzione%20e%20la%20lotta%20contro%20le%20infezioni%20correlate%20all%E2%80%99assistenza%20(ICA)%20negli%20ospedali%20per%20cure%20acute%20svizzeri.pdf,government,,Switzerland,Hospital; Waste management; Audit,health; science and technology; health>health treatment>medicine
https://dx.doi.org/10.1016/j.jhin.2006.12.020,11.0,adminch-b662bb0a94536115dd2a4e4ad29108f0,Government of Switzerland,Strukturelle Mindestanforderungen,2022-05-19,https://www.bag.admin.ch/dam/bag/de/dokumente/mt/i-und-i/noso/mindestanforderungen-fuer-spitaeler.pdf.download.pdf/Strukturelle%20Mindestanforderungen%20f%FCr%20die%20Pr%E4vention%20und%20Bek%E4mpfung%20von%20healthcare-assoziierten%20Infektionen%20(HAI)%20in%20Schweizer%20Akutspit%E4lern.pdf,government,,Switzerland,Preventive healthcare; Hospital; Antimicrobial resistance,health; science and technology; health>health treatment>medicine
https://dx.doi.org/10.1016/j.jhin.2006.12.020,11.0,finnishpublichealth-28e0050c2a5f5173299f466382fceb17,Kansanterveyslaitos,Healthcare-associated infections in pediatrics,2012-04-19,http://www.julkari.fi/handle/10024/78109,government,,Finland,Hospital-acquired infection; Infection; Pathogen transmission,health>diseases and conditions; health>diseases and conditions>illness; science and technology>natural science>biology
https://dx.doi.org/10.1016/j.jhin.2006.12.020,11.0,governmentofportugal-1694b03e4554b1d1998859174047cdc9,Government of Portugal,Para A Vigilancia Epidemiologica Das Infeccoes Nosocomiais ; Nas Unidades De : Cuidados Intensivos Neonatais,2010-12-14,https://www.arsalgarve.min-saude.pt/wp-content/uploads/sites/2/2013/04/_images_centrodocs_normas_normas_IACS_VE_UCIN_Protoc_UCIN.pdf,government,,Portugal,Sepsis; Epidemiology; Health care,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1016/j.jhin.2006.12.020,11.0,governmentofportugal-d15b080cc427d93db06adb82f612157a,Government of Portugal,Contents lists available at,2017-10-23,http://repositorio.chlc.min-saude.pt/bitstream/10400.17/2903/1/Clin%20Nutrition%20ESPEN%202017_7.pdf,government,,Portugal,Liver function tests; Parenteral nutrition; Clinical medicine,health>diseases and conditions; science and technology>biomedical science>pharmacology; health
https://dx.doi.org/10.1016/j.jhin.2006.12.020,11.0,paho-42eb71d8d291ada06b63f70f8aa128c2,Pan American Health Organization (PAHO),Directrices sobre componentes básicos para los programas de prevención y control de infecciones a nivel nacional y de establecimientos de atención de salud para pacientes agudos,2017-06-19,https://iris.paho.org/handle/10665.2/49769,igo,,IGO,WASH; Health; World Health Organization,health; science and technology; health>health treatment>medicine
https://dx.doi.org/10.1016/j.jhin.2006.12.020,11.0,who-3916b82863c870826b59578078fa2727,World Health Organization,Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level,2016-11-29,https://apps.who.int/iris/handle/10665/251730,igo,healthcare agency,IGO,Adherence (medicine); Education; Health,health; environment; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1016/j.jhin.2006.12.020,11.0,who-7a5c43a2596bd85aecf935be6da2f7a1,World Health Organization,Report on the burden of endemic health care-associated infection worldwide,2013-04-23,https://apps.who.int/iris/handle/10665/80135,igo,healthcare agency,IGO,Medicine; Health sciences; Medical specialties,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment
https://dx.doi.org/10.1016/j.jhin.2006.12.020,11.0,who-889514570b609259ea2721abfca91655,World Health Organization,Lignes directrices sur les principales composantes des programmes de prévention et de contrôle des infections au niveau national et au niveau des établissements de soins de courte durée,2018-06-18,https://apps.who.int/iris/handle/10665/272850,igo,healthcare agency,IGO,,
https://dx.doi.org/10.1016/j.jhin.2006.12.020,11.0,who-a4eaf47e2e6260c51d2c5cb31a81fff1,World Health Organization,[‎‎Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level]‎‎,2020-04-14,https://apps.who.int/iris/handle/10665/331750,igo,healthcare agency,IGO,,
https://dx.doi.org/10.1016/j.jhin.2006.12.020,11.0,who-a617be12c2ab9cbf674dc416fa584b3c,World Health Organization,Directrices sobre componentes básicos para los programas de prevención y control de infecciones a nivel nacional y de establecimientos de atención de salud para pacientes agudos,2017-06-26,https://apps.who.int/iris/handle/10665/255764,igo,healthcare agency,IGO,Health care; Medicine; Health sciences,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1111/j.1600-0668.2006.00443.x,4.0,california_state_agencies-20f1df532c2b8e329ecb9d5396e43f31,State of California,Appendix 2 Quanta Generation Rates for Aerosol Transmissible Diseases,2020-09-09,https://www.cdph.ca.gov/Programs/CCDPHP/DEODC/EHLB/IAQ/CDPH%20Document%20Library/Appendix_2_Quanta_Generation_Rates_for_Aerosol_Transmissible_Diseases.pdf,government,,USA,COVID-19; Chickenpox; SARS-CoV-2,health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1111/j.1600-0668.2006.00443.x,4.0,california_state_agencies-bc9f3484b44134fdcc70101cce9f0595,State of California,Appendix 2 Quanta Generation Rates for Aerosol Transmissable Diseases,2020-09-09,https://www.cdph.ca.gov/Programs/CCDPHP/DEODC/EHLB/IAQ/CDPH%20Document%20Library/Appendix%202%20-%20Quanta%20Generation%20Rates%20for%20Aerosol%20Transmissible%20Diseases.pdf,government,,USA,SARS-CoV-2; Airborne transmission; COVID-19,health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1111/j.1600-0668.2006.00443.x,4.0,fgvbr-a51d28745aebea76cbf99587cfa1827b,Fundação Getulio Vargas,Tecnologias disruptivas: teste rápido na medicina laboratorial no combate do coronavírus,2021-08-06,https://repositorio.fgv.br/items/2fae8631-a05d-4dba-aab1-fcc9e84b2b3d/full,think tank,research center,Brazil,Artificial intelligence; COVID-19 pandemic; Information technology,"economy, business and finance>economic sector>computing and information technology; science and technology; health"
https://dx.doi.org/10.1111/j.1600-0668.2006.00443.x,4.0,provinceofbc-fa5a5ac64f0bd317cd43490c4958f4bc,Province of British Columbia,Public Health Measures – Technical Document Overview,2010-03-03,https://www2.gov.bc.ca/assets/gov/health/about-bc-s-health-care-system/office-of-the-provincial-health-officer/public_health_measures_technical_document.pdf,government,,Canada,Influenza pandemic; Surgical mask; Influenza,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1371/journal.pntd.0007814,2.0,ahrq-81483526743f096862bc29140ffd3f43,AHRQ,Resource Allocation and Pandemic Response: An Evidence Synthesis To Inform Decision Making,2020-09-28,https://effectivehealthcare.ahrq.gov/products/allocation-scarce-resources/rapid-review,government,healthcare agency,USA,Social distancing; Influenza pandemic; Coronavirus disease 2019,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1371/journal.pntd.0007814,2.0,instituteofdevelopmentstudies-995db65a46906bf4d78c92768972bacf,Institute of Development Studies,Social Inclusion and Immunisation,2021-02-03,https://opendocs.ids.ac.uk/opendocs/handle/20.500.12413/16430,think tank,,UK,COVID-19 pandemic; Western African Ebola virus epidemic; COVAX,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.burns.2012.12.005,2.0,stateofnsw-198580d4d24c1579a9a600d9d027baa5,State of New South Wales,Appendices - IPC Practice Handbook,2022-02-16,https://www.cec.health.nsw.gov.au/__data/assets/pdf_file/0011/706547/appendices-ipc-practice-handbook.pdf,government,,Australia,Infectious diseases; Infection prevention and control; Isolation (health care),health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/j.burns.2012.12.005,2.0,stateofnsw-21560a25313ae4bf51da08ce16f0a0df,State of New South Wales,Infection Prevention and Control Practice Handbook,2020-02-11,https://www.cec.health.nsw.gov.au/__data/assets/pdf_file/0010/383239/IPC-Practice-Handbook-2020.PDF,government,,Australia,Pathogen transmission; Infection; Infection prevention and control,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1093/oxfordjournals.aje.a116275,1.0,unodc-e6f55af85b6695e6df85cb09fbcb0183,United Nations Office on Drugs and Crime,Women who inject drugs,2011-08-17,https://www.unodc.org/documents/hiv-aids/Women_who_inject_drugs.pdf,igo,,IGO,Sexual intercourse; Violence; HIV/AIDS,health; health>diseases and conditions>communicable disease>virus disease; science and technology>social sciences
https://dx.doi.org/10.1097/00002030-199908200-00018,1.0,unitednations-b5911fbfe801ff62457e5ccfceed518a,United Nations,The impact of voluntary counselling and testing :a global review of the benefits and challenges,2001-06-01,https://digitallibrary.un.org/record/451429?ln=en,igo,,IGO,HIV/AIDS; HIV; Serology,health; health; health>diseases and conditions
https://dx.doi.org/10.1098/rstb.2013.0435,10.0,edulinksusa-ac2c1ff144cad98031eca0dfb8f229e1,EduLinks,Optimizing Education Outcomes,2018-01-01,https://www.edu-links.org/resources/optimizing-education-outcomes,government,research center,USA,Health; Sexual and reproductive health; Child,health; health>diseases and conditions; education
https://dx.doi.org/10.1098/rstb.2013.0435,10.0,governmentofperu-8fadad074ae7daf80bb7ff0fad4587f7,Government of Peru,Re-Imagining School Feeding: A High-Return Investment in Human Capital and Local Economies,2018-09-26,https://repositorio.minedu.gob.pe/bitstream/handle/20.500.12799/6582/Re%20Imagining%20School%20Feeding%20A%20High-Return%20Investment%20in%20Human%20Capital%20and%20Local%20Economies.pdf,government,,Peru,Purchase for Progress; Health; Sexual and reproductive health,health; health>diseases and conditions; education
https://dx.doi.org/10.1098/rstb.2013.0435,10.0,gpeusa-e69631da099f83c58e4613ef21cd63ce,Global Partnership for Education,Optimizing education outcomes: High-return investments in school health for increased participation and learning,2018-04-06,https://www.globalpartnership.org/content/optimizing-education-outcomes-high-return-investments-school-health-increased-participation-and-learning,think tank,,USA,Health; Education; Adolescence,health; health>diseases and conditions; education
https://dx.doi.org/10.1098/rstb.2013.0435,10.0,iadb-caaa920ccb437e3423696aef89141af0,Inter-American Development Bank,It Can Be Done: An Integrated Approach for Controlling and Eliminating Neglected Tropical Diseases,2014-09-01,https://publications.iadb.org/en/it-can-be-done-integrated-approach-controlling-and-eliminating-neglected-tropical-diseases,igo,development bank,IGO,Neglected tropical diseases; WASH; Public health,health>diseases and conditions; health; education
https://dx.doi.org/10.1098/rstb.2013.0435,10.0,nber-7dd85f7bd34a6c41f56943a79f12eceb,NBER,"Does Mass Deworming Affect Child Nutrition? Meta-analysis, Cost-Effectiveness, and Statistical Power",2016-07-07,https://www.nber.org/papers/w22382,think tank,,USA,Power (statistics); P-value; Meta-analysis,health; science and technology; science and technology>social sciences
https://dx.doi.org/10.1098/rstb.2013.0435,10.0,pubmedcentral-459ce85d3e28d854a9b385b1f9a6c6ba,Guidelines in PubMed Central,Review of the 2017 WHO Guideline: Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups. An opportunity lost in translation,2018-04-26,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919405/pdf,other,aggregator,USA,Neglected tropical diseases; Mass deworming; World Health Organization,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1098/rstb.2013.0435,10.0,who-b34e579224a3f4d125c28228aa788c5c,World Health Organization,Towards universal coverage for preventive chemotherapy for Neglected Tropical Diseases: guidance for assessing “who is being left behind and why”: working draft for further piloting during 2018-2019,2017-11-21,https://apps.who.int/iris/handle/10665/259487,igo,healthcare agency,IGO,Qualitative research; WASH; Health,health; society; science and technology>social sciences
https://dx.doi.org/10.1098/rstb.2013.0435,10.0,worldbank-a8c5944b04b7b9999c995c91c050329d,World Bank,"Disease Control Priorities, Third Edition",2017-11-01,https://hdl.handle.net/10986/28876,igo,development bank,IGO,Creative Commons license; Health; Government spending,health; health; health
https://dx.doi.org/10.1098/rstb.2013.0435,10.0,worldbank-ec94cedad1962b3e621825725ec3aaf9,World Bank,"Disease Control Priorities, Third Edition : Volume 8. Child and Adolescent Health and Development",2017-11-15,https://openknowledge.worldbank.org/handle/10986/28876,igo,development bank,IGO,Human activities; Statistics; Intelligence quotient,health; education; education>school
https://dx.doi.org/10.1098/rstb.2013.0435,10.0,worldfood-d0a2700e775e9e41a08ec6b8eb0c1437,World Food Programme,Re-imagining School Feeding - A High Return Investment in Human Capital & Local Economies,2018-09-26,https://www.wfp.org/publications/re-imagining-school-feeding-high-return-investment-human-capital-local-economies,igo,,IGO,Human activities; Adolescence; Health,health; health>diseases and conditions; education
https://dx.doi.org/10.1086/655470,2.0,pubmedcentral-6400f212fbfabb0ec8e5235594e7fb50,Guidelines in PubMed Central,Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for and Efavirenz-containing Antiretroviral Therapy,2019-04-30,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739160/pdf,other,aggregator,USA,Pharmacogenomics; Efavirenz; Allele,science and technology>biomedical science>pharmacology; science and technology>natural science>biology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1086/655470,2.0,pubmedcentral-bd6098eb69164cead8d40800bce0f34f,Guidelines in PubMed Central,French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults,2014-06-17,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062879/pdf,other,aggregator,USA,Management of HIV/AIDS; Nevirapine; HIV/AIDS,science and technology>biomedical science>pharmacology; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1089/fpd.2011.0951,3.0,efsaeu-b8599964bb7f4a8325bbecbe01f53a14,EFSA,Scientific Opinion on the public health hazards to be covered by inspection of meat (poultry),2012-06-29,https://www.efsa.europa.eu/en/efsajournal/pub/2741,government,agency,EU,Risk; Hazard; Animal welfare,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1089/fpd.2011.0951,3.0,epagov-42aeaaadf2945a6ccbffd5de1944ef99,EPA,Microbial Risk Assessment Guideline,2012-07-24,https://www.epa.gov/sites/default/files/2013-09/documents/mra-guideline-final.pdf,government,agency,USA,Microorganism; Virulence; Pathogen transmission,science and technology>natural science>biology; health>diseases and conditions; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1089/fpd.2011.0951,3.0,foodgovuk-0cee5f63f07eb86a1308817304e8d37e,Food Standards Agency,"Review of national food control plans in Australia, Canada, New Zealand and United States | Food Standards Agency",2021-12-07,https://www.food.gov.uk/research/capabilities/review-of-national-food-control-plans-in-australia-canada-new-zealand-and-united-states,government,food and drug safety,UK,Food and drink; Health; Regulatory compliance,"lifestyle and leisure>lifestyle>food and drink; politics>government policy>regulatory of industry>food and drink regulations; economy, business and finance>economic sector>consumer goods>food"
https://dx.doi.org/10.1097/01.qai.0000174929.87015.d6,1.0,provinceofquebec-bc0415a1733c3c495c5669402bedc4c7,Province of Québec,Décembre 2022,2022-11-17,https://publications.msss.gouv.qc.ca/msss/fichiers/2022/22-337-01W.pdf,government,,Canada,HIV; Hepatitis B; Raltegravir,health>diseases and conditions; science and technology>biomedical science>pharmacology; health>diseases and conditions>illness
https://dx.doi.org/10.1016/0040-5809(88)90019-6,2.0,iiasaat-0a39434e07e340ce8507742789d9ed9c,IIASA,Seasons and Chaos in Ecosystems,1992-01-01,https://pure.iiasa.ac.at/id/eprint/3590/?template=default_internal,think tank,research center,Austria,Chaos theory; Bifurcation theory; Attractor,science and technology>mathematics; science and technology; science and technology>natural science>physics
https://dx.doi.org/10.1016/0040-5809(88)90019-6,2.0,iiasaat-88a87016f7147e48379d92b0b4e3a0ca,IIASA,"Multiple Attractors, Catastrophes and Chaos in Seasonally Perturbed Predator-Prey Communities",1991-10-01,https://pure.iiasa.ac.at/id/eprint/3525/?template=default_internal,think tank,research center,Austria,Bifurcation theory; Chaos theory; Attractor,science and technology>mathematics; science and technology; science and technology>natural science>physics
https://dx.doi.org/10.1016/j.ijantimicag.2017.01.017,3.0,awmf-bc7805ef2c06f12b1512d4d0579f49d9,Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF),Tuberkulose im Erwachsenenalter,2023-09-21,https://register.awmf.org/de/leitlinien/detail/020-019,government,healthcare agency,Germany,Latent tuberculosis; Tuberculosis; Mycobacterium bovis,health>diseases and conditions; health>diseases and conditions>illness; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1016/j.ijantimicag.2017.01.017,3.0,cdc-ddadb7e1ffdf696fdc7d497b5f73e94e,Centers for Disease Control and Prevention (CDC),Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline,2019-01-01,https://stacks.cdc.gov/view/cdc/91163,government,healthcare agency,USA,Multi-drug-resistant tuberculosis; Extensively drug-resistant tuberculosis; Levofloxacin,science and technology>biomedical science>pharmacology; science and technology; health>health treatment
https://dx.doi.org/10.1016/j.ijantimicag.2017.01.017,3.0,pubmedcentral-a11806e63ae35255607304037daa449a,Guidelines in PubMed Central,Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline,2019-11-15,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857485/pdf,other,aggregator,USA,Multidrug-resistant tuberculosis; Tuberculosis; Levofloxacin,science and technology>biomedical science>pharmacology; health>diseases and conditions; health
https://dx.doi.org/10.1002/hep.26385,2.0,nice-4d9815fc6ebe5db7706ff80c1910b6fc,NICE,Cirrhosis in over 16s: assessment and management,2016-07-06,https://www.nice.org.uk/guidance/ng50,government,healthcare agency,UK,Hepatocellular carcinoma; Quality-adjusted life year; Cost–utility analysis,health; health>health treatment; science and technology>social sciences
https://dx.doi.org/10.1002/hep.26385,2.0,pubmedcentral-f44345558938c295dde12097e3804dae,Guidelines in PubMed Central,Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update,2015-11-13,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722087/pdf,other,aggregator,USA,Medicine; Hepatitis B; Hepatitis,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology
https://dx.doi.org/10.1016/j.epidem.2010.02.002,1.0,governmentofperu-9a028cd3d616dddf73da3feb48e06c17,Government of Peru,Guía Técnica,2017-07-04,https://bvs.minsa.gob.pe/local/MINSA/4146.pdf,government,,Peru,Human papillomavirus infection; Cervical cancer; Pap test,health; health>diseases and conditions; health>diseases and conditions>cancer
https://dx.doi.org/10.1016/j.vaccine.2019.12.021,1.0,rivmnl-bbaf91c16a16b7d004ec71fefb6ace49,Rijksinstituut voor Volksgezondheid en Milieu,The National Immunisation Programme in the Netherlands : Surveillance and developments in 2019-2020,2020-11-27,https://www.rivm.nl/publicaties/national-immunisation-programme-in-netherlands-surveillance-and-developments-in-2019,government,research center,Netherlands,MMR vaccine; Vaccine; DPT vaccine,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1111/j.1471-0528.2011.02974.x,3.0,awmf-d425f31d76d55eac5f234704a42150bb,Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF),Impfprävention HPV-assoziierter Neoplasien,2013-12-31,https://www.awmf.org/leitlinien/detail/ll/082-002.html,government,healthcare agency,Germany,Genital wart; Human papillomavirus infection; Cervical cancer,health; science and technology>natural science>biology; health>health treatment>preventative medicine
https://dx.doi.org/10.1111/j.1471-0528.2011.02974.x,3.0,copenhagenconsensus-feadbcf535dc346f68a1d847714f740d,Copenhagen Consensus,"Bangladesh Priorities: Non-communicable Diseases, Koehlmoos et al. Center",2017-07-11,https://www.copenhagenconsensus.com/publication/bangladesh-priorities-non-communicable-diseases-koehlmoos-et-al,think tank,,Denmark,Cervical cancer; Non-communicable disease; Preventive healthcare,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1111/j.1471-0528.2011.02974.x,3.0,worldbank-af90464585cb2727e093d5306147b415,World Bank,"Disease Control Priorities, Third Edition : Volume 3. Cancer",2015-08-27,https://openknowledge.worldbank.org/handle/10986/22552,igo,development bank,IGO,Cancer; Preventive healthcare; Non-communicable disease,health; health>diseases and conditions>cancer; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.5582/bst.2020.01482,1.0,ecdc-edeb1da0e2eed4b366cb1011acff71f4,European Centre for Disease Prevention and Control,Rapid risk assessment: Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – eighth update,2020-04-09,https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-coronavirus-disease-2019-covid-19-pandemic-eighth-update,government,agency,EU,Coronavirus disease 2019; 2019–20 coronavirus pandemic; Infection,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.4269/ajtmh.2012.11-0342,7.0,california_state_agencies-52fb433999bdc01967c6024134d17cae,State of California,Indicators of Climate Change in California,2018-05-02,https://oehha.ca.gov/media/downloads/climate-change/report/2018caindicatorsreportmay2018.pdf,government,,USA,Greenhouse gas emissions; Chlorofluorocarbon; Climate change,environment>natural resources>water; environment>environmental pollution; environment
https://dx.doi.org/10.4269/ajtmh.2012.11-0342,7.0,california_state_agencies-65c6ca4c0ae107ce7bc53260bc14d12f,State of California,"Draft Final Report - A Scenario Tool for Assessing the Health Benefits of Conserving, Restoring, and Managing Natural and Working Lands in California",2023-10-27,https://ww2.arb.ca.gov/sites/default/files/2023-11/IV.1%20-%20SUBMITTED20231023_CURRENT_NEW_With_CITATIONS_19RD015_Draft_Report.pdf,government,,USA,Blood pressure; Wildfire; Meta-analysis,health>diseases and conditions; health; environment
https://dx.doi.org/10.4269/ajtmh.2012.11-0342,7.0,california_state_agencies-7b08a7701d4e451410dcc42b511a5b4d,State of California,Indicators of climate change in california,2022-10-28,https://oehha.ca.gov/media/downloads/climate-change/document/2022caindicatorsreport.pdf,government,,USA,Greenhouse gas emissions; Greenhouse gas; Global warming potential,"environment>natural resources>water; environment>environmental pollution; economy, business and finance>economic sector>energy and resource"
https://dx.doi.org/10.4269/ajtmh.2012.11-0342,7.0,california_state_agencies-c90e93ba5db835392389b1f378dd2702,State of California,West Nile Virus : Review of the Literature,2013-07-09,https://westnile.ca.gov/download?download_id=2784,government,,USA,West Nile fever; Medical specialties; Immunology,health>diseases and conditions; health>diseases and conditions>illness; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.4269/ajtmh.2012.11-0342,7.0,cdc-981c614959c29c1e766d6827a9b4fff6,Centers for Disease Control and Prevention (CDC),"West Nile virus in the United States : guidelines for surveillance, prevention, and control. 4th revision",2013-06-14,https://stacks.cdc.gov/view/cdc/22064,government,healthcare agency,USA,Insect repellent; Virus; Mosquito control,health>diseases and conditions>communicable disease>virus disease; health; health>diseases and conditions>communicable disease>epidemic
https://dx.doi.org/10.4269/ajtmh.2012.11-0342,7.0,efsaeu-303ab9b1e36f3f32b073c6c94e09a89e,EFSA,Vector-borne diseases,2017-05-11,https://www.efsa.europa.eu/en/efsajournal/pub/4793,government,agency,EU,Medical specialties; Epidemiology; Infectious diseases,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.4269/ajtmh.2012.11-0342,7.0,gpogov-15f5258261ce008032012c9d1709dbb8,Government Publishing Office (GPO),The impacts of climate change on human health in the United States : a scientific assessment /,2016-04-22,https://purl.fdlp.gov/GPO/gpo68498,government,,USA,Disease; Mental disorder; Confidence interval,health; environment; weather
https://dx.doi.org/10.1073/pnas.0509551103,4.0,centerforanewamericansecurity-6492f6bc92fa618425c0d4435a3bf3f8,Center for a New American Security,After an Attack,2007-06-27,https://www.cnas.org/publications/reports/after-an-attack-preparing-citizens-for-bioterrorism,think tank,,USA,Bioterrorism; Emergency department; Anthrax,health>diseases and conditions>communicable disease>epidemic; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1073/pnas.0509551103,4.0,fema-77fb94f875b4b72fe45b653eb97fb3ea,Federal Emergency Management Agency,Key Planning Factors: For Recovery from a Biological Terrorism Incident,2014-05-16,https://www.fema.gov/media-library/assets/documents/31721,government,,USA,Anthrax; Waste management; Waste,health; health>diseases and conditions>communicable disease>virus disease; science and technology
https://dx.doi.org/10.1073/pnas.0509551103,4.0,healthprotectionscotland-a4ab2948d759a90db1c0df9d92b9b700,Health Protection Scotland,Interim Clinical Guidance for the Management of Suspected Anthrax in Drug Users. Version 12.2,2013-03-15,https://hps.scot.nhs.uk/web-resources-container/interim-clinical-guidance-for-the-management-of-suspected-anthrax-in-drug-users-version-122/,government,healthcare agency,UK,Anthrax; Infection; Necrotizing fasciitis,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1073/pnas.0509551103,4.0,randcorporation-06d85a0aee9b47c1f4ed87ae1ad5c12d,RAND Corporation,Recommended Infrastructure Standards for Mass Antibiotic Dispensing,2008-09-29,https://www.rand.org/pubs/technical_reports/TR553.html,think tank,research center,USA,Preventive healthcare; Emergency management; RAND Corporation,health; science and technology; health>health treatment
https://dx.doi.org/10.1093/imammb/dqv036,1.0,fhithreesixty-506cbc58cc874987717f096867c5cb2b,FHI 360,Linkages across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES): Research Digests,2018-06-18,https://www.fhi360.org/resource/linkages-across-continuum-hiv-services-key-populations-affected-hiv-linkages-research,think tank,,USA,Pre-exposure prophylaxis; Men who have sex with men; HIV/AIDS,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.1093/jac/dkq013,1.0,cdc-c05f4439031976277a8f504d3bfa9519,Centers for Disease Control and Prevention (CDC),"Workshop summary : One health zoonotic disease prioritization for multisectoral engagements in Mali, Bamako, Mali",2020-02-12,https://stacks.cdc.gov/view/cdc/85523,government,healthcare agency,USA,One Health; Zoonosis; Virus,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1186/s12879-017-2631-2,2.0,norweiganinstituteofpublichealth-0aeb00f7a89473ac8bad06de12b76d75,Norweigan Institute of Public Health,Health status in Norway 2018,2018-12-20,https://www.fhi.no/en/publ/2018/health-status-in-norway-2018/,government,healthcare agency,Norway,Cardiovascular disease; Disease; Disease burden,health; education; science and technology>natural science>biology
https://dx.doi.org/10.1186/s12879-017-2631-2,2.0,regjeringa-0a8f165dded91cc17d4e91efaadc102b,Regjeringa.no,Nasjonal strategi mot hepatitter,2018-11-09,https://www.regjeringen.no/no/dokumenter/nasjonal-strategi-mot-hepatitter/id2618584/,government,,Norway,Medication; Health sciences; Hepatitis C virus,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1371/journal.pone.0010911,1.0,idrc-447dc0f928a1085eda1d29c44b24bc7b,International Development Research Centre,Modelling and controlling infectious diseases,2019-02-28,https://idl-bnc-idrc.dspacedirect.org/handle/10625/57464,think tank,,Canada,HIV/AIDS; Management of HIV/AIDS; Public health,science and technology>natural science>biology>genetics; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.18553/jmcp.2022.21469,1.0,nice-420ed9b38b873fc9c6c0d9171b426d9f,NICE,Tixagevimab plus cilgavimab for preventing COVID-19,2023-06-14,https://www.nice.org.uk/guidance/ta900,government,healthcare agency,UK,COVID-19 vaccine; Tixagevimab/cilgavimab; COVID-19 pandemic,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.26719/2016.22.2.87,2.0,who-75df0d404f28374044b687f684e58dae,World Health Organization,Index medicus for the WHO Eastern Mediterranean Region: with abstract: IMEMR current content,2019-09-18,https://apps.who.int/iris/handle/10665/327581,igo,healthcare agency,IGO,Middle East respiratory syndrome; Fractional flow reserve; Amikacin,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.26719/2016.22.2.87,2.0,who-e48c6b7041b64af9f57d3b9e1d4ea974,World Health Organization,Index medicus for the WHO Eastern Mediterranean Region: with abstract: IMEMR current content,2019-09-18,https://apps.who.int/iris/handle/10665/327580,igo,healthcare agency,IGO,Medical Subject Headings; Middle East respiratory syndrome; Medicine,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1093/cid/cis272,1.0,pubmedcentral-024a8112d21c58805b22e06392e6ba54,Guidelines in PubMed Central,Evaluating implementation of methicillin-resistant (MRSA) prevention guidelines in spinal cord injury centers using the PARIHS framework: a mixed methods study,2015-09-09,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564999/pdf,other,aggregator,USA,Health; Methicillin-resistant Staphylococcus aureus; Survey methodology,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1136/bmj.d5694,9.0,cadth-6339a5440f00aadd2e907572fbcd9f91,Canadian Agency for Drugs and Technologies in Health,Universal Screening for Antibiotic-Resistant Organisms: A Review of the Clinical and Cost-Effectiveness,2015-10-13,https://cadth.ca/universal-screening-antibiotic-resistant-organisms-review-clinical-and-cost-effectiveness,government,healthcare agency,Canada,Methicillin-resistant Staphylococcus aureus; Sensitivity analysis; Confounding,health; health>health treatment; science and technology>social sciences
https://dx.doi.org/10.1136/bmj.d5694,9.0,cadth-71dd662230e3795a41a624c67dd967f9,Canadian Agency for Drugs and Technologies in Health,"Screening, Isolation and Decolonization Strategies for Methicillin-Resistant Staphylococcus Aureus: A Review of the Clinical Evidence",2012-10-31,https://cadth.ca/screening-isolation-and-decolonization-strategies-methicillin-resistant-staphylococcus-aureus-review,government,healthcare agency,Canada,Methicillin-resistant Staphylococcus aureus; Hospital-acquired infection; Randomized controlled trial,health; health>health treatment; health>health treatment>medicine
https://dx.doi.org/10.1136/bmj.d5694,9.0,ecdc-3b03dea5ff96ea484962b6304d94f4da,European Centre for Disease Prevention and Control,Economic evaluations of interventions to prevent healthcare-associated infections – literature review,2017-04-19,https://www.ecdc.europa.eu/en/publications-data/economic-evaluations-interventions-prevent-healthcare-associated-infections,government,agency,EU,Research; Cohort study; Health care,health; science and technology; science and technology>social sciences
https://dx.doi.org/10.1136/bmj.d5694,9.0,europa-9724c28160f5a316598eb0416f58fd00,Publications Office of the European Union,Economic evaluations of interventions to prevent healthcare-associated infections : literature review.,2017-06-15,https://op.europa.eu/en/publication-detail/-/publication/a370f170-523d-11e7-a5ca-01aa75ed71a1/language-en/format-PDF,government,,EU,Methicillin-resistant Staphylococcus aureus; Hospital-acquired infection; Quality-adjusted life year,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1136/bmj.d5694,9.0,govuk-7c232c64219638189045a782afa3f4dd,The UK Government,Who to screen for MRSA,2014-08-18,https://www.gov.uk/government/publications/how-to-approach-mrsa-screening,government,,UK,Methicillin-resistant Staphylococcus aureus; Risk; Adherence (medicine),health; science and technology; health>health treatment
https://dx.doi.org/10.1136/bmj.d5694,9.0,nice-2b3c551fd19e2ba3cbd735ef5e11d108,NICE,Surgical site infections: prevention and treatment,2019-04-11,https://www.nice.org.uk/guidance/ng125,government,healthcare agency,UK,Meta-analysis; Randomized controlled trial; Surgery,health; science and technology; health>health treatment
https://dx.doi.org/10.1136/bmj.d5694,9.0,oecddiscovery-43808e0ec30fa2f8fdc2d338955342f0,OECD,Antimicrobial Resistance in G7 Countries and Beyond,2015-02-08,https://dx.doi.org/https://doi.org/10.1787/5ea8ed24-en,igo,,IGO,Antimicrobial resistance; Antibiotic; One Health,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1136/bmj.d5694,9.0,sbuse-c8a34f49a1885114f01552880228df6d,Swedish Agency for Health Technology Assessment and Assessment of Social Services,Vetenskaplig evidens för MRSA screening av gravida,2018-06-04,https://www.sbu.se/sv/publikationer/regional-hta/vetenskaplig-evidens-for-mrsa-screening-av-gravida/,government,healthcare agency,Sweden,Methicillin-resistant Staphylococcus aureus; Swedish Agency for Health Technology Assessment and Assessment of Social Services; Medicine,health; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1136/bmj.d5694,9.0,who-54aa3705130c33dcd045db54a54cb9cd,World Health Organization,Global report on infection prevention and control,2022-05-23,https://apps.who.int/iris/handle/10665/354489,igo,healthcare agency,IGO,Carbapenem; WASH; Health,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1183/13993003.01190-2017,3.0,awmf-19886d0a24f0c9e58dc7584c09c917f5,Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF),Katastrophenmedizinische prähospitale Behandlungsleitlinien,2023-09-28,https://register.awmf.org/de/leitlinien/detail/001-043,government,healthcare agency,Germany,Medical guideline; Emergency medicine; Triage,"disaster, accident and emergency incident>disaster; health>diseases and conditions>injury; health>diseases and conditions"
https://dx.doi.org/10.1183/13993003.01190-2017,3.0,pubmedcentral-e02deffbfce67b316cc4e290043a242c,Guidelines in PubMed Central,Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America,2019-10-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812437/pdf,other,aggregator,USA,Procalcitonin; Methicillin-resistant Staphylococcus aureus; Influenza,health>diseases and conditions>illness; science and technology>biomedical science>pharmacology; health>diseases and conditions
https://dx.doi.org/10.1183/13993003.01190-2017,3.0,pubmedcentral-f5b4460ceebdf412de43066a4f62f625,Guidelines in PubMed Central,Treatment of Community-Acquired Pneumonia in Immunocompromised Adults - A Consensus Statement Regarding Initial Strategies,2020-06-16,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297164/pdf,other,aggregator,USA,Pneumonia; Multiple drug resistance; Methicillin-resistant Staphylococcus aureus,science and technology>biomedical science>pharmacology; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1183/13993003.01363-2018,3.0,paho-271e9bb979d4a1f0a7d484e37ff6c694,Pan American Health Organization (PAHO),Manual operacional de tuberculose da OMS Módulo 4: Tratamento - Atenção e apoio ao tratamento da tuberculose,2024-05-27,https://iris.paho.org/handle/10665.2/59880,igo,,IGO,Health; Family; Major depressive disorder,"health; economy, business and finance>economic sector>computing and information technology; education"
https://dx.doi.org/10.1183/13993003.01363-2018,3.0,paho-f8c967beee82161085d74edc82a1f318,Pan American Health Organization (PAHO),Manual operativo de la OMS sobre la tuberculosis. Módulo 4: Tratamiento. Atención y apoyo para la tuberculosis,2024-05-27,https://iris.paho.org/handle/10665.2/60234,igo,,IGO,Health; Disease; Mental health,health; education; science and technology
https://dx.doi.org/10.1183/13993003.01363-2018,3.0,who-f7aa7030e8179215686a54c8551fdba3,World Health Organization,WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support,2022-07-08,https://apps.who.int/iris/handle/10665/359147,igo,healthcare agency,IGO,Adherence (medicine); Tuberculosis; Grief,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1002/sim.4780131918,2.0,unaids-6ee0a2f3b6c3edfee8aba56ce7d2ac09,UNAIDS,Relationships of HIV and STD declines in Thailand to behavioural change,1998-04-02,https://www.unaids.org/en/resources/documents/1999/19990602_una98-2_en.pdf,igo,,IGO,HIV/AIDS; Safe sex; Condom,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1002/sim.4780131918,2.0,unitednations-ad201d0a130702e4313f58f70d637dac,United Nations,Relationships of HIV and STD declines in Thailand to behavioural change : a synthesis of existing studies,1998-01-01,https://digitallibrary.un.org/record/3958097?ln=en,igo,,IGO,Risk; Men who have sex with men; Infection,health; science and technology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1177/0962280219856380,1.0,efsaeu-8af881e93b169aa55620dbffc954fd6b,EFSA,"Active wild bird surveillance of avian influenza viruses, a report",2022-12-22,https://www.efsa.europa.eu/en/supporting/pub/en-7791,government,agency,EU,Avian influenza; Bird migration; Flyway,science and technology>natural science>biology; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1371/journal.pone.0244920,2.0,instituteofdevelopmentstudies-e350150592ea6a7554a11faedea74576,Institute of Development Studies,A Gender Approach to Monetary and Financial Policies in the Covid-19 Recovery,2021-11-01,https://opendocs.ids.ac.uk/opendocs/handle/20.500.12413/17264,think tank,,UK,Economics; Inflation; Taylor rule,"economy, business and finance>economy; economy, business and finance>economy>macro economics>inflation; economy, business and finance>economic sector>financial and business service>banking"
https://dx.doi.org/10.1371/journal.pone.0244920,2.0,odi-feacd0a3b1aea63193fbcf56a02c5568,Overseas Development Institute (ODI),A gender approach to monetary and financial policies in the COVID-19 recovery,2021-11-30,https://odi.org/en/publications/a-gender-approach-to-monetary-and-financial-policies-in-the-covid-19-recovery/,think tank,,UK,Monetary policy; Inflation; Taylor rule,"economy, business and finance>economy; economy, business and finance>economy>macro economics>inflation; economy, business and finance>economic sector>financial and business service>banking"
https://dx.doi.org/10.1002/ijc.25585,1.0,cdc-08824a237139ff4290bfd6b3fb83131d,Centers for Disease Control and Prevention (CDC),Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965,2012-08-09,https://stacks.cdc.gov/view/cdc/24427,government,healthcare agency,USA,Hepatitis C; Hepatitis; Alcoholism,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1098/rsif.2006.0167,1.0,govdeptsjapan-0a61022c8b6c5f5c148cd3334f6521e8,Government of Japan,実効 再生産の推定 (2022 年 10 月 4 日版 り更新),2022-10-11,https://www.mhlw.go.jp/content/10900000/001000574.pdf,government,,Japan,Intensive care unit; Extracorporeal membrane oxygenation; Hospital bed,health; health>diseases and conditions; health>health treatment>medicine
https://dx.doi.org/10.1016/j.clinthera.2020.08.013,2.0,has-48d600473671706801178a0d9724e4d1,Haute Autorité de Santé,Recommandation vaccinale contre les infections à rotavirus - Révision de la stratégie vaccinale et détermination de la place des vaccins Rotarix et RotaTeq,2022-07-11,https://www.has-sante.fr/jcms/p_3321070/fr/recommandation-vaccinale-contre-les-infections-a-rotavirus-revision-de-la-strategie-vaccinale-et-determination-de-la-place-des-vaccins-rotarix-et-rotateq,government,healthcare agency,France,Clinical medicine; Vaccination; Gastroenteritis,health>diseases and conditions; health; science and technology>natural science>biology
https://dx.doi.org/10.1016/j.clinthera.2020.08.013,2.0,nice-ed91da5f73ccad127988b8f60d9dfc79,NICE,Avalglucosidase alfa for treating Pompe disease,2022-08-24,https://www.nice.org.uk/guidance/ta821,government,healthcare agency,UK,Glycogen storage disease type II; National Institute for Health and Care Excellence; Caregiver,health>diseases and conditions; health; science and technology>natural science>biology
https://dx.doi.org/10.1046/j.1365-3016.1997.d01-5.x,1.0,nice-d65984d911ee18ca14dd091f808a8b2a,NICE,Specialist neonatal respiratory care for babies born preterm,2019-04-03,https://www.nice.org.uk/guidance/ng124,government,healthcare agency,UK,Preterm birth; Childbirth; Gestational age,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1001/archsurg.133.12.1347,1.0,nice-e5b026d481795747b6527edf83c957c1,NICE,"Sepsis: recognition, diagnosis and early management",2017-09-13,https://www.nice.org.uk/guidance/ng51,government,healthcare agency,UK,Quality-adjusted life year; Cost–utility analysis; Cost-effectiveness analysis,health; health>health treatment; science and technology>social sciences
https://dx.doi.org/10.1098/rspb.2003.2369,3.0,ipeabr-2b9918da5726bd3077d20f64b409da85,Instituto de Pesquisa Econômica Aplicada,Modeling complex systems for public policies,2015-01-01,https://www.ipea.gov.br/portal/publicacao-item?id=23ed14d0-b18b-426e-a1ce-4c10790c81fe,think tank,,Brazil,Complex system; System; Reaction–diffusion system,science and technology>mathematics; science and technology>natural science>physics; science and technology
https://dx.doi.org/10.1098/rspb.2003.2369,3.0,ipeabr-5469e7f7691f830b86c8d22f31d8f08a,Instituto de Pesquisa Econômica Aplicada,Modeling Complex Systems for Public Policies,2015-07-23,http://www.ipea.gov.br/portal/index.php?option=com_content&view=article&id=25858,think tank,,Brazil,Complex system; Scale invariance; System,"science and technology; economy, business and finance>economic sector>computing and information technology; education"
https://dx.doi.org/10.1098/rspb.2003.2369,3.0,ipeabr-ceed51158603a01d418a5c5d668fcb0f,Instituto de Pesquisa Econômica Aplicada,Modelagem de sistemas complexos para políticas públicas,2015-01-01,https://www.ipea.gov.br/portal/publicacao-item?id=e3e2e461-b772-4330-ab93-781f2433a9b6,think tank,,Brazil,Economics; Computer simulation; Science,"science and technology; education; economy, business and finance>economic sector>computing and information technology"
https://dx.doi.org/10.1099/jmm.0.000020,1.0,govuk-d2557d53739ff589f00f6d1180a93e74,The UK Government,Freedom of Information responses from the MHRA - week commencing 21 November 2022,2024-01-17,https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-21-november-2022,government,,UK,Caspofungin; Pharmacovigilance; Diseases and disorders,health>diseases and conditions; science and technology>biomedical science>pharmacology; health>diseases and conditions>illness
https://dx.doi.org/10.1111/jvh.13742,1.0,who-8cb90b838754dbc14d7c37a1866e940e,World Health Organization,"Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection",2024-01-01,https://apps.who.int/iris/handle/10665/376353,igo,healthcare agency,IGO,Hepatitis B; Hepatitis; Cirrhosis,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>illness
https://dx.doi.org/10.1007/s00134-012-2747-1,5.0,govdeptsjapan-43fa8e78e08b0db7bec59c1f3b83e8ec,Government of Japan,成人の新型インフルエンザ治療ガイドライン,2014-05-30,https://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/kenkou/kekkaku-kansenshou/infulenza/dl/guideline.pdf,government,,Japan,Influenza; Oseltamivir; Pneumonia,health; health>diseases and conditions; health>health treatment
https://dx.doi.org/10.1007/s00134-012-2747-1,5.0,govdeptsjapan-8913da69136a3b70c017950b5583400a,Government of Japan,成人の新型インフルエンザ 治療ガイドライン 第,2017-12-27,https://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000189936.pdf,government,,Japan,Respiratory failure; Neuraminidase inhibitor; Influenza,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1007/s00134-012-2747-1,5.0,pubmedcentral-323ed616ddfa1fe8145cc61ceeacb54f,Guidelines in PubMed Central,Severe influenza treatment guideline,2014-01-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932389/pdf,other,aggregator,USA,Immunoglobulin therapy; Oseltamivir; Antiviral drug,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1007/s00134-012-2747-1,5.0,pubmedcentral-acd9bd19a3189b9813a8288f0a01d3e3,Guidelines in PubMed Central,Joint SCCM-ELSO Task Force Position Paper on the Role of the Intensivist in the Initiation and Management of Extracorporeal Membrane Oxygenation,2020-07-30,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422732/pdf,other,aggregator,USA,Health care; Medicine; Medical specialties,health; health>health treatment>medical procedure/test
https://dx.doi.org/10.1007/s00134-012-2747-1,5.0,pubmedcentral-b06d80373d6913cb264508002ccbdd52,Guidelines in PubMed Central,Extracorporeal membrane oxygenation for critically ill adults,2015-01-22,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353247/pdf,other,aggregator,USA,Health care; Health; Health sciences,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1371/journal.pone.0076044,1.0,governmentoftaiwan-c6c34268b07ec6c0f3c86a8c5f0f018b,Government of Taiwan,登革熱 的,2016-05-26,https://www.most.gov.tw/most/attachments/645d0f96-b8c9-4b3f-8bf0-38f1c26bcda9,government,,Taiwan,Dengue fever; Protein; RNA,science and technology>natural science>biology; health>diseases and conditions; science and technology
https://dx.doi.org/10.1371/journal.pone.0135092,7.0,gatestoneinstitute-4aea1a341a82aae8aebefc5ce5f8074b,Gatestone Institute,"Looking Ahead at Middle East ""Peace""",2015-08-17,https://www.gatestoneinstitute.org/6342/middle-east-peace,think tank,,USA,UNRWA; Hamas; Gaza Strip,"conflicts, war and peace; politics; politics>government"
https://dx.doi.org/10.1371/journal.pone.0135092,7.0,unitednations-18413e6cf93a502a2ddb43f7982a19b6,United Nations,Report to the Ad Hoc Liaison Committee : May 2017 / United Nations Special Coordinator for the Middle East Peace Process,2017-01-01,https://digitallibrary.un.org/record/4024653?ln=en,igo,,IGO,Gaza Strip; Israeli–Palestinian conflict; Palestinian territories,"conflicts, war and peace; politics>government; politics"
https://dx.doi.org/10.1371/journal.pone.0135092,7.0,who-026c49605ba5dbf7b7791061de6dfd76,World Health Organization,الأحوال الصحية في الأرض الفلسطينية المحتلة، بما فيها القدس الشرقية، وفي الجولان السوري المحتل,2017-05-08,https://apps.who.int/iris/handle/10665/255279,igo,healthcare agency,IGO,,
https://dx.doi.org/10.1371/journal.pone.0135092,7.0,who-20d2af732ef7f4dd50dea76842fed442,World Health Organization,"Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan: report by the Secretariat",2017-01-03,https://apps.who.int/iris/handle/10665/252704,igo,healthcare agency,IGO,World Health Organization; Palestinian territories; West Bank,health>diseases and conditions; health; environment
https://dx.doi.org/10.1371/journal.pone.0135092,7.0,who-7d52096405dfa8f9c7e259dfb9f93bad,World Health Organization,Country cooperation strategy for WHO and the Occupied Palestinian Territory: 2017–2020,2018-01-17,https://apps.who.int/iris/handle/10665/259862,igo,healthcare agency,IGO,Primary health care; Development aid; Infant mortality,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1371/journal.pone.0135092,7.0,who-808d1ebaf119b3ed3ba552f5f2f95a21,World Health Organization,"Situation sanitaire dans le territoire palestinien occupé, y compris Jérusalem-Est, et dans le Golan syrien occupé : rapport du Secrétariat",2017-01-11,https://apps.who.int/iris/handle/10665/252902,igo,healthcare agency,IGO,Gaza Strip; Public health; Mental health,health; health>diseases and conditions; health>health treatment
https://dx.doi.org/10.1371/journal.pone.0135092,7.0,who-c7f3f827d59824b35873f1b0f7750345,World Health Organization,"Медико-санитарные условия проживания населения на оккупированной палестинской территории, включая Восточный Иерусалим, а также на оккупированных сирийских Голанских высотах Доклад Секретариата",2017-01-17,https://apps.who.int/iris/handle/10665/253309,igo,healthcare agency,IGO,Health sciences; Medicine; Jerusalem,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1590/s0102-311x1999000300003,1.0,california_state_agencies-1324d5fa60ee1a1f0a4ade89af49c9d5,State of California,"CA Science Framework, Chapter 8 - Curriculum Frameworks (CA Dept of Education)",2018-05-09,https://www.cde.ca.gov/ci/sc/cf/documents/scifwchapter8.pdf,government,,USA,Evolution; Genetics; Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid,science and technology>natural science>biology; science and technology>natural science>biology>genetics; science and technology>natural science>biology>physiology
https://dx.doi.org/10.14740/cr490w,1.0,governmentofphillippines-1a6a8dfb0b6aa481e06c0acb26c5718c,Government of the Philippines,SpecializedPhilippine EnterpriseReference ofExpertsandScientists (SPHERES),2019-12-06,http://www.spheres.dost.gov.ph/images/issues/spheresDecember2020.pdf,government,,Philippines,Quantum entanglement; Myocardial infarction; Pericardial effusion,science and technology>natural science>biology; science and technology>natural science>physics; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1073/pnas.2004978117,28.0,boe-9b3c529e53464b9c94635a00f68194d9,Boletín Oficial del Estado,"Efectividad de las medidas de distanciamiento social, en el contexto de la pandemia por COVID-19",2022-06-15,https://cpage.mpr.gob.es/producto/efectividad-de-las-medidas-de-distanciamiento-social-en-el-contexto-de-la-pandemia-por-covid-19-3/,government,,Spain,Health; Health sciences; Epidemiology,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1073/pnas.2004978117,28.0,boe-afb56fa81d7d84cebbfdbb5b0faf618e,Boletín Oficial del Estado,Revisión de la evidencia sobre el uso de mascarillas en la evolución de la pandemia por COVID-19,2022-05-31,https://cpage.mpr.gob.es/producto/revision-de-la-evidencia-sobre-el-uso-de-mascarillas-en-la-evolucion-de-la-pandemia-por-covid-19/,government,,Spain,Clinical medicine; Public health; Medical specialties,health; health>health treatment>medicine; health>diseases and conditions
https://dx.doi.org/10.1073/pnas.2004978117,28.0,bundestag-eac072bdde89fb945441b0154a638a89,Deutscher Bundestag,WD 9 - 051/20 Gesundheitspolitische MaÃnahmen zur EindÃ¤mmung des Coronavirus SARS-CoV-2 Informationen zu aktuellen Studien (Stand: 11. Juli 2020),2020-07-14,https://www.bundestag.de/resource/blob/710022/f0ec20d4b753b151cf09947d1621db6c/WD-9-051-20-pdf-data.pdf,government,,Germany,Severe acute respiratory syndrome coronavirus 2; Epidemiology; Sweden,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.2004978117,28.0,cdc-67eb63c1a58fdb90f0d2d93c1ce5dfaa,Centers for Disease Control and Prevention (CDC),Geospatial perspectives on the intersection of chronic disease and COVID-19,2022-07-11,https://stacks.cdc.gov/view/cdc/119417,government,healthcare agency,USA,Research; Disease; Chronic condition,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.2004978117,28.0,cityofmadrid-85008dcbe1dd7e5899e2d025d050563d,Comunidad de Madrid,Revisión de la evidencia sobre el uso de mascarillas en la evolución de la pandemia por COVID-19,2022-05-31,https://www.comunidad.madrid/sites/default/files/doc/informe_uets-madrid_covid_mascarillas.pdf,government,city,Spain,Health; Health sciences; Medicine,health>diseases and conditions; health; health>health treatment>medicine
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-06e4b0db563659cb011e7b5cece3acc2,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2020-10-22,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf,government,,USA,Coronavirus disease 2019; Infection; Transmission (medicine),health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-07fb0e77b88ab97750003d3d688bed00,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-11-04,https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf,government,,USA,Epidemiology; Clinical medicine; Health,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-264c920487c0beac78573c6c3fd232d3,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2020-05-28,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200526.pdf,government,,USA,Infection; Coronavirus disease 2019; Severe acute respiratory syndrome coronavirus 2,health>diseases and conditions>illness; science and technology>natural science>biology>genetics; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-38fd23e57dd8ec707294d25fb8fb9019,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-01-28,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210126.pdf,government,,USA,Health sciences; Health; Clinical medicine,science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-6d422045165469a763b7c31921bd52c8,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-07-15,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf,government,,USA,Variants of SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; COVID-19 vaccine,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-7d012ca698e16eb5ab13f18f1d8c20b1,Department of Homeland Security,For Public Release,2020-09-03,https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Serology; Infection,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-986e8907503bb52624c6b7c7297258a3,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2020-05-07,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_05_05.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Infection; Coronavirus disease 2019,health>diseases and conditions>illness; science and technology>natural science>biology>genetics; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-9ea33450cd010f0bc26135ded24818ba,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2020-05-15,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200512.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Infection; COVID-19 pandemic,science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-c2c5f296cd093cb97fbd27974ea82088,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-Cov-2),2020-09-17,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Symptoms of COVID-19; Infection,science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-c4ca50594c2444482cbf59ab303a2991,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2020-11-05,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Symptoms of COVID-19; Infection,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-c7c066a7980e1f94e43e90e1e29d3feb,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2020-07-23,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf,government,,USA,Symptoms of COVID-19; Infection; Severe acute respiratory syndrome coronavirus 2,health>diseases and conditions>illness; science and technology>natural science>biology>genetics; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-d03d62734a42fe925cf1a6d5dd96f67c,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-01-07,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf,government,,USA,Health care; Microbiology; Diseases and disorders,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-d200536d006998d2083e74b1255d5c5f,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2020-07-09,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200707.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Infection; N95 respirator,health>diseases and conditions>illness; science and technology>natural science>biology>genetics; health>diseases and conditions
https://dx.doi.org/10.1073/pnas.2004978117,28.0,dhsgov-eeb18fe8690357c6b05b850ab4cf6b68,Department of Homeland Security,Master Question List fgor COVID-19 (caused by SARS-CoV-2),2023-02-21,https://www.dhs.gov/sites/default/files/2023-02/23_0131_st_mql_sars_cov-2.pdf,government,,USA,Public health; Health; Immunology,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1073/pnas.2004978117,28.0,fgvbr-d52502daff4ff07c6192ce041cc3f144,Fundação Getulio Vargas,"Alocação orçamentária em saúde, destinada aos municípios brasileiros no enfrentamento da COVID-19",2022-04-09,https://repositorio.fgv.br/items/05da73c5-1216-429e-b961-eacdc764788a/full,think tank,research center,Brazil,Budget; Government budget; Sistema Único de Saúde,politics>government; education; politics
https://dx.doi.org/10.1073/pnas.2004978117,28.0,ifode-6aa3bfd507d3977e0287620e4e291f18,Ifo Institute,"The ""Great Lockdown"": Inactive Workers and Mortality by Covid-19",2020-09-28,https://www.cesifo.org/en/publications/2020/working-paper/great-lockdown-inactive-workers-and-mortality-covid-19,think tank,,Germany,Economics; Difference in differences; Facebook,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.2004978117,28.0,izade-cefccef8b07133a356baf709704a7c28,IZA Institute of Labor Economics,Uneven Recovery from the COVID-19 Pandemic: Post-lockdown Human Mobility Across Chinese Cities,2021-01-31,https://www.iza.org/publications/dp/14187/uneven-recovery-from-the-covid-19-pandemic-post-lockdown-human-mobility-across-chinese-cities,think tank,,Germany,COVID-19 pandemic; COVID-19 pandemic lockdown in Hubei; IZA Institute of Labor Economics,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.2004978117,28.0,nber-74c2bd440822e24c2a3b9a38c13435ee,NBER,Socioeconomic Network Heterogeneity and Pandemic Policy Response,2020-06-11,https://www.nber.org/papers/w27374,think tank,,USA,Infection; American Community Survey; Coronavirus disease 2019,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1073/pnas.2004978117,28.0,pubmedcentral-5ea128ce4c1cabb2fb9d87c30cbc36a4,Guidelines in PubMed Central,International travel‐related control measures to contain the COVID‐19 pandemic: a rapid review,2021-03-25,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406796/pdf,other,aggregator,USA,Health; Medicine; Health sciences,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.2004978117,28.0,stateofcatalunya-81f579a3581cce007997d0fb444e40ea,Generalitat de Catalunya,Evidencia impacto cierre centros educativos por evolución COVID-19,2022-06-07,https://scientiasalut.gencat.cat/bitstream/handle/11351/7723/revision_evidencia_impacto_cierre_centros_educativos_pandemia_evolucion_pandemia_covid19_2021.pdf,government,,Spain,Health; SARS; Risk,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1073/pnas.2004978117,28.0,stateofgalicia-bf0e61b8047e6d866e4fa8214c2f5c12,Xunta de Galicia,Efectividad de las medidas no farmacológicas dirigidas a los lugares de trabajo en el control de la diseminación de la COVID-19,2022-07-09,https://libraria.xunta.gal/sites/default/files/downloads/publicacion/texto_avalia-t_inf_trabajo_covid19_def_mod_2.pdf,government,,Spain,Medicine; Health sciences; Health,health; politics; science and technology
https://dx.doi.org/10.1073/pnas.2004978117,28.0,worldbank-4e4424f82b15923ff55b9805721b4858,World Bank,Modeling and Predicting the Spread of Covid-19,2020-10-01,https://hdl.handle.net/10986/34590,igo,development bank,IGO,Econometrics; Coronavirus disease 2019; Logarithm,health>diseases and conditions; science and technology; science and technology>mathematics
https://dx.doi.org/10.1073/pnas.2004978117,28.0,worldbank-d443e4524d34193786a3b6a88804cb40,World Bank,"Modeling and Predicting the Spread of Covid-19 : Comparative Results for the United States, the Philippines, and South Africa",2020-10-08,https://openknowledge.worldbank.org/handle/10986/34590,igo,development bank,IGO,Regression analysis; Forecasting; Research,health>diseases and conditions; science and technology; science and technology>mathematics
https://dx.doi.org/10.1093/biostatistics/kxj023,1.0,thlfi-816e4332f5e3c95d6d4b550777575711,Terveyden ja hyvinvoinnin laitos,Population Attributable Fraction (PAF) in epidemiologic follow-up studies,2010-06-01,http://www.julkari.fi/handle/10024/80153,government,healthcare agency,Finland,Type 2 diabetes; Metabolic syndrome; Cohort study,science and technology; health; health>diseases and conditions
https://dx.doi.org/10.18632/aging.103694,1.0,pubmedcentral-264bb007ae15436e6d39ffef0980a54b,Guidelines in PubMed Central,Pragmatic Recommendations for Identification and Triage of Patients with COVID-19 in Low- and Middle-Income Countries,2021-03-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957239/pdf,other,aggregator,USA,Medical imaging; COVID-19 testing; CT scan,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1002/sim.6274,1.0,pubmedcentral-a4786a3ed966e90fcadb7def81695e71,Guidelines in PubMed Central,A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic,2020-08-12,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422467/pdf,other,aggregator,USA,Health; Missing data; Estimand,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/s41598-017-00493-1,1.0,datapopalliance-6c09f3f6d7e64b361c355e5e4d6892e9,Data-Pop Alliance,Data for Refugees: The D4R Challenge on Mobility of Syrian Refugees in Turkey,2018-10-16,https://datapopalliance.org/publications/data-for-refugees-the-d4r-challenge-on-mobility-of-syrian-refugees-in-turkey/,think tank,,USA,Technology; Data re-identification; Human activities,"science and technology; conflicts, war and peace>armed conflict>war; society>values>ethics"
https://dx.doi.org/10.1093/cid/ciaa443,3.0,pubmedcentral-264bb007ae15436e6d39ffef0980a54b,Guidelines in PubMed Central,Pragmatic Recommendations for Identification and Triage of Patients with COVID-19 in Low- and Middle-Income Countries,2021-03-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957239/pdf,other,aggregator,USA,COVID-19 testing; CT scan; COVID-19 pandemic,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1093/cid/ciaa443,3.0,swisscovid-735e904184dcb160ed5165d044e38900,Swiss National COVID-19 Science Task Force,Risk factors for severe manifestations of SARS-CoV-2 infection (27 July 20 -EN),2020-07-29,https://ncs-tf.ch/en/policy-briefs/risk-factors-for-severe-manifestations-of-sars-cov-2-infection-27-july-20-en-2/download,government,healthcare agency,Switzerland,Medical specialties; Health; Health sciences,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1093/cid/ciaa443,3.0,swisscovid-8949c5bbfcbb0e3a3e708c261d5a46d0,Swiss National COVID-19 Science Task Force,Risk factors for severe manifestations of SARS-CoV-2 infection 1 May 02 - en,2020-05-06,https://ncs-tf.ch/en/policy-briefs/risk-factors-for-severe-manifestations-of-sars-cov-2-infection-1-may-02-en-2/download,government,healthcare agency,Switzerland,Epidemiology; Public health; Health care,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.2012370118,8.0,adminch-ce048affa2c9ae385ef01f0a8e14dd9b,Government of Switzerland,Wirksamkeit und Kosten von Corona-Massnahmen und optimale Interventionsebene,2021-06-21,https://www.seco.admin.ch/dam/seco/fr/dokumente/Publikationen_Dienstleistungen/Publikationen_Formulare/Wirtschaftslage/Strukturwandel_Wachstum/Wachstum/wp_23_wirksamkeit_kosten_corona-massnahmen_interventionsebene.pdf.download.pdf/wp_23_wirksamkeit_kosten_corona-massnahmen_interventionsebene.pdf,government,,Switzerland,Lockdown; Peer review; Unemployment,"economy, business and finance>economy; science and technology; health"
https://dx.doi.org/10.1073/pnas.2012370118,8.0,adminch-f23611dd66e98afdf85955adaade4c3e,Government of Switzerland,Wirksamkeit und Kosten von Corona-Massnahmen und optimale Interventionsebene,2021-06-21,https://www.seco.admin.ch/dam/seco/de/dokumente/Publikationen_Dienstleistungen/Publikationen_Formulare/Wirtschaftslage/Strukturwandel_Wachstum/Wachstum/wp_23_wirksamkeit_kosten_corona-massnahmen_interventionsebene.pdf.download.pdf/wp_23_wirksamkeit_kosten_corona-massnahmen_interventionsebene.pdf,government,,Switzerland,Peer review; Unemployment; COVID-19,"economy, business and finance>economy; science and technology; health"
https://dx.doi.org/10.1073/pnas.2012370118,8.0,bancoes-7e7737db398c5ed61acddf81ca0e7fbc,Banco de España,Documentos de Trabajo. 2129.,2021-08-13,https://www.bde.es/f/webbde/SES/Secciones/Publicaciones/PublicacionesSeriadas/DocumentosTrabajo/21/Files/dt2129e.pdf,government,bank,Spain,Basic reproduction number; Influenza; Compartmental models in epidemiology,science and technology>natural science>biology; science and technology>natural science>biology>genetics; science and technology
https://dx.doi.org/10.1073/pnas.2012370118,8.0,euparl_library-8b8331b89cafbfe2694749191e380c6b,European Parliamentary Research Service,Pollution and the spread of Covid-19,2021-12-09,https://www.europarl.europa.eu/thinktank/en/document/EPRS_STU(2021)697192,government,legislative research,EU,Airborne transmission; Pathogen transmission; Severe acute respiratory syndrome coronavirus 2,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1073/pnas.2012370118,8.0,europa-b42beadb5f531493cd4bfdd8c9d05fe0,Publications Office of the European Union,Pollution and the spread of COVID-19.,2022-02-02,https://op.europa.eu/en/publication-detail/-/publication/d4089312-8a24-11ec-8c40-01aa75ed71a1/language-en/format-PDF,government,,EU,Airborne transmission; Severe acute respiratory syndrome coronavirus 2; Air pollution,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1073/pnas.2012370118,8.0,ifode-7fb008391f441bcc0eafee495df35045,Ifo Institute,Financial Risk-Taking under Health Risk,2023-04-24,https://www.cesifo.org/en/publications/2023/working-paper/financial-risk-taking-under-health-risk,think tank,,Germany,Risk; COVID-19 pandemic; Errors and residuals,science and technology; health; health>diseases and conditions
https://dx.doi.org/10.1073/pnas.2012370118,8.0,stoa-691cf9c37fa4795c72f3a9daffc85a2a,Panel for the Future of Science and Technology (STOA) for the European Parliament,Pollution and the spread of Covid-19 | Panel for the Future of Science and Technology (STOA) | European Parliament,2021-12-09,https://www.europarl.europa.eu/stoa/en/document/EPRS_STU(2021)697192,government,legislative research,Belgium,Airborne transmission; SARS-CoV-2; Pathogen transmission,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1073/pnas.2012370118,8.0,wmo-c08e22cb95f861b174edd45faa2c6547,World Meteorological Organization,Review on Meteorological and Air Quality Factors Affecting the COVID-19 Pandemic,2021-02-25,https://library.wmo.int/records/item/57336-first-report-of-the-wmo-covid-19-task-team-review-on-meteorological-and-air-quality-factors-affecting-the-covid-19-pandemic,igo,,IGO,Innate immune system; Respiratory droplet; SARS-CoV-2,weather; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.3934/mbe.2020153,1.0,governmentofindonesia-83472b61d34d2a59f622aa85c0407d9e,Government of Indonesia,An analysis of Covid-19 transmission in Indonesia and Saudi Arabia,2020-06-03,http://download.garuda.kemdikbud.go.id/article.php?article=1726565&val=12227&title=AN%20ANALYSIS%20OF%20COVID-19%20TRANSMISSION%20IN%20INDONESIA%20AND%20SAUDI%20ARABIA,government,,Indonesia,Linear regression; Compartmental models in epidemiology; Medical statistics,science and technology>mathematics; science and technology; health>diseases and conditions
https://dx.doi.org/10.1371/journal.pcbi.1006857,2.0,who-2ef1dcb36782c7aec3cb68cfc09b7e12,World Health Organization,2nd ed,2021-09-14,https://apps.who.int/iris/handle/10665/345178,igo,healthcare agency,IGO,Coalition for Epidemic Preparedness Innovations; Vaccine adverse event; Pharmacovigilance,science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1371/journal.pcbi.1006857,2.0,who-edf129ec56c042e8e9f4521e354b6af7,World Health Organization,COVID-19 vaccines: safety surveillance manual,2021-01-06,https://apps.who.int/iris/handle/10665/338400,igo,healthcare agency,IGO,Coronavirus disease 2019; Clinical medicine; Health care,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology>genetics; science and technology>natural science>biology
https://dx.doi.org/10.1371/journal.pntd.0001330,1.0,stateofwesternaustralia-37cd02478fd3bf44c5104c994a48dcd9,State of Western Australia,"Guidelines for the Diagnosis, Management and Prevention of Leprosy",2023-04-28,https://www.health.wa.gov.au/~/media/Files/Corporate/general-documents/Leprosy/PDF/WATBCP-WA-Leprosy-Guideline.pdf,government,,Australia,Leprosy; Peripheral neuropathy; Thalidomide,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1136/bmj.297.6650.711,1.0,who-145904e985485ac0deacce021d9835d3,World Health Organization,"Public health surveillance: historical origins, methods and evaluation.",2018-03-25,https://apps.who.int/iris/handle/10665/263897,igo,healthcare agency,IGO,,
https://dx.doi.org/10.1186/1478-7547-10-10,5.0,apo-b163d2fee6c5df858ad015f5be20aee0,Analysis & Policy Observatory,Access all areas: new solutions for GP shortages in rural Australia,2018-05-08,https://apo.org.au/node/145366,other,aggregator,Australia,General practitioner; Pharmacy; Health care,health; health>diseases and conditions; education
https://dx.doi.org/10.1186/1478-7547-10-10,5.0,grattaninstitute-46804694ae6467e24b839f08f6b21f0c,Grattan Institute,Access all areas: new solutions for GP shortages in rural Australia,2013-09-29,https://grattan.edu.au/report/access-all-areas-new-solutions-for-gp-shortages-in-rural-australia/,think tank,,Australia,Medicare (United States); Medicare (Australia); Pharmaceutical Benefits Scheme,health; health>diseases and conditions; education
https://dx.doi.org/10.1186/1478-7547-10-10,5.0,kce-a05b29ac5724834a67057c2caa46be7d,Belgian Health Care Knowledge Centre,Seasonal influenza vaccination: prioritizing children or other target groups? - Part II,2013-01-01,https://kce.fgov.be/en/seasonal-influenza-vaccination-prioritizing-children-or-other-target-groups-part-ii,government,healthcare agency,Belgium,Influenza vaccine; Influenza; Randomized controlled trial,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1186/1478-7547-10-10,5.0,nice-9521fe181b37333ff4d827412f3c720b,NICE,Flu vaccination: increasing uptake,2018-08-22,https://www.nice.org.uk/guidance/ng103,government,healthcare agency,UK,Randomized controlled trial; Influenza vaccine; Influenza,health; education; health>health treatment>preventative medicine
https://dx.doi.org/10.1186/1478-7547-10-10,5.0,stateofalaska-91a224ccf7773d06c8429c6e62e3ced1,State of Alaska,Flu and Norovirus Prevention Tool Kit - Clorox Healthcare,2013-10-16,http://www.dhss.alaska.gov/dph/Epi/id/SiteAssets/Pages/Norovirus/Flu-Norovirus-Prevention-Kit.pdf,government,,USA,Norovirus; Influenza; Infection control,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1186/s12889-020-09278-0,2.0,ilo-d52c6b5bb9f237075d5396fa8ca1f861,International Labour Organization,Child labour and the impact of financial services on small holder tea house holds in Malawi,2022-01-01,https://researchrepository.ilo.org/esploro/outputs/report/Child-labour-and-the-impact-of/995264909502676,igo,,IGO,Microfinance in Tanzania; Microfinance; Labour economics,"economy, business and finance>economy; health; labour"
https://dx.doi.org/10.1186/s12889-020-09278-0,2.0,worldbank-a41e4bdf63b79397113c735f39752694,World Bank,Malawi - Climate and Health Vulnerability Assessment,2024-07-10,https://hdl.handle.net/10986/41847,igo,development bank,IGO,Climate change adaptation; Climate resilience; Health,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1111/jvh.13187,5.0,ecdc-f8ca470227fc020e599e811a727268f4,European Centre for Disease Prevention and Control,Prevention and control of infectious diseases among people who inject drugs - 2023 update,2023-11-07,https://www.ecdc.europa.eu/en/publications-data/prevention-and-control-infectious-diseases-among-people-who-inject-drugs-2023,government,agency,EU,Hepatitis C; Sexually transmitted infection; Tuberculosis,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health>health treatment
https://dx.doi.org/10.1111/jvh.13187,5.0,europa-31e1cfe9637423c94702ea7b086aee40,Publications Office of the European Union,Prevention and control of infectious diseases among people who inject drugs - Publications Office of the EU,2023-12-04,https://op.europa.eu/en/publication-detail/-/publication/2303fbb3-94bc-11ee-b164-01aa75ed71a1/language-en,government,,EU,Harm reduction; Hepatitis C; Sexually transmitted infection,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health>health treatment
https://dx.doi.org/10.1111/jvh.13187,5.0,kirbyinstitute-d2ee587301e3de6cc0a0079367489489,Kirby Institute,Annual Report 2019,2020-12-17,https://www.kirby.unsw.edu.au/research/reports/annual-report-2019,think tank,university affiliated,Australia,Human papillomavirus infection; Cervical cancer; HPV vaccine,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1111/jvh.13187,5.0,stateofcatalunya-3ff5b1066fe1b4cfff15fdcc6360fa4a,Generalitat de Catalunya,Protocol de diagnòstic i tractament del virus de l’hepatitis C per persones drogodependents,2021-03-24,https://salutpublica.gencat.cat/web/.content/minisite/aspcat/vigilancia_salut_publica/vih-sida-its/04_Hepatitis_viriques/guies_i_protocols/Protocol-diagnostic-i-tractament-VHC-persones-drogodependents_Act-2021_okDef.pdf,government,,Spain,,
https://dx.doi.org/10.1111/jvh.13187,5.0,stateofcatalunya-7c41a23fd1958362a683a9a820b7191b,Generalitat de Catalunya,Protocol de diagnòstic i tractament del virus de l’hepatitis C per persones drogodependents,2020-06-23,https://salutpublica.gencat.cat/web/.content/minisite/aspcat/vigilancia_salut_publica/vih-sida-its/04_Hepatitis_viriques/guies_i_protocols/Protocol-diagnostic-i-tractament-VHC-persones-drogodependents_defOK.pdf,government,,Spain,,
https://dx.doi.org/10.1111/j.1532-5415.2000.tb02604.x,3.0,hcspfr-b55a09ef1a5460cf84e812b59c90accc,Haut Conseil de la santé publique,Conduite à tenir devant une ou plusieurs infections respiratoires aiguës en Ehpad,2012-07-03,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=288,government,agency,France,Influenza; Infection; Acute bronchitis,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1111/j.1532-5415.2000.tb02604.x,3.0,pubmedcentral-62b62ac51cf5f312699b888aa002a66b,Guidelines in PubMed Central,SHEA/APIC Guideline: Infection prevention and control in the long-term care facility,2008-09-09,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375028/pdf,other,aggregator,USA,Infection; Pressure ulcer; Influenza,health>diseases and conditions>illness; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1111/j.1532-5415.2000.tb02604.x,3.0,stateofalaska-4b5272d7d2a19e024814ccc883ae12af,State of Alaska,SHEA / APIC Guideline : Infection prevention and control in the long-term care facility,2012-03-09,https://health.alaska.gov/dph/Epi/id/SiteAssets/Pages/Infection-Prevention-Boot-Camp/id_APIC-SHEA_GuidelineforICinLTCFs.pdf,government,,USA,Isolation (health care); Transmission-based precautions; Infection prevention and control,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1186/1471-2334-13-309,1.0,nice-e1db5edd8c90781a0a4ad7d4de87ecac,NICE,Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management,2023-11-02,https://www.nice.org.uk/guidance/ng237,government,healthcare agency,UK,Procalcitonin; Respiratory disease; Pneumonia,health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1136/bmjopen-2018-025553,2.0,govdeptsjapan-8784d4a3b1d5608992f2d647be7e262e,Government of Japan,帯状疱疹ワクチンファクトシート 第,2024-06-20,https://www.mhlw.go.jp/content/10900000/001266215.pdf,government,,Japan,Epidemiology; Chickenpox; Varicella vaccine,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1136/bmjopen-2018-025553,2.0,govdeptsspain-54a3070245c7416311782d2de228e6f2,Government of Spain,HerpesZoster RecomendacionesVacunacion,2021-03-29,https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/docs/HerpesZoster_RecomendacionesVacunacion.pdf,government,,Spain,Varicella zoster virus; Shingles; Health care,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1136/sti.2004.009654,2.0,signuk-58c25f50a27b9ef727e81309666ebe95,Scottish Intercollegiate Guidelines Network,SIGN 109 Management of genital chlamydia trachomatis infection,2016-04-01,http://www.sign.ac.uk/sign-109-management-of-genital-chlamydia-trachomatis-infection.html,government,healthcare agency,UK,National Institute for Health and Care Excellence; National Health Service; NHS Scotland,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1136/sti.2004.009654,2.0,tewhatuoranz-ebfb996c44006dd63f9f5c7b44c6cd70,Te Whatu Ora,Chlamydia Screening in New Zealand: Report for the National Screening Unit July 2006,2006-12-13,https://www.tewhatuora.govt.nz/publications/chlamydia-screening-in-new-zealand-report-for-the-national-screening-unit-july-2006,government,agency,New Zealand,Evidence-based medicine; Randomized controlled trial; Sexual and reproductive health,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.epidem.2014.07.002,1.0,novanorway-6f21fdbaaeddc3c603b348d6b6cccc44,NOVA,Konsekvenser av sykepleiermangel i kommunene fra et pasient- og pårørendeperspektiv,2020-06-21,https://fagarkivet-hioa.archive.knowledgearc.net/handle/20.500.12199/5118,think tank,,Norway,Major depressive disorder; Communication; Information,health; science and technology; health>health treatment>medicine
https://dx.doi.org/10.1023/b:ddas.0000011597.92851.56,2.0,pubmedcentral-1a385dd54d1f5a956089ea9235afcc34,Guidelines in PubMed Central,Quality Standards for the Management of NAFLD: Consensus Recommendations from the British Association for the Study of the Liver (BASL) and British Society of Gastroenterology (BSG) NAFLD Special Interest Group,2022-08-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614852/pdf,other,aggregator,USA,Metabolic dysfunction–associated steatotic liver disease; Cirrhosis; Statin,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1023/b:ddas.0000011597.92851.56,2.0,pubmedcentral-b5dbb51e5e354dd92746c630b915221f,Guidelines in PubMed Central,"APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing",2016-05-26,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003900/pdf,other,aggregator,USA,Hepatitis C; Hepatocellular carcinoma; Cirrhosis,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1007/s10096-012-1681-z,1.0,aspehhsgovus-ebae6093b992d2a5a19be13d75868c12,ASPE,"Economic Incentives for the Development of Rapid Point-of-Care (POC) Diagnostic Devices for C.Difficile, Carbapenem-Resistant Enterobacteriaceae (CRE), and Neisseria Gonorrhoeae",2018-11-29,https://aspe.hhs.gov/reports/economic-incentives-development-rapid-point-care-poc-diagnostic-devices-cdifficile-carbapenem,government,,USA,Clostridioides difficile infection; Quality-adjusted life year; Carbapenem,health>diseases and conditions; health; science and technology>natural science>biology
https://dx.doi.org/10.1016/j.socscimed.2008.09.061,11.0,awmf-291e3223bc011572eb13d22f0e853a43,Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF),Metamphetamin-bezogene Störungen,2016-11-21,https://www.awmf.org//leitlinien/detail/ll/038-024.html,government,healthcare agency,Germany,Evidence-based medicine; Human sexual activity; Posttraumatic stress disorder,health; health; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1016/j.socscimed.2008.09.061,11.0,edulinksusa-c1dcbd22c046eaf46487aab8f32f8e2c,EduLinks,Evidence and Promising Practices from Peer-Based Approaches in Youth Programs,2020-04-01,https://www.edu-links.org/resources/evidence-and-promising-practices-peer-based-approaches-youth-programs,government,research center,USA,Positive youth development; Sexual and reproductive health; Behavioural sciences,education; health; education>school>further education
https://dx.doi.org/10.1016/j.socscimed.2008.09.061,11.0,edulinksusa-e1bfc64ff8f82b02575ed67f8b6c90c6,EduLinks,Life Skills in Non-Formal Contexts for Adolescent Girls in Developing Countries,2018-04-01,https://www.edu-links.org/resources/life-skills-non-formal-contexts-adolescent-girls-developing-countries,government,research center,USA,Adolescence; Education; Research,education; health; science and technology
https://dx.doi.org/10.1016/j.socscimed.2008.09.061,11.0,edulinksusa-fe80da2d770b440bc1d3545fd07c1d82,EduLinks,Evidence Gap Map: Youth & Transferable Skills,2015-08-01,https://www.edu-links.org/resources/youth-transferable-skills-evidence-gap-map,government,research center,USA,Systematic review; Impact evaluation; Theory of Change,education; education; science and technology
https://dx.doi.org/10.1016/j.socscimed.2008.09.061,11.0,odi-e97a28ea0f02cccf8deb294ff3066087,Overseas Development Institute (ODI),Young people as agents and advocates of development,2016-10-01,https://odi.org/en/publications/young-people-as-agents-and-advocates-of-development/,think tank,,UK,Peacebuilding; Quasi-experiment; Research,education; health; society
https://dx.doi.org/10.1016/j.socscimed.2008.09.061,11.0,opensocietyfoundations-fe72842d9cc03baf0ac5310c7a000559,Open Society Foundations,Detention as Treatment,2010-05-01,https://www.opensocietyfoundations.org/publications/detention-treatment,think tank,,USA,Heroin; Preventive healthcare; Dopamine,"health>diseases and conditions; crime, law and justice>crime; health"
https://dx.doi.org/10.1016/j.socscimed.2008.09.061,11.0,pubmedcentral-36ec8d354d85f8741daf32e0cf7a60db,Guidelines in PubMed Central,Primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries,2021-08-05,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf,other,aggregator,USA,Health sciences; Clinical medicine; Medicine,health; education; science and technology
https://dx.doi.org/10.1016/j.socscimed.2008.09.061,11.0,pubmedcentral-c7059446df09a9fe29d606f0ee2b1159,Guidelines in PubMed Central,Primary‐level and community worker interventions for the prevention of mental disorders and the promotion of well‐being in low‐ and middle‐income countries,2023-10-24,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594594/pdf,other,aggregator,USA,Medicine; Health care; DSM-5,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1016/j.socscimed.2008.09.061,11.0,saxinstitute-d013a59fdda94b6a049c6bb155d99451,Sax Institute,Evidence for the effectiveness of peer-led education for at risk youth,2016-06-23,https://www.saxinstitute.org.au/evidence-check/evidence-for-the-effectiveness-of-peer-led-education-for-at-risk-youth-resilience-and-harm-minimisation-in-alcohol-and-other-drug-use/,think tank,,Australia,Binge drinking; Youth; Education,education>school; education; health
https://dx.doi.org/10.1016/j.socscimed.2008.09.061,11.0,unpopulation-4f1f8f24da522205d1396c9f1c1dcf5d,United Nations Population Fund,International Technical and Programmatic Guidance on Out-of-School Comprehensive Sexuality Education (CSE),2020-11-17,https://www.unfpa.org/publications/international-technical-and-programmatic-guidance-out-school-comprehensive-sexuality,igo,,IGO,UNESCO; Technology; Discrimination,education; health; health
https://dx.doi.org/10.1016/j.socscimed.2008.09.061,11.0,wellcometrust-f51be154af952a1a87af2a64389adf5b,Wellcome Trust,A rapid evidence review of young people's involvement in health research,2021-01-29,https://cms.wellcome.org/sites/default/files/2021-02/a-rapid-evidence-review-of-young-peoples-involvement-in-health-research.pdf,think tank,,UK,Branches of science; Cognition; Science,health; education; science and technology
https://dx.doi.org/10.1016/j.medengphy.2012.07.011,3.0,govdeptsbrazil-95d2961d77b74b3b1da72860c3f9d994,Government of Brazil,Relatório Anual 2013 Termo de Compromisso de Gestão,2014-03-16,https://antigo.mctic.gov.br/mctic/export/sites/institucional/contratos_gestao_organizacoes_sociais/arquivos/TCG/LNCC/Relatorio-2013.pdf,government,,Brazil,Computer simulation; Rede Nacional de Ensino e Pesquisa; Bioinformatics,"economy, business and finance>economic sector>computing and information technology; science and technology; science and technology>natural science>biology"
https://dx.doi.org/10.1016/j.medengphy.2012.07.011,3.0,stateofcatalunya-a45de966b7bf307af82742d9d903a7b3,Generalitat de Catalunya,Aj-ahrt230068 1..29,2023-06-12,https://scientiasalut.gencat.cat/bitstream/handle/11351/9728/arterial_pulse_wave_modeling_analysis_vascular_age_studies_a_review_vascagenet_2023.pdf,government,,Spain,Cardiovascular system; Physiology; Cardiovascular physiology,science and technology>mathematics; science and technology>natural science>physics; science and technology>natural science>biology>physiology
https://dx.doi.org/10.1016/j.medengphy.2012.07.011,3.0,stateofcatalunya-ddc6ab0908adf63eae0990426045c793,Generalitat de Catalunya,Aj-ahrt230068 1..29,2023-06-12,https://scientiasalut.gencat.cat/bitstream/handle/11351/9728/arterial_pulse_wave_modeling_analysis_vascular_age_studies_a_review_vascagenet_2023.pdf?sequence=1&isAllowed=y,government,,Spain,Artery; Pulse wave velocity; Windkessel effect,science and technology>mathematics; science and technology>natural science>physics; science and technology>natural science>biology>physiology
https://dx.doi.org/10.1016/j.ypmed.2020.106066,1.0,rivmnl-bbaf91c16a16b7d004ec71fefb6ace49,Rijksinstituut voor Volksgezondheid en Milieu,The National Immunisation Programme in the Netherlands : Surveillance and developments in 2019-2020,2020-11-27,https://www.rivm.nl/publicaties/national-immunisation-programme-in-netherlands-surveillance-and-developments-in-2019,government,research center,Netherlands,MMR vaccine; Vaccine; DPT vaccine,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1136/sextrans-2020-054741,1.0,rivmnl-ae0d940c7ea812af2e3e70e0b7ec3269,Rijksinstituut voor Volksgezondheid en Milieu,Sexually transmitted infections in the Netherlands in 2021,2022-06-23,https://www.rivm.nl/publicaties/sexually-transmitted-infections-in-netherlands-in-2021,government,research center,Netherlands,Epidemiology; Sexually transmitted infection; Pre-exposure prophylaxis,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1111/1471-0528.13503,7.0,edulinksusa-ac2c1ff144cad98031eca0dfb8f229e1,EduLinks,Optimizing Education Outcomes,2018-01-01,https://www.edu-links.org/resources/optimizing-education-outcomes,government,research center,USA,Sexual and reproductive health; Child; Sustainable Development Goal 4,health; health>diseases and conditions; education
https://dx.doi.org/10.1111/1471-0528.13503,7.0,gpeusa-e69631da099f83c58e4613ef21cd63ce,Global Partnership for Education,Optimizing education outcomes: High-return investments in school health for increased participation and learning,2018-04-06,https://www.globalpartnership.org/content/optimizing-education-outcomes-high-return-investments-school-health-increased-participation-and-learning,think tank,,USA,Health; Education; Adolescence,health; health>diseases and conditions; education
https://dx.doi.org/10.1111/1471-0528.13503,7.0,has-5ae9fa86b39448aeecb18770116b8899,Haute Autorité de Santé,Recommandation sur l’élargissement de la vaccination contre les papillomavirus aux garçons,2019-12-16,https://www.has-sante.fr/jcms/p_3116022/fr/recommandation-sur-l-elargissement-de-la-vaccination-contre-les-papillomavirus-aux-garcons,government,healthcare agency,France,Human papillomavirus infection; Vaccination; Gardasil,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1111/1471-0528.13503,7.0,hiqaie-42ace8734fbb882eeceec6a85697f672,Health Information and Quality Authority,HTA of extending the HPV vaccination to boys,2018-12-05,https://www.hiqa.ie/reports-and-publications/health-technology-assessment/hta-extending-hpv-vaccination-boys,government,healthcare agency,Ireland,Cervarix; Wart; DPT vaccine,health>diseases and conditions; science and technology>natural science>biology; health
https://dx.doi.org/10.1111/1471-0528.13503,7.0,kce-beafcfa334bd7c891491a9a540e34f3a,Belgian Health Care Knowledge Centre,Cost-effectiveness analysis of HPV vaccination of boys in Belgium,2019-01-01,https://kce.fgov.be/en/cost-effectiveness-analysis-of-hpv-vaccination-of-boys-in-belgium,government,healthcare agency,Belgium,Gardasil; Human papillomavirus infection; Genital wart,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment>preventative medicine
https://dx.doi.org/10.1111/1471-0528.13503,7.0,worldbank-a8c5944b04b7b9999c995c91c050329d,World Bank,"Disease Control Priorities, Third Edition",2017-11-01,https://hdl.handle.net/10986/28876,igo,development bank,IGO,Sexual and reproductive health; Sustainable Development Goal 4; Developing country,health; health; health>diseases and conditions
https://dx.doi.org/10.1111/1471-0528.13503,7.0,worldbank-ec94cedad1962b3e621825725ec3aaf9,World Bank,"Disease Control Priorities, Third Edition : Volume 8. Child and Adolescent Health and Development",2017-11-15,https://openknowledge.worldbank.org/handle/10986/28876,igo,development bank,IGO,Human activities; Statistics; Intelligence quotient,health; education; education>school
https://dx.doi.org/10.1111/j.1865-1682.2009.01086.x,2.0,efsaeu-a6143df822fa05a54bddce7965e863be,EFSA,Development of a risk assessment methodological framework for potentially pandemic influenza strains (FLURISK),2014-05-22,https://www.efsa.europa.eu/en/supporting/pub/en-571,government,agency,EU,Health sciences; Avian influenza; Influenza A virus subtype H3N2,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1111/j.1865-1682.2009.01086.x,2.0,oieint-d57bc1c57b6cc8023c05947a3273ddaa,World Organization for Animal Health,Development of a risk assessment methodological framework for potentially pandemic influenza strains (FLURISK) - (CFP/EFSA/AHAW/2011/01),2014-05-01,https://doc.oie.int/dyn/portal/index.xhtml?page=alo&aloId=24350,igo,,IGO,Avian influenza; Influenza; Influenza A virus subtype H5N1,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1046/j.1365-3156.1998.00289.x,2.0,who-03bb48969569f914469d07634edb81e7,World Health Organization,The global prevalence of hepatitis E virus infection and susceptibility: a systematic review,2012-06-17,https://apps.who.int/iris/handle/10665/70513,igo,healthcare agency,IGO,Clinical medicine; Hepatitis E; Transmission (medicine),health; health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology
https://dx.doi.org/10.1046/j.1365-3156.1998.00289.x,2.0,who-78f74a9716e3f8dc846569dcbb1e53e2,World Health Organization,The global prevalence of hepatitis A virus infection and susceptibility : a systematic review,2012-06-17,https://apps.who.int/iris/handle/10665/70180,igo,healthcare agency,IGO,Chūbu region; Jaundice; Hepatitis,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1093/ofid/ofab415,2.0,dhsgov-07fb0e77b88ab97750003d3d688bed00,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-11-04,https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Infection; COVID-19 vaccine,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1093/ofid/ofab415,2.0,dhsgov-eeb18fe8690357c6b05b850ab4cf6b68,Department of Homeland Security,Master Question List fgor COVID-19 (caused by SARS-CoV-2),2023-02-21,https://www.dhs.gov/sites/default/files/2023-02/23_0131_st_mql_sars_cov-2.pdf,government,,USA,Variants of SARS-CoV-2; N95 respirator; Surgical mask,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1128/jvi.76.3.968-979.2002,1.0,pubmedcentral-0ce3d71ef9826c22a95e572575de72c4,Guidelines in PubMed Central,Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults,2006-07-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390496/pdf,other,aggregator,USA,Management of HIV/AIDS; HIV/AIDS; Randomized controlled trial,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.2196/10503,1.0,stateofnorthcarolina-8d363b6b4c8365775727ae9f21414573,State of North Carolina,The road to Oral Health Equity in NC,2018-09-20,https://publichealth.nc.gov/oralhealth/docs/OralHealth-Newsletter-092418-WEB.pdf,government,,USA,Tooth decay; Fluoride therapy; Human papillomavirus infection,health>diseases and conditions; health; science and technology>biomedical science>dentistry
https://dx.doi.org/10.3390/ijerph9124704,1.0,who-f9e4072a2bbd2aa7a6a201b1b8db8f7d,World Health Organization,Bibliography of scientific publications on vector-borne diseases from WHO South-East Asia region 2009-2013,2016-04-05,https://apps.who.int/iris/handle/10665/204819,igo,healthcare agency,IGO,Chikungunya; Visceral leishmaniasis; Dengue fever,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.3934/mbe.2011.8.95,2.0,ecdc-75e2d1e62e77f705110e9fbc163393bf,European Centre for Disease Prevention and Control,Key aspects regarding the introduction and prioritisation of COVID-19 vaccination in the EU/EEA and the UK,2020-10-23,https://www.ecdc.europa.eu/en/publications-data/key-aspects-regarding-introduction-and-prioritisation-covid-19-vaccination,government,agency,EU,Health sciences; Coronavirus disease 2019; Infection,health>diseases and conditions; health>diseases and conditions>illness; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.3934/mbe.2011.8.95,2.0,ecdc-f4bd2be88ead63200295f7c607f98af1,European Centre for Disease Prevention and Control,COVID-19 vaccination and prioritisation strategies in the EU/EEA,2020-12-22,https://www.ecdc.europa.eu/en/publications-data/covid-19-vaccination-and-prioritisation-strategies-eueea,government,agency,EU,Epidemiology; 2009 flu pandemic; Pharmacovigilance,health>diseases and conditions; health>diseases and conditions>illness; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.watres.2016.03.057,1.0,rijksoverheid-381eb1bf8ec7dcf65344433dde036b5b,Rijksoverheid,Key findings from literature review on the SARS-CoV-2 transmission in aircraft cabins,2020-10-20,https://www.rijksoverheid.nl/documenten/rapporten/2020/10/20/bijlage-1-nlr-cr-2020-288-key-findings-from-literature-review-on-the-sars-cov-2-transmission-in-aircraft-cabins,government,,Netherlands,Transmission (medicine); Airline seat; Cabin pressurization,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; health
https://dx.doi.org/10.1016/s0899-3289(01)00068-2,4.0,pubmedcentral-9068dbe6b086a9682ba43313592589d3,Guidelines in PubMed Central,Addressing Intimate Partner Violence with Male Patients: A Review and Introduction of Pilot Guidelines,2008-10-02,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596504/pdf,other,aggregator,USA,Violence; Domestic violence; Victimisation,"crime, law and justice>crime; health; science and technology"
https://dx.doi.org/10.1016/s0899-3289(01)00068-2,4.0,stateofcatalunya-bad1444917312fe5473a47324078609f,Generalitat de Catalunya,Dependència,2013-04-15,http://www20.gencat.cat/docs/canalsalut/Minisite/Drogues/Professionals/Tractament/Col%E2%80%A2lectius%20amb%20nec%20espec%C3%ADfiques/Prog%20Drogues%20i%20viol%C3%A8ncia/pdf/HOMES_RELACIONS_SALUT%20amb%20marcadors.pdf,government,,Spain,,
https://dx.doi.org/10.1016/s0899-3289(01)00068-2,4.0,stateofcatalunya-c0b5d532936e0d5fa96f068617a03b76,Generalitat de Catalunya,Dependència,2015-03-30,https://drogues.gencat.cat/web/.content/minisite/drogues/professionals/tractament/col_lectius_amb_nec_especifiques/prog_drogues_i_violencia/pdf/HOMES_RELACIONS_SALUT_OK.pdf,government,,Spain,,
https://dx.doi.org/10.1016/s0899-3289(01)00068-2,4.0,unodc-e6f55af85b6695e6df85cb09fbcb0183,United Nations Office on Drugs and Crime,Women who inject drugs,2011-08-17,https://www.unodc.org/documents/hiv-aids/Women_who_inject_drugs.pdf,igo,,IGO,Sexual intercourse; Violence; HIV/AIDS,health; health>diseases and conditions>communicable disease>virus disease; science and technology>social sciences
https://dx.doi.org/10.1023/a:1007594911541,1.0,governmentofcanada-bfa6fa746a4299e2d6632464e0881ae9,Government of Canada,Supplemental guidance on influenza vaccination in adults 65 years of age and older.: HP40-363/1-2024E-PDF ; HP40-363/2-2024E-PDF Publications - Canada.ca,2024-07-01,http://publications.gc.ca/site/eng/9.937059/publication.html,government,,Canada,Influenza vaccine; Herd immunity; Vaccine,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1080/17441692.2014.984742,4.0,governmentofuganda-9c29f57c134bf91536016fbb9e85bf91,Government of Uganda,Guidelines On Hepatitis B And C Testing,2017-02-27,http://library.health.go.ug/sites/default/files/resources/Guidlines%20on%20Hepatitis%20B%20and%20C%20Testing.pdf,government,,Uganda,Hepatitis C; Hepatitis B; Hepatitis,health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1080/17441692.2014.984742,4.0,hiqaie-d065fa163eb9eb9e8f6ff2adb1b15bf9,Health Information and Quality Authority,HTA of birth cohort testing for hepatitis C,2021-07-28,https://www.hiqa.ie/reports-and-publications/health-technology-assessment/hta-birth-cohort-testing-hepatitis-c,government,healthcare agency,Ireland,Hepatitis C; Hepatitis; Screening (medicine),health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1080/17441692.2014.984742,4.0,who-71f9e521af60bcd3f099086d5aabe377,World Health Organization,WHO guidelines on hepatitis B and C testing,2017-02-16,https://apps.who.int/iris/handle/10665/254621,igo,healthcare agency,IGO,Hepatitis; HIV/AIDS; Hepatitis C,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease>virus disease>retrovirus
https://dx.doi.org/10.1080/17441692.2014.984742,4.0,who-d10ac4305f37905993d9eb54c3afd6e0,World Health Organization,Руководство по тестированию на гепатиты В и С,2018-02-06,https://apps.who.int/iris/handle/10665/260130,igo,healthcare agency,IGO,,
https://dx.doi.org/10.1093/bib/bbz056,1.0,idrc-aa044cdcfb2a6257c7a3f2ab5533d15a,International Development Research Centre,"Streptococcus sputorum, a novel member of Streptococcus with multidrug resistance, exhibits cytotoxicity",2021-12-14,https://idrc-crdi.ca/en/node/114665,think tank,,Canada,Streptococcus; Streptococcus pneumoniae; Antimicrobial resistance,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health>diseases and conditions
https://dx.doi.org/10.1093/oxfordjournals.aje.a008807,2.0,cdc-075c8b420e93cf0d8e092d62483bddb6,Centers for Disease Control and Prevention (CDC),"HIV prevalence trends in selected populations in the United States; results from national serosurveillance, 1993-1997",2001-10-03,https://stacks.cdc.gov/view/cdc/6427,government,healthcare agency,USA,HIV/AIDS; Diagnosis of HIV/AIDS; Sexually transmitted infection,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1093/oxfordjournals.aje.a008807,2.0,cdc-363eb17e64ba096045073472e7ac3ea2,Centers for Disease Control and Prevention (CDC),HIV prevention among drug users; a resource book for community planners and program managers,2000-05-28,https://stacks.cdc.gov/view/cdc/12418,government,healthcare agency,USA,HIV/AIDS; Substance abuse; Prevention of HIV/AIDS,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1371/journal.pone.0072088,2.0,hcspfr-ad964499ddaa489c01e71fb37fd179f0,Haut Conseil de la santé publique,Vaccination contre les infections à papillomavirus humains. Données actualisées,2014-07-10,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=454,government,agency,France,Human papillomavirus infection; Vaccination; Gardasil,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1371/journal.pone.0072088,2.0,thlfi-f356a9ffec28140ee789c17fb84bf1b2,Terveyden ja hyvinvoinnin laitos,Tulisiko poikien HPV-rokotusten olla osa kansallista rokotusohjelmaa? : Työryhmän loppuraportti,2019-01-22,http://www.julkari.fi/handle/10024/137477,government,healthcare agency,Finland,Health; Public health; Clinical medicine,health; health>diseases and conditions; health>diseases and conditions>cancer
https://dx.doi.org/10.1371/journal.pntd.0009091,1.0,who-e522845c422d3d4a8fc1d028c53a751b,World Health Organization,"Ending disease in Africa: control, elimination, and eradication efforts for neglected tropical diseases, scoping review of the literature in the WHO African Region since 1990",2023-01-01,https://apps.who.int/iris/handle/10665/375839,igo,healthcare agency,IGO,Neglected tropical diseases; Eradication of infectious diseases; Onchocerciasis,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.2807/1560-7917.es2015.20.2.21011,4.0,ecdc-7109b2d86e0d50b766a562dfdbb4f516,European Centre for Disease Prevention and Control,"Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines",2020-10-01,https://www.ecdc.europa.eu/en/publications-data/seasonal-influenza-systematic-review-efficacy-vaccines,government,agency,EU,Vaccine efficacy; Influenza A virus subtype H3N2; Influenza vaccine,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.2807/1560-7917.es2015.20.2.21011,4.0,europa-d56f4bf322f89f8eec32ed6e4cf100ab,Publications Office of the European Union,"Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals aged 18 years and over.",2020-10-08,https://op.europa.eu/en/publication-detail/-/publication/faa39733-0d03-11eb-bc07-01aa75ed71a1/language-en/format-PDF,government,,EU,Vaccine efficacy; Influenza A virus subtype H3N2; Influenza vaccine,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.2807/1560-7917.es2015.20.2.21011,4.0,robertkochde-819a9908d6706b57ed2b52583a798bce,Robert Koch Institut,Epidemiologisches Bulletin 1/2021,2021-03-05,https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2021/Ausgaben/01_21.pdf?__blob=publicationFile,government,healthcare agency,Germany,Influenza vaccine; Health economics; Medical specialties,health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.2807/1560-7917.es2015.20.2.21011,4.0,stateofvalencia-8ecd400c373416e14c523678b130b4e3,Generalitat Valenciana,Memoria Científica 2015,2016-12-20,https://fisabio.san.gva.es/media/upload/arxius/investigacion/memoria-cientifica/memoria-cientifica-fisabio-2015.pdf,government,,Spain,Biobank; Metagenomics; Virus,science and technology>natural science>biology; science and technology>natural science>biology>genetics; science and technology
https://dx.doi.org/10.1093/jac/48.4.535,1.0,apo-5773908e214400c0205afc2f47262f07,Analysis & Policy Observatory,Antibiotic resistance: how did we get here and what can we do?,2015-03-18,https://apo.org.au/node/53724,other,aggregator,Australia,Antimicrobial resistance; Antibiotic use in livestock; Antibiotic,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.7326/0003-4819-113-7-495,4.0,awmf-fc24e8e625175f5c6b3780425cbce370,Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF),"Sepsis - Prävention, Diagnose, Therapie und Nachsorge",2010-02-01,https://www.awmf.org//leitlinien/detail/ll/079-001.html,government,healthcare agency,Germany,Acute respiratory distress syndrome; Asplenia; Shock (circulatory),health; science and technology>biomedical science>pharmacology; health>health treatment>medicine
https://dx.doi.org/10.7326/0003-4819-113-7-495,4.0,nice-555045de1754b11181cbc8e725961393,NICE,"Meningitis (bacterial) and meningococcal septicaemia in under 16s: recognition, diagnosis and management",2015-02-01,https://www.nice.org.uk/guidance/cg102,government,healthcare agency,UK,Streptococcus pneumoniae; Pneumonia; Streptococcus,health; health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology
https://dx.doi.org/10.7326/0003-4819-113-7-495,4.0,nice-e5b026d481795747b6527edf83c957c1,NICE,"Sepsis: recognition, diagnosis and early management",2017-09-13,https://www.nice.org.uk/guidance/ng51,government,healthcare agency,UK,Clinical medicine; Quality-adjusted life year; Cost–utility analysis,health; health; health
https://dx.doi.org/10.7326/0003-4819-113-7-495,4.0,pubmedcentral-d566597803542e081e00911055904423,Guidelines in PubMed Central,"Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI))",2010-06-28,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899863/pdf,other,aggregator,USA,Sepsis; Acute respiratory distress syndrome; Hypoglycemia,science and technology>biomedical science>pharmacology; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1016/j.dld.2014.12.008,1.0,kce-406272860e834a882a65e0907fde7abc,Belgian Health Care Knowledge Centre,Economic evaluation of novel direct acting antiviral (DAA) treatment strategies for chronic hepatitis C,2016-01-01,https://kce.fgov.be/en/economic-evaluation-of-novel-direct-acting-antiviral-daa-treatment-strategies-for-chronic-hepatitis,government,healthcare agency,Belgium,Incremental cost-effectiveness ratio; Quality-adjusted life year; Hepatitis C,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1073/pnas.1708856115,1.0,wmo-c08e22cb95f861b174edd45faa2c6547,World Meteorological Organization,Review on Meteorological and Air Quality Factors Affecting the COVID-19 Pandemic,2021-02-25,https://library.wmo.int/records/item/57336-first-report-of-the-wmo-covid-19-task-team-review-on-meteorological-and-air-quality-factors-affecting-the-covid-19-pandemic,igo,,IGO,Innate immune system; Respiratory droplet; SARS-CoV-2,weather; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.trstmh.2003.11.003,2.0,who-3df44034ccd576b3d715b3bdfe8fff6b,World Health Organization,Health system considerations related to voluntary and forced displacement in the eastern mediterranean region: a critical analysis of the available literature,2022-06-14,https://apps.who.int/iris/handle/10665/356185,igo,healthcare agency,IGO,Refugee; Health; Human migration,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.trstmh.2003.11.003,2.0,who-88cca75691e711fd8ac7f4398cca05a5,World Health Organization,"Eastern Mediterranean Health Journal [‎2021; Vol.27, Issue 12]‎",2022-02-21,https://apps.who.int/iris/handle/10665/352039,igo,healthcare agency,IGO,Palestinian refugees; Health; Chronic condition,health; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1197/j.aem.2006.07.017,1.0,who-051628fb85389729c5814a9f9a8e0b18,World Health Organization,Population-based simulations of influenza pandemics: validity and significance for public health policy,2018-03-26,https://apps.who.int/iris/handle/10665/270401,igo,healthcare agency,IGO,Simulation; Influenza pandemic; Influenza,"health>diseases and conditions; health; economy, business and finance>economic sector>computing and information technology"
https://dx.doi.org/10.1371/journal.pone.0071692,2.0,ahrq-81483526743f096862bc29140ffd3f43,AHRQ,Resource Allocation and Pandemic Response: An Evidence Synthesis To Inform Decision Making,2020-09-28,https://effectivehealthcare.ahrq.gov/products/allocation-scarce-resources/rapid-review,government,healthcare agency,USA,Influenza vaccine; Influenza pandemic; Coronavirus disease 2019,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1371/journal.pone.0071692,2.0,instituteofdevelopmentstudies-a4288b8b77387f02ae41045b1a81db11,Institute of Development Studies,"Key Considerations: Dying, Bereavement and Mortuary and Funerary Practices in the Context of COVID-19 (April 2020)",2020-04-01,https://opendocs.ids.ac.uk/opendocs/handle/20.500.12413/15236,think tank,,UK,Ebola virus disease; Embalming; Health,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,adminch-0769a890c4c89881c8e972ede88bbc61,Government of Switzerland,BAG-Bulletin 3/2024,2024-01-11,https://www.bag.admin.ch/dam/bag/de/dokumente/mt/i-und-b/richtlinien-empfehlungen/neue-empfehlungen/hpv-basisimpfung-jungen.pdf.download.pdf/Die%20HPV-Impfung%20als%20Basisimpfung%20für%20Jungen.pdf,government,,Switzerland,Papillomavirus; Causes of death; Pediatrics,health; health>diseases and conditions; health>diseases and conditions>cancer
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,adminch-21ce3ee6082f91fcd8621109b233197d,Government of Switzerland,BAG-Bulletin 3/2024,2024-01-11,https://www.bag.admin.ch/dam/bag/de/dokumente/cc/Kampagnen/Bulletin/2024/bu-3-24.pdf.download.pdf/BU_3_24_DE.pdf,government,,Switzerland,Immunology; HPV vaccine; Meningococcal vaccine,health; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,adminch-2d3faab84eec5e6f036e60e36922480f,Government of Switzerland,OFSP-Bulletin 3/2024,2024-01-11,https://www.bag.admin.ch/dam/bag/fr/dokumente/cc/Kampagnen/Bulletin/2024/bu-3-24.pdf.download.pdf/BU_3_24_FR.pdf,government,,Switzerland,Human papillomavirus infection; Vaccination; Cervix,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,adminch-300c7c9dee880acb40e25fa2d4c19bc6,Government of Switzerland,Die HPV-Impfung als Basisimpfung für Jungen,2023-11-03,https://www.bag.admin.ch/dam/bag/de/dokumente/kuv-leistungen/leistungen-und-tarife/aerztliche-leistungen/Anhang1a-KLV/art.12a%20bst.%20q_klv_empf_basisimpfung_hpv_jungen_6november2023.pdf.download.pdf/Art.12a_KLV_Empfehlungen%20des%20BAG%20und%20der%20EKIF%20zur%20Basisimpfung%20gegen%20Humane%20Papillomaviren%20bei%20Jungen%20vom%206.%20November%202023.pdf,government,,Switzerland,HPV vaccine; Health sciences; Medicine,health>diseases and conditions; health; health>diseases and conditions>cancer
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,adminch-4bc78c8ed7def8054ccba2b15e6761b1,Government of Switzerland,BAG-Bulletin 3/2024,2024-01-11,https://www.bag.admin.ch/dam/bag/de/dokumente/mt/i-und-b/richtlinien-empfehlungen/neue-empfehlungen/hpv-basisimpfung-jungen.pdf.download.pdf/Die%20HPV-Impfung%20als%20Basisimpfung%20f%C3%BCr%20Jungen.pdf,government,,Switzerland,HPV vaccine; Papillomavirus; Causes of death,health; health>diseases and conditions; health>diseases and conditions>cancer
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,adminch-97498bffd9c1458bee22f33a1a5c6265,Government of Switzerland,Vaccination de base contre les HPV pour les garçons,2023-11-03,https://www.bag.admin.ch/dam/bag/fr/dokumente/kuv-leistungen/leistungen-und-tarife/aerztliche-leistungen/Anhang1a-KLV/art.12a%20bst.%20q_klv_empf_basisimpfung_hpv_jungen_6november2023.pdf.download.pdf/Art.12a_OPAS_Recommandations%20de%20l’OFSP%20et%20de%20la%20CFV%20concernant%20la%20vaccination%20contre%20les%20papillomavirus%20humain%20du%206%20novembre%202023.pdf,government,,Switzerland,Human papillomavirus infection; Vaccination; Cancer,health>diseases and conditions; health; health>health treatment>preventative medicine>vaccines
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,adminch-b7b183fdc43d4c4a28fcd71eb9883685,Government of Switzerland,OFSP-Bulletin 3/2024,2024-01-11,https://www.bag.admin.ch/dam/bag/fr/dokumente/mt/i-und-b/richtlinien-empfehlungen/neue-empfehlungen/hpv-basisimpfung-jungen.pdf.download.pdf/Vaccination%20de%20base%20contre%20les%20HPV%20pour%20les%20gar%C3%A7ons.pdf,government,,Switzerland,Human papillomavirus infection; Vaccination; Cervical cancer,health>diseases and conditions; health; health>health treatment>preventative medicine>vaccines
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,adminch-bd08e06b3aa56c8353431dc822d575fc,Government of Switzerland,OFSP-Bulletin 3/2024,2024-01-11,https://www.bag.admin.ch/dam/bag/fr/dokumente/mt/i-und-b/richtlinien-empfehlungen/neue-empfehlungen/hpv-basisimpfung-jungen.pdf.download.pdf/Vaccination%20de%20base%20contre%20les%20HPV%20pour%20les%20gar%E7ons.pdf,government,,Switzerland,Human papillomavirus infection; Vaccination; Cervical cancer,health>diseases and conditions; health; health>health treatment>preventative medicine>vaccines
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,adminch-f3f2ea6df9ee111e414a138edd8f39d2,Government of Switzerland,Vaccination de base contre les HPV pour les garçons,2023-11-03,https://www.bag.admin.ch/dam/bag/fr/dokumente/kuv-leistungen/leistungen-und-tarife/aerztliche-leistungen/Anhang1a-KLV/art.12a%20bst.%20q_klv_empf_basisimpfung_hpv_jungen_6november2023.pdf.download.pdf/Art.12a_OPAS_Recommandations%20de%20l%E2%80%99OFSP%20et%20de%20la%20CFV%20concernant%20la%20vaccination%20contre%20les%20papillomavirus%20humain%20du%206%20novembre%202023.pdf,government,,Switzerland,Human papillomavirus infection; Vaccination; Cancer,health>diseases and conditions; health; health>health treatment>preventative medicine>vaccines
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,govdeptsjapan-198053a3a0db2ec39f1bf1fe5d21da22,Government of Japan,9 価ヒトパピローマウイルス (hpv) ワクチン,2021-10-19,https://www.mhlw.go.jp/content/10601000/001010132.pdf,government,,Japan,Human papillomavirus infection; Gardasil; HPV vaccine,health; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,govdeptsjapan-20e7c856c89301ccb34498085926d7a4,Government of Japan,9 価ヒトパピローマウイルス (hpv) ワクチン,2021-10-19,https://www.mhlw.go.jp/content/10900000/001067262.pdf,government,,Japan,Health; Human papillomavirus infection; Gardasil,health; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,govdeptsjapan-39e799556b998a4e4004e57585069ace,Government of Japan,9 価ヒトパピローマウイルス (hpv) ワクチン,2021-10-19,https://www.mhlw.go.jp/content/10601000/000907645.pdf,government,,Japan,Human papillomavirus infection; Gardasil; HPV vaccine,health; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,govdeptsjapan-9c967b720c854282cbd2e405830d0432,Government of Japan,国⽴感染症研究所,2021-01-31,https://www.mhlw.go.jp/content/10900000/001224783.pdf,government,,Japan,Human papillomavirus infection; Gardasil; HPV vaccine,health>diseases and conditions; health; science and technology>natural science>biology
https://dx.doi.org/10.1136/bmjopen-2019-031186,14.0,govdeptsjapan-c37ef2267bec71dbb5c5e7aca2d49451,Government of Japan,国⽴感染症研究所,2021-01-31,https://www.mhlw.go.jp/content/10906000/000770615.pdf,government,,Japan,Human papillomavirus infection; Gardasil; HPV vaccine,health>diseases and conditions; health; science and technology>natural science>biology
https://dx.doi.org/10.1155/2012/540295,2.0,parliamentoficeland-c07cd1d2b3dcf4729125b2dfcdf322e0,Alþingi,"Kæri móttakandi, ég vona að bréf mitt komi ykkur að góðum notum. Mig langar mjög að hjálpa Íslendingum í þessum málum. Þið eruð ekki ein. Meðfylgjandi er framlag mitt .""",2018-05-29,https://www.althingi.is/pdf/erindi_mals/?lthing=148&malnr=114,government,,Iceland,Female genital mutilation; Brit milah; Circumcision,health; politics; science and technology
https://dx.doi.org/10.1155/2012/540295,2.0,parliamentoficeland-cf61b04c62861784abc23d50a25c4a21,Alþingi,Peds20121989 585..586,2018-04-03,https://www.althingi.is/altext/erindi/148/148-1008.pdf,government,,Iceland,Circumcision; Phimosis; Human papillomavirus infection,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1185/030079904125003638,1.0,hpscie-5528a87912864d259d8e94dd727b428b,Health Protection Surveillance Centre,Sari,2009-12-14,"https://www.hpsc.ie/a-z/microbiologyantimicrobialresistance/infectioncontrolandhai/guidelines/File,4116,en.pdf",government,healthcare agency,Ireland,Antimicrobial stewardship; Antimicrobial resistance; Antibiotic,health>diseases and conditions; science and technology; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1016/j.vaccine.2013.02.018,2.0,hcspfr-ad964499ddaa489c01e71fb37fd179f0,Haut Conseil de la santé publique,Vaccination contre les infections à papillomavirus humains. Données actualisées,2014-07-10,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=454,government,agency,France,Medicine; Human papillomavirus infection; Vaccination,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.vaccine.2013.02.018,2.0,kirbyinstitute-47622071e28a12244b7c099e8041da0c,Kirby Institute,Annual Report 2013,2014-11-11,https://www.kirby.unsw.edu.au/research/reports/annual-report-2013,think tank,university affiliated,Australia,Gonorrhea; Infection; Virus,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>illness
https://dx.doi.org/10.1016/s0264-410x(97)00271-5,4.0,stateofmurcia-ed32d54bdbfadb4ff0e9adf945c94be1,Comunidad Autónoma de la Región de Murcia,Eliminación Del Sarampión En España,2002-10-01,https://sms.carm.es/ricsmur/bitstream/handle/123456789/4159/Plan.de.eliminacion.137399.0.pdf?sequence=1&isAllowed=y,government,,Spain,Vaccination; Measles; MMR vaccine,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1016/s0264-410x(97)00271-5,4.0,who-1810dbdca90ba37a867b12a755ae88f5,World Health Organization,"Weekly Epidemiological Record, 2007, vol. 82, 14 [‎full issue]‎",2016-06-16,https://apps.who.int/iris/handle/10665/240914,igo,healthcare agency,IGO,Measles; Eradication of infectious diseases; Vaccine,health; health>diseases and conditions>communicable disease>epidemic; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/s0264-410x(97)00271-5,4.0,who-6257d89bcc3e488022b0a4a2059e427e,World Health Organization,"A strategic framework for the elimination of measles in the European Region by Mary Ramsay, February 1997",2014-03-19,https://apps.who.int/iris/handle/10665/108278,igo,healthcare agency,IGO,Measles; Eradication of infectious diseases; Vaccine,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1016/s0264-410x(97)00271-5,4.0,who-d3ec356d678dec8efb4809a3888aec6a,World Health Organization,"Elimination of measles in the Republic of Korea, 2001-2006 = Elimination de la rougeole en République de Corée, 2001-2006",2016-06-16,https://apps.who.int/iris/handle/10665/240910,igo,healthcare agency,IGO,Measles; World Health Organization; Immunization,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment>preventative medicine
https://dx.doi.org/10.1038/s41467-021-20991-1,4.0,izade-fb9aba86cc1bbc932f169a77ed305170,IZA Institute of Labor Economics,Is Large-Scale Rapid Cov-2 Testing a Substitute For Lockdowns? The Case of Tuebingen,2021-05-11,https://www.iza.org/publications/dp/14334/is-large-scale-rapid-cov-2-testing-a-substitute-for-lockdowns-the-case-of-tuebingen,think tank,,Germany,Infection; Compartmental models in epidemiology; Dependent and independent variables,science and technology; health; science and technology>mathematics
https://dx.doi.org/10.1038/s41467-021-20991-1,4.0,kdi-d07088abb50e7a0ce011732a47721f83,Korea Development Institute,KOR A Study on Effective Innovation Policy: Focusing on Vaccine R&D,2021-12-31,https://www.kdi.re.kr/eng/research/reportView?pub_no=17483,think tank,,South Korea,Immune system; Clinical trial; Medical specialties,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/s41467-021-20991-1,4.0,rockwoolfonden-bd8184354739b3208b949fec15f8ad4a,ROCKWOOL Fonden,The unseen toll: excess mortality during covid-19 lockdowns,2023-11-01,https://rockwoolfonden.dk/udgivelser/the-unseen-toll-excess-mortality-during-covid-19-lockdowns/,think tank,industry association,Denmark,Health care; Mortality rate; Life expectancy,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/s41467-021-20991-1,4.0,stateofnsw-f5faf43a003c7e055cd645452c44f192,State of New South Wales,Daily evidence digest,2021-02-10,https://ciap.health.nsw.gov.au/assets/docs/covid-19/daily-evidence-digest/2021/20210210-daily-evidence-digest.pdf,government,,Australia,Health care; Microbiology; COVID-19,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment>preventative medicine>vaccines
https://dx.doi.org/10.2214/ajr.166.2.8553928,1.0,governmentofcanada-23b66eebd46ecb5a327e10f65f6baabd,Government of Canada,Guideline on the prevention of transmission of bloodborne viruses from infected healthcare workers in healthcare settings.,2019-06-01,http://publications.gc.ca/site/eng/9.874871/publication.html,government,,Canada,Needlestick injury; Post-exposure prophylaxis; Hepatitis C,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1007/s00192-019-04119-0,1.0,nice-ca9f6981b6c156a5b9067787c2debbb9,NICE,Pelvic floor dysfunction: prevention and non-surgical management,2021-12-09,https://www.nice.org.uk/guidance/ng210,government,healthcare agency,UK,Medicine; Urinary incontinence; Defecation,health; health>health treatment>medicine; science and technology
https://dx.doi.org/10.1097/00126334-200308150-00014,1.0,pubmedcentral-30e464515ea61a7d46680fcad6f9dbf1,Guidelines in PubMed Central,Screening for Gonorrhea: Recommendation Statement,2005-05-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1466867/pdf,other,aggregator,USA,Gonorrhea; Chlamydia; United States Preventive Services Task Force,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1097/00126334-200309010-00008,4.0,cdc-2df174972b56e6ed6df758d092476a57,Centers for Disease Control and Prevention (CDC),Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents,2017-07-31,https://stacks.cdc.gov/view/cdc/7385,government,healthcare agency,USA,HIV/AIDS; CCR5; CD4,health; health>diseases and conditions>communicable disease>virus disease; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1097/00126334-200309010-00008,4.0,cdc-3a4364b791449f987a47acf7f6ccafd1,Centers for Disease Control and Prevention (CDC),Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents,2015-09-16,https://stacks.cdc.gov/view/cdc/34252,government,healthcare agency,USA,Management of HIV/AIDS; HIV/AIDS; CCR5,health; health>diseases and conditions>communicable disease>virus disease; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1097/00126334-200309010-00008,4.0,cdc-525c14aa75a0ecd782bb155d4f162d98,Centers for Disease Control and Prevention (CDC),Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents,2014-04-23,https://stacks.cdc.gov/view/cdc/22444,government,healthcare agency,USA,Management of HIV/AIDS; Abacavir; CCR5,health; health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology
https://dx.doi.org/10.1097/00126334-200309010-00008,4.0,governmentofestonia-aaac70f94597ad5304267a94d59086d6,Government of Estonia,HIV/AIDS Guidelines,2015-02-18,https://www.sm.ee/sites/default/files/content-editors/eesmargid_ja_tegevused/Tervis/Ravimid/guidlines_for_the_use_of_antiretroviral_treatment_nov2014.pdf,government,,Estonia,Health care; Health; Health sciences,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.1111/j.1600-6143.2008.02402.x,1.0,pubmedcentral-739ca16a2ba1b7f11156c54f64fc8647,Guidelines in PubMed Central,The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation,2024-04-12,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11335089/pdf,other,aggregator,USA,Medical specialties; BK virus; Transplant rejection,science and technology>natural science>biology; science and technology>natural science>biology>genetics; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1111/j.1537-2995.2010.02877.x,7.0,ecdc-90f380b0def7450c40708cb318000281,European Centre for Disease Prevention and Control,"Novel approaches to testing for sexually transmitted infections, including HIV and hepatitis B and C in Europe",2012-10-31,https://www.ecdc.europa.eu/en/publications-data/novel-approaches-testing-sexually-transmitted-infections-including-hiv-and,government,agency,EU,HIV/AIDS; Hepatitis C; Infection,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1111/j.1537-2995.2010.02877.x,7.0,europa-f20ef65322b3a1220386ed4b808a95ad,Publications Office of the European Union,"Novel approaches to testing for sexually transmitted infections, including HIV and hepatitis B and C in Europe.",2013-01-24,https://op.europa.eu/en/publication-detail/-/publication/f85bdca0-67a9-42d7-a03e-a509ab845516/language-en/format-PDF,government,,EU,Medical specialties; Health; Clinical medicine,health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1111/j.1537-2995.2010.02877.x,7.0,folkhalsomyndigheten-4385b704c2093b7d223115df8eeabbd3,Folkhälsomyndigheten,Smittsamhet vid infektion av hepatit C-virus,2014-04-07,https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/s/smittsamhet-vid-infektion-av-hepatit-c-virus/,government,healthcare agency,Sweden,Viral hepatitis; Transmission (medicine); Biology,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1111/j.1537-2995.2010.02877.x,7.0,folkhalsomyndigheten-f1b49000874f87d6880d46c6b8685a16,Folkhälsomyndigheten,Kunskapsunderlag: Hepatit B-vaccination till riskgrupper,2016-02-05,https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/h/hepatit-b-vaccination-till-riskgrupper/,government,healthcare agency,Sweden,Hepatitis B; Hepatitis C; Foster care,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1111/j.1537-2995.2010.02877.x,7.0,folkhalsomyndigheten-f2805941f6226fe6e082002ff97bee0c,Folkhälsomyndigheten,Hepatit B-vaccination till riskgrupper – Kunskapsunderlag,2016-02-05,https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/h/hepatit-b-vaccination-till-riskgrupper/,government,healthcare agency,Sweden,Health sciences; Hepatitis B; Swedish National Board of Institutional Care,health; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1111/j.1537-2995.2010.02877.x,7.0,governmentofphillippines-5e27833a630c35dbb0ccc81a118bba91,Government of the Philippines,Review of the Cost Effectiveness of Nucleic Acid Test for Transfusion Transmitted Infections in other Countries,2018-11-09,https://doh.gov.ph/sites/default/files/publications/IB_NAT.pdf,government,,Philippines,Hepatitis C; Hepatitis B; Hepatitis,health>diseases and conditions>communicable disease>virus disease; health; health>diseases and conditions
https://dx.doi.org/10.1111/j.1537-2995.2010.02877.x,7.0,healthwelfaresweden-d577599dc24563012fbc032702a0ac91,Socialstyrelsen,Uppdrag att utreda möjligheterna för ett införande av NAT för smittscreening av blodgivare,2024-10-30,https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/ovrigt/2024-9-9200.pdf,government,agency,Sweden,Blood donation; Medicine; Clinical medicine,health; health>diseases and conditions>communicable disease>virus disease; science and technology
https://dx.doi.org/10.1080/09540121.2011.565034,1.0,who-859c57175a10c10db02674a5f474dd30,World Health Organization,Moving ahead on elimination of sexually transmitted infections (‎STIs)‎ in WHO South-East Asia Region - progress and challenges,2019-12-03,https://apps.who.int/iris/handle/10665/330031,igo,healthcare agency,IGO,Sexually transmitted infection; Safe sex; HIV/AIDS,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,adminch-ce048affa2c9ae385ef01f0a8e14dd9b,Government of Switzerland,Wirksamkeit und Kosten von Corona-Massnahmen und optimale Interventionsebene,2021-06-21,https://www.seco.admin.ch/dam/seco/fr/dokumente/Publikationen_Dienstleistungen/Publikationen_Formulare/Wirtschaftslage/Strukturwandel_Wachstum/Wachstum/wp_23_wirksamkeit_kosten_corona-massnahmen_interventionsebene.pdf.download.pdf/wp_23_wirksamkeit_kosten_corona-massnahmen_interventionsebene.pdf,government,,Switzerland,Economy; Gross domestic product; Cloth face mask,"economy, business and finance>economy; science and technology; health"
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,adminch-f23611dd66e98afdf85955adaade4c3e,Government of Switzerland,Wirksamkeit und Kosten von Corona-Massnahmen und optimale Interventionsebene,2021-06-21,https://www.seco.admin.ch/dam/seco/de/dokumente/Publikationen_Dienstleistungen/Publikationen_Formulare/Wirtschaftslage/Strukturwandel_Wachstum/Wachstum/wp_23_wirksamkeit_kosten_corona-massnahmen_interventionsebene.pdf.download.pdf/wp_23_wirksamkeit_kosten_corona-massnahmen_interventionsebene.pdf,government,,Switzerland,Lockdown; Peer review; Unemployment,"economy, business and finance>economy; science and technology; health"
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,africacdc-d8099d377259af3902709b8eefb98974,Africa CDC,COVID-19 Scientific and Public Health Policy Update – (17 November 2020),2020-11-17,https://africacdc.org/download/covid-19-scientific-and-public-health-policy-update-17-november-2020/,igo,healthcare agency,IGO,Coronavirus disease 2019; Clinical trial; Infection,health>diseases and conditions>illness; health>diseases and conditions; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,agendano-7c94f0a4c5d9bdf77d6fb6cb2b3710d5,Agenda,Et nytt Agenda-notat om hvem som betaler mest for koronakrisen,2021-02-23,https://www.tankesmienagenda.no/post/et-nytt-agenda-notat-om-hvem-som-betaler-mest-for-koronakrisen/details,think tank,,Norway,COVID-19 pandemic; Layoff; Norway,health>diseases and conditions; health; labour
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,agendano-c5eb7bcd72aa271bae92424b3915bbce,Agenda,Agenda-notat om hvem som betaler mest for koronakrisen,2021-02-23,https://www.tankesmienagenda.no/post/agenda-notat-om-hvem-som-betaler-mest-for-koronakrisen/details,think tank,,Norway,COVID-19 pandemic; Layoff; Norway,health>diseases and conditions; health; labour
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,anses-f0f085ba7419f9254f2634a06e046f04,ANSES,NOTE AST de l'Anses relative à la viabilité dans l’air et la dose infectante du virus SARS-COV-2,2021-07-08,https://www.anses.fr/fr/system/files/AIR2021SA0018.pdf,government,food and drug safety,France,Interferon; Severe acute respiratory syndrome coronavirus 2; COVID-19 pandemic,health>diseases and conditions; science and technology>natural science>biology; health>diseases and conditions>illness
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,asiandevelopmentbank-6fb25814f648ca8026916625c0cadae3,Asian Development Bank,Sustainable Tourism After COVID-19: Insights and Recommendations for Asia and the Pacific,2021-12-27,https://www.adb.org/publications/sustainable-tourism-after-covid-19-insights-recommendations,igo,development bank,IGO,Sustainability; Tourism; Sustainable Development Goals,"environment>nature; economy, business and finance>economy; environment"
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,atlantafed-92b671a3faa181756b0437bbe7c32b9f,Federal Reserve Bank of Atlanta,Modeling to Inform Economy-Wide Pandemic Policy: Bringing Epidemiologists and Economists Together,2021-11-04,https://www.atlantafed.org/research/publications/wp/2021/11/16/26--modeling-pandemic-policy.aspx,government,bank,USA,Epidemiology; Policy; Economics,health>diseases and conditions; science and technology>social sciences; science and technology
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,bancoes-b78eaee168dd0c6b53b9f262953cc6cc,Banco de España,Documentos de Trabajo. 2109. ,2021-03-05,https://www.bde.es/f/webbde/SES/Secciones/Publicaciones/PublicacionesSeriadas/DocumentosTrabajo/21/Files/dt2109e.pdf,government,bank,Spain,Dependent and independent variables; Programme for the International Assessment of Adult Competencies; Coronavirus disease 2019,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,bundestag-17d4a0a8d4068bebd6454eb41b73f417,Deutscher Bundestag,WD 9 - 038/21 Studien zu Infektionswegen und Ansteckungsrisiken des Coronavirus in ausgewÃ¤hlten sozialen Bereichen,2021-05-06,https://www.bundestag.de/resource/blob/854062/735ca79691d7c608cb814667b4505b33/WD-9-038-21-pdf-data.pdf,government,,Germany,COVID-19 pandemic; Severe acute respiratory syndrome coronavirus 2; COVID-19,health; science and technology; health>health treatment>medicine
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,catoinstitute-7ab81bd7a774e4c83512f89c5b2fb508,Cato Institute,Hard Questions about Hard Lockdowns,2021-01-29,https://www.cato.org/article/hard-questions-about-hard-lockdowns,think tank,,USA,Sweden; Coronavirus disease 2019; COVID-19 pandemic,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,catoinstitute-882019a51e8f141d6b7350106f074fdd,Cato Institute,COVID-19 Policy: A Failure of Economic Thinking,2021-01-28,https://www.cato.org/pandemics-policy/covid-19-policy-failure-economic-thinking,think tank,,USA,COVID-19 pandemic; Coronavirus disease 2019; Economics,health>diseases and conditions; science and technology>social sciences>economics; health
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,cdc-873a74dfabf5d840ec2ba5d3c497c786,Centers for Disease Control and Prevention (CDC),COVID-19 science update ; 2020-11-24,2020-11-24,https://stacks.cdc.gov/view/cdc/97653,government,healthcare agency,USA,Coronavirus disease 2019; Antibody; Infection,health>diseases and conditions; health>diseases and conditions>illness; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,centraalplanbureau-c780913dea00f9393794eaa8acd703fc,Het Centraal Planbureau,Novemberraming: Economische vooruitzichten 2021,2020-11-25,https://www.cpb.nl/raming-november-2020-vooruitzicht-2021,government,agency,Netherlands,Financial crisis; Unemployment; Economics,"economy, business and finance>economy; labour; economy, business and finance>economy>macro economics>recession"
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,committee_house-8f97fc793fde2cba6dc69e65f2148e96,House Committees,"House Hearing, 117th Congress — CONFRONTING THE CORONAVIRUS: PERSPECTIVES ON THE COVID-19 PANDEMIC ONE YEAR LATER",2021-02-24,https://www.congress.gov/event/117th-congress/house-event/LC66013/text,government,,USA,Race and ethnicity in the United States Census; Coronavirus disease 2019; Race and ethnicity in the United States,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,committee_house-98bdf4a80e2348ab17dfb37b45e5a0a7,House Committees,"""No Time to Lose: Solutions to Increase COVID-19 Vaccinations in the States"" (Virtual Hearing)",2021-02-02,https://www.congress.gov/event/117th-congress/house-event/111137,government,,USA,COVID-19 vaccine; Coronavirus disease 2019; Advisory Committee on Immunization Practices,health; health>diseases and conditions; health>health treatment>preventative medicine>vaccines
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,committee_house-a9059e7a8ed98953ef8918983367ee0b,House Committees,Confronting the Coronavirus: Perspectives on the COVID-19 Pandemic One Year Later,2021-02-24,https://www.congress.gov/event/117th-congress/house-event/111239,government,,USA,Coronavirus disease 2019; COVID-19 vaccine; COVID-19 testing,health; health>diseases and conditions; health>health treatment>preventative medicine>vaccines
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,dhsgov-07fb0e77b88ab97750003d3d688bed00,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-11-04,https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf,government,,USA,Variants of SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Infection,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,dhsgov-38fd23e57dd8ec707294d25fb8fb9019,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-01-28,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210126.pdf,government,,USA,SARS-CoV-2; Variants of SARS-CoV-2; COVID-19 testing,science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,dhsgov-6d422045165469a763b7c31921bd52c8,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-07-15,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf,government,,USA,Variants of SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; COVID-19 vaccine,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,dhsgov-d03d62734a42fe925cf1a6d5dd96f67c,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-01-07,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Infection; COVID-19,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,dhsgov-eeb18fe8690357c6b05b850ab4cf6b68,Department of Homeland Security,Master Question List fgor COVID-19 (caused by SARS-CoV-2),2023-02-21,https://www.dhs.gov/sites/default/files/2023-02/23_0131_st_mql_sars_cov-2.pdf,government,,USA,SARS-CoV-2 Omicron variant; Variants of SARS-CoV-2; COVID-19 testing,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,euparl_library-a8966aedefe4efece32dba8598ad9127,European Parliamentary Research Service,Air pollution and COVID-19,2021-01-11,https://www.europarl.europa.eu/thinktank/en/document/IPOL_STU(2021)658216,government,legislative research,EU,Air pollution; Coronavirus disease 2019; Infection,health>diseases and conditions>illness; health>diseases and conditions; environment>environmental pollution
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,europa-14b9c1ece59e2bc55a25b7bcdc35405b,Publications Office of the European Union,"Air pollution and COVID-19 : including elements of air pollution in rural areas, indoor air pollution, vulnerability and resilience aspects of our society against respiratory disease, social inequality stemming from air pollution.",2021-01-18,https://op.europa.eu/en/publication-detail/-/publication/98e5d442-5a04-11eb-b59f-01aa75ed71a1/language-en/format-PDF,government,,EU,Air pollution; Coronavirus disease 2019; Infection,health>diseases and conditions>illness; health>diseases and conditions; environment>environmental pollution
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,frac-34ddf79ccfdf3319704edc10d4df59c4,Food Research & Action Center,"Linkages Between Food Insecurity, Poverty, and Health During COVID-19",2021-08-26,https://frac.org/wp-content/uploads/Linkages-_2021.pdf,think tank,,USA,Cost of living; Poverty; Food security,health; health>health treatment>diet; lifestyle and leisure>lifestyle>food and drink
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,govdeptsfrance-d9b098ad878141e0a601c5202992c629,French Government Ministries,Entre Vaccins Et Variants : Une Course Contre La Montre,2021-01-13,https://solidarites-sante.gouv.fr/IMG/pdf/avis_conseil_scientifique_12_janvier_2021_actualise_13_janvier_2021.pdf,government,,France,COVID-19 testing; COVID-19 pandemic; Vaccination,science and technology>natural science>biology; science and technology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,govdeptsjapan-a70bfc832d5d55e5c9679fcbe7dda339,Government of Japan,【資料２－１ ①】押谷先生提出資料_s,2020-12-03,https://www.mhlw.go.jp/content/10900000/000701630.pdf,government,,Japan,Causes of death; Immunology; Microbiology,health; science and technology; health>health treatment>medicine
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,govdeptsspain-f3c772959c2aa8845e1e80b33b3cb4e6,Government of Spain,Actuaciones de respuesta coordinada para el control de la transmisión de COVID-19,2021-06-03,https://www.mscbs.gob.es/fr/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Actuaciones_respuesta_COVID_2021.06.02.pdf,government,,Spain,COVID-19 pandemic; Spanish National Health System; COVID-19,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,gpogov-6e48bdcf02c1512308a40f9d612c6e21,Government Publishing Office (GPO),Further support for restaurants and restaurant workers Is needed.,2021-01-15,https://purl.fdlp.gov/GPO/gpo215036,government,,USA,Economy; COVID-19 pandemic; Unemployment,"lifestyle and leisure>leisure>leisure venue>restaurant; economy, business and finance>economic sector>tourism and leisure>restaurant and catering; labour>unemployment"
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,hcspfr-08cfadf931eb0df9103033d010321766,Haut Conseil de la santé publique,Covid-19 : avis sur le protocole sanitaire renforcé proposé pour les commerces,2020-11-22,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=946,government,agency,France,Harm reduction; Health; COVID-19 testing,health; science and technology; health>health treatment>medicine
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,hcspfr-8bfe21cedd039a8abfdd633cac9717b6,Haut Conseil de la santé publique,Diagnostic et dépistage du Covid-19 à l’aide du poolage : actualisation des recommandations,2020-11-30,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=968,government,agency,France,Biology; Life sciences; Medicine,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,iadb-4dc872c5f8294ba8788f28d82cc3dc0f,Inter-American Development Bank,"Reopening schools in the pandemic did not increase COVID-19 cases or deaths in São Paulo State, Brazil",2022-03-03,https://publications.iadb.org/en/reopening-schools-pandemic-did-not-increase-covid-19-cases-or-deaths-sao-paulo-state-brazil,igo,development bank,IGO,COVID-19 pandemic; Difference in differences; Developing country,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,ifode-11e4609bddb9ce3ad5971df88a5faff5,Ifo Institute,Essays in angewandter Wirtschaftsforschung,2023-08-10,https://www.ifo.de/publikationen/2023/monographie-autorenschaft/essays-angewandter-wirtschaftsforschung,think tank,,Germany,Voter turnout; Elections; Correlation,politics>government; science and technology; politics
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,ifode-457ef2303cc838444cea3c6e22f280dc,Ifo Institute,Essays in Applied Economics,2023-08-10,https://www.ifo.de/publikationen/2023/monographie-autorenschaft/essays-applied-economics,think tank,,Germany,Elections; Correlation; Regression analysis,politics>government; science and technology; politics
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,ifode-7ce93b77734961c82b6f3d9534043094,Ifo Institute,"Symptom or Culprit? Social Media, Air Pollution, and Violence",2023-03-01,https://www.cesifo.org/en/publications/2023/working-paper/symptom-or-culprit-social-media-air-pollution-and-violence,think tank,,Germany,Externality; National Incident-Based Reporting System; Social media,environment; science and technology; science and technology>social sciences
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,ifode-a4b39523a5b67c8e2caafe705c9d2e0a,Ifo Institute,The Association of Opening K-12 Schools and Colleges with the Spread of Covid-19 in the United States: County-Level Panel Data Analysis,2021-03-01,https://www.cesifo.org/en/publications/2021/working-paper/association-opening-k-12-schools-and-colleges-spread-covid-19,think tank,,Germany,Fixed effects model; Regression analysis; Estimator,science and technology; health; science and technology>mathematics
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,ifode-c6ec0384b411b31a518b8ebd7546b796,Ifo Institute,My Home Is my Castle – The Benefits of Working from Home During a Pandemic Crisis Evidence from Germany,2020-06-09,https://www.ifo.de/en/publications/2020/working-paper/my-home-my-castle-benefits-working-home-during-pandemic-crisis,think tank,,Germany,Telecommuting; COVID-19 pandemic; Employment,health>diseases and conditions; science and technology; labour
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,kemri-56e1af08225e7fa985f01f107ca014ac,Kenyan Medical Research Institute (KEMRI),Explaining the Three Waves of the COVID-19 Transmission in Kenya using a Mathematical Model,2021-04-26,https://www.kemri.go.ke/wp-content/uploads/2021/07/POLICY-BRIEF-Explaining-the-Three-Waves-of-the-COVID-19-Transmission-in-Kenya-using-a-Mathematical-Model-compressed.pdf,government,research center,Kenya,Health; Epidemiology; Public health,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,konradadenauerstiftung-533741a6aea85495d85a3170050f4853,Konrad Adenauer Stiftung,"Das uneingelöste Versprechen? – Daten, die Lockdowns hätten verhindern können",2021-05-03,https://www.kas.de/de/analysen-und-argumente/detail/-/content/das-uneingeloeste-versprechen-daten-die-lockdowns-haetten-verhindern-koennen,think tank,,Germany,General Data Protection Regulation; COVID-19 pandemic; Corona-Warn-App,"economy, business and finance>economic sector>computing and information technology; science and technology; health"
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,ladocumentationfrancaise-b18f894260fe5dd94f5eed2cfff253a6,La Documentation Française,Conseil scientifique Covid 12012021 Entre vaccins et variants.fr,2021-01-06,https://www.vie-publique.fr/rapport/278133-conseil-scientifique-covid-12012021-entre-vaccins-et-variants,government,,France,COVID-19 testing; COVID-19 pandemic; Vaccination,science and technology>natural science>biology>genetics; health>diseases and conditions; health
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,nber-9356c5c44d41b176961cace55e80481d,NBER,Modeling to Inform Economy-Wide Pandemic Policy: Bringing Epidemiologists and Economists Together,2021-11-15,https://www.nber.org/papers/w29475,think tank,,USA,Epidemiology; Policy; Economics,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,nber-ed7790c2e8930dcd15ab341fe7e33f57,NBER,Geospatial Analysis of the September 2020 Coronavirus Outbreak at the University of Wisconsin – Madison: Did a Cluster of Local Bars Play a Critical Role?,2020-11-23,https://www.nber.org/papers/w28132,think tank,,USA,COVID-19 pandemic; University of Wisconsin–Madison; Dormitory,science and technology; health; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,randcorporation-3abe52a537e16dc8ed2cb8b177df4816,RAND Corporation,Reopening California,2021-04-26,https://www.rand.org/pubs/working_papers/WRA1080-2.html,think tank,research center,USA,Basic reproduction number; Compartmental models in epidemiology; Regret (decision theory),health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,randcorporation-7b289de441142482b693221becbf9c69,RAND Corporation,Robust Decision Making in Health Policy,2022-12-22,https://www.rand.org/pubs/rgs_dissertations/RGSDA2531-1.html,think tank,research center,USA,Robust decision-making; Branches of science; Health sciences,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,randcorporation-a3ecc93e497ee1e597e5b7dc4d91d87f,RAND Corporation,Modeling the Impact of Social Distancing and Targeted Vaccination on the Spread of COVID-19 Through a Real City-Scale Contact Network,2021-07-13,https://www.rand.org/pubs/working_papers/WRA1068-1.html,think tank,research center,USA,Compartmental models in epidemiology; Scale-free network; Social distancing,science and technology; health>diseases and conditions; science and technology>mathematics
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,regjeringa-b0aaf4c2245390fb4200c42493bb906f,Regjeringa.no,Samfunnsøkonomiske vurderinger av smitteverntiltak,2022-04-05,https://www.regjeringen.no/no/dokumenter/samfunnsokonomiske-vurderinger-av-smitteverntiltak/id2907388/,government,,Norway,Vaccine; Immune system; Severe acute respiratory syndrome coronavirus 2,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,rssuk-cc59e85da78d0bf87b3c99e963628de2,Royal Statistical Society,Letter from Sylvia Richardson to William Wragg MP re: Data transparency and accountability: Covid 19,2020-12-08,https://rss.org.uk/RSS/media/Policy-and-campaigns/Policy/Sylvia-Richardson-to-William-Wragg-08-12-20.pdf?ext=.pdf,think tank,,UK,Non-pharmaceutical intervention (epidemiology); Face masks during the COVID-19 pandemic; Social distancing,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,sapeaeu-dddb632a49351b0d3d541bb7c7f0b3ea,SAPEA,Strategic crisis management in the EU,2022-12-13,https://www.sapea.info/topic/crisis-management/,government,agency,EU,Crisis management; Crisis; Climate resilience,"disaster, accident and emergency incident>disaster; disaster, accident and emergency incident>accident and emergency incident; environment"
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofasturias-0e155f3d0a9fb44c15c3ca880c69c0f7,Principado de Asturias,Boletín Oficial del Principado de Asturias,2021-05-28,https://sede.asturias.es/bopa/2021/05/28/20210528Su1.pdf,government,,Spain,Health; SARS-CoV-2; Respiratory droplet,health; politics>government; science and technology
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofasturias-a79243dff694b50d72f717a2ef2dc350,Principado de Asturias,Boletín Oficial del Principado de Asturias,2021-05-05,https://sede.asturias.es/bopa/2021/05/05/20210505Su1.pdf,government,,Spain,Health; Respiratory droplet; Airborne transmission,health; science and technology; politics>government
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofasturias-d5ab54f02f4479c1a4526c7db6e5afb7,Principado de Asturias,Boletín Oficial del Principado de Asturias,2021-04-23,https://sede.asturias.es/bopa/2021/04/23/20210423Su3.pdf,government,,Spain,Health; SARS-CoV-2; Respiratory droplet,health; politics>government; science and technology
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofcanarias-ce437e84b7ed4f3d6f6162c7cc8f2994,Gobierno de Canarias,"Efectividad de las medidas de cierre o restricción de aforos en lugares destinados a ceremonias y culto, en el contexto de la pandemia por SARS- CoV-2",2022-05-23,https://www3.gobiernodecanarias.org/sanidad/scs/content/3b000860-da96-11ec-b5a1-09a3f6864e19/SESCS_2021_,government,,Spain,Health; Evolution; SARS-CoV-2,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofcatalunya-00b19edc87fc10696e86037ce46dfe7c,Generalitat de Catalunya,Proposta per considerar l’ús del certificat COVID en altres àmbits,2021-11-21,https://salutpublica.gencat.cat/web/.content/minisite/aspcat/sobre_lagencia/comite_assessor_covid19/1322-ASPCAT-posicionament-CCAC-Certificat-COVID_v211121.pdf,government,,Spain,,
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofeuskadi-1864dca8aca1362d4164e7058813f7c2,Euskal Autonomia Erkidegoa,EAEn Nekazaritzako Sasoikako Lan,2022-04-29,https://www.euskadi.eus/contenidos/informacion/campana_temporeros/eu_agripes/adjuntos/Protocolo-Temporerismo-y-Covid-22042022-R12_eu.pdf,government,,Spain,,
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofeuskadi-2aa46524fcf597d547ff8c3a35a65947,Euskal Autonomia Erkidegoa,Estrategia Euskadipreben-2022,2022-04-29,https://www.euskadi.eus/contenidos/informacion/campana_temporeros/es_agripes/adjuntos/Protocolo-Temporerismo-y-Covid-22042022-R12_cas.pdf,government,,Spain,Health; SARS-CoV-2; Cloth face mask,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofeuskadi-6f32df00cdfbc370174a611f94520b35,Euskal Autonomia Erkidegoa,EAEn Nekazaritzako Sasoikako Lan Jardueretan COVID-19a geldiarazteko Jarduera Protokoloa,2021-09-07,https://www.euskadi.eus/contenidos/informacion/campana_temporeros/eu_agripes/adjuntos/Protocolo-Temporerismo-y-Covid-2708221eus.pdf,government,,Spain,,
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofeuskadi-83184d791c8ce2b6bff369af62407b6a,Euskal Autonomia Erkidegoa,Estrategia Euskadipreben-2021,2021-09-07,https://www.euskadi.eus/contenidos/informacion/campana_temporeros/es_agripes/adjuntos/Protocolo-Temporerismo-y-Covid-2708221cas.pdf,government,,Spain,Health; Virus; Respirator,health; science and technology; health>health treatment>medicine
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofeuskadi-f3640925b05aefbe4e7b7907880469c0,Euskal Autonomia Erkidegoa,Euskadi-preben Estrategía de País Herriestralegía,2022-05-19,https://www.osalan.euskadi.eus/contenidos/informacion/info_temporerismo_2020_covid/eu_def/adjuntos/protocolo_temporerismo_covid_2022_eu.pdf,government,,Spain,,
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofmichigan-3a658132fa7524c1b10546437f297394,State of Michigan,COVID-19 Crisis,2020-12-09,https://www.michigan.gov/-/media/Project/Websites/coronavirus/Folder10/20201208_COVID_Data_update_media__final.pdf?rev=1d578483870040d9823fbe439d377222,government,,USA,Medicine; Health sciences; Health,"health>diseases and conditions; health; crime, law and justice>law enforcement"
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofmichigan-97c42434cb28d8ee6dcec455496f6591,State of Michigan,COVID-19 Crisis,2020-12-09,https://www.michigan.gov/documents/coronavirus/20201208_COVID_Data_update_media__final_710128_7.pdf,government,,USA,Health; Health sciences; Medicine,"health>diseases and conditions; health; crime, law and justice>law enforcement"
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofvirginia-6904daa51bf42b1386491cb0e36a58c0,Commonwealth of Virginia,Estimation of COVID-19 Impact in Virginia,2022-06-10,https://www.vdh.virginia.gov/content/uploads/sites/182/2022/06/COVID-19_VA_Spread_08-June-2022.pdf,government,,USA,Infectious diseases; Epidemiology; Health,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofvirginia-7d478bd3d1b9acfbe874639513fde89f,Commonwealth of Virginia,Estimation of COVID-19 Impact in Virginia,2022-04-15,https://www.vdh.virginia.gov/content/uploads/sites/182/2022/04/COVID-19_VA_Spread_13-April-2022r1.pdf,government,,USA,Medicine; Health sciences; Medical specialties,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,stateofvirginia-8dad2ab2e03b8c987104822918387758,Commonwealth of Virginia,Estimation of COVID-19 Impact in Virginia,2022-07-15,https://www.vdh.virginia.gov/content/uploads/sites/182/2022/07/COVID-19_VA_Spread_13-July-2022.pdf,government,,USA,Infectious diseases; Health; Variants of SARS-CoV-2,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,ukparliament_select-da8b30439b04ee43e7ce3383da4d3f0c,UK Parliament Select Committee Publications,"Letter from Professor Sylvia Richardson CBE, President-Elect of the Royal Statistical Society and Co-Chair of the RSS Covid-19 Task Force on follow-up evidence after 24.11 session, dated 8.12.20",2020-12-16,https://committees.parliament.uk/publications/4009/documents/40147/default/,government,,UK,Super-spreader; Coronavirus disease 2019; Social distancing,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,voxeu-deb2e11519d7022601be56a8a4a346ae,VoxEU,Opening K-12 schools in the US with no mask requirement for staff may increase the spread of COVID-19,2021-03-08,https://cepr.org/voxeu/columns/opening-k-12-schools-us-no-mask-requirement-staff-may-increase-spread-covid-19,think tank,research center,UK,Confounding; Sensitivity analysis; Panel analysis,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,worldbank-265be945df13978db79db75fa3e33505,World Bank,Assessing Bias in Smartphone Mobility Estimates in Low Income Countries,2021-11-19,https://openknowledge.worldbank.org/handle/10986/36611,igo,development bank,IGO,Smartphone; Mobile app; Feature phone,"science and technology; economy, business and finance>economic sector>computing and information technology; health"
https://dx.doi.org/10.1038/s41586-020-2923-3,67.0,worldbank-e81b87e2db7fe093cdfb5f2f098fbb4e,World Bank,Assessing Bias in Smartphone Mobility Estimates in Low Income Countries,2021-06-28,https://hdl.handle.net/10986/36611,igo,development bank,IGO,Technology; Landline; Developing country,"science and technology; economy, business and finance>economic sector>computing and information technology; health"
https://dx.doi.org/10.1016/j.clinthera.2009.10.014,7.0,ahrq-6ea471795968c7481058aac90d20bcd4,AHRQ,Safety of Vaccines Used for Routine Immunization in the United States: An Update,2021-05-21,https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research,government,healthcare agency,USA,DPT vaccine; Hepatitis B vaccine; Vaccine,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/j.clinthera.2009.10.014,7.0,governmentofmalaysia-e71764d653c5f472ff3be05eb26dff90,Government of Malaysia,Ee Uaas,2014-12-08,https://www.moh.gov.my/moh/resources/auto%20download%20images/587f11568fcaa.pdf,government,,Malaysia,Pneumococcal conjugate vaccine; Pneumococcal vaccine; Streptococcus pneumoniae,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1016/j.clinthera.2009.10.014,7.0,inspq_canada-2b73f5309748fb41019f6d7b7608ff5a,Institut national de santé publique du Québec,"Impact du programme d’immunisation contre les maladies invasives à pneumocoque au Québec, 2010-2014",2018-02-08,https://www.inspq.qc.ca/publications/2348,government,healthcare agency,Canada,Vaccination; Vaccine; International Classification of Diseases,health; health>diseases and conditions; health>health treatment>medicine
https://dx.doi.org/10.1016/j.clinthera.2009.10.014,7.0,inspq_canada-884b7bb97a23b4f0b8e3964c06f9d6cb,Institut national de santé publique du Québec,Évaluation de deux nouveaux vaccins pneumococciques conjugués pour l'immunisation des enfants au Québec,2010-11-29,https://www.inspq.qc.ca/publications/1172,government,healthcare agency,Canada,Vaccine; Meningococcal vaccine; Herd immunity,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.clinthera.2009.10.014,7.0,inspq_canada-be963348d7bdba42c39515b9da63a4c6,Institut national de santé publique du Québec,Évaluation de la pertinence d’utiliser le vaccin pneumococcique conjugué 13 valent plutôt que 10-valent dans une perspective économique au Québec,2019-07-31,https://www.inspq.qc.ca/publications/2574,government,healthcare agency,Canada,Vaccine; Pneumonia; Vaccination,health; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1016/j.clinthera.2009.10.014,7.0,kce-c9aa00a7644795ad5e10c693c030def6,Belgian Health Care Knowledge Centre,Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood,2011-01-01,https://kce.fgov.be/en/cost-effectiveness-of-10-and-13-valent-pneumococcal-conjugate-vaccines-in-childhood,government,healthcare agency,Belgium,,
https://dx.doi.org/10.1016/j.clinthera.2009.10.014,7.0,who-a1dcc5e001a2efb3b9e4b6ca9f45f512,World Health Organization,Eastern Mediterranean Health Journal,2020-07-20,https://apps.who.int/iris/handle/10665/333341,igo,healthcare agency,IGO,Cardiovascular disease; Hypertension; Health,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1371/journal.ppat.1001196,1.0,stateofcatalunya-80ab14c01fcfe2349eac3ef62b9e4f7d,Generalitat de Catalunya,Arnaiz Joan Albert_CEX_CV_2018,2018-04-16,https://catsalut.gencat.cat/web/.content/minisite/catsalut/proveidors_professionals/medicaments_farmacia/harmonitzacio/participants-programa/consultors-experts/CV/ArnaizJoan-Albert_CV_CEX_2018.pdf,government,,Spain,Management of HIV/AIDS; HIV/AIDS; Nevirapine,science and technology>biomedical science>pharmacology; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.2165/00019053-200220070-00005,2.0,hiqaie-1ee49eff8a3d81136e425df499464ef6,Health Information and Quality Authority,Rapid health technology assessment of the extension of the seasonal influenza vaccination programme to include those aged 50 to 64 years (general population),2023-08-17,https://www.hiqa.ie/reports-and-publications/health-technology-assessment/rapid-health-technology-assessment-extension,government,healthcare agency,Ireland,Influenza vaccine; Flu season; Influenza-like illness,health>diseases and conditions>illness; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.2165/00019053-200220070-00005,2.0,pubmedcentral-9d2dc3a194d55b46eabfc2da2315577e,Guidelines in PubMed Central,Vaccines for preventing influenza in healthy adults,2018-02-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491184/pdf,other,aggregator,USA,Cochrane (organisation); Vaccine efficacy; Influenza vaccine,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/s0264-410x(03)00449-3,5.0,europa-5972b1633e27446a00c7765292fc352c,Publications Office of the European Union,Eurosurveillance : special focus : measles. January - June 2010.,2010-10-25,https://op.europa.eu/en/publication-detail/-/publication/757db14a-8304-4581-a79e-c8bfc155ea6b/language-en/format-PDF,government,,EU,MMR vaccine; Measles; Rubella,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1016/s0264-410x(03)00449-3,5.0,governmentofluxembourg-a0a5c4c952f76e15a16e1581b12178cd,gouvernement.lu,Rapport d'activité 2004 du ministère de la Santé,2005-02-24,https://gouvernement.lu/fr/publications/rapport-activite/minist-sante/msan/2004-rapport-activite-sante.html,government,,Luxembourg,Hospital-acquired infection; Public health; Family medicine,health; health>diseases and conditions; education
https://dx.doi.org/10.1016/s0264-410x(03)00449-3,5.0,governmentofportugal-52eaeba07487a557d4b8809f159cad24,Government of Portugal,2 .º Inquérito Serológico Nacional Portugal Continental 2001-2002,2004-12-23,https://www.dgs.pt/upload/membro.id/ficheiros/i009552.pdf,government,,Portugal,Vaccine; MMR vaccine; Vaccination,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1016/s0264-410x(03)00449-3,5.0,who-1cad15530f74a9461fad3998aa53244b,World Health Organization,Eastern Mediterranean Health Journal,2019-09-04,https://apps.who.int/iris/handle/10665/326878,igo,healthcare agency,IGO,,
https://dx.doi.org/10.1016/s0264-410x(03)00449-3,5.0,who-581cd05d86358c8a5049c678f98ef87c,World Health Organization,Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay,2014-06-17,https://apps.who.int/iris/handle/10665/117152,igo,healthcare agency,IGO,Measles; Vaccine; Antibody,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1038/s41467-021-21018-5,2.0,randcorporation-4b86d0a3a85e857ccfc3c4bc3084fbc8,RAND Corporation,Digital Health Products Miss a Massive and Crucial Piece of a Person's Health,2022-12-27,https://www.rand.org/pubs/commentary/2022/12/digital-health-products-miss-a-massive-and-crucial.html,think tank,research center,USA,Health; Privacy concerns with social networking services; Artificial intelligence,health; science and technology; society>values>death and dying>suicide
https://dx.doi.org/10.1038/s41467-021-21018-5,2.0,randcorporation-cf546622de5c3ba01b6f30cd2635d1cf,RAND Corporation,Digital Health Products Miss a Massive and Crucial Piece of a Person's Health,2022-12-27,https://www.rand.org/blog/2022/12/digital-health-products-miss-a-massive-and-crucial.html,think tank,research center,USA,Health; Digital health; Privacy concerns with social networking services,"health; economy, business and finance>economic sector>computing and information technology; science and technology"
https://dx.doi.org/10.1073/pnas.0636861100,14.0,ahrq-81483526743f096862bc29140ffd3f43,AHRQ,Resource Allocation and Pandemic Response: An Evidence Synthesis To Inform Decision Making,2020-09-28,https://effectivehealthcare.ahrq.gov/products/allocation-scarce-resources/rapid-review,government,healthcare agency,USA,Influenza pandemic; Coronavirus disease 2019; Influenza,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1073/pnas.0636861100,14.0,brookings-60977d10fae9cacd605adf530a482fb2,Brookings Institution,Building the analytic capacity to support critical technology strategy,2022-09-28,https://www.brookings.edu/research/building-the-analytic-capacity-to-support-critical-technology-strategy/,think tank,,USA,Analytics; Electric vehicle; Supply chain,"science and technology; economy, business and finance>economy; economy, business and finance>economic sector>computing and information technology"
https://dx.doi.org/10.1073/pnas.0636861100,14.0,catoinstitute-791fb0bca5eb9dc4379af0e5de33e535,Cato Institute,Smallpox and Bioterrorism: Why the Plan to Protect the Nation Is Stalled and What to Do,2003-09-05,https://www.cato.org/briefing-paper/smallpox-bioterrorism-why-plan-protect-nation-stalled-what-do,think tank,,USA,Vaccination; Bioterrorism; Smallpox,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1073/pnas.0636861100,14.0,cdc-b78e5e5b4e2b78a0d59fbce4fdaae6c5,Centers for Disease Control and Prevention (CDC),"Syndromic surveillance; reports from a national conference, 2004",2005-07-28,https://stacks.cdc.gov/view/cdc/6649,government,healthcare agency,USA,Public Health Information Network; Public health surveillance; Foodborne illness,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease>epidemic
https://dx.doi.org/10.1073/pnas.0636861100,14.0,cdc-ebb9d8a7cfdf93139d68c3d2440caa75,Centers for Disease Control and Prevention (CDC),"Syndromic surveillance; reports from a national conference, 2003",2004-09-08,https://stacks.cdc.gov/view/cdc/6577,government,healthcare agency,USA,Public health surveillance; Health Insurance Portability and Accountability Act; Surveillance,"health; economy, business and finance>economic sector>computing and information technology; health>diseases and conditions>communicable disease>virus disease"
https://dx.doi.org/10.1073/pnas.0636861100,14.0,committee_house-2802870d1eaa2d5e47cac99c857f1704,House Committees,"House Hearing, 110th Congress — THE RESILIENT HOMELAND: BROADENING THE HOMELAND SECURITY STRATEGY",2008-05-06,https://www.congress.gov/event/110th-congress/house-event/LC7671/text,government,,USA,Terrorism; Human activities; Climate resilience,"disaster, accident and emergency incident>accident and emergency incident; disaster, accident and emergency incident>disaster; economy, business and finance>economic sector>transport"
https://dx.doi.org/10.1073/pnas.0636861100,14.0,congressionalresearch-5604ba836d6585f45c46d23ae078568b,Congressional Research Service,Federal Efforts to Address the Threat of Bioterrorism: Selected Issues and Options for Congress,2011-02-08,https://crsreports.congress.gov/product/pdf/download/R/R41123/R41123.pdf/,government,legislative research,USA,Bioterrorism; Biological warfare; National security,"conflicts, war and peace>act of terror; health; health>diseases and conditions"
https://dx.doi.org/10.1073/pnas.0636861100,14.0,congressionalresearch-5cae19c1be4eda6902e731905bafa54a,Congressional Research Service,The BioWatch Program: Detection of Bioterrorism,2003-11-19,https://crsreports.congress.gov/product/pdf/download/RL/RL32152/RL32152.pdf/,government,legislative research,USA,Health; Human activities; Biological warfare,"health>diseases and conditions; health; conflicts, war and peace>act of terror"
https://dx.doi.org/10.1073/pnas.0636861100,14.0,governmentofserbia-13226a6e479ca7459c87193c85dd705e,Government of Serbia,Vojno Delo,2018-01-24,http://www.vojnodelo.mod.gov.rs/vojnodelo/391/vd-391-2017-69-3-00-Ceo_broj_VD.pdf,government,,Serbia,,
https://dx.doi.org/10.1073/pnas.0636861100,14.0,govuk-9ee228a1eadcbba7a4192dbfedcf72de,The UK Government,Wide-area biological detection: Blackett review,2014-02-11,https://www.gov.uk/government/publications/wide-area-biological-detection-blackett-review,government,,UK,Biology; Biological warfare; Infection,science and technology>natural science>biology; science and technology; health
https://dx.doi.org/10.1073/pnas.0636861100,14.0,iaiit-59c914607132aecee9f7deba02767cb7,Istituto Affari Internazionali,La minaccia dei droni duali e le sfide per l'Italia,2020-03-25,https://www.iai.it/en/pubblicazioni/la-minaccia-dei-droni-duali-e-le-sfide-litalia,think tank,,Italy,Human activities; Justification (jurisprudence); Nuclear power,"science and technology; economy, business and finance>economic sector>computing and information technology; crime, law and justice>law"
https://dx.doi.org/10.1073/pnas.0636861100,14.0,randcorporation-06d85a0aee9b47c1f4ed87ae1ad5c12d,RAND Corporation,Recommended Infrastructure Standards for Mass Antibiotic Dispensing,2008-09-29,https://www.rand.org/pubs/technical_reports/TR553.html,think tank,research center,USA,Human activities; Health; Public transport,health; science and technology; health>health treatment
https://dx.doi.org/10.1073/pnas.0636861100,14.0,randcorporation-7fcb07cd55a5f24a2729e8b9633a42bf,RAND Corporation,Evaluating the Reliability of Emergency Response Systems for Large-Scale Incident Operations,2010-06-22,https://www.rand.org/pubs/monographs/MG994.html,think tank,research center,USA,Human activities; Probability; Evaluation,"science and technology; economy, business and finance>business information>human resources; science and technology>mathematics"
https://dx.doi.org/10.1073/pnas.0636861100,14.0,randcorporation-8df31da8883f8bb6a848fb9d057784ab,RAND Corporation,A National Agenda for Public Health Systems Research on Emergency Preparedness,2009-08-11,https://www.rand.org/pubs/technical_reports/TR660.html,think tank,research center,USA,Human activities; Simulation; Health human resources,health; education; science and technology
https://dx.doi.org/10.1164/ajrccm.164.3.2009052,5.0,eurohealthobservatory-0ffb890757a0cc59372fec815b2c9b72,European Observatory on Health Systems and Policies,Ensuring innovation in diagnostics for bacterial infection: implications for policy,2016-02-16,https://eurohealthobservatory.who.int/publications/i/ensuring-innovation-in-diagnostics-for-bacterial-infection-implications-for-policy-study,igo,,IGO,Antimicrobial resistance; Procalcitonin; Sepsis,health>diseases and conditions>illness; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.1164/ajrccm.164.3.2009052,5.0,governmentofhungary-a911e7ac8f859ff76cabdad2c463a395,Government of Hungary,Az Egészségügyi Minisztérium Hivatalos Lapja,2010-02-22,https://2010-2014.kormany.hu/download/f/d3/00000/Eg%C3%A9szs%C3%A9g%C3%BCgyi%20K%C3%B6zl%C3%B6ny%C3%B6k_2010_4.pdf,government,,Hungary,,
https://dx.doi.org/10.1164/ajrccm.164.3.2009052,5.0,pubmedcentral-50c4c9f2ffed7714d82c8bb7e1487395,Guidelines in PubMed Central,Plasma interleukin‐6 concentration for the diagnosis of sepsis in critically ill adults,2019-04-30,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490303/pdf,other,aggregator,USA,Medical diagnosis; Diseases and disorders; Immunology,health>diseases and conditions>illness; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.1164/ajrccm.164.3.2009052,5.0,pubmedcentral-d566597803542e081e00911055904423,Guidelines in PubMed Central,"Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI))",2010-06-28,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899863/pdf,other,aggregator,USA,Sepsis; Acute respiratory distress syndrome; Hypoglycemia,science and technology>biomedical science>pharmacology; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1164/ajrccm.164.3.2009052,5.0,who-ccd4ac821700971be1dbbf974c15b4df,World Health Organization,Ensuring innovation in diagnostics for bacterial infection: implications for policy,2019-08-13,https://apps.who.int/iris/handle/10665/326319,igo,healthcare agency,IGO,Antimicrobial resistance; Procalcitonin; Sepsis,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1371/journal.pcbi.1002452,8.0,ecdc-1e794126fcdbdb8a28725a5d00e08084,European Centre for Disease Prevention and Control,Measles and rubella elimination: communicating the importance of vaccination,2014-08-01,https://www.ecdc.europa.eu/en/publications-data/measles-and-rubella-elimination-communicating-importance-vaccination,government,agency,EU,MMR vaccine; Measles; Vaccination,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1371/journal.pcbi.1002452,8.0,europa-f0131a71c33ffe614a7c80c52db0a29a,Publications Office of the European Union,Measles and rubella elimination : communicating the importance of vaccination.,2015-02-23,https://op.europa.eu/en/publication-detail/-/publication/bb60076a-fd90-4121-97b2-7c64920ff066/language-en/format-PDF,government,,EU,Rubella; MMR vaccine; Measles,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1371/journal.pcbi.1002452,8.0,govdeptsitaly-3ff206ed5dc587f76227617c19f47e19,Government of Italy,11.Poster il morbillo è una malattia seria,2018-04-12,http://www.salute.gov.it/imgs/C_17_opuscoliPoster_365_ulterioriallegati_ulterioreallegato_9_alleg.pdf,government,,Italy,Vaccine; Measles; Herd immunity,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1371/journal.pcbi.1002452,8.0,izade-7c8b759b368419d2ae13423423a8c5f7,IZA Institute of Labor Economics,"Personal Belief Exemptions for School-Entry Vaccinations, Vaccination Rates, and Academic Achievement",2020-02-07,https://www.iza.org/publications/dp/12978/personal-belief-exemptions-for-school-entry-vaccinations-vaccination-rates-and-academic-achievement,think tank,,Germany,DPT vaccine; Vaccine; Hib vaccine,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1371/journal.pcbi.1002452,8.0,stateofwisconsin-75dafdcb4b60f5b4e44a0c0ff0ae57ca,State of Wisconsin,Therapies for Children With Autism Spectrum Disorder: Behavioral Interventions Update,2014-08-19,https://tiac.wisconsin.gov/tiacfiles/pdf/ahrq-therapies-asd.pdf,government,,USA,Autism spectrum; Evidence-based medicine; Agency for Healthcare Research and Quality,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1371/journal.pcbi.1002452,8.0,unesco-0e90acd0c5de780d7fd9c25a07766338,UNESCO,Des maths pour agir : accompagner la prise de décision par la science,2023-01-01,https://unesdoc.unesco.org/notice?id=p::usmarcdef_0000384607,igo,,IGO,Branches of science; Vaccine; COVID-19 pandemic,science and technology; science and technology>mathematics; health
https://dx.doi.org/10.1371/journal.pcbi.1002452,8.0,unesco-2f45515bfc826a45eeddc063437465a6,UNESCO,Mathematics for action: supporting science-based decision-making,2022-01-01,https://unesdoc.unesco.org/notice?id=p::usmarcdef_0000380883,igo,,IGO,Game theory; Genetics; Nanopore,science and technology>natural science>biology; science and technology; science and technology>mathematics
https://dx.doi.org/10.1371/journal.pcbi.1002452,8.0,who-416902ced3414daf6325a18958443389,World Health Organization,Promotion of behavioural change for health in a heterogeneous population,2021-11-07,https://apps.who.int/iris/handle/10665/348203,igo,healthcare agency,IGO,Health sciences; Health; Psychological concepts,health; science and technology; health>health treatment>medicine
https://dx.doi.org/10.1016/j.jtbi.2014.05.023,1.0,who-f3f9f795c3e8cfbb194a94b21160b674,World Health Organization,"WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance, to guide research, development and strategies to prevent and control antimicrobial resistance",2024-01-01,https://apps.who.int/iris/handle/10665/376776,igo,healthcare agency,IGO,Antimicrobial resistance; Antibiotic; Typhoid fever,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/j.vaccine.2010.10.075,1.0,govuk-003db51ad135f090ef8bb9d46f570d17,The UK Government,"Hepatitis B: the green book, chapter 18",2017-07-17,https://www.gov.uk/government/publications/hepatitis-b-the-green-book-chapter-18,government,,UK,Hepatitis B; Hepatitis; Vaccine,health>diseases and conditions>communicable disease>virus disease; health; health>diseases and conditions>communicable disease>virus disease>retrovirus
https://dx.doi.org/10.1038/s41591-023-02615-x,2.0,who-251028c26f4bfe992d6c7ec4c9cef4b9,World Health Organization,WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: provider module for oral and long-acting PrEP,2024-01-01,https://apps.who.int/iris/handle/10665/378164,igo,healthcare agency,IGO,Post-exposure prophylaxis; Hepatitis B; Sexually transmitted infection,science and technology>biomedical science>pharmacology; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1038/s41591-023-02615-x,2.0,who-8c477fceaf44804c61ac77249fe8eb69,World Health Organization,Guidelines for HIV post-exposure prophylaxis,2024-01-01,https://apps.who.int/iris/handle/10665/378221,igo,healthcare agency,IGO,Post-exposure prophylaxis; Health; Clinical medicine,science and technology>biomedical science>pharmacology; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1016/j.cmi.2015.04.012,3.0,stateofcatalunya-0f67cf460bb69c918a2280da1027926c,Generalitat de Catalunya,Clinical Medicine,2019-05-15,https://scientiasalut.gencat.cat/bitstream/handle/11351/4186/different_microbia_etiology_prosthetic_joint_infections_route_acquisition_2019.pdf,government,,Spain,Streptococcus; Staphylococcus aureus; Empiric therapy,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/j.cmi.2015.04.012,3.0,stateofcatalunya-7083975fbf2d39a3c55c008f5bc44564,Generalitat de Catalunya,Clinical Medicine,2019-05-15,https://scientiasalut.gencat.cat/bitstream/handle/11351/4186/different_microbia_etiology_prosthetic_joint_infections_route_acquisition_2019.pdf?sequence=1&isAllowed=y,government,,Spain,Staphylococcus; Streptococcus; Staphylococcus aureus,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/j.cmi.2015.04.012,3.0,stateofcatalunya-abba93bae9ee1f8e6d8f181b361a88fa,Generalitat de Catalunya,Implant Removal in the Management of Prosthetic Joint Infection by Staphylococcus aureus: Outcome and Predictors of Failure in a Large Retrospective Multicenter Study,2021-01-26,https://scientiasalut.gencat.cat/bitstream/handle/11351/6199/implant_removal_management_prosthetic_joint_infection_staphylococcus_aureus_outcome_predictors_failure_large_retrospective_multicenter_study_2021.pdf,government,,Spain,Methicillin-resistant Staphylococcus aureus; Prosthetic joint infection; Bloodstream infections,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1046/j.1468-1293.2001.00048.x,4.0,anrsfr-e5ff765f8307ffff790d1911f626a137,ANRS Maladies infectieuses émergentes,Économie du sida et accès aux soins pour le VIH/sida dans les pays en développement. Enjeux et défis,2003-07-01,https://anrs.fr/wp-content/uploads/2023/11/7.-economics-aids-juin2003-1.pdf,government,research center,France,TRIPS Agreement; Access to medicines; Compulsory license,health>diseases and conditions; health; society
https://dx.doi.org/10.1046/j.1468-1293.2001.00048.x,4.0,nice-eca1723ed17559ddf0d6be29d6507833,NICE,Cabotegravir with rilpivirine for treating HIV-1,2022-01-05,https://www.nice.org.uk/guidance/ta757,government,healthcare agency,UK,Rilpivirine; Management of HIV/AIDS; Cabotegravir,science and technology>biomedical science>pharmacology; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1046/j.1468-1293.2001.00048.x,4.0,worldbank-73b7e12270be50ebdebadfbd5a4a2fda,World Bank,The Global HIV Epidemics among Men Who Have Sex with Men,2011-05-27,https://hdl.handle.net/10986/2308,igo,development bank,IGO,Men who have sex with men; Epidemiology of HIV/AIDS; Sexually transmitted infection,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1046/j.1468-1293.2001.00048.x,4.0,worldbank-8f3a5ebf1c9996a90cb260b36a12e8da,World Bank,The Global HIV Epidemics among Men Who Have Sex with Men,2012-03-19,https://openknowledge.worldbank.org/handle/10986/2308,igo,development bank,IGO,IPrEx; Men who have sex with men; HIV/AIDS,health; health>diseases and conditions>communicable disease>virus disease; society
https://dx.doi.org/10.4269/ajtmh.20-0483,13.0,cdc-5c0eef32c9599533706f89b7778def56,Centers for Disease Control and Prevention (CDC),Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19,2021-01-01,https://stacks.cdc.gov/view/cdc/110771,government,healthcare agency,USA,Cohort study; Hepatitis; Comorbidity,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.4269/ajtmh.20-0483,13.0,cdc-71f995c54fb6159040cdf61db2d4736e,Centers for Disease Control and Prevention (CDC),Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19,2022-01-01,https://stacks.cdc.gov/view/cdc/114448,government,healthcare agency,USA,COVID-19; Cirrhosis; Hepatitis,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.4269/ajtmh.20-0483,13.0,cdc-b2993f364296bb07ecf57d701b51f322,Centers for Disease Control and Prevention (CDC),Science brief : Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19,2021-05-12,https://stacks.cdc.gov/view/cdc/106171,government,healthcare agency,USA,Coronavirus disease 2019; Cohort study; Hepatitis,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.4269/ajtmh.20-0483,13.0,has-6ef2f95832031c8ff24224f608864908,Haute Autorité de Santé,Stratégie de vaccination contre le Sars-Cov-2 - Actualisation des facteurs de risque de formes graves de la Covid-19 et des recommandations sur la stratégie de priorisation des populations à vacciner,2021-03-02,https://www.has-sante.fr/jcms/p_3240117/fr/strategie-de-vaccination-contre-le-sars-cov-2-actualisation-des-facteurs-de-risque-de-formes-graves-de-la-covid-19-et-des-recommandations-sur-la-strategie-de-priorisation-des-populations-a-vacciner,government,healthcare agency,France,COVID-19; Hypertension; Heart failure,health>diseases and conditions; health>diseases and conditions>illness; health>diseases and conditions>illness
https://dx.doi.org/10.4269/ajtmh.20-0483,13.0,hiqaie-fd0717aad5dadb01a8b4ac3c3f7354bf,Health Information and Quality Authority,Interventions that prevent infection or minimise progression of COVID-19,2021-08-16,https://www.hiqa.ie/reports-and-publications/health-technology-assessment/interventions-prevent-infection-or-minimise,government,healthcare agency,Ireland,Randomized controlled trial; Obesity; Body mass index,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.4269/ajtmh.20-0483,13.0,paho-5ca9737b6e4af1e463bf8fcd59e7e8e9,Pan American Health Organization (PAHO),Gendered Health Analysis: COVID-19 in the Americas,2021-12-22,https://iris.paho.org/handle/10665.2/55432,igo,,IGO,Violence; Poverty; Health,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.4269/ajtmh.20-0483,13.0,paho-daff8180fe92c9da8b4513929b120f6f,Pan American Health Organization (PAHO),Análisis de género y salud: COVID-19 en las Américas,2022-01-06,https://iris.paho.org/handle/10665.2/55557,igo,,IGO,Poverty; Pan American Health Organization; Americas,health>diseases and conditions; health; education
https://dx.doi.org/10.4269/ajtmh.20-0483,13.0,pubmedcentral-1c47d6ac241c82a14e62f84054551661,Guidelines in PubMed Central,COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies,2021-03-11,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf,other,aggregator,USA,Hypertension; Comorbidity; COVID-19 pandemic,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.4269/ajtmh.20-0483,13.0,pubmedcentral-b441510b66023f034f02be528e9e9b92,Guidelines in PubMed Central,Obesity as an independent risk factor for COVID‐19 severity and mortality,2023-05-24,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207996/pdf,other,aggregator,USA,Medicine; Health; Missing data,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.4269/ajtmh.20-0483,13.0,undp-de09e3bfdb39d5a64ab551d58d3ea2ee,United Nations Development Programme,Responding to non-communicable diseases during and beyond the COVID-19 pandemic,2020-08-27,https://www.undp.org/content/undp/en/home/librarypage/hiv-aids/responding-to-non-communicable-diseases-during-and-beyond-the-co.html,igo,,IGO,Medical specialties; Clinical medicine; Medicine,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.4269/ajtmh.20-0483,13.0,who-42c1714ddb11dc8eed4191914aadb2c1,World Health Organization,Responding to non-communicable diseases during and beyond the COVID-19 pandemic: state of the evidence on COVID-19 and non-communicable diseases: a rapid review,2020-09-04,https://apps.who.int/iris/handle/10665/334143,igo,healthcare agency,IGO,Health care; Diseases and disorders; Epidemiology,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.4269/ajtmh.20-0483,13.0,who-93f00f7afa8bfa398adf2d02c855e220,World Health Organization,Responder a las enfermedades no transmisibles durante la pandemia de COVID-19 y después de esta: situación de las pruebas relativas a la COVID-19 y las enfermedades no transmisibles: una revisión rápida,2020-10-05,https://apps.who.int/iris/handle/10665/335829,igo,healthcare agency,IGO,Medical specialties; Health sciences; Medicine,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.4269/ajtmh.20-0483,13.0,who-e95b21256d97ccc1981a63ca6d38aa72,World Health Organization,Répondre aux maladies non transmissibles pendant et après la pandémie de COVID-19 : rapide tour d’horizon des données probantes sur la COVID 19 et les maladies non transmissibles,2020-10-05,https://apps.who.int/iris/handle/10665/335828,igo,healthcare agency,IGO,Diseases and disorders; Clinical medicine; Public health,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1371/journal.pone.0248920,2.0,pubmedcentral-9e7c365844015751e4fb78a04012944c,Guidelines in PubMed Central,Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19,2022-05-20,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf,other,aggregator,USA,Health sciences; Cochrane (organisation); Coronavirus disease 2019,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1371/journal.pone.0248920,2.0,randcorporation-9d4f0005b3f9b342923dfbfde44f2ba7,RAND Corporation,Artificial Intelligence in the COVID-19 Response,2023-06-02,https://www.rand.org/pubs/external_publications/EP70086.html,think tank,research center,USA,Machine learning; COVID-19 pandemic; Health,"economy, business and finance>economic sector>computing and information technology; health>diseases and conditions; health"
https://dx.doi.org/10.1542/peds.2012-0295,2.0,cancercareontario-36b35b72c1292221a377c6d221a37cf0,Cancer Care Ontario,Safe Administration of Systemic Cancer Therapy Part 2: Administration of Systemic Treatment and Management of Preventable Adverse Events,2019-01-08,https://www.cancercareontario.ca/en/guidelines-advice/types-of-cancer/1201,government,healthcare agency,Canada,Intravenous therapy; Evidence-based medicine; Chemotherapy,science and technology>biomedical science>pharmacology; science and technology>biomedical science>pharmacology; health>diseases and conditions
https://dx.doi.org/10.1542/peds.2012-0295,2.0,stateofalaska-eff3d3f9a62a306828577e3830635597,State of Alaska,Leiation for Profes als in,2015-12-21,https://health.alaska.gov/dph/Epi/id/SiteAssets/Pages/Infection-Prevention-Boot-Camp/APIC_CLABSI_WEB.pdf,government,,USA,Central venous catheter; Intravenous therapy; Peripherally inserted central catheter,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.2989/16085900709490407,3.0,randcorporation-4f5832c346ef5998a5a2a47365ac615a,RAND Corporation,International Report on HIV Prevention Urges Localised ARV Strategies,2013-06-19,https://www.rand.org/pubs/research_reports/RR326.html,think tank,research center,USA,Rectal microbicide; Management of HIV/AIDS; Pre-exposure prophylaxis,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.2989/16085900709490407,3.0,worldbank-4d35bdd983483891934d53ad04ae428b,World Bank,Economic Impact of HIV and Antiretroviral Therapy on Education Supply in High Prevalence Regions,2012-11-16,https://hdl.handle.net/10986/23207,igo,development bank,IGO,Sub-Saharan Africa; Management of HIV/AIDS; Health,health; education; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.2989/16085900709490407,3.0,worldbank-c572a427da77c85a0508c0dd5519787f,World Bank,Economic Impact of HIV and Antiretroviral Therapy on Education Supply in High Prevalence Regions,2015-12-03,https://openknowledge.worldbank.org/handle/10986/23207,igo,development bank,IGO,Preventive healthcare; Education; Epidemiology of HIV/AIDS,health; education; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1007/s00702-016-1571-0,1.0,stateofwesterncape-3252e195896e38691eeb48acc9070bdb,Western Cape Provincial Government,Western Cape Government,2018-02-21,https://www.westerncape.gov.za/sites/www.westerncape.gov.za/files/tygerberg_hospital_annual_report_2016_web.pdf,government,,South Africa,Nursing; Health care; Hospital,health>diseases and conditions; health; education
https://dx.doi.org/10.1002/ijc.30926,3.0,ecdc-ab86bc472eae3eadd93a648d842d6da9,European Centre for Disease Prevention and Control,"Efficacy, effectiveness and safety of HPV vaccination in women with conisation: a systematic review and meta-analyses",2024-04-17,https://www.ecdc.europa.eu/en/publications-data/efficacy-effectiveness-and-safety-hpv-vaccination-women-conisation-systematic,government,agency,EU,Cervical intraepithelial neoplasia; Cervical cancer; Human papillomavirus infection,health; health>diseases and conditions; health>diseases and conditions>cancer
https://dx.doi.org/10.1002/ijc.30926,3.0,europa-1d8fbad3781fdc656f1677c6d438a085,Publications Office of the European Union,"Efficacy, effectiveness and safety of HPV vaccination in women with conisation - Publications Office of the EU",2024-04-30,https://op.europa.eu/en/publication-detail/-/publication/f81ca4d6-0766-11ef-a251-01aa75ed71a1/language-en,government,,EU,Cervical intraepithelial neoplasia; Cervical cancer; Human papillomavirus infection,health; science and technology; health>diseases and conditions>cancer
https://dx.doi.org/10.1002/ijc.30926,3.0,who-6c2d2f0054942b77e1869d7aadfe8725,World Health Organization,WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of dual-stain cytology to triage women after a positive test for human papillomavirus (HPV): web annex B: evidence summaries,2024-01-01,https://apps.who.int/iris/handle/10665/376493,igo,healthcare agency,IGO,Cervical cancer; Cervical screening; Human papillomavirus infection,health; science and technology>natural science>biology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1002/lt.20517,2.0,awmf-92b472bdc702eec0f74372e24a7263bb,Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF),"Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion",2017-12-31,https://www.awmf.org//leitlinien/detail/ll/021-012.html,government,healthcare agency,Germany,Hepatitis C; Boceprevir; Telaprevir,health; health>diseases and conditions>communicable disease>virus disease; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1002/lt.20517,2.0,awmf-a077362fa4f04b942fdf6a800c258fe8,Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF),"Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion",2018-07-09,https://register.awmf.org/de/leitlinien/detail/021-012,government,healthcare agency,Germany,Hepatitis; Sofosbuvir; Telaprevir,science and technology>biomedical science>pharmacology; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1007/s11999-009-1013-5,2.0,federalregister-9e1d3b55ec3fc4cfb058845676eb53e5,Federal Register,Medicare Program; Advancing Care Coordination Through Episode Payment Models (EPMs); Cardiac Rehabilitation Incentive Payment Model; and Changes to the Comprehensive Care for Joint Replacement Model (CJR),2017-01-03,https://www.federalregister.gov/documents/2017/01/03/2016-30746/medicare-program-advancing-care-coordination-through-episode-payment-models-epms-cardiac,government,,USA,Bundled payment; Medicare (United States); Accountable care organization,health; health>healthcare policy>government health care; health>health treatment
https://dx.doi.org/10.1007/s11999-009-1013-5,2.0,pubmedcentral-79f28944f56c879164b10c7f8d2556f5,Guidelines in PubMed Central,Success After Treatment of Periprosthetic Joint Infection: A Delphi-based International Multidisciplinary Consensus,2013-02-26,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676607/pdf,other,aggregator,USA,C-reactive protein; Antibiotic; Research,health>diseases and conditions; health; health>health treatment
https://dx.doi.org/10.1016/j.drugalcdep.2013.01.020,6.0,emcdda-3954cfc4dd79a8fda0a819e88802c1bd,EMCDDA,"Hepatitis C among drug users in Europe: epidemiology, treatment and prevention",2016-07-01,https://www.emcdda.europa.eu/publications/insights/hepatitis-c-among-drug-users-in-europe_en,government,agency,EU,Hepatocellular carcinoma; Hepatitis; Harm reduction,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1016/j.drugalcdep.2013.01.020,6.0,emcdda-71b3c20f6f39350df4aa0b3d427a556f,EMCDDA,General Report of Activities 2013: Key achievements and governance — a year in review,2014-06-01,https://www.emcdda.europa.eu/publications/gra/2013_en,government,agency,EU,Europol; European Monitoring Centre for Drugs and Drug Addiction; European Union,"crime, law and justice>crime; crime, law and justice>crime>drug related crimes; health"
https://dx.doi.org/10.1016/j.drugalcdep.2013.01.020,6.0,europa-3a28de57aa58d4992a851e1e9ec7384d,Publications Office of the European Union,General report of activities 2013 : key achievements and governance : a year in review.,2014-07-17,https://op.europa.eu/en/publication-detail/-/publication/6c46b8a7-093e-4b4e-b905-0d88bb209d7f/language-en/format-PDF,government,,EU,Europol; European Monitoring Centre for Drugs and Drug Addiction; Internal control,"crime, law and justice>crime>drug related crimes; crime, law and justice>crime; science and technology"
https://dx.doi.org/10.1016/j.drugalcdep.2013.01.020,6.0,europa-847a9f7e839e41246a9bfa413ee461ea,Publications Office of the European Union,"Hepatitis C among drug users in Europe : epidemiology, treatment and prevention.",2016-08-02,https://op.europa.eu/en/publication-detail/-/publication/a33add41-b9ca-4b84-996b-8291fea801fa/language-en/format-PDF,government,,EU,Health care; Public health; Hepatitis C,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.drugalcdep.2013.01.020,6.0,stateofcatalunya-10acf02f9b120ab48ca4e6d4c576014f,Generalitat de Catalunya,Sives 2015,2016-04-14,https://scientiasalut.gencat.cat/bitstream/handle/11351/3418/informe_SIVES_2012_informe_epidemiologic_CEEISCAT_2015_cas.pdf,government,,Spain,Human reproduction; Medical specialties; Sexually transmitted diseases and infections,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1016/j.drugalcdep.2013.01.020,6.0,stateofcatalunya-60431c7ecbb7fdea4f3762cd080cf288,Generalitat de Catalunya,Sives 2015,2016-04-07,https://salutpublica.gencat.cat/web/.content/minisite/aspcat/vigilancia_salut_publica/vih-sida-its/05_CEEISCAT/publicacions-cientifiques/informes/SIVES/SIVES_2015/sives2015_ENG.pdf,government,,Spain,Hepatitis; Chlamydia; Sexually transmitted infection,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>illness
https://dx.doi.org/10.3346/jkms.2020.35.e321,5.0,adminch-ce048affa2c9ae385ef01f0a8e14dd9b,Government of Switzerland,Wirksamkeit und Kosten von Corona-Massnahmen und optimale Interventionsebene,2021-06-21,https://www.seco.admin.ch/dam/seco/fr/dokumente/Publikationen_Dienstleistungen/Publikationen_Formulare/Wirtschaftslage/Strukturwandel_Wachstum/Wachstum/wp_23_wirksamkeit_kosten_corona-massnahmen_interventionsebene.pdf.download.pdf/wp_23_wirksamkeit_kosten_corona-massnahmen_interventionsebene.pdf,government,,Switzerland,Lockdown; Peer review; Unemployment,"economy, business and finance>economy; science and technology; health"
https://dx.doi.org/10.3346/jkms.2020.35.e321,5.0,adminch-f23611dd66e98afdf85955adaade4c3e,Government of Switzerland,Wirksamkeit und Kosten von Corona-Massnahmen und optimale Interventionsebene,2021-06-21,https://www.seco.admin.ch/dam/seco/de/dokumente/Publikationen_Dienstleistungen/Publikationen_Formulare/Wirtschaftslage/Strukturwandel_Wachstum/Wachstum/wp_23_wirksamkeit_kosten_corona-massnahmen_interventionsebene.pdf.download.pdf/wp_23_wirksamkeit_kosten_corona-massnahmen_interventionsebene.pdf,government,,Switzerland,Lockdown; Peer review; Unemployment,"economy, business and finance>economy; science and technology; health"
https://dx.doi.org/10.3346/jkms.2020.35.e321,5.0,who-318a8468bf57d147f5d8f4442cc4761b,World Health Organization,Efficacité de différentes mesures de distanciation dans l’interruption de la transmission de la COVID-19 — sur la base des informations disponibles au 18 décembre 2020,2021-01-22,https://apps.who.int/iris/handle/10665/338828,igo,healthcare agency,IGO,Social distancing; Coronavirus disease 2019; Atypical pneumonias,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.3346/jkms.2020.35.e321,5.0,who-64298bfca392ac9e238cfec41ee640b0,World Health Organization,Effectiveness of different distancing measures in interrupting COVID-19 transmission — based on information as at 18 December 2020,2021-01-22,https://apps.who.int/iris/handle/10665/338795,igo,healthcare agency,IGO,Medical statistics; Immunology; Public health,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.3346/jkms.2020.35.e321,5.0,who-6bf069147b41dd8aa287456d1c12a22e,World Health Organization,Eficácia de diferentes medidas de distanciamento na interrupção da transmissão da COVID-19 — com base na informação disponível a 18 de Dezembro de 2020,2021-01-22,https://apps.who.int/iris/handle/10665/338819,igo,healthcare agency,IGO,Coronavirus disease 2019; COVID-19 pandemic; Atypical pneumonias,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/j.jocn.2016.10.005,2.0,nice-3059d5b79e5ab14e0d1ca1dfbb508dd8,NICE,"Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management",2024-03-19,https://www.nice.org.uk/guidance/ng240,government,healthcare agency,UK,Meningitis; Neisseria meningitidis; Procalcitonin,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/j.jocn.2016.10.005,2.0,nice-555045de1754b11181cbc8e725961393,NICE,"Meningitis (bacterial) and meningococcal septicaemia in under 16s: recognition, diagnosis and management",2015-02-01,https://www.nice.org.uk/guidance/cg102,government,healthcare agency,UK,Neisseria meningitidis; Meningitis; National Institute for Health and Care Excellence,health; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/s0140-6736(94)90126-0,1.0,idrc-c28030560e8130551ca9ed3f230ddda0,International Development Research Centre,In her lifetime : female morbidity and mortality in Sub-Saharan Africa,2007-11-13,https://idl-bnc-idrc.dspacedirect.org/handle/10625/13918,think tank,,Canada,Health care; HIV/AIDS; Mortality rate,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.4178/epih.e2016059,1.0,nice-28bc0a4c6ae9d11a91e501417a6f7098,NICE,Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues,2020-01-22,https://www.nice.org.uk/guidance/ipg666,government,healthcare agency,UK,Creutzfeldt–Jakob disease; Variant Creutzfeldt–Jakob disease; PRNP,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.3390/vaccines10111908,1.0,cset-cb6a74f75bef55e3bf9a561a5c89bd2e,Center for Security and Emerging Technology (CSET),A Shot of Resilience,2023-05-01,https://cset.georgetown.edu/publication/a-shot-of-resilience/,think tank,university affiliated,USA,Vaccine; Tetanus vaccine; Hepatitis B vaccine,health>diseases and conditions>communicable disease>virus disease; health>health treatment>preventative medicine>vaccines; health
https://dx.doi.org/10.1002/sim.3317,1.0,pubmedcentral-d044e19561d5f08cd258bbc9f98a6691,Guidelines in PubMed Central,Diagnostic test evaluation methodology: A systematic review of methods employed to evaluate diagnostic tests in the absence of gold standard – An update,2019-10-11,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788703/pdf,other,aggregator,USA,Sensitivity and specificity; Receiver operating characteristic; Medical test,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/s0376-8716(99)00142-8,4.0,who-13ffdab84dbe9acf20f1f9b285ba90fb,World Health Organization,Management of tuberculosis and HIV coinfection: clinical protocol for the WHO European Region (2013 revision),2013-01-01,https://apps.who.int/iris/handle/10665/375513,igo,healthcare agency,IGO,Tuberculosis; Latent tuberculosis; Mantoux test,science and technology>biomedical science>pharmacology; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1016/s0376-8716(99)00142-8,4.0,who-27d722df95e4a85abef6875a5e7f5971,World Health Organization,Туберкулез и ВИЧ-инфекция: ведение больных с коинфекцией: клинический протокол для Европейского региона ВОЗ (обновленная версия 2013 г.),2013-01-01,https://apps.who.int/iris/handle/10665/375514,igo,healthcare agency,IGO,Hepatitis; Diagnosis of HIV/AIDS; BCG vaccine,health; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1016/s0376-8716(99)00142-8,4.0,who-cf61b68a57df1f1e0b12348d0edfebf0,World Health Organization,"Экспресс-оценка доступности и интеграции услуг, связанных с ВИЧ-инфекцией, туберкулезом и снижением вреда, для людей, употребляющих инъекционные наркотики, в Португалии: заключительный доклад по исследованию, апрель 2012 г.",2012-01-01,https://apps.who.int/iris/handle/10665/375427,igo,healthcare agency,IGO,Hepatitis C; Substance dependence; HIV,health; health>diseases and conditions>communicable disease>virus disease; science and technology
https://dx.doi.org/10.1016/s0376-8716(99)00142-8,4.0,who-f87e1a24985e030b6ae0bd8e5664d9ea,World Health Organization,"Accessibility and integration of HIV, TB and harm reduction services for people who inject drugs in Portugal: a rapid assessment: April 2012",2012-01-01,https://apps.who.int/iris/handle/10665/375347,igo,healthcare agency,IGO,Tuberculosis; HIV/AIDS; Harm reduction,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1080/21645515.2019.1625644,9.0,ahrq-6ea471795968c7481058aac90d20bcd4,AHRQ,Safety of Vaccines Used for Routine Immunization in the United States: An Update,2021-05-21,https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research,government,healthcare agency,USA,Hepatitis B vaccine; Vaccine; Pneumococcal conjugate vaccine,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1080/21645515.2019.1625644,9.0,awmf-38abe03b538eefe81c9b99f4c0868066,Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF),Impfprävention HPV-assoziierter Neoplasien,2020-07-21,https://register.awmf.org/de/leitlinien/detail/082-002,government,healthcare agency,Germany,HPV vaccine; Human papillomavirus infection; Genital wart,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1080/21645515.2019.1625644,9.0,govdeptsjapan-9c967b720c854282cbd2e405830d0432,Government of Japan,国⽴感染症研究所,2021-01-31,https://www.mhlw.go.jp/content/10900000/001224783.pdf,government,,Japan,Human papillomavirus infection; Gardasil; HPV vaccine,health>diseases and conditions; health; science and technology>natural science>biology
https://dx.doi.org/10.1080/21645515.2019.1625644,9.0,govdeptsjapan-c37ef2267bec71dbb5c5e7aca2d49451,Government of Japan,国⽴感染症研究所,2021-01-31,https://www.mhlw.go.jp/content/10906000/000770615.pdf,government,,Japan,Human papillomavirus infection; Gardasil; HPV vaccine,health>diseases and conditions; health; science and technology>natural science>biology
https://dx.doi.org/10.1080/21645515.2019.1625644,9.0,rivmnl-b6ef706e54b0c8fd9bc2650dc3d18c00,Rijksinstituut voor Volksgezondheid en Milieu,Optimalisation of the schedule of the National Immunisation Programme. Background information for the advice of the Health Council of The Netherlands on the vaccination schedule of the National Immunisation Programme,2022-06-07,https://www.rivm.nl/publicaties/optimalisation-of-schedule-of-national-immunisation-programme-background-information,government,research center,Netherlands,DPT vaccine; Booster dose; Hepatitis B,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1080/21645515.2019.1625644,9.0,rivmnl-bbaf91c16a16b7d004ec71fefb6ace49,Rijksinstituut voor Volksgezondheid en Milieu,The National Immunisation Programme in the Netherlands : Surveillance and developments in 2019-2020,2020-11-27,https://www.rivm.nl/publicaties/national-immunisation-programme-in-netherlands-surveillance-and-developments-in-2019,government,research center,Netherlands,Preventive medicine; Medicine; MMR vaccine,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1080/21645515.2019.1625644,9.0,who-055edee2b046dd2955e45be22dfb68b7,World Health Organization,"Weekly Epidemiological Record, 2022, vol. 97, 50 [‎full issue]‎",2022-12-16,https://apps.who.int/iris/handle/10665/365350,igo,healthcare agency,IGO,HPV vaccine; Gardasil; Genital wart,health>diseases and conditions; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1080/21645515.2019.1625644,9.0,who-1632f13222528ea8abc72fc7495eba86,World Health Organization,"Еженедельный эпидемиологический бюллетень, 2022 г., 97-й том, No. 50 645–672 [‎весь выпуск]‎",2023-03-06,https://apps.who.int/iris/handle/10665/366371,igo,healthcare agency,IGO,Public health; Medical specialties; Microbiology,health>diseases and conditions; science and technology>natural science>biology; health
https://dx.doi.org/10.1080/21645515.2019.1625644,9.0,who-9447528788751654517dff5a844016cb,World Health Organization,Human papillomavirus vaccines: WHO position paper (‎2022 update)‎ –Vaccins contre les papillomavirus humains: note de synthèse de l’OMS (‎mise à jour de 2022)‎,2022-12-16,https://apps.who.int/iris/handle/10665/365351,igo,healthcare agency,IGO,Medical specialties; Clinical medicine; Health sciences,science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.4414/smw.2017.14543,14.0,adminch-00e22c8d7baad5c1735555737b78c70a,Government of Switzerland,L’hépatite C chez les usagers de drogue,2019-03-21,https://www.bag.admin.ch/dam/bag/fr/dokumente/mt/i-und-b/richtlinien-empfehlungen/empfehlungen-risikogruppen-risikosituationen/richtlinien-hepatitis-c-drogen.pdf.download.pdf/richtlinien-hepatitis-c-drogen-fr.pdf,government,,Switzerland,Hepatitis C; Hepatitis B; Viral hepatitis,health; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.4414/smw.2017.14543,14.0,adminch-47ee13cde1b948f229d378a25b2ef432,Government of Switzerland,Prospettive della politica svizzera in materia di droghe,2021-04-28,https://www.bag.admin.ch/dam/bag/it/dokumente/npp/sucht/drogenpolitik/bericht-po-rechsteiner.pdf.download.pdf/bericht-po-rechsteiner.pdf,government,,Switzerland,Drug; Drug liberalization; Cannabis,"crime, law and justice>crime; crime, law and justice>crime>drug related crimes; crime, law and justice>law"
https://dx.doi.org/10.4414/smw.2017.14543,14.0,adminch-4ceea3df3b118111776e4d8d909e5e25,Government of Switzerland,Avenir de la politique suisse en matière de drogue,2021-04-28,https://www.bag.admin.ch/dam/bag/en/dokumente/npp/sucht/drogenpolitik/bericht-po-rechsteiner.pdf.download.pdf/Bericht_Po_Rechsteiner_d.pdf,government,,Switzerland,Drug; Cannabis (drug); Addiction,"crime, law and justice>crime>drug related crimes; crime, law and justice>crime; society>social problem>addiction"
https://dx.doi.org/10.4414/smw.2017.14543,14.0,adminch-5929f19ead0cc876acad2806efd4017a,Government of Switzerland,Medizinische Empfehlungen für Opioidagonistentherapie (OAT) bei Opioidabhängigkeits-Syndrom 2020,2020-07-21,https://www.bag.admin.ch/dam/bag/de/dokumente/kuv-leistungen/referenzdokumente-klv-anhang-1/08-opiatagonistentherapie-oat-de-fr-it.pdf.download.pdf/08_Opiatagonistentherapie_OAT_DE.pdf,government,,Switzerland,Buprenorphine; Methadone; Heroin,science and technology>biomedical science>pharmacology; society>social problem>addiction; health>health treatment
https://dx.doi.org/10.4414/smw.2017.14543,14.0,adminch-5f72a9cdf2048825607aa9f63a7773f0,Government of Switzerland,Perspektiven der schweizerischen Drogenpolitik,2021-04-28,https://www.bag.admin.ch/dam/bag/de/dokumente/npp/sucht/drogenpolitik/bericht-po-rechsteiner.pdf.download.pdf/Bericht_Po_Rechsteiner_d.pdf,government,,Switzerland,Drug; Cannabis (drug); Substance dependence,"crime, law and justice>crime>drug related crimes; crime, law and justice>crime; crime, law and justice>law"
https://dx.doi.org/10.4414/smw.2017.14543,14.0,adminch-645344dc7f62e5eea8f7e83cac018232,Government of Switzerland,Recommandations médicales relatives au traitement agoniste opioïde (TAO) du syndrome de dépendance aux opioïdes 2020,2020-07-21,https://www.bag.admin.ch/dam/bag/fr/dokumente/kuv-leistungen/referenzdokumente-klv-anhang-1/08-opiatagonistentherapie-oat-de-fr-it.pdf.download.pdf/08_Traitement%20agoniste%20opioïde_TAO_FR.pdf,government,,Switzerland,Buprenorphine; Heroin; Morphine,science and technology>biomedical science>pharmacology; health>diseases and conditions; society>social problem>addiction
https://dx.doi.org/10.4414/smw.2017.14543,14.0,adminch-720f14e18be751dbd3cf3ace1a0c6362,Government of Switzerland,2018,2019-02-27,"https://www.bag.admin.ch/dam/bag/it/dokumente/npp/forschungsberichte/forschungsberichte_drogen/The%20State%20of%20Harm%20Reduction%20in%20Western%20Europe%202018.%20Harm%20Reduction%20International,%20London.pdf.download.pdf/HRI_WesternEuropeGlobalState_Feb2019_Final.pdf",government,,Switzerland,Harm reduction; Naloxone; Drug overdose,"society>social problem>addiction; crime, law and justice>crime>drug related crimes; health>diseases and conditions"
https://dx.doi.org/10.4414/smw.2017.14543,14.0,adminch-84509f90c7a184eb7cdea5b013aca9fd,Government of Switzerland,Hepatitis C bei Drogenkonsumierenden,2019-03-21,https://www.bag.admin.ch/dam/bag/de/dokumente/mt/infektionskrankheiten/hepatitis-c/richtlinien-hepatitis-c-drogen.pdf.download.pdf/richtlinien-hepatitis-c-drogen-de.pdf,government,,Switzerland,Hepatitis C; Hepatitis B; Vaccination,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.4414/smw.2017.14543,14.0,adminch-c38a482162be562b4ca3376535f633e1,Government of Switzerland,Raccomandazioni mediche 2020 per la terapia con agonisti oppioidi (TAO) della sindrome da dipendenza da oppioidi,2020-12-03,https://www.bag.admin.ch/dam/bag/it/dokumente/kuv-leistungen/referenzdokumente-klv-anhang-1/08-opiatagonistentherapie-oat-de-fr-it.pdf.download.pdf/08_terapia%20con%20agonisti%20oppioidi_TAO_IT.pdf,government,,Switzerland,Medicine; Morphine; Codeine,science and technology>biomedical science>pharmacology; science and technology; health
https://dx.doi.org/10.4414/smw.2017.14543,14.0,adminch-cd41e9717211d6c9f8270daaf9d9669b,Government of Switzerland,Hepatitis C bei Drogenkonsumierenden,2019-03-21,https://www.bag.admin.ch/dam/bag/de/dokumente/mt/infektionskrankheiten/hepatitis-c/richtlinien-hepatitis-c-drogen.pdf,government,,Switzerland,Hepatitis C; Hepatitis B; Vaccination,health; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.4414/smw.2017.14543,14.0,adminch-f10b53ee7b65c04d14efe85b5749126b,Government of Switzerland,L’epatite C nei consumatori di stupefacenti,2019-03-21,https://www.bag.admin.ch/dam/bag/it/dokumente/mt/infektionskrankheiten/hepatitis-c/richtlinien-hepatitis-c-drogen.pdf.download.pdf/richtlinien-hepatitis-c-drogen-it.pdf,government,,Switzerland,Hepatitis C; Hepatitis B; HIV,health; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.4414/smw.2017.14543,14.0,parliamentofswitzerland-7e813d6007527d4e159f1be2174bbe35,Federal Assembly,Perspektiven der schweizerischen Drogenpolitik,2021-04-28,https://www.parlament.ch/centers/eparl/curia/2017/20174076/Bericht%20BR%20D.pdf,government,,Switzerland,Drug; Cannabis (drug); Drug liberalization,"crime, law and justice>crime>drug related crimes; crime, law and justice>crime; crime, law and justice>law"
https://dx.doi.org/10.4414/smw.2017.14543,14.0,stateofcatalunya-3ff5b1066fe1b4cfff15fdcc6360fa4a,Generalitat de Catalunya,Protocol de diagnòstic i tractament del virus de l’hepatitis C per persones drogodependents,2021-03-24,https://salutpublica.gencat.cat/web/.content/minisite/aspcat/vigilancia_salut_publica/vih-sida-its/04_Hepatitis_viriques/guies_i_protocols/Protocol-diagnostic-i-tractament-VHC-persones-drogodependents_Act-2021_okDef.pdf,government,,Spain,,
https://dx.doi.org/10.4414/smw.2017.14543,14.0,stateofcatalunya-7c41a23fd1958362a683a9a820b7191b,Generalitat de Catalunya,Protocol de diagnòstic i tractament del virus de l’hepatitis C per persones drogodependents,2020-06-23,https://salutpublica.gencat.cat/web/.content/minisite/aspcat/vigilancia_salut_publica/vih-sida-its/04_Hepatitis_viriques/guies_i_protocols/Protocol-diagnostic-i-tractament-VHC-persones-drogodependents_defOK.pdf,government,,Spain,,
https://dx.doi.org/10.1073/pnas.0510077103,5.0,finnishpublichealth-19d6926ccd0ae7460b3ef64e5a4cb1d6,Kansanterveyslaitos,"Methicillin-resistant Staphylococcus aureus in Finland: recent changes in the epidemiology, long-term facility aspects, and phenotypic and molecular detection of isolates",2012-04-19,http://www.julkari.fi/handle/10024/78184,government,,Finland,Methicillin-resistant Staphylococcus aureus; Staphylococcus aureus; Multilocus sequence typing,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health>diseases and conditions
https://dx.doi.org/10.1073/pnas.0510077103,5.0,gezondheidsraad-dd37866b4e7b296548da60a331dbfc41,Gezondheidsraad,MRSA-beleid in Nederland,2006-10-16,https://www.gezondheidsraad.nl/documenten/adviezen/2006/10/16/mrsa-beleid-in-nederland,government,healthcare agency,Netherlands,,"economy, business and finance>economic sector>computing and information technology; economy, business and finance>economic sector>computing and information technology>software"
https://dx.doi.org/10.1073/pnas.0510077103,5.0,healthprotectionscotland-e77fd70aa1063c0e5506841d8596a860,Health Protection Scotland,NHS Scotland MRSA Screening Pathfinder Programme. Interim Report,2009-10-01,https://hps.scot.nhs.uk/web-resources-container/nhs-scotland-mrsa-screening-pathfinder-programme-interim-report/,government,healthcare agency,UK,Isolation (health care); NHS Scotland; Antimicrobial resistance,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1073/pnas.0510077103,5.0,inspq_canada-ab6b2a1f001bbd94a148f7019e40c8e3,Institut national de santé publique du Québec,Proportion de chambres individuelles avec salle de toilette non partagée devant être disponibles dans les établissements de soins de santé physique du Québec,2010-09-08,https://www.inspq.qc.ca/publications/937,government,healthcare agency,Canada,Infectious diseases; Isolation (health care); Infection,health; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1073/pnas.0510077103,5.0,pubmedcentral-8ff2f59c0cbe6085afab1272f712532b,Guidelines in PubMed Central,Further lessons from the TGN1412 tragedy - New guidelines call for a change in the culture of research,2006-08-05,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526936/pdf,other,aggregator,USA,Methicillin-resistant Staphylococcus aureus; Staphylococcus aureus; Theralizumab,science and technology>biomedical science>pharmacology; science and technology; health
https://dx.doi.org/10.1098/rsif.2020.1006,2.0,governmentofindia-c8d8acccd0f2685c43b2258a6ee495fa,Government of India,India ' s Climate Research Agenda : 2030 and beyond,2023-05-26,https://dst.gov.in/sites/default/files/India%27s%20Climate%20Research%20Agenda%202030%20and%20beyond.pdf,government,,India,General circulation model; Climate change; El Niño–Southern Oscillation,weather; science and technology>natural science>meteorology; environment>natural resources>water
https://dx.doi.org/10.1098/rsif.2020.1006,2.0,unfccc-4870def4216f7883ea2908a1f3598e09,United Nations Framework Convention on Climate Change,Seychelles. National Communication (NC). NC 3. Biennial Update Report (BUR). BUR 1.,2024-02-23,https://unfccc.int/documents/637274,igo,,IGO,Renewable energy; Blue carbon; Climate resilience,environment; environment>nature; environment>natural resources>water
https://dx.doi.org/10.1016/j.parepi.2016.02.004,1.0,pubmedcentral-51a9673698758f1d8b6eaa08452c4ff5,Guidelines in PubMed Central,Investigating the Effectiveness of Current and Modified World Health Organization Guidelines for the Control of Soil-Transmitted Helminth Infections,2018-06-15,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982801/pdf,other,aggregator,USA,Soil-transmitted helminthiasis; Neglected tropical diseases; Epidemiology,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/j.ttbdis.2020.101437,1.0,rivmnl-764528f2311d13eeeafb59d6f7e87ecc,Rijksinstituut voor Volksgezondheid en Milieu,Mondiaal klimaatbeleid: gezondheidswinst in Nederland bij minder klimaatverandering,2021-05-28,https://www.rivm.nl/publicaties/mondiaal-klimaatbeleid-gezondheidswinst-in-nederland-bij-minder-klimaatverandering,government,research center,Netherlands,Climate change; Storm; Sea level rise,health>diseases and conditions; environment; health
https://dx.doi.org/10.1016/j.vaccine.2022.12.032,2.0,hcspfr-36cde91696a5124fa72c5af9d9bf0518,Haut Conseil de la santé publique,Opportunité d’une campagne de vaccination à Mayotte (pénurie d’eau potable),2023-06-22,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=1318,government,agency,France,Epidemiology; Polio; Cholera,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/j.vaccine.2022.12.032,2.0,hcspfr-d75d91f84b2bab0dfdf56bb55859751b,Haut Conseil de la santé publique,Opportunité d’une campagne de vaccination à Mayotte (pénurie d’eau potable),2023-06-22,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=1319,government,agency,France,Vaccine; Hepatitis A; Infectious diseases,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/j.gie.2022.01.002,1.0,hrbie-f42b649d49a7ef5d9694fcf70cf70cb3,Health Research Board,"Cost, safety, and environmental impact of reprocessing single-use medical devices. A systematic review and meta-analysis",2023-09-11,https://www.hrb.ie/publications/publication/cost-safety-and-environmental-impact-of-reprocessing-single-use-medical-devices-a-systematic-revi/returnPage/1/,government,,Ireland,Systematic review; Cohort study; Meta-analysis,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1016/j.ijfoodmicro.2020.108775,4.0,efsaeu-c0f79ef9567f58a35a35267b231253db,EFSA,Training in tools to develop quantitative risk assessment of fresh produce using water reuse systems in Mediterranean production,2022-05-25,https://www.efsa.europa.eu/en/efsajournal/pub/e200416,government,agency,EU,Sewage treatment; Risk assessment; Health,lifestyle and leisure>lifestyle>food and drink; health>diseases and conditions; health>health treatment
https://dx.doi.org/10.1016/j.ijfoodmicro.2020.108775,4.0,efsaeu-fc804121d1e0623760bcf72adfc2b122,EFSA,Modelling and magnitude estimation of cross‐contamination in the kitchen for quantitative microbiological risk assessment (QMRA),2020-11-26,https://www.efsa.europa.eu/en/efsajournal/pub/e181106,government,agency,EU,Microbiology; Foodborne illness; Risk,"health>diseases and conditions; economy, business and finance>economic sector>consumer goods>food; lifestyle and leisure>lifestyle>food and drink"
https://dx.doi.org/10.1016/j.ijfoodmicro.2020.108775,4.0,europa-26806af482588f657f0c3df545323d52,Publications Office of the European Union,"The European food risk assessment fellowship programme. Series 3, 2020-2021.",2021-01-18,https://op.europa.eu/en/publication-detail/-/publication/b6b3470c-5a09-11eb-b59f-01aa75ed71a1/language-en/format-PDF,government,,EU,Dietary supplement; Praseodymium; Chemistry,"economy, business and finance>economic sector>chemicals; science and technology>natural science>biology; economy, business and finance>economic sector>chemicals>inorganic chemical"
https://dx.doi.org/10.1016/j.ijfoodmicro.2020.108775,4.0,europa-e2207415ac220a544fa7451e3a66e5aa,Publications Office of the European Union,"The European food risk assessment fellowship programme. Series 4, 2020-2021.",2022-07-22,https://op.europa.eu/en/publication-detail/-/publication/9756b1af-0bc4-11ed-b11c-01aa75ed71a1/language-en/format-PDF,government,,EU,Medical specialties; Life sciences; Biology,science and technology>natural science>biology; science and technology>natural science>biology>genetics; lifestyle and leisure>lifestyle>food and drink
https://dx.doi.org/10.1053/jscd.2001.30366,1.0,pubmedcentral-92d973a4d6c837dd06c1a4528101d19c,Guidelines in PubMed Central,Antibiotic therapy for preventing infections in people with acute stroke,2018-01-22,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491314/pdf,other,aggregator,USA,Systematic review; Meta-analysis; Stroke,science and technology>biomedical science>pharmacology; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1086/647837,1.0,has-26c0d8860185df804719410247c1c945,Haute Autorité de Santé,Stratégie d'antibiothérapie et prévention des résistances bactériennes en établissement de santé,2008-05-29,https://www.has-sante.fr/portail/jcms/c_665169/fr/strategie-d-antibiotherapie-et-prevention-des-resistances-bacteriennes-en-etablissement-de-sante,government,healthcare agency,France,Antibiotic; Antimicrobial resistance; Infection,health; science and technology>biomedical science>pharmacology; science and technology>biomedical science
https://dx.doi.org/10.1073/pnas.1801338115,1.0,pmcsa-b93e0fcce751fb57051f0ad449e827bc,Office of the Prime Minister’s Chief Science Advisor,Antimicrobial resistance and infectious disease,2022-02-16,https://www.pmcsa.ac.nz/files/2020/01/Full-report-FINAL-15122021-V2-PDF-160222.pdf,government,,New Zealand,Antimicrobial resistance; Horizontal gene transfer; Antibiotic,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1093/cid/ciz1103,3.0,aerckenya-64cddf218dd916de86ef190dc6dd345c,African Economic Research Consortium,Impact of COVID-19 Measures on Kenya’s Health System,2021-10-08,https://publication.aercafricalibrary.org/items/61ff246d-5162-4b68-9297-b1bc06286745,think tank,,Kenya,Non-communicable disease; Health; COVID-19,health; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1093/cid/ciz1103,3.0,unaids-498ad51ff5483c8ad1c350e80acdd5c9,UNAIDS,Prevailing against pandemics by putting people at the centre,2020-11-26,https://www.unaids.org/en/resources/documents/2020/prevailing-against-pandemics,igo,,IGO,HIV/AIDS; Prevention of HIV/AIDS; Pre-exposure prophylaxis,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1093/cid/ciz1103,3.0,unitednations-91f7b9367a2a4bd5309ee133db119aa2,United Nations,Prevailing against pandemics by putting people at the centre :World AIDS Day report 2020,2020-01-01,https://digitallibrary.un.org/record/3937177?ln=en,igo,,IGO,HIV/AIDS; Virus; HIV,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1086/505877,29.0,europa-6ac438b33c9e4a64f06624d546d463cb,Publications Office of the European Union,Eurosurveillance : special focus : tuberculosis. March 2010.,2010-10-25,https://op.europa.eu/en/publication-detail/-/publication/0a3d12f4-7bac-4b79-85aa-070855cf8988/language-en/format-PDF,government,,EU,Extensively drug-resistant tuberculosis; Tuberculosis; Multi-drug-resistant tuberculosis,health; health>diseases and conditions; health>health treatment
https://dx.doi.org/10.1086/505877,29.0,governmentofcanada-8be8f683e7c56541025a3976d8d71110,Government of Canada,"Canadian tuberculosis standards / Joint project of Tuberculosis Prevention and Control, Public Health Agency of Canada, and the Canadian Lung Association/Canadian Thoracic Society.: HP40-18/2007E-PDF Publications - Canada.ca",2007-01-01,http://publications.gc.ca/site/eng/9.689773/publication.html,government,,Canada,Mantoux test; Tuberculosis; Tuberculosis diagnosis,health>diseases and conditions; science and technology>natural science>biology; health>diseases and conditions>illness
https://dx.doi.org/10.1086/505877,29.0,governmentofuganda-ef709fffc364c839c4a19dee4cc9b81f,Government of Uganda,A handbook for national tuberculosis control programmes,2008-11-13,http://library.health.go.ug/sites/default/files/resources/Implementing%20the%20WHO%20stop%20TB%20strategy.pdf,government,,Uganda,Tuberculosis; Multi-drug-resistant tuberculosis; Extensively drug-resistant tuberculosis,health>diseases and conditions>illness; science and technology>biomedical science>pharmacology; health>diseases and conditions
https://dx.doi.org/10.1086/505877,29.0,instituteforhealthmetricsandevaluation-ba0a65ea74b933f13ad2fdc9b74e9af4,Institute for Health Metrics and Evaluation,Financing Global Health 2013: Transition in an Age of Austerity,2014-03-24,https://www.healthdata.org/policy-report/financing-global-health-2013-transition-age-austerity,think tank,university affiliated,USA,"The Global Fund to Fight AIDS, Tuberculosis and Malaria; Organisation of African Unity; Public sphere",health>diseases and conditions; health; health>diseases and conditions
https://dx.doi.org/10.1086/505877,29.0,stateofgeorgia-bd120e39ad3e7e17416c293694e620b0,State of Georgia,Guidelines For Prevention And Control,2008-06-11,https://dph.georgia.gov/document/document/who-tuberculosis-and-air-travel-guidelines-prevention-and-control-2008/download,government,,USA,Mantoux test; Tuberculosis; Extensively drug-resistant tuberculosis,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1086/505877,29.0,stateoftennessee-01cde53984fd291a48bf6ac52ad9a415,State of Tennessee,Drug-Resistant Tuberculosis,2008-03-21,https://www.tn.gov/content/dam/tn/health/documents/tuberculosis_guidelines/TB_FJCSurvivalGuide.pdf,government,,USA,Multi-drug-resistant tuberculosis; Extensively drug-resistant tuberculosis; Tuberculosis,science and technology>biomedical science>pharmacology; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1086/505877,29.0,unaids-57f87c81581a81ae0c0da661de027531,UNAIDS,Global Tuberculosis Control 2008,2008-03-13,https://www.unaids.org/en/resources/documents/2008/20080317_who2008globaltbreport_en.pdf,igo,,IGO,"Multi-drug-resistant tuberculosis; Directly observed treatment, short-course; Tuberculosis",health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1086/505877,29.0,who-02875bc2c9f7b9aa58bfca321e66766f,World Health Organization,"Weekly Epidemiological Record, 2006, vol. 81, 41 [‎full issue]‎",2016-06-16,https://apps.who.int/iris/handle/10665/233218,igo,healthcare agency,IGO,Tuberculosis; Influenza; Influenza A virus subtype H5N1,health>diseases and conditions>communicable disease>epidemic; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1086/505877,29.0,who-0cc8c8083938c6bff9144aee367aa73c,World Health Organization,"Global tuberculosis control : surveillance, planning, financing : WHO report 2008",2012-06-16,http://apps.who.int/iris/handle/10665/43831,igo,healthcare agency,IGO,Multi-drug-resistant tuberculosis; Tuberculosis; Tuberculosis management,health; health>health treatment; health>health treatment>medicine
https://dx.doi.org/10.1086/505877,29.0,who-1db98140633db03da29b4d743f8a8fb8,World Health Organization,Tuberculosis control in the Western Pacific Region : 2009 report,2016-05-26,https://apps.who.int/iris/handle/10665/207036,igo,healthcare agency,IGO,"Animal bacterial diseases; Directly observed treatment, short-course; Multi-drug-resistant tuberculosis",health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1086/505877,29.0,who-1faf1faa9c95479fcf7e22ced313051f,World Health Organization,Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis,2018-03-26,https://apps.who.int/iris/handle/10665/270085,igo,healthcare agency,IGO,Multi-drug-resistant tuberculosis; Extensively drug-resistant tuberculosis; Tuberculosis,health; health>diseases and conditions; health>health treatment
https://dx.doi.org/10.1086/505877,29.0,who-45d5a0adc8546ff6d45996ac836d4820,World Health Organization,"Global tuberculosis control : epidemiology, planning, financing : WHO report 2009",2012-06-16,http://apps.who.int/iris/handle/10665/44035,igo,healthcare agency,IGO,"Multi-drug-resistant tuberculosis; Tuberculosis; Directly observed treatment, short-course",health; health>diseases and conditions>communicable disease>virus disease; health>health treatment
https://dx.doi.org/10.1086/505877,29.0,who-49b0bb630d5bf9cb5d77b94ed6740370,World Health Organization,"Tuberculosis control in the South-East Asia Region, 2006",2016-05-09,https://apps.who.int/iris/handle/10665/206057,igo,healthcare agency,IGO,"Multi-drug-resistant tuberculosis; Tuberculosis; Directly observed treatment, short-course",health; health>diseases and conditions; health>health treatment
https://dx.doi.org/10.1086/505877,29.0,who-53a1848cd56077ce93918c6a28354c89,World Health Organization,Tuberculosis control in the Western Pacific Region : 2008 report,2016-05-26,https://apps.who.int/iris/handle/10665/206986,igo,healthcare agency,IGO,"Multi-drug-resistant tuberculosis; Directly observed treatment, short-course; Tuberculosis",health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1086/505877,29.0,who-5447d830da28c7de26d30e70ddeda6c6,World Health Organization,Addressing the threat of tuberculosis caused by extensively drug-resistant Mycobacterium tuberculosis = Parer à la menace de tuberculose à bacilles ultrarésistants,2016-06-16,https://apps.who.int/iris/handle/10665/233217,igo,healthcare agency,IGO,Epidemiology; Diseases and disorders; Infectious diseases,health; health>diseases and conditions>communicable disease>epidemic; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1086/505877,29.0,who-63686ae8ca2452bafb5492cfba6f63cc,World Health Organization,Characterization of Mycobacterium tuberculosis of Lebanese patients by double-repetitive-element polymerase chain reaction,2014-06-17,https://apps.who.int/iris/handle/10665/117944,igo,healthcare agency,IGO,Tuberculosis; Mycobacterium; Medical microbiology,science and technology>natural science>biology; health>diseases and conditions; science and technology
https://dx.doi.org/10.1086/505877,29.0,who-68434be69ff7e344c11727af33b619e4,World Health Organization,"Plan to Stop TB in 18 High-priority Countries in the WHO European Region, 2007–2015",2021-09-22,https://apps.who.int/iris/handle/10665/345352,igo,healthcare agency,IGO,Multidrug-resistant tuberculosis; Extensively drug-resistant tuberculosis; Tuberculosis,health>diseases and conditions; health; education
https://dx.doi.org/10.1086/505877,29.0,who-6e30d1e1ac7b9ceb934d6d51e121f678,World Health Organization,"Diagnostics for tuberculosis : global demand and market potential / TDR, FIND SA",2012-06-16,http://apps.who.int/iris/handle/10665/43543,igo,healthcare agency,IGO,Tuberculosis; Multi-drug-resistant tuberculosis; Infection,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease>virus disease>retrovirus
https://dx.doi.org/10.1086/505877,29.0,who-89df5b4aec7f1b1e466dcba2c9b31021,World Health Organization,Implementing the WHO Stop TB Strategy : a handbook for national tuberculosis control programmes,2012-06-16,http://apps.who.int/iris/handle/10665/43792,igo,healthcare agency,IGO,Tuberculosis; HIV; Biology,health; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1086/505877,29.0,who-b620adcc99fca0bed096f14eb670f275,World Health Organization,3rd ed,2012-06-16,http://apps.who.int/iris/handle/10665/43921,igo,healthcare agency,IGO,Extensively drug-resistant tuberculosis; Multi-drug-resistant tuberculosis; Infection,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1086/505877,29.0,who-b8d174dca29a907d86cba35694a7fa8f,World Health Organization,Treatment and management of MDR-TB in Latvia,2018-03-26,https://apps.who.int/iris/handle/10665/270079,igo,healthcare agency,IGO,Multi-drug-resistant tuberculosis; Extensively drug-resistant tuberculosis; Tuberculosis,health; health>diseases and conditions; health>health treatment
https://dx.doi.org/10.1086/505877,29.0,who-ce5949ad7971e0f7a5abf8a651712614,World Health Organization,Case study: South Africa,2018-03-26,https://apps.who.int/iris/handle/10665/270080,igo,healthcare agency,IGO,Multi-drug-resistant tuberculosis; Extensively drug-resistant tuberculosis; Tuberculosis,health; health>diseases and conditions; health>health treatment
https://dx.doi.org/10.1086/505877,29.0,who-dc0f98e01cadb26031eb5acebb22c744,World Health Organization,Реализация стратегии ВОЗ “Остановить туберкулёз”. Справочник для национальных программ борьбы с туберкулёзом.,2013-07-22,https://apps.who.int/iris/handle/10665/85531,igo,healthcare agency,IGO,Tuberculosis; HIV; Biology,health; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1086/505877,29.0,who-deb0f01f8aff2dad19da010967660b0d,World Health Organization,The Philippines case study,2018-03-26,https://apps.who.int/iris/handle/10665/270056,igo,healthcare agency,IGO,Multi-drug-resistant tuberculosis; Extensively drug-resistant tuberculosis; Tuberculosis,health; health>diseases and conditions; health>health treatment
https://dx.doi.org/10.1086/505877,29.0,who-df1f1ea5800232c013412e4adc84191b,World Health Organization,"План “Остановить ТБ» для 18 наиболее приоритетных стран Европейского региона ВОЗ, 2007–2015 гг.",2021-09-22,https://apps.who.int/iris/handle/10665/345353,igo,healthcare agency,IGO,Europe; World Health Organization; Tuberculosis,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1086/505877,29.0,who-ecf7692381b9bba2380e92bf3266d947,World Health Organization,Eastern Mediterranean Health Journal,2019-09-20,https://apps.who.int/iris/handle/10665/327665,igo,healthcare agency,IGO,Diarrhea; Gastroenteritis; Tuberculosis,health>diseases and conditions; health; science and technology>natural science>biology
https://dx.doi.org/10.1086/505877,29.0,who-eff54c4bd977837a585e826ba916c95a,World Health Organization,"Global tuberculosis control : surveillance, planning, financing : WHO report 2007",2012-06-16,http://apps.who.int/iris/handle/10665/43629,igo,healthcare agency,IGO,Multi-drug-resistant tuberculosis; Tuberculosis; Tuberculosis management,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment
https://dx.doi.org/10.1086/505877,29.0,worldbank-0a5ae9fe555bfd556cfbba5da4081bc5,World Bank,The Importance of Health and Safety at African Mine Sites,2017-02-02,https://openknowledge.worldbank.org/handle/10986/25997,igo,development bank,IGO,Fuel; Renewable energy; Mining,"health; environment; economy, business and finance>economic sector>energy and resource"
https://dx.doi.org/10.1086/505877,29.0,worldbank-3cb9cafb77f03db77ba97ab377de6238,World Bank,The Importance of Health and Safety at African Mine Sites,2016-01-01,https://hdl.handle.net/10986/25997,igo,development bank,IGO,Fuel; Renewable energy; Mining,"health; environment; economy, business and finance>economic sector>energy and resource"
https://dx.doi.org/10.1093/infdis/jiab147,2.0,who-1db6c44962e4639f091604bbf9778757,World Health Organization,"Weekly Epidemiological Record, 2021, vol. 96, 25 [‎full issue]‎",2021-06-25,https://apps.who.int/iris/handle/10665/341994,igo,healthcare agency,IGO,Health; Health sciences; Viral respiratory tract infections,health>diseases and conditions; health>diseases and conditions>illness; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1093/infdis/jiab147,2.0,who-b62619f4d20ac92cb7e348e337fd4a06,World Health Organization,"Review of global influenza circulation, late 2019 to 2020, and the impact of the COVID-19 pandemic on influenza circulation – WHO European Region, 2005–2019 – Bilan de la circulation mondiale de la grippe entre fin 2019 et fin 2020 et effets de la pandémie de COVID-19 sur la circulation de la grippe",2021-06-25,https://apps.who.int/iris/handle/10665/341995,igo,healthcare agency,IGO,Influenza A virus subtype H3N2; Influenza; Microbiology,health>diseases and conditions; health>diseases and conditions>illness; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1111/jvh.12010,3.0,who-5e7d4ec3bd2ab841ff1fa514833c4d29,World Health Organization,Appendix 2: systematic review reports and evidence summaries,2015-11-06,https://apps.who.int/iris/handle/10665/193041,igo,healthcare agency,IGO,Health; Cirrhosis; Hepatitis,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1111/jvh.12010,3.0,who-7cff5d40e8490a4c3e565fc0544b3787,World Health Organization,"Lignes directrices pour la prévention, les soins et le traitement en faveur des personnes atteintes de l’infection à hépatite B chronique",2018-02-22,https://apps.who.int/iris/handle/10665/260296,igo,healthcare agency,IGO,Hepatitis; Cirrhosis; Viral hepatitis,health>diseases and conditions>communicable disease>virus disease; health; health>diseases and conditions
https://dx.doi.org/10.1111/jvh.12010,3.0,who-e7da8058f83a8dc1b24968864dda432c,World Health Organization,"Руководство по хроническому гепатиту В: профилактика, помощь и лечение",2021-08-10,https://apps.who.int/iris/handle/10665/343841,igo,healthcare agency,IGO,Hepatitis B; Hepatitis; Hepatitis C,health>diseases and conditions>communicable disease>virus disease; health; science and technology>natural science>biology
https://dx.doi.org/10.1111/liv.15584,3.0,hstza-61f495678627325a494b227b5045ac5a,Health Systems Trust,Action for access in low- and middle-income countries,2024-04-08,https://www.hst.org.za/publications/NonHST%20Publications/9789240091672-eng%20(2).pdf,think tank,,South Africa,Hepatitis B; Hepatitis D; Hepatitis,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1111/liv.15584,3.0,unitednations-80fae5a66b74c5d45505a3488f5fb561,United Nations,Global hepatitis report 2024 :action for access in low- and middle-income countries,2024-01-01,https://digitallibrary.un.org/record/4043391?ln=en,igo,,IGO,Infection; Viral hepatitis; Vertically transmitted infection,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1111/liv.15584,3.0,who-24f1b38b9a8510a458fc71a8a29c7a06,World Health Organization,Global hepatitis report 2024: action for access in low- and middle-income countries,2024-01-01,https://apps.who.int/iris/handle/10665/376461,igo,healthcare agency,IGO,Hepatitis B; Hepatitis D; Hepatitis,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.3168/jds.2012-5809,1.0,efsaeu-6febe44429c6ed39d83ff80d1e8261bb,EFSA,MAPRA: Modelling Animal Pathogens: Review and Adaptation,2016-12-21,https://www.efsa.europa.eu/en/supporting/pub/en-1112,government,agency,EU,Parameter; Database; Research,"economy, business and finance>economic sector>computing and information technology; science and technology; science and technology>mathematics"
https://dx.doi.org/10.1111/j.1541-0420.2006.00569.x,1.0,who-17758f136c7d88faaffaea34576fe16e,World Health Organization,Correlates of vaccine-induced protection: methods and implications,2013-06-03,https://apps.who.int/iris/handle/10665/84288,igo,healthcare agency,IGO,Vaccine; Immunity (medical); Passive immunity,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease>virus disease>retrovirus
https://dx.doi.org/10.1016/j.epidem.2021.100526,1.0,govuk-d7ab9eedddfad2ea08bc5be89126b725,The UK Government,COVID-19: non-pharmaceutical interventions to reduce transmission,2023-09-28,https://www.gov.uk/government/publications/covid-19-non-pharmaceutical-interventions-to-reduce-transmission,government,,UK,Health care; COVID-19 pandemic; Social distancing,health>diseases and conditions; health; health>diseases and conditions
https://dx.doi.org/10.1016/j.jhep.2013.09.029,2.0,nice-4d9815fc6ebe5db7706ff80c1910b6fc,NICE,Cirrhosis in over 16s: assessment and management,2016-07-06,https://www.nice.org.uk/guidance/ng50,government,healthcare agency,UK,Hepatocellular carcinoma; Quality-adjusted life year; Cost–utility analysis,health; health>health treatment; science and technology>social sciences
https://dx.doi.org/10.1016/j.jhep.2013.09.029,2.0,pubmedcentral-f44345558938c295dde12097e3804dae,Guidelines in PubMed Central,Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update,2015-11-13,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722087/pdf,other,aggregator,USA,Medicine; Hepatitis B; Hepatitis,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,ahrq-81483526743f096862bc29140ffd3f43,AHRQ,Resource Allocation and Pandemic Response: An Evidence Synthesis To Inform Decision Making,2020-09-28,https://effectivehealthcare.ahrq.gov/products/allocation-scarce-resources/rapid-review,government,healthcare agency,USA,Influenza pandemic; Coronavirus disease 2019; Influenza,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,dhsgov-06e4b0db563659cb011e7b5cece3acc2,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2020-10-22,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf,government,,USA,Coronavirus disease 2019; Infection; Transmission (medicine),health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,dhsgov-38fd23e57dd8ec707294d25fb8fb9019,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-01-28,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210126.pdf,government,,USA,Medicine; Public health; Epidemiology,science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,dhsgov-7d012ca698e16eb5ab13f18f1d8c20b1,Department of Homeland Security,For Public Release,2020-09-03,https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Serology; Infection,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,dhsgov-c2c5f296cd093cb97fbd27974ea82088,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-Cov-2),2020-09-17,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Symptoms of COVID-19; Infection,science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,dhsgov-c4ca50594c2444482cbf59ab303a2991,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2020-11-05,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Symptoms of COVID-19; Infection,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,dhsgov-c7c066a7980e1f94e43e90e1e29d3feb,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2020-07-23,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf,government,,USA,Symptoms of COVID-19; Infection; Severe acute respiratory syndrome coronavirus 2,health>diseases and conditions>illness; science and technology>natural science>biology>genetics; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,dhsgov-d03d62734a42fe925cf1a6d5dd96f67c,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-01-07,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Infection; COVID-19,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,dhsgov-d200536d006998d2083e74b1255d5c5f,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2020-07-09,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200707.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Infection; N95 respirator,health>diseases and conditions>illness; science and technology>natural science>biology>genetics; health>diseases and conditions
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,govdeptsspain-6d1b0c056d956615af8a4932c4532d45,Government of Spain,El Uso De Mascarillas En La Práctica De Ejercicio Físico De Alta Intensidad Durante La Pandemia,2020-08-31,https://www.mscbs.gob.es/biblioPublic/publicaciones/recursos_propios/resp/revista_cdrom/VOL94/REVISIONES/RS94C_202008108.pdf,government,,Spain,Partial pressure; Cloth face mask; Capillary,science and technology>natural science>biology; health; science and technology>natural science>biology>physiology
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,hiqaie-3a09e645a19acbdb19e2ad6b84cf3511,Health Information and Quality Authority,Face mask use in the community to reduce SARS-COV-2 transmission – rapid evidence update,2020-12-17,https://www.hiqa.ie/reports-and-publications/health-technology-assessment/face-mask-use-community-reduce-sars-cov-2,government,healthcare agency,Ireland,Face masks during the COVID-19 pandemic; Airborne transmission; Surgical mask,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,hiqaie-7ae12f4aee2335348c03996596ae625d,Health Information and Quality Authority,Face masks in the community,2020-08-20,https://www.hiqa.ie/reports-and-publications/health-technology-assessment/evidence-summary-face-masks-community,government,healthcare agency,Ireland,Airborne transmission; Face masks during the COVID-19 pandemic; Cloth face mask,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,inspq_canada-56937b4715744aa9b2365f84a1f7c5ca,Institut national de santé publique du Québec,COVID-19 : Port du couvre-visage ou du masque médical par la population générale,2021-10-29,https://www.inspq.qc.ca/publications/2972-couvre-visage-masque-medical-population-covid19,government,healthcare agency,Canada,COVID-19 pandemic; Vaccination; Social distancing,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,nber-8267519c4c16dc182d9136a3e20ad046,NBER,Risk Perceptions and Protective Behaviors: Evidence from COVID-19 Pandemic,2021-05-03,https://www.nber.org/papers/w28741,think tank,,USA,Survey methodology; Risk; COVID-19 pandemic,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1016/j.mbs.2020.108364,15.0,swisscovid-90b9eec694fbdcc29c43d5eaa0db4e86,Swiss National COVID-19 Science Task Force,Benefits Of Mask Wearing (1 July 2020 - EN),2020-07-01,https://ncs-tf.ch/en/policy-briefs/benefits-of-mask-wearing-1-july-2020-en-2/download,government,healthcare agency,Switzerland,Randomized controlled trial; Surgical mask; FFP mask,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1093/jac/dkg461,1.0,thlfi-5ec92294b3905afc4a269a4a6dc55d25,Terveyden ja hyvinvoinnin laitos,Antimicrobial resistance in Streptococcus Pneumoniae in Finland with special reference to macrolides and telithromycin,2009-04-07,http://www.julkari.fi/handle/10024/79861,government,healthcare agency,Finland,Streptococcus pneumoniae; Pneumococcal vaccine; Macrolide,science and technology>natural science>biology; health>diseases and conditions; health
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,governmentofcapeverde-22e268d202c64021d86e033ac111604e,Government of Cape Verde,Directrices,2014-07-29,https://minsaude.gov.cv/wp-admin/admin-ajax.php?juwpfisadmin=false&action=wpfd&task=file.download&wpfd_category_id=159&wpfd_file_id=4675&token=&preview=1,government,,Cape Verde,Breastfeeding; Management of HIV/AIDS; Health,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,governmentofestonia-65c171de2ccc9a5033a5d8dad3760228,Government of Estonia,For Treating And Preventing Hiv Infection,2013-12-04,https://www.sm.ee/sites/default/files/content-editors/eesmargid_ja_tegevused/Tervis/Ravimid/who_guidelines_june_2013.pdf,government,,Estonia,Management of HIV/AIDS; HIV/AIDS; Evidence-based medicine,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,governmentofuganda-60c3b62fd86cff5e52018b6b9fa3f7bf,Government of Uganda,Guidelines,2015-10-14,http://library.health.go.ug/download/file/fid/974,government,,Uganda,Pre-exposure prophylaxis; Management of HIV/AIDS; HIV/AIDS,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,kenyagov-7671657273ca5d5f8e54ab83a0f9a985,Government of Kenya,Guidelines,2015-09-29,http://guidelines.health.go.ke:8000/media/WHO_Guideline_on_when_to_start_Antiretroviral_Therapy.pdf,government,,Kenya,Pre-exposure prophylaxis; Management of HIV/AIDS; HIV/AIDS,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,paho-118d01ea2927acc86ccdb03c0b87d23d,Pan American Health Organization (PAHO),Directrices unificadas sobre el uso de los antirretrovirales para el tratamiento y la prevención de la infección por el VIH. Recomendaciones para un enfoque de salud pública. Segunda edición,2019-01-13,https://iris.paho.org/handle/10665.2/49784,igo,,IGO,HIV; Tuberculosis; Breastfeeding,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,who-0d74fc986667ab0a8af763249de89a80,World Health Organization,"When to start ART: &gt;350 cells/mm3, individuals living with HIV",2013-10-11,https://apps.who.int/iris/handle/10665/90574,igo,healthcare agency,IGO,Management of HIV/AIDS; HIV/AIDS; Cohort study,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,who-4312a1121cf629c8a6012b5e1581683c,World Health Organization,Сводное руководство по использованию антиретровирусных препаратов для лечения и профилактики ВИЧ-инфекции: рекомендации с позиций общественного здоровья,2014-04-15,https://apps.who.int/iris/handle/10665/112474,igo,healthcare agency,IGO,HIV; Management of HIV/AIDS; Tenofovir disoproxil,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,who-47b65b0f0d79e669f33a528fc6fab378,World Health Organization,Руководство о времени назначения антиретровирусной терапии и по доконтактной профилактике ВИЧ-инфекции,2021-08-09,https://apps.who.int/iris/handle/10665/343785,igo,healthcare agency,IGO,HIV/AIDS; HIV; Tenofovir disoproxil,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,who-4d11b399d162fb5ab1c112368da6f68a,World Health Organization,второе издание 2016,2021-08-12,https://apps.who.int/iris/handle/10665/343998,igo,healthcare agency,IGO,HIV; Zidovudine; Diagnosis of HIV/AIDS,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; health
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,who-579449b91d99c746da9b6e32fda52225,World Health Organization,Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach,2013-06-26,https://apps.who.int/iris/handle/10665/85321,igo,healthcare agency,IGO,Health sciences; Clinical medicine; HIV,health; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,who-647e3a0a352399c6bff4b4ed21d6af1c,World Health Organization,Lignes directrices unifiées sur l’utilisation des antirétroviraux pour le traitement et la prévention de l’infection à VIH : recommandations pour une approche de santé publique,2014-01-29,https://apps.who.int/iris/handle/10665/101196,igo,healthcare agency,IGO,Infection; Health; Breastfeeding,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,who-6eab04b1675f586842dddb668041ed45,World Health Organization,Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV,2015-09-29,https://apps.who.int/iris/handle/10665/186275,igo,healthcare agency,IGO,Health; Health sciences; Medicine,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,who-8c98f71192dc1802787f33a387c6c8a7,World Health Organization,2nd ed,2016-06-06,https://apps.who.int/iris/handle/10665/208825,igo,healthcare agency,IGO,Clinical medicine; Health care; Health policy,health; health>diseases and conditions>communicable disease>virus disease; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,who-94167745bcfc5f13880a542f2aa8593b,World Health Organization,"Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV, web supplement: annex 2: evidence to decision-making tables and supporting evidence",2015-10-21,https://apps.who.int/iris/handle/10665/189977,igo,healthcare agency,IGO,Medicine; Medical humanities; Health economics,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,who-9cb26ff269f9c9ca47303cf458f842f5,World Health Organization,When to start ART in pregnant women living with HIV?,2013-10-11,https://apps.who.int/iris/handle/10665/90570,igo,healthcare agency,IGO,Health sciences; Medicine; Medical humanities,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment
https://dx.doi.org/10.1007/s10198-005-0327-9,16.0,who-c93d6bad48557037f802dbe503d291ad,World Health Organization,"Directrices unificadas sobre el uso de los antirretrovirales en el tratamiento y la prevención de la infección por VIH: recomendaciones para un enfoque de salud pública, junio de 2013",2014-07-30,https://apps.who.int/iris/handle/10665/129493,igo,healthcare agency,IGO,Medical specialties; Health sciences; Medicine,health; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,iiasaat-854b8dc0af2910beb266bb090d870ff5,IIASA,Stochastic Optimization of Screening strategies for Preventing Irreversible Changes,1994-12-01,https://pure.iiasa.ac.at/id/eprint/4090/?template=default_internal,think tank,research center,Austria,Mathematics; Analysis; Finite difference,science and technology>mathematics; science and technology; health
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-2ea08816b3bab2d4d048524d6da96685,World Health Organization,"Rapport des activités de l’OCP sur la Kulpan, la Mole et la Sissili de 1975 à 2001",2023-06-09,https://apps.who.int/iris/handle/10665/368962,igo,healthcare agency,IGO,Medical specialties; Insecticide; Health,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-2fab795f9c72d03bd52f656c39159158,World Health Organization,Can ivermectin mass treatments eliminate onchocerciasis in Africa? / M. Winnen ... [‎et al.]‎,2012-06-26,https://apps.who.int/iris/handle/10665/71245,igo,healthcare agency,IGO,Onchocerciasis; Logistic regression; Regression analysis,health; science and technology; health>health treatment
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-3b23102cab28af1e459f096b13037137,World Health Organization,The predicted and observed decline in onchocerciasis infection during 14 years of successful control of Simulium spp. in west Africa.,2018-03-25,https://apps.who.int/iris/handle/10665/261284,igo,healthcare agency,IGO,Onchocerciasis; Prediction; Natural reservoir,health; science and technology; science and technology>mathematics
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-4a78344721a7d9bf86137f19d26f6ef6,World Health Organization,Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa.,2018-03-25,https://apps.who.int/iris/handle/10665/264237,igo,healthcare agency,IGO,Public health; Clinical medicine; Health sciences,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-68752158f372ab82399ebfb879c09eb9,World Health Organization,"The use of ONCHOSIM for the evaluation and prediction of OCP operations - past, present and future",2019-01-15,https://apps.who.int/iris/handle/10665/279493,igo,healthcare agency,IGO,Onchocerciasis; Computer simulation; Epidemiology,science and technology; health; science and technology>mathematics
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-689eb10851acbf759e66be65de1e1bcc,World Health Organization,Modelling onchocerciasis transmission and control,2021-03-26,https://apps.who.int/iris/handle/10665/340332,igo,healthcare agency,IGO,Medical specialties; Logistic regression; Ivermectin,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-6975a7e98f1dc40ff8f973045e9d68c5,World Health Organization,Partnership and promise: evolution of the african riverblindness campaigns,2018-12-18,https://apps.who.int/iris/handle/10665/277228,igo,healthcare agency,IGO,Health; Medicine; Medical specialties,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-7d3e9aad01eeb8af1cbf384753bd859b,World Health Organization,"Report of the Scientific Working Group meeting on lymphatic filariasis, Geneva, 10-12 May, 2005",2012-06-17,https://apps.who.int/iris/handle/10665/69484,igo,healthcare agency,IGO,Filariasis; Wuchereria bancrofti; Lymphatic filariasis,health; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-7e61a93999da81393b3e5983338557ce,World Health Organization,The risk and dynamics of onchocerciasis recrudescence after cessation of vector control.,2018-03-25,https://apps.who.int/iris/handle/10665/261306,igo,healthcare agency,IGO,Onchocerciasis; Maximum likelihood estimation; Risk,science and technology; health; science and technology>mathematics
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-8237ceb912cfb5e8cabd97fcd6266202,World Health Organization,"Annual internal technical review meeting: Ouagadougou, 11-14 March 1991; includes EPI progress report and main information on delinition of recrudescence",2019-01-02,https://apps.who.int/iris/handle/10665/277437,igo,healthcare agency,IGO,Onchocerciasis; Polymerase chain reaction; Ivermectin,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-984af517641516d4f70a733e1cf0e961,World Health Organization,"Annual internal technical review meeting: Ouagadougou, 11-14 March 1991",2023-08-31,https://apps.who.int/iris/handle/10665/372792,igo,healthcare agency,IGO,Polymerase chain reaction; Medical specialties; Onchocerciasis,science and technology>natural science>biology; health; science and technology
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-a806dfc218ec46c6f6bc3454fde5a36d,World Health Organization,"Rapport de synthèse des activités de l'OCP sur la Kulpawn, la Mole et la Sissili de 1975 à 2001",2021-07-13,https://apps.who.int/iris/handle/10665/342700,igo,healthcare agency,IGO,Medical specialties; Insecticide; Health,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-a9499d5ae9e7041853c065d5143e2572,World Health Organization,"Annual internal technical review meeting: Ouagadougou, 15-19 January 1990",2022-11-30,https://apps.who.int/iris/handle/10665/364890,igo,healthcare agency,IGO,Medical specialties; Clinical medicine; Onchocerciasis,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-af7d2e211fe5caecc39908025302cdc9,World Health Organization,"Onchosim training workshop: 16-18 November 2010, Ouagadougou, Burkina Faso",2023-07-12,https://apps.who.int/iris/handle/10665/370962,igo,healthcare agency,IGO,Medical specialties; Clinical medicine; Health sciences,"health>diseases and conditions; health; economy, business and finance>economic sector>computing and information technology"
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-bb6d2bc5834d75428e43245e236982f6,World Health Organization,Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in West Africa / A. P .Plaisier ... [‎et al.]‎,2012-06-16,https://apps.who.int/iris/handle/10665/54822,igo,healthcare agency,IGO,Onchocerciasis; Regression analysis; Ivermectin,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-c5e12283a71df1df94b9014ea49c22ff,World Health Organization,Rapport de synthèse des activités de l'OCP sur l'Oti-Pendjari et la Daka de 1976 à 2001,2023-05-05,https://apps.who.int/iris/handle/10665/367529,igo,healthcare agency,IGO,Onchocerciasis; Oti River; Medical specialties,health; science and technology; environment>natural resources>water
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-c756c265fadaefc29a5fd27caca72529,World Health Organization,Research priorities for helminth infections: technical report of the TDR disease reference group on helminth infections,2012-10-15,https://apps.who.int/iris/handle/10665/75922,igo,healthcare agency,IGO,Schistosomiasis; Infection; Cysticercosis,health; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-c7dbaed99238dfa6c8313d0b1bd8e438,World Health Organization,Lignes directrices pour l’arrêt de l’administration de masse de médicaments et la vérification de l’élimination de l’onchocercose humaine : critères et procédures,2017-03-08,https://apps.who.int/iris/handle/10665/254704,igo,healthcare agency,IGO,Onchocerciasis; Epidemiology; Health,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-d59d94cea2a54314f30df10f0504f0b6,World Health Organization,Can ivermectin mass treatments eliminate onchocerciasis in Africa?,2018-03-26,https://apps.who.int/iris/handle/10665/268778,igo,healthcare agency,IGO,Logistic regression; Health sciences; Clinical medicine,health; science and technology; health>health treatment
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-e835fba17d1d8ada8271395669c9b214,World Health Organization,Modelling onchocerciasis transmission and control,2021-03-26,https://apps.who.int/iris/handle/10665/340330,igo,healthcare agency,IGO,Logistic regression; Ivermectin; Confidence interval,science and technology; health; science and technology>mathematics
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-f00ab56b09220717289e9dc3404820d4,World Health Organization,"Rapport de synthèse des activités de l’OCP sur la Kulpawn, la Mole et la Sissili de 1975 à 2001",2019-03-21,https://apps.who.int/iris/handle/10665/311425,igo,healthcare agency,IGO,Medical specialties; Insecticide; Health,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,who-f9c4ac285ad110bd40e0709d94b39b29,World Health Organization,"Consultation informelle sur l'élimination de la transmission de l'onchocercose en Afrique avec les outils actuellement disponibles : "" rétrécir la carte""",2018-11-08,https://apps.who.int/iris/handle/10665/275792,igo,healthcare agency,IGO,Animal migration; Onchocerciasis; Infection,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1016/0169-2607(90)90030-d,24.0,worldbank-eab7075653ce6d452c8ae10bf491fbdb,World Bank,African Programme for Onchocerciasis Control 1995– 2015 : Model-Estimated Health Impact and Cost,2015-12-03,https://openknowledge.worldbank.org/handle/10986/23206,igo,development bank,IGO,Onchocerciasis; Ivermectin; Disability-adjusted life year,health; health>health treatment; health>health treatment>medicine
https://dx.doi.org/10.1016/j.vaccine.2018.06.049,2.0,has-07ec7c5533e31e263aa24ab2d3515a10,Haute Autorité de Santé,Recommandations vaccinales contre le Zona. Place du vaccin Shingrix,2024-03-07,https://www.has-sante.fr/jcms/p_3498915/fr/recommandations-vaccinales-contre-le-zona-place-du-vaccin-shingrix,government,healthcare agency,France,COVID-19 vaccine; Shingles; Vaccine,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/j.vaccine.2018.06.049,2.0,rivmnl-1e28a3920b07ac7878232f43a85ea81c,Rijksinstituut voor Volksgezondheid en Milieu,Herpes zoster in the Netherlands : Background information for the Health Council,2019-01-15,https://www.rivm.nl/publicaties/herpes-zoster-in-netherlands-background-information-for-health-council,government,research center,Netherlands,Health sciences; Diseases and disorders; Health care,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1002/sim.3514,1.0,pubmedcentral-d044e19561d5f08cd258bbc9f98a6691,Guidelines in PubMed Central,Diagnostic test evaluation methodology: A systematic review of methods employed to evaluate diagnostic tests in the absence of gold standard – An update,2019-10-11,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788703/pdf,other,aggregator,USA,Sensitivity and specificity; Receiver operating characteristic; Medical test,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/j.sste.2022.100559,1.0,govuk-d7ab9eedddfad2ea08bc5be89126b725,The UK Government,COVID-19: non-pharmaceutical interventions to reduce transmission,2023-09-28,https://www.gov.uk/government/publications/covid-19-non-pharmaceutical-interventions-to-reduce-transmission,government,,UK,Health care; COVID-19 pandemic; Social distancing,health>diseases and conditions; health; health>diseases and conditions
https://dx.doi.org/10.1016/j.tmaid.2022.102398,1.0,governmentofcolombia-da643ba21808c1e2e19d71a3e5d626a6,Government of Colombia,Viruela Símica,2022-11-08,https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/lineamiento-abordaje-casos-recomendaciones-prevencion-viruela-simica.pdf,government,,Colombia,Chickenpox; Work accident; Smallpox,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1038/s41467-023-40305-x,1.0,stateofvirginia-976d48fbcbf6e8177a9cc4ac2a10dc65,Commonwealth of Virginia,Foresight and Analysis of Infectious Disease Threats,2023-08-11,https://www.vdh.virginia.gov/content/uploads/sites/182/2023/08/COVID-19_VA_UVA-BI-Update_10-August-2023.pdf,government,,USA,SARS-CoV-2 Omicron variant; COVID-19 vaccine; Variants of SARS-CoV-2,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1016/j.annepidem.2016.06.004,4.0,cityofparis-a078a1038a927341526e8d5cb4015592,City of Paris,Seizing,2020-07-24,https://cdn.paris.fr/paris/2020/11/30/9a23e157b247f9cee044245c1a976a8f.pdf,government,city,France,HIV/AIDS; Management of HIV/AIDS; Pre-exposure prophylaxis,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.annepidem.2016.06.004,4.0,unaids-881217a83969c1d2b89a88dd8df49f01,UNAIDS,2020 Global AIDS Update â â Seizing the moment â â Tackling entrenched inequalities to end epidemics,2020-07-03,https://www.unaids.org/en/resources/documents/2020/global-aids-report,igo,,IGO,HIV/AIDS; Management of HIV/AIDS; Treatment as prevention,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1016/j.annepidem.2016.06.004,4.0,unitednations-4c90788f0d4b4b349f61f8a49d451263,United Nations,Seizing the moment :tackling entrenched inequalities to end epidemics : global AIDS update 2020,2020-01-01,https://digitallibrary.un.org/record/3936385?ln=en,igo,,IGO,Millennium Development Goals; Clinical medicine; HIV/AIDS,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1016/j.annepidem.2016.06.004,4.0,who-b756aad87e16bd67fc15ebdcba0335ce,World Health Organization,WHO preferred product characteristics for monoclonal antibodies for HIV prevention,2022-07-21,https://apps.who.int/iris/handle/10665/360491,igo,healthcare agency,IGO,Clinical medicine; Health care; Health sciences,health>diseases and conditions>communicable disease>virus disease; science and technology>biomedical science>pharmacology; science and technology>natural science>biology
https://dx.doi.org/10.1016/j.jhep.2016.10.038,4.0,governmentofportugal-52c21038ce72e9be9220ab5fef4a63b2,Government of Portugal,Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis,2019-06-16,http://repositorio.chlc.min-saude.pt/bitstream/10400.17/3683/1/J%20Gastrointest%20Surg%202020%201552.pdf,government,,Portugal,Hepatectomy; Surgery; Resection margin,health>diseases and conditions; health; health>diseases and conditions>cancer
https://dx.doi.org/10.1016/j.jhep.2016.10.038,4.0,pubmedcentral-84d9e92e1831221ba91ab15b24da9ce8,Guidelines in PubMed Central,2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma,2019-05-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529163/pdf,other,aggregator,USA,Hepatocellular carcinoma; Hepatitis B; Cancer staging,health>diseases and conditions; health>health treatment
https://dx.doi.org/10.1016/j.jhep.2016.10.038,4.0,pubmedcentral-ced3b0211d84e8f428562eb9eb6c77f2,Guidelines in PubMed Central,2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma,2019-07-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609431/pdf,other,aggregator,USA,Sievert; Metastasis; Biopsy,health>diseases and conditions; health>health treatment
https://dx.doi.org/10.1016/j.jhep.2016.10.038,4.0,pubmedcentral-dbbfe5f795756538cf38956935a5cd67,Guidelines in PubMed Central,2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma,2022-10-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf,other,aggregator,USA,Hepatitis B; Hepatitis C; Cirrhosis,health>diseases and conditions; health>health treatment; health
https://dx.doi.org/10.5588/ijtld.10.0542,1.0,nice-138db351a7025d738a56ca490200304a,NICE,Tuberculosis,2016-05-27,https://www.nice.org.uk/guidance/ng33,government,healthcare agency,UK,Tuberculosis; QuantiFERON; Mantoux test,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1371/journal.pone.0272009,6.0,bancaditalia-860b92171ee854acc48d255fbc48af34,Banca D'Italia,Banca d'Italia - N. 1427 - Il commercio internazionale ai tempi del Covid-19: un'analisi empirica su dati italiani,2023-11-06,https://www.bancaditalia.it/pubblicazioni/temi-discussione/2023/2023-1427/index.html,government,bank,Italy,COVID-19 pandemic; Ordinary least squares; Regression analysis,"economy, business and finance>economy; science and technology; science and technology>social sciences>economics"
https://dx.doi.org/10.1371/journal.pone.0272009,6.0,oecddiscovery-9571e85678f3fc60abcbdfe83656bda5,OECD,Strengthening Pandemic Preparedness and Response Through Integrated Modelling,2024-05-07,https://dx.doi.org/https://doi.org/10.1787/5f046115-en,igo,,IGO,Pandemic; Policy; Epidemiology,health>diseases and conditions; health; science and technology>social sciences
https://dx.doi.org/10.1371/journal.pone.0272009,6.0,who-86507ae895a434518420709cb9ccf536,World Health Organization,"Shifting towards fiscally resilient, healthy societies: finding common ground between public health and finance sectors and central banks",2024-01-01,https://apps.who.int/iris/handle/10665/376415,igo,healthcare agency,IGO,Cost of living; Health; Economic inequality,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1371/journal.pone.0272009,6.0,who-885a78108f48c957faf5417a059a9739,World Health Organization,Verso società in salute e fiscalmente resilienti: trovare un terreno comune tra i settori della sanità pubblica e della finanza e le banche centrali,2024-04-05,https://apps.who.int/iris/handle/10665/376416,igo,healthcare agency,IGO,Health; Sustainability; Sustainable Development Goals,"science and technology; health; economy, business and finance>economy"
https://dx.doi.org/10.1371/journal.pone.0272009,6.0,who-ce54cc0ae7b995108ea0dc4195cb7259,World Health Organization,Strengthening pandemic preparedness and response through integrated modelling,2024-01-01,https://apps.who.int/iris/handle/10665/376712,igo,healthcare agency,IGO,Pandemic; Policy; Epidemiology,health>diseases and conditions; health; science and technology>social sciences
https://dx.doi.org/10.1371/journal.pone.0272009,6.0,worldbank-d09db66c3c9a5a3c8d35f652c8bc2627,World Bank,Strengthening Pandemic Preparedness and Response through Integrated Modelling,2024-05-30,https://hdl.handle.net/10986/41630,igo,development bank,IGO,Pandemic; Policy; Epidemiology,health>diseases and conditions; health; science and technology>social sciences
https://dx.doi.org/10.1002/sim.1406,1.0,kirbyinstitute-ddf1a7ebe1cba0e5f7690cf0ea9016aa,Kirby Institute,Annual Report 2003,2004-10-02,https://www.kirby.unsw.edu.au/research/reports/annual-report-2003,think tank,university affiliated,Australia,Management of HIV/AIDS; HIV/AIDS; Hepatitis C,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1007/s00430-002-0123-4,2.0,ecdc-e0f568f1703674ae826f5929cc504751,European Centre for Disease Prevention and Control,Public health guidance on varicella vaccination in the European Union,2015-01-26,https://www.ecdc.europa.eu/en/publications-data/public-health-guidance-varicella-vaccination-european-union,government,agency,EU,Health sciences; Chickenpox; MMR vaccine,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1007/s00430-002-0123-4,2.0,europa-d575d9b1f40d83388efb7e52806ba3e7,Publications Office of the European Union,Varicella vaccination in the European Union.,2015-04-28,https://op.europa.eu/en/publication-detail/-/publication/ccf10902-b7cb-43e8-81c3-719fe409dbdc/language-en/format-PDF,government,,EU,MMRV vaccine; Vaccine; Varicella zoster virus,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1017/s0031182000075806,4.0,iucn-f3847d9ac6c6c3e49a01ae1a78dfa787,International Union for Conservation of Nature,The African wild dog : status survey and conservation action plan,1997-01-01,https://portals.iucn.org/library/node/7327,think tank,,France,Species reintroduction; Black-backed jackal; World Wide Fund for Nature,science and technology>natural science>biology; health; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1017/s0031182000075806,4.0,iucn-fe77f4873342abc2b53d50c241965445,International Union for Conservation of Nature,Regional conservation strategy for the cheetah and African wild dog in southern Africa,2007-01-01,https://portals.iucn.org/library/node/12761,think tank,,France,International Union for Conservation of Nature; South Africa; Miombo,environment; environment>nature; environment>natural resources
https://dx.doi.org/10.1017/s0031182000075806,4.0,odi-4b7cdc1e335974cb504b2e580d566341,Overseas Development Institute (ODI),Can Livestock and Wildlife Co-exist? An Interdisciplinary Approach,1999-06-01,https://odi.org/en/publications/can-livestock-and-wildlife-co-exist-an-interdisciplinary-approach/,think tank,,UK,Natural environment; Environmental social science; Rinderpest,"economy, business and finance>economic sector>agriculture; environment>nature; environment"
https://dx.doi.org/10.1017/s0031182000075806,4.0,oieint-90eaf2a0aa958c05613d4549f5935089,World Organization for Animal Health,"22nd Conference of the OIE Regional Commission for Africa (Swakopmund, Namibia, 20–24 February 2017) – Final report",2017-02-01,https://doc.oie.int/dyn/portal/index.xhtml?page=alo&aloId=36977&req=89,igo,,IGO,Health sciences; Health; Influenza A virus subtype H5N8,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1073/pnas.1110507108,1.0,who-1a170c54bb9ec4839c761de5bd241d36,World Health Organization,Technical series on adapting to climate-sensitive health impacts: diarrhoeal diseases,2023-01-12,https://apps.who.int/iris/handle/10665/365582,igo,healthcare agency,IGO,Climate change adaptation; WASH; Sanitation,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1093/aje/kwi005,6.0,anses-abfdbd9e097d7a41305e17fa4a12c178,ANSES,Virus transmissibles à l'homme par voie orale,2007-02-01,https://www.anses.fr/fr/system/files/MIC-Ra-VirusOral.pdf,government,food and drug safety,France,Infection; Virus; Risk,science and technology>natural science>biology; health; health>diseases and conditions
https://dx.doi.org/10.1093/aje/kwi005,6.0,california_state_agencies-6fa8fefb844fd096c73e462c81e48561,State of California,Cost Benefit Analysis: San Diego Region Bacteria TMDLs,2017-09-14,https://www.waterboards.ca.gov/sandiego/water_issues/programs/basin_plan/docs/issue3/Final_CBA.pdf,government,,USA,Cost–benefit analysis; Sanitary sewer; Septic tank,environment>natural resources>water; environment>environmental pollution; environment
https://dx.doi.org/10.1093/aje/kwi005,6.0,california_state_agencies-a614a773ece00f0d5469a89765598aa8,State of California,The Surfer Health Study,2016-09-15,https://www.waterboards.ca.gov/sandiego/water_issues/programs/san_diego_river_io/docs/SurferHealthStudy.pdf,government,,USA,Digital polymerase chain reaction; Real-time polymerase chain reaction; Reverse transcription polymerase chain reaction,environment>natural resources>water; health>diseases and conditions; environment
https://dx.doi.org/10.1093/aje/kwi005,6.0,committee_house-8a127609bb024519989a4d08b59b449c,House Committees,Solving the Climate Crisis: Drawing Down Carbon and Building Up the American Economy,2019-04-30,https://www.congress.gov/event/116th-congress/house-event/109329,government,,USA,Climate change; Renewable energy; Hydroelectricity,"environment>natural resources>water; economy, business and finance>economic sector>energy and resource; environment"
https://dx.doi.org/10.1093/aje/kwi005,6.0,epagov-42aeaaadf2945a6ccbffd5de1944ef99,EPA,Microbial Risk Assessment Guideline,2012-07-24,https://www.epa.gov/sites/default/files/2013-09/documents/mra-guideline-final.pdf,government,agency,USA,Risk; Risk assessment; Infection,science and technology>natural science>biology; health>diseases and conditions; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1093/aje/kwi005,6.0,thlfi-2d92e9e352606f45bc92f33470b9589f,Terveyden ja hyvinvoinnin laitos,"Large waterborne epidemic in Pirkanmaa, Finland 2007 - Study on disease burden, health consequences and health-economic costs",2014-04-01,http://www.julkari.fi/handle/10024/116163,government,healthcare agency,Finland,Irritable bowel syndrome; Gastroenteritis; Diarrhea,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1093/clinids/13.6.1093,2.0,agenasit-a1a107f6eb5ae2a7459ee6534d9d2814,AGENAS,10 Urgenze nel travaglio e nel parto,2004-06-20,https://www.agenas.gov.it/images/agenas/pnlg/gravid_parto_3.pdf,government,healthcare agency,Italy,Childbirth; Epidural administration; Caesarean section,science and technology>biomedical science>pharmacology; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1093/clinids/13.6.1093,2.0,inspq_canada-1fef28634cfc7d467ca69c5d73848b18,Institut national de santé publique du Québec,L'infection génitale au virus Herpès Simplex,2003-07-14,https://www.inspq.qc.ca/publications/177,government,healthcare agency,Canada,Aciclovir; Herpes; Neonatal herpes,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1093/ije/17.1.202,1.0,pubmedcentral-80fa391df3e0e667655e7822be606fff,Guidelines in PubMed Central,Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas,2015-03-11,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455231/pdf,other,aggregator,USA,Schistosomiasis; Systematic review; Sensitivity and specificity,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1186/cc5942,1.0,ahrq-72e6e2631c884d7791bc896aae8b9f8e,AHRQ,Decision and Simulation Modeling in Systematic Reviews,2013-02-21,https://effectivehealthcare.ahrq.gov/products/methods-decision-simulation-modeling/research,government,healthcare agency,USA,Systematic review; Evidence-based medicine; Sensitivity analysis,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1080/10550880802544997,1.0,emcdda-f581dc687b30a36546202f09356e6b58,EMCDDA,National report 2010: Sweden,2011-10-01,https://www.emcdda.europa.eu/html.cfm/index142549EN.html,government,agency,EU,Needle and syringe programmes; Substance abuse; Hepatitis,"society>social problem>addiction; crime, law and justice>crime>drug related crimes; crime, law and justice>crime"
https://dx.doi.org/10.1371/journal.pcbi.1003673,2.0,governmentofcanada-23b66eebd46ecb5a327e10f65f6baabd,Government of Canada,Guideline on the prevention of transmission of bloodborne viruses from infected healthcare workers in healthcare settings.,2019-06-01,http://publications.gc.ca/site/eng/9.874871/publication.html,government,,Canada,Health professional; Post-exposure prophylaxis; Hepatitis C,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1371/journal.pcbi.1003673,2.0,nice-eca1723ed17559ddf0d6be29d6507833,NICE,Cabotegravir with rilpivirine for treating HIV-1,2022-01-05,https://www.nice.org.uk/guidance/ta757,government,healthcare agency,UK,Adherence (medicine); Rilpivirine; Management of HIV/AIDS,science and technology>biomedical science>pharmacology; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.3346/jkms.2020.35.e143,10.0,ahrq-81483526743f096862bc29140ffd3f43,AHRQ,Resource Allocation and Pandemic Response: An Evidence Synthesis To Inform Decision Making,2020-09-28,https://effectivehealthcare.ahrq.gov/products/allocation-scarce-resources/rapid-review,government,healthcare agency,USA,Influenza pandemic; Coronavirus disease 2019; Influenza,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.3346/jkms.2020.35.e143,10.0,folkhalsomyndigheten-935d7e4b5141167d6559a6d7f145e17d,Folkhälsomyndigheten,Covid-19 hos barn och unga – en kunskapssammanställning,2020-05-29,https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/c/covid-19-hos-barn-och-unga--en-kunskapssammanstallning/,government,healthcare agency,Sweden,Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Secondary school,health>diseases and conditions; health; education>school
https://dx.doi.org/10.3346/jkms.2020.35.e143,10.0,govie-47849d7bc20dbf5f1c1f40edd7576988,GOV.IE,Educational facilities mid-term review – a focus on primary and post-primary schools,2020-11-26,https://www.gov.ie/en/publication/0d5d2-educational-facilities-mid-term-review-a-focus-on-primary-and-post-primary-schools/,government,,Ireland,Coronavirus disease 2019; Severe acute respiratory syndrome coronavirus 2; Infection,health>diseases and conditions; education; health
https://dx.doi.org/10.3346/jkms.2020.35.e143,10.0,govie-e61b86ca37d310edd59782434a7b9b07,GOV.IE,Reopening our post primary schools,2021-04-20,https://www.gov.ie/en/publication/7acad-reopening-our-post-primary-schools/,government,,Ireland,Coronavirus disease 2019; Severe acute respiratory syndrome coronavirus 2; Infection,health>diseases and conditions; education; health
https://dx.doi.org/10.3346/jkms.2020.35.e143,10.0,govie-fae415e1e41b05566b7e32fe8e881293,GOV.IE,Reopening our primary and special schools,2021-06-24,https://www.gov.ie/en/publication/a0bff-reopening-our-primary-and-special-schools/,government,,Ireland,Coronavirus disease 2019; Severe acute respiratory syndrome coronavirus 2; Infection,health>diseases and conditions; education; health
https://dx.doi.org/10.3346/jkms.2020.35.e143,10.0,pubmedcentral-0786037773e4f1bff4990dd61f24d8bb,Guidelines in PubMed Central,Measures implemented in the school setting to contain the COVID‐19 pandemic,2022-01-17,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762709/pdf,other,aggregator,USA,Systematic review; COVID-19 pandemic; Social distancing,education>school; health>diseases and conditions; education
https://dx.doi.org/10.3346/jkms.2020.35.e143,10.0,pubmedcentral-361f83c799b1feca693d342b1a14cedc,Guidelines in PubMed Central,Measures implemented in the school setting to contain the COVID‐19 pandemic: a rapid scoping review,2020-12-17,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206727/pdf,other,aggregator,USA,Systematic review; COVID-19 pandemic; Social distancing,education>school; health>diseases and conditions; education
https://dx.doi.org/10.3346/jkms.2020.35.e143,10.0,robertkochde-9b2e2c2244c31ddda2371f8586c5941d,Robert Koch Institut,Epidemiologisches Bulletin 19/2020,2020-05-07,https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2020/Ausgaben/19_20.pdf?__blob=publicationFile,government,healthcare agency,Germany,Medical specialties; Health; Hand sanitizer,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.3346/jkms.2020.35.e143,10.0,robertkochde-b088708fa049020cef420babfc94cf05,Robert Koch Institut,Epidemiologisches Bulletin 19/2020,2020-04-23,https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2020/Ausgaben/19_20_02.pdf?__blob=publicationFile,government,healthcare agency,Germany,Biology; Epidemiology; Medical specialties,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.3346/jkms.2020.35.e143,10.0,stateofwashington-88ded4ac6a812f3d00a30083d3378eac,State of Washington,Summary of School Re-Opening Models and Implementation Approaches During the COVID 19 Pandemic,2020-07-06,https://doh.wa.gov/sites/default/files/legacy/Documents/1600/coronavirus/20200706-SchoolsSummary.pdf,government,,USA,Medicine; Epidemiology; Health sciences,education>school; education; health>diseases and conditions
https://dx.doi.org/10.1371/journal.pbio.3000206,1.0,usaid-c36880ef0f23a6b043178e521c721297,USAID,"Governance, land use change, and mitigating viral zoonotic emergence at the human-environment interface",2021-10-13,https://dec.usaid.gov/dec/content/Detail.aspx?&ctID=ODVhZjk4NWQtM2YyMi00YjRmLTkxNjktZTcxMjM2NDBmY2Uy&rID=NTk2MjIy,government,agency,USA,Zoonosis; Virus; Natural reservoir,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1371/journal.pmed.1001869,4.0,herozaorg-86582fd5b2efdfee016d4c2d444ea440,Health Economics and Epidemiology Research Office,Bridging research and policy: The economic impact of the HIV response,2024-07-29,https://www.heroza.org/publications/bridging-research-and-policy-the-economic-impact-of-the-hiv-response-2/,think tank,university affiliated,South Africa,Joint United Nations Programme on HIV/AIDS; Developing country; Gross domestic product,health; science and technology; health>diseases and conditions>communicable disease>virus disease>AIDS
https://dx.doi.org/10.1371/journal.pmed.1001869,4.0,herozaorg-8d761d8c367af487c17134ab2187a66a,Health Economics and Epidemiology Research Office,Bridging research and policy: The economic impact of the HIV response,2024-07-29,https://www.heroza.org/publications/bridging-research-and-policy-the-economic-impact-of-the-hiv-response/,think tank,university affiliated,South Africa,HIV/AIDS; President's Emergency Plan for AIDS Relief; Joint United Nations Programme on HIV/AIDS,health; science and technology; health>diseases and conditions>communicable disease>virus disease>AIDS
https://dx.doi.org/10.1371/journal.pmed.1001869,4.0,herozaorg-b90b183a3ab4fd86c4c9c87f51bdf23b,Health Economics and Epidemiology Research Office,2015 ANNUAL REPORT,2022-07-14,https://www.heroza.org/publications/2015-annual-report/,think tank,university affiliated,South Africa,Multidrug-resistant tuberculosis; Tuberculosis; Health economics,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1371/journal.pmed.1001869,4.0,randcorporation-00729ba1143eb5a85930ca3b9c73ac8c,RAND Corporation,The return of investment for preventive healthcare programmes,2017-05-22,https://www.rand.org/pubs/research_reports/RR1787.html,think tank,research center,USA,Health sciences; Medical specialties; Medicine,health; labour; labour>employment
https://dx.doi.org/10.1371/journal.pcbi.1005876,2.0,ocwnl-545237992c849d195b3f2de3a61b0715,"Ministerie van Onderwijs, Cultuur en Wetenschap",The Research Modernisation Deal A Strategy to Ending Animal Experiments,2022-04-20,https://open.overheid.nl/Details/ronl-c8cdc566f24aaef9b385db741842e321d7d41908/1?hit=1908&organisatie=mnre1109&sort=date-desc&count=50&informatiesoort=c_056a75e1&page=39,government,agency,Netherlands,Organoid; HIV/AIDS; Animal testing,science and technology>natural science>biology; science and technology>natural science>biology>genetics; science and technology>natural science>biology>physiology
https://dx.doi.org/10.1371/journal.pcbi.1005876,2.0,rijksoverheid-f94a474df5e0f79dadd165b15481a1e9,Rijksoverheid,The Research Modernisation Deal A Strategy to Ending Animal Experiments,2022-04-20,https://www.rijksoverheid.nl/documenten/kamerstukken/2022/04/20/rapport-the-research-modernisation-deal-a-strategy-to-ending-animal-experiments,government,,Netherlands,Clinical medicine; Medical specialties; Biology,science and technology>natural science>biology; science and technology>natural science>biology>genetics; science and technology>natural science>biology>physiology
https://dx.doi.org/10.1371/journal.pgph.0001864,3.0,unaids-99e164fee91aa6e29da714ec76409ae1,UNAIDS,The path that ends AIDS: UNAIDS Global AIDS Update 2023,2023-12-07,https://www.unaids.org/en/resources/documents/2023/global-aids-update-2023,igo,,IGO,Management of HIV/AIDS; Pre-exposure prophylaxis; President's Emergency Plan for AIDS Relief,health>diseases and conditions; health; society
https://dx.doi.org/10.1371/journal.pgph.0001864,3.0,unitednations-4f804fb06c968a51c6418997a704cbcc,United Nations,"Women, the girl child and HIV and AIDS :report of the Secretary-General",2024-01-16,https://digitallibrary.un.org/record/4037336?ln=en,igo,,IGO,Discrimination; HIV/AIDS; Pre-exposure prophylaxis,health; health; health
https://dx.doi.org/10.1371/journal.pgph.0001864,3.0,unitednations-a612c540c918cde1ed10a8e1218dd6af,United Nations,The path that ends AIDS : 2023 UNAIDS global AIDS update,2023-01-01,https://digitallibrary.un.org/record/4015631?ln=en,igo,,IGO,HIV/AIDS; Management of HIV/AIDS; Pre-exposure prophylaxis,health>diseases and conditions; health; society
https://dx.doi.org/10.1186/s40249-015-0043-3,1.0,gradeperu-a4ba9f1e3c9184f533b02deeae189b5e,Grupo de Análisis para el Desarrollo,"Young lives, interrupted: Short‑term effects of the COVID-19 pandemic on adolescents in low- and middleincome countries",2021-02-03,http://www.grade.org.pe/publicaciones/vidas-jovenes-interrumpidas-efectos-a-corto-plazo-de-la-pandemia-de-covid-19-en-los-adolescentes-de-los-paises-de-ingresos-bajos-y-medios/,think tank,,Peru,Economics; Policy; COVID-19 pandemic,"economy, business and finance>economy; science and technology; health>diseases and conditions"
https://dx.doi.org/10.1371/journal.pone.0210353,2.0,stateofcatalunya-0977747556f2c10e600aa57548a63b0e,Generalitat de Catalunya,Servel Cata,2019-12-12,https://scientiasalut.gencat.cat/bitstream/handle/11351/6426/regio_sanitaria_lleida_memoria_2018.pdf?sequence=1&isAllowed=y,government,,Spain,,
https://dx.doi.org/10.1371/journal.pone.0210353,2.0,stateofcatalunya-ff1733487a32582ad00e75a57d0f925a,Generalitat de Catalunya,Servel Cata a de la Salut,2019-12-12,https://scientiasalut.gencat.cat/bitstream/handle/11351/6426/regio_sanitaria_lleida_memoria_2018.pdf,government,,Spain,,
https://dx.doi.org/10.1542/peds.2012-3350,3.0,cdc-3559c30f7f8add06b306b57299ef13a0,Centers for Disease Control and Prevention (CDC),Summary of three economic analyses of the use of 20-valent pneumococcal conjugate vaccine (PCV20) in children in the United States,2023-06-22,https://stacks.cdc.gov/view/cdc/130006,government,healthcare agency,USA,Pneumococcal conjugate vaccine; Pneumococcal vaccine; Vaccination,health>diseases and conditions; health; health>health treatment>preventative medicine>vaccines
https://dx.doi.org/10.1542/peds.2012-3350,3.0,cdc-df52f0649cf711af9bfeb9c5b17f20c8,Centers for Disease Control and Prevention (CDC),"Advisory Committee on Immunization Practices (ACIP) summary report : October 23-34, 2013, Atlanta, Georgia",2014-02-01,https://stacks.cdc.gov/view/cdc/75319,government,healthcare agency,USA,Vaccine; Influenza vaccine; Meningococcal disease,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1542/peds.2012-3350,3.0,cdc-eebb7fb94912f281efd8753189a6359f,Centers for Disease Control and Prevention (CDC),Incremental cost-effectiveness of using two instead of three primary doses in the 13-valent pneumococcal conjugate vaccination schedule,2013-10-23,https://stacks.cdc.gov/view/cdc/75333,government,healthcare agency,USA,Pneumococcal conjugate vaccine; Pediatrics; Medicine,health>diseases and conditions; health; health>health treatment>preventative medicine
https://dx.doi.org/10.3390/ijerph17020417,1.0,who-1bc6ab886fe153ef59a2464da1bd9121,World Health Organization,Global expenditure on health: public spending on the rise?,2021-12-15,https://apps.who.int/iris/handle/10665/350560,igo,healthcare agency,IGO,Government spending; Economic growth; Disease,"health; health>diseases and conditions; economy, business and finance>economy"
https://dx.doi.org/10.1371/journal.pbio.1001970,5.0,geologicalsurveyusa-a2371d8715754933bb45e17cd08a5799,United States Geological Survey,U.S. Geological Survey science strategy for highly pathogenic avian influenza in wildlife and the environment (2016–2020),2016-08-18,https://pubs.usgs.gov/of/2016/1121/ofr20161121.pdf,government,agency,USA,Influenza; Influenza A virus subtype H1N1; Disease surveillance,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1371/journal.pbio.1001970,5.0,gpogov-581f6bd67e9d510f7ae01d4edbdfbf38,Government Publishing Office (GPO),U.S. Geological Survey science strategy for highly pathogenic avian influenza in wildlife and the environment (2016-2020) /,2016-08-16,https://purl.fdlp.gov/GPO/gpo121689,government,,USA,Avian influenza; Decision-making; Influenza pandemic,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology
https://dx.doi.org/10.1371/journal.pbio.1001970,5.0,odi-1268b8123b25d710a6dd80357d7be26e,Overseas Development Institute (ODI),"Adaptive leadership in the coronavirus response: bridging science, policy and practice",2020-04-01,https://www.odi.org/publications/16817-adaptive-leadership-coronavirus-response-bridging-science-policy-and-practice,think tank,,UK,Adaptive management; Health; Leadership,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1371/journal.pbio.1001970,5.0,odi-5e8e547fb4aa0c08b6409d89a810158c,Overseas Development Institute (ODI),"Adaptive leadership in the coronavirus response: bridging science, policy and practice",2020-04-02,https://odi.org/en/publications/adaptive-leadership-in-the-coronavirus-response-bridging-science-policy-and-practice/,think tank,,UK,Infectious diseases; Epidemiology; Public health,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1371/journal.pbio.1001970,5.0,thersa-eb2e14d8022faef6b99ac4298696cc79,RSA,Adaptive leadership in the coronavirus response,2020-03-31,https://www.thersa.org/blog/2020/03/adaptive-leadership-cornavirus/,think tank,,UK,COVID-19 pandemic; Adaptive management; Branches of science,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1371/journal.pone.0169344,3.0,stateofmichigan-50318e2d07f94b9ec4e550487a5f2e6f,State of Michigan,Influenza Surveillance Updates Bureaus of Epidemiology and Laboratories,2017-02-06,https://www.michigan.gov/documents/mdhhs/MIFF_02-06-17_553834_7.pdf,government,,USA,FluView; Influenza; Microbiology,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1371/journal.pone.0169344,3.0,stateofmichigan-69c5c6c9806a57bad0b255db487b4964,State of Michigan,Influenza Surveillance Updates Bureaus of Epidemiology and Laboratories,2017-01-09,https://www.michigan.gov/documents/mdhhs/MIFF_01-09-17_548467_7.pdf,government,,USA,Influenza; Influenza vaccine; Avian influenza,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1371/journal.pone.0169344,3.0,who-1fca2e126139eafbc6a92d77a5794401,World Health Organization,WHO guidance on research methods for health emergency and disaster risk management,2021-09-30,https://apps.who.int/iris/handle/10665/345591,igo,healthcare agency,IGO,Research; Systematic review; Health,"disaster, accident and emergency incident>accident and emergency incident; science and technology>mathematics; disaster, accident and emergency incident>disaster"
https://dx.doi.org/10.3390/ijerph13070666,1.0,fanrpan-896cd5ed23370f8e8dfcbd0d3a46fda0,"Food, Agriculture and Natural Resources Policy Analysis Network",Zambia FNS Policy Analysis Reports,2017-02-20,https://www.fanrpan.org/publication/zambia-fns-policy-analysis-reports,think tank,,South Africa,Agriculture; Reducing emissions from deforestation and forest degradation; Climate change adaptation,politics; politics>government; science and technology
https://dx.doi.org/10.1098/rsif.2010.0216,2.0,brookings-d87da8be56009cfe7d03a08dd6c652b4,Brookings Institution,The impact of vaccines and behavior on US cumulative deaths from COVID-19,2024-03-27,https://www.brookings.edu/articles/the-impact-of-vaccines-and-behavior-on-us-cumulative-deaths-from-covid-19/,think tank,,USA,Health; COVID-19 pandemic; Pandemic,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1098/rsif.2010.0216,2.0,europa-4584a50e7466d5b6fa22929bb7ea91ce,Publications Office of the European Union,Eurosurveillance : special edition : Chikungunya and Zika virus. October 2014.,2014-10-20,https://op.europa.eu/en/publication-detail/-/publication/310053c1-ebd7-4574-ad90-df225abd4f33/language-en/format-PDF,government,,EU,Mosquito-borne disease; Arbovirus; Transmission (medicine),health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1002/sim.4780141402,1.0,paho-8289a81d439b45e67ba5ff342d30b0c8,Pan American Health Organization (PAHO),Vigilancia de la infección por el VIH basada en la notificación de casos: recomendaciones para mejorar y fortalecer los sistemas de vigilancia del VIH,2012-08-24,https://iris.paho.org/handle/10665.2/49347,igo,,IGO,HIV; Tuberculosis; HIV/AIDS,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1371/journal.pmed.1000342,4.0,cdc-adebb9e65e340753e5562af518dbdd12,Centers for Disease Control and Prevention (CDC),Laboratory testing for the diagnosis of HIV infection : updated recommendations,2014-06-12,https://stacks.cdc.gov/view/cdc/23447,government,healthcare agency,USA,Diagnosis of HIV/AIDS; HIV/AIDS; Management of HIV/AIDS,health; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1371/journal.pmed.1000342,4.0,cdc-d3f80b7c3f6d0d3729f2d855c27bf5e2,Centers for Disease Control and Prevention (CDC),Managing HIV and hepatitis C outbreaks among people who inject drugs : guide for state and local health departments. Version 1.0,2018-03-20,https://stacks.cdc.gov/view/cdc/53008,government,healthcare agency,USA,Diagnosis of HIV/AIDS; Pharmacy; Health,health; health>diseases and conditions>communicable disease>virus disease; education
https://dx.doi.org/10.1371/journal.pmed.1000342,4.0,gpogov-c628ec7dfc8a7db92338c11a1fa50cc0,Government Publishing Office (GPO),Managing HIV and Hepatitis C outbreaks among people who inject drugs : a guide for state and local health departments.,2018-03-20,https://purl.fdlp.gov/GPO/gpo189589,government,,USA,Hepatitis C; HIV/AIDS; Management of HIV/AIDS,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1371/journal.pmed.1000342,4.0,nygov-65421e622d3f25c07ae1e5fef7cd55f2,New York State,Lifetime Costs and Quality-Adjusted Life Years Saved from HIV Prevention in the Test and Treat Era,2013-09-10,https://health.ny.gov/diseases/aids/ending_the_epidemic/docs/key_resources/data_committee_resources/lifetime_costs.pdf,government,,USA,Management of HIV/AIDS; Quality-adjusted life year; CD4,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1038/jes.2008.68,3.0,governmentofcanada-8b5a29d3b2f75e78ef2afe81780add2c,Government of Canada,Guidelines for Canadian Drinking Water Quality : guideline technical document - turbidity : H144-9/2013E-PDF Publications - Canada.ca,2012-12-01,http://publications.gc.ca/site/eng/9.697281/publication.html,government,,Canada,Hydrology; Water purification; Microfiltration,environment>environmental pollution; environment; environment>natural resources>water
https://dx.doi.org/10.1038/jes.2008.68,3.0,santepubliquefrance-efc6c55a7c9a1b95d5882e0defca84c3,Santé Publique France,"Qualité de l'eau distribuée à Angoulême et incidence des gastro-entérites aiguës, 2002-2007",2013-02-14,https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-infectieuses-d-origine-alimentaire/gastro-enterites-aigues/documents/rapport-synthese/qualite-de-l-eau-distribuee-a-angouleme-et-incidence-des-gastro-enterites-aigues-2002-2007,government,healthcare agency,France,Coagulation (water treatment); Water; Risk,environment; health; science and technology
https://dx.doi.org/10.1038/jes.2008.68,3.0,who-e95200c44b737222dda527616fe089df,World Health Organization,Water quality and health - review of turbidity: information for regulators and water suppliers,2017-02-20,https://apps.who.int/iris/handle/10665/254631,igo,healthcare agency,IGO,Turbidity; Drinking water; Water purification,environment; environment>environmental pollution; health
https://dx.doi.org/10.1038/s41467-023-41937-9,1.0,who-f3f9f795c3e8cfbb194a94b21160b674,World Health Organization,"WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance, to guide research, development and strategies to prevent and control antimicrobial resistance",2024-01-01,https://apps.who.int/iris/handle/10665/376776,igo,healthcare agency,IGO,Antimicrobial resistance; Antibiotic; Typhoid fever,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1111/j.1469-0691.2005.01294.x,1.0,oecddiscovery-39a0f41cd80b46ce501675f0edbe17da,OECD,Tackling Wasteful Spending on Health,2017-01-10,https://dx.doi.org/10.1787/9789264266414-en,igo,,IGO,Generic drug; Health; Health system,"health; health>diseases and conditions; economy, business and finance>economy"
https://dx.doi.org/10.1002/ppul.2009.abs,11.0,cityofmadrid-31e272fa6145a10d043a346c4289bef5,Comunidad de Madrid,Right ventricular dysfunction in adolescents with mild cystic fibrosis,2012-04-05,https://www.comunidad.madrid/hospital/gregoriomaranon/file/3536/download?token=ElUXdnJx,government,city,Spain,Tissue Doppler echocardiography; Spirometry; Ventricle (heart),health>diseases and conditions; health; science and technology>natural science>biology>physiology
https://dx.doi.org/10.1002/ppul.2009.abs,11.0,pubmedcentral-25880d6e684c94e58b269e6de29fe614,Guidelines in PubMed Central,Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis,2017-06-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481487/pdf,other,aggregator,USA,Antibiotic; Antibiotic sensitivity testing; Cystic fibrosis,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1002/ppul.2009.abs,11.0,pubmedcentral-2bd2af473e4c499f902b06ddf571d768,Guidelines in PubMed Central,Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis,2018-11-22,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324931/pdf,other,aggregator,USA,CT scan; Breast milk; Bronchiectasis,health>diseases and conditions; health; health>health treatment>diet
https://dx.doi.org/10.1002/ppul.2009.abs,11.0,pubmedcentral-31b345092862ea6289bda3b85dc73819,Guidelines in PubMed Central,Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis,2023-06-02,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237531/pdf,other,aggregator,USA,Study heterogeneity; Cystic fibrosis; Tobramycin,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1002/ppul.2009.abs,11.0,pubmedcentral-4c3f1fedffb324bb5c897f3111aab7c6,Guidelines in PubMed Central,Treatments for preventing recurrence of infection with in people with cystic fibrosis,2019-12-17,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916140/pdf,other,aggregator,USA,Systematic review; Cystic fibrosis; Cochrane (organisation),science and technology>biomedical science>pharmacology; health>diseases and conditions; science and technology
https://dx.doi.org/10.1002/ppul.2009.abs,11.0,pubmedcentral-6c19fb8c9517e250ba9115ddb24d67de,Guidelines in PubMed Central,Oral anti‐pseudomonal antibiotics for cystic fibrosis,2016-07-14,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457863/pdf,other,aggregator,USA,Cystic fibrosis; Pseudomonas aeruginosa; Randomized controlled trial,science and technology>biomedical science>pharmacology; health>diseases and conditions; science and technology
https://dx.doi.org/10.1002/ppul.2009.abs,11.0,pubmedcentral-78693132438501c740c5a4c671632a46,Guidelines in PubMed Central,"Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT, Brazilian Thoracic Association)",2023-05-04,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171269/pdf,other,aggregator,USA,Health sciences; Pseudomonas aeruginosa; Medicine,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1002/ppul.2009.abs,11.0,pubmedcentral-a073e9899f715c3f160e84e4d6dff698,Guidelines in PubMed Central,Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis,2020-06-10,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388933/pdf,other,aggregator,USA,Health; Health care; Clinical medicine,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1002/ppul.2009.abs,11.0,pubmedcentral-b0129d7c0c736af1be0c1ef872433c26,Guidelines in PubMed Central,Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis,2020-05-15,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387858/pdf,other,aggregator,USA,Public health; Clinical medicine; Medical specialties,health>diseases and conditions; health; science and technology>natural science>biology
https://dx.doi.org/10.1002/ppul.2009.abs,11.0,pubmedcentral-d664a01b96c4c59c177fad7d8f1ebe3e,Guidelines in PubMed Central,Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis,2017-04-25,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478104/pdf,other,aggregator,USA,Clinical medicine; Health sciences; Health care,health>diseases and conditions; health>health treatment; health
https://dx.doi.org/10.1002/ppul.2009.abs,11.0,pubmedcentral-e03b600fd7b11a9128e4be862e187e78,Guidelines in PubMed Central,Newborn screening for cystic fibrosis,2009-01-21,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075106/pdf,other,aggregator,USA,Health; Health care; Health sciences,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.rmed.2004.08.016,1.0,who-257db8c8191bca292c43fdaefb222e6b,World Health Organization,A WHO / the Union monograph on TB and tobacco control : joining efforts to control two related global epidemics,2012-06-16,http://apps.who.int/iris/handle/10665/43812,igo,healthcare agency,IGO,Tuberculosis; Tobacco smoking; Tuberculosis management,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.2165/00044011-200727070-00001,1.0,cadth-df42f232d0f7936e732ed350135d2372,Canadian Agency for Drugs and Technologies in Health,Highly Active Antiretroviral Therapy (HAART) Treatment for Adults in Developed Countries: Cost-Effectiveness,2011-05-30,https://cadth.ca/highly-active-antiretroviral-therapy-haart-treatment-adults-developed-countries-cost-effectiveness,government,healthcare agency,Canada,Management of HIV/AIDS; Systematic review; Public health,health; science and technology>biomedical science>pharmacology; science and technology
https://dx.doi.org/10.1371/journal.pcbi.1000103,1.0,santafeinstitute-03fcab52a5a1f8a227bef6f0c0398de8,Santa Fe Institute,Defeating Drug Resistance in Pathogens: Guidance from Evolutionary Theory,an unknown date,https://sfi-edu.s3.amazonaws.com/sfi-edu/production/uploads/sfi-com/dev/uploads/filer/a0/eb/a0ebab85-cdda-460f-9a43-e659584f3ed8/08-05-019.pdf,think tank,,USA,Natural selection; Antimicrobial resistance; Angiogenesis,science and technology>natural science>biology>genetics; science and technology>natural science>biology; science and technology
https://dx.doi.org/10.1542/peds.2006-2168,1.0,california_state_agencies-5eca27d9186f2a5750293acc68d83005,State of California,Tuberculosis Control Branch Published Studies,2020-02-03,https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/TBCB-Published-Studies.pdf,government,,USA,Tuberculosis; Multi-drug-resistant tuberculosis; Tuberculosis management,health>diseases and conditions; health; health>health treatment
https://dx.doi.org/10.1038/clpt.2011.254,15.0,governmentofuganda-a56b159d2ecf2980a54bd81f82211b45,Government of Uganda,Guidelines,2015-06-08,http://library.health.go.ug/download/file/fid/1005,government,,Uganda,Malaria; Artesunate; Primaquine,science and technology>biomedical science>pharmacology; health>diseases and conditions; health
https://dx.doi.org/10.1038/clpt.2011.254,15.0,paho-4b5496b9801514cddd9ebe4c342b7ade,Pan American Health Organization (PAHO),"Directrices de la OMS sobre la malaria, 13 de julio del 2021",2023-01-01,https://iris.paho.org/handle/10665.2/57291,igo,,IGO,Health; Malaria; Mosquito,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1038/clpt.2011.254,15.0,who-1f1cf77ec2083e79de257e723d49a1d4,World Health Organization,"WHO guidelines for malaria, 3 June 2022",2022-06-03,https://apps.who.int/iris/handle/10665/354781,igo,healthcare agency,IGO,Malaria; Artesunate; Intermittent preventive therapy,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1038/clpt.2011.254,15.0,who-3584521b76f111aa15ea15256204f218,World Health Organization,المبادئ التوجيهيه لمنظمة الصحة العالمية بشأن الملاريا، 16 شباط/فبراير 2021,2022-04-21,https://apps.who.int/iris/handle/10665/353396,igo,healthcare agency,IGO,Mosquito; Primaquine; Malaria,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1038/clpt.2011.254,15.0,who-4a6cc2599eb54cec86180fc6c5415d73,World Health Organization,"Lignes directrices de l’OMS sur le paludisme, 16 février 2021",2021-08-16,https://apps.who.int/iris/handle/10665/344167,igo,healthcare agency,IGO,Malaria; Mosquito; Anopheles,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1038/clpt.2011.254,15.0,who-5b3eae0fe82f983863f7d0d95fb9b53e,World Health Organization,3rd ed,2015-04-21,https://apps.who.int/iris/handle/10665/162441,igo,healthcare agency,IGO,Antimalarial medication; Malaria; Artesunate,science and technology>biomedical science>pharmacology; health>diseases and conditions; health
https://dx.doi.org/10.1038/clpt.2011.254,15.0,who-70b7aff01fbf4f9c4b8efa0a2ba7d706,World Health Organization,"WHO guidelines for malaria, 31 March 2022",2022-03-31,https://apps.who.int/iris/handle/10665/352687,igo,healthcare agency,IGO,Malaria; Mosquito net; Artesunate,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1038/clpt.2011.254,15.0,who-b713d75f6f52ba50191ea737872a6fed,World Health Organization,"WHO guidelines for malaria, 18 February 2022",2022-02-16,https://apps.who.int/iris/handle/10665/351995,igo,healthcare agency,IGO,Antimalarial medication; Indoor residual spraying; DDT,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1038/clpt.2011.254,15.0,who-ba3f5ee55d9feb67852ac2df467c9add,World Health Organization,"WHO guidelines for malaria, 25 November 2022",2022-11-24,https://apps.who.int/iris/handle/10665/364714,igo,healthcare agency,IGO,Medicine; Public health; Health care,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/clpt.2011.254,15.0,who-bfb1bda74004cea6d7c8cbce8411f335,World Health Organization,"WHO guideline for malaria, 13 July 2021",2021-08-09,https://apps.who.int/iris/handle/10665/343751,igo,healthcare agency,IGO,Antimalarial medication; Malaria; Anopheles,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1038/clpt.2011.254,15.0,who-ca650b6dde0d53bbe7a9361828ab26ba,World Health Organization,"WHO guidelines for malaria, 16 October 2023",2023-01-01,https://apps.who.int/iris/handle/10665/373339,igo,healthcare agency,IGO,Clinical medicine; Public health; Glucose-6-phosphate dehydrogenase deficiency,health>diseases and conditions; science and technology>natural science>biology; science and technology
https://dx.doi.org/10.1038/clpt.2011.254,15.0,who-cd8bce6cf938b54325e7419b7d9618c8,World Health Organization,"Lignes directrices de l’OMS sur le paludisme, 25 novembre 2022",2024-01-01,https://apps.who.int/iris/handle/10665/378272,igo,healthcare agency,IGO,Clinical medicine; Medical specialties; Health sciences,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1038/clpt.2011.254,15.0,who-e2d47cdc8ba67cda8baf1842ce7c491c,World Health Organization,"WHO guidelines for malaria, 14 March 2023",2023-03-14,https://apps.who.int/iris/handle/10665/366432,igo,healthcare agency,IGO,Clinical medicine; Medical specialties; Health sciences,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/clpt.2011.254,15.0,who-eedbc2555d948324b7f6ee1f3f605ca4,World Health Organization,المبادئ التوجيهيه لمنظمة الصحة العالمية بشأن الملاريا، 3 حزيران/يونيو 2022,2023-12-01,https://apps.who.int/iris/handle/10665/375846,igo,healthcare agency,IGO,Clinical medicine; Medical specialties; Health sciences,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1038/clpt.2011.254,15.0,who-f9e4072a2bbd2aa7a6a201b1b8db8f7d,World Health Organization,Bibliography of scientific publications on vector-borne diseases from WHO South-East Asia region 2009-2013,2016-04-05,https://apps.who.int/iris/handle/10665/204819,igo,healthcare agency,IGO,Medical specialties; Clinical medicine; Immunology,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1038/s41467-020-18297-9,1.0,randcorporation-9d4f0005b3f9b342923dfbfde44f2ba7,RAND Corporation,Artificial Intelligence in the COVID-19 Response,2023-06-02,https://www.rand.org/pubs/external_publications/EP70086.html,think tank,research center,USA,Machine learning; COVID-19 pandemic; Health,"economy, business and finance>economic sector>computing and information technology; health>diseases and conditions; health"
https://dx.doi.org/10.1126/science.abe6522,14.0,cdc-539edecf854290e40ea6747540bafd19,Centers for Disease Control and Prevention (CDC),COVID-19 science update ; Edition 2021-01-22 (73),2021-01-22,https://stacks.cdc.gov/view/cdc/100860,government,healthcare agency,USA,Health care; Coronavirus disease 2019; Variant of Concern 202012/01,health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1126/science.abe6522,14.0,dhsgov-eeb18fe8690357c6b05b850ab4cf6b68,Department of Homeland Security,Master Question List fgor COVID-19 (caused by SARS-CoV-2),2023-02-21,https://www.dhs.gov/sites/default/files/2023-02/23_0131_st_mql_sars_cov-2.pdf,government,,USA,SARS-CoV-2 Omicron variant; Variants of SARS-CoV-2; COVID-19 testing,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1126/science.abe6522,14.0,ecdc-3a2330f2ad2fdd86d5cb6e21bc55cb95,European Centre for Disease Prevention and Control,Objectives of vaccination strategies against COVID-19,2021-04-23,https://www.ecdc.europa.eu/en/publications-data/objectives-vaccination-strategies-against-covid-19,government,agency,EU,Public health; Risk; COVID-19 vaccine,health; health>diseases and conditions; health>health treatment>preventative medicine>vaccines
https://dx.doi.org/10.1126/science.abe6522,14.0,ecdc-eb140bdd9124a23382d07a37b98bdbd5,European Centre for Disease Prevention and Control,Risk of SARS-CoV-2 transmission from newly-infected individuals with documented previous infection or vaccination,2021-03-29,https://www.ecdc.europa.eu/en/publications-data/sars-cov-2-transmission-newly-infected-individuals-previous-infection,government,agency,EU,Coronavirus disease 2019; Infection; Severe acute respiratory syndrome coronavirus 2,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1126/science.abe6522,14.0,finnishgovernment-fbf1fecdb1dff488382dbf1adc12756f,Government of Finland,Valto: COVID-19-tutkimuskatsaus 2/2021,2021-01-27,http://julkaisut.valtioneuvosto.fi/handle/10024/162695,government,,Finland,Research; Vaccination; Virus,education; health; health>diseases and conditions
https://dx.doi.org/10.1126/science.abe6522,14.0,governmentofsouthafrica-23ba83cc864b73233cf3ea21cda1c5f7,Government of South Africa,Ministerial Advisory Committee Technical Working Group on the Third Wave,2021-03-31,https://www.health.gov.za/wp-content/uploads/2021/04/Advisory_ThirdWave_Appendix_FINAL-31-March-2021.pdf,government,,South Africa,Variants of SARS-CoV-2; Face masks during the COVID-19 pandemic; COVID-19 pandemic,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1126/science.abe6522,14.0,hcspfr-0ab0464b308f90037faaea58ea06ab3f,Haut Conseil de la santé publique,Covid-19 : stratégie pour la définition de mesures permettant la réouverture des établissements recevant du public,2021-04-18,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=1010,government,agency,France,COVID-19 pandemic; Risk; Vaccination,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1126/science.abe6522,14.0,ifode-b0acad2b4713f6413ced7fcfdd3ae67d,Ifo Institute,How Do Pandemics End? Two Decades of Recurrent Outbreak Risk Following the Main Waves,2021-12-13,https://www.cesifo.org/en/publications/2021/working-paper/how-do-pandemics-end-two-decades-recurrent-outbreak-risk-following,think tank,,Germany,Pandemic; Pareto distribution; Risk,science and technology; health>diseases and conditions; health
https://dx.doi.org/10.1126/science.abe6522,14.0,iucn-076e9cf88938802e45b5e56a69e62279,International Union for Conservation of Nature,Situation analysis on the roles and risks of wildlife in the emergence of human infectious diseases,2022-01-01,https://portals.iucn.org/library/node/49880,think tank,,France,International Union for Conservation of Nature; Microbiology; Health sciences,health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1126/science.abe6522,14.0,nber-c150eed5c74830d4e0954d23f30a5d03,NBER,Behavior and the Dynamics of Epidemics,2021-05-10,https://www.nber.org/papers/w28760,think tank,,USA,Compartmental models in epidemiology; COVID-19 pandemic; Mathematical modelling of infectious disease,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1126/science.abe6522,14.0,randcorporation-0ab6264bcf67fb1019d74411e42620d4,RAND Corporation,Modeling COVID-19 Nonpharmaceutical Interventions,2021-04-22,https://www.rand.org/pubs/working_papers/WRA1080-1.html,think tank,research center,USA,Basic reproduction number; Compartmental models in epidemiology; Decision tree learning,health>diseases and conditions; science and technology>mathematics; science and technology
https://dx.doi.org/10.1126/science.abe6522,14.0,randcorporation-3abe52a537e16dc8ed2cb8b177df4816,RAND Corporation,Reopening California,2021-04-26,https://www.rand.org/pubs/working_papers/WRA1080-2.html,think tank,research center,USA,Robust decision-making; Basic reproduction number; Compartmental models in epidemiology,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1126/science.abe6522,14.0,randcorporation-7b289de441142482b693221becbf9c69,RAND Corporation,Robust Decision Making in Health Policy,2022-12-22,https://www.rand.org/pubs/rgs_dissertations/RGSDA2531-1.html,think tank,research center,USA,Robust decision-making; Branches of science; Health sciences,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1126/science.abe6522,14.0,stateofnsw-76be69be27c7ee505dc139c9c3a80ce5,State of New South Wales,Evidence check,2021-03-16,https://ciap.health.nsw.gov.au/assets/docs/covid-19/evidence-checks/2021/20210316-evidence-check-endemicity.pdf,government,,Australia,Virus; Herd immunity; SARS-CoV-2,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1111/tbed.13651,1.0,pubmedcentral-264bb007ae15436e6d39ffef0980a54b,Guidelines in PubMed Central,Pragmatic Recommendations for Identification and Triage of Patients with COVID-19 in Low- and Middle-Income Countries,2021-03-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957239/pdf,other,aggregator,USA,Medical imaging; COVID-19 testing; CT scan,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/j.jadohealth.2019.07.022,2.0,cdc-0ebd8f214b22fe546e68a6032ae58aa4,Centers for Disease Control and Prevention (CDC),"Charles C. Shepard 2020 Science Awards : Racism as a public health crisis : September 15, 2020 • 1:00 P.M. ET",2021-10-15,https://stacks.cdc.gov/view/cdc/111008,government,healthcare agency,USA,Coalworker's pneumoconiosis; Antimicrobial resistance; Medicine,health>diseases and conditions>illness; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.1016/j.jadohealth.2019.07.022,2.0,nice-f545e15c59495b5ab9f59a0987b42ae9,NICE,Reducing sexually transmitted infections,2022-06-15,https://www.nice.org.uk/guidance/ng221,government,healthcare agency,UK,Pre-exposure prophylaxis; Incremental cost-effectiveness ratio; Quality-adjusted life year,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1016/j.jhepr.2019.07.005,1.0,stateofcatalunya-92b08775ebfb5daf9bdfa08a1260cae7,Generalitat de Catalunya,Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium,2020-12-11,https://scientiasalut.gencat.cat/bitstream/handle/11351/7669/endpoints_design_clinical_trials_patients_decompensated_cirrhosis_position_paper_liverhope_consortium_2021.pdf,government,,Spain,Ascites; Cirrhosis; Clinical endpoint,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1073/pnas.2017962118,3.0,anses-f0f085ba7419f9254f2634a06e046f04,ANSES,NOTE AST de l'Anses relative à la viabilité dans l’air et la dose infectante du virus SARS-COV-2,2021-07-08,https://www.anses.fr/fr/system/files/AIR2021SA0018.pdf,government,food and drug safety,France,Severe acute respiratory syndrome coronavirus 2; COVID-19 pandemic; Endothelium,health>diseases and conditions; science and technology>natural science>biology; health>diseases and conditions>illness
https://dx.doi.org/10.1073/pnas.2017962118,3.0,ecdc-67770d3a27d0f46127b3ac2d7e9b4cdd,European Centre for Disease Prevention and Control,"Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed SARS-CoV-2 using healthcare worker cohorts, version 2.0",2022-11-21,https://www.ecdc.europa.eu/en/publications-data/generic-protocol-ecdc-studies-covid-19-vaccine-effectiveness,government,agency,EU,COVID-19 pandemic; DNA sequencing; Variants of SARS-CoV-2,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1073/pnas.2017962118,3.0,who-e9d1f8b4eaad7cbbcc7701a934bcafea,World Health Organization,Indoor airborne risk assessment in the context of SARS-CoV-2: description of airborne transmission mechanism and method to develop a new standardized model for risk assessment,2024-01-01,https://apps.who.int/iris/handle/10665/376346,igo,healthcare agency,IGO,Pathogen transmission; Airborne transmission; Respiratory system,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; health
https://dx.doi.org/10.1080/21645515.2022.2058304,2.0,has-067a0f46a923ab1de54e34a72c69e8df,Haute Autorité de Santé,"Consultation publique ""Stratégie de vaccination contre la grippe saisonnière chez l'enfant""",2022-12-05,https://www.has-sante.fr/jcms/p_3390542/fr/consultation-publique-strategie-de-vaccination-contre-la-grippe-saisonniere-chez-l-enfant,government,healthcare agency,France,Health sciences; Vaccine; Vaccination,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1080/21645515.2022.2058304,2.0,has-4713af95b727affe71b88305cfb0b052,Haute Autorité de Santé,Révision de la stratégie de vaccination contre la grippe saisonnière : évaluation de la pertinence de l’extension de la vaccination chez les enfants sans comorbidité,2023-02-07,https://www.has-sante.fr/jcms/p_3350703/fr/revision-de-la-strategie-de-vaccination-contre-la-grippe-saisonniere-evaluation-de-la-pertinence-de-l-extension-de-la-vaccination-chez-les-enfants-sans-comorbidite,government,healthcare agency,France,Influenza; Vaccine; Vaccination,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1093/aje/kwt196,4.0,mathematicaus-0e38c0a9421f94040129930be93ee60d,Mathematica,Implementing Covid-19 Routine Testing in K-12 Schools: Lessons and Recommendations from Pilot Sites,2021-07-23,https://mathematica.org/publications/implementing-covid-19-routine-testing-in-k-12-schools-lessons-and-recommendations-from-pilot-sites,think tank,consultancy,USA,Infection; COVID-19 testing; Face masks during the COVID-19 pandemic,education>school; education; health>diseases and conditions
https://dx.doi.org/10.1093/aje/kwt196,4.0,mathematicaus-5297e1e3b72bddd296139058faff4a00,Mathematica,Considerations for Reopening Pennsylvania Schools,2020-10-07,https://mathematica.org/publications/considerations-for-reopening-pennsylvania-schools,think tank,consultancy,USA,COVID-19 pandemic; Face masks during the COVID-19 pandemic; Multisystem inflammatory syndrome in children,education; education>school; health>diseases and conditions
https://dx.doi.org/10.1093/aje/kwt196,4.0,mathematicaus-910f06d4dc559f856a5a935a1a77b0b1,Mathematica,"Operating Schools in a Pandemic: Predicted Effects of Opening, Quarantining, and Closing Strategies",2020-09-10,https://mathematica.org/publications/operating-schools-in-a-pandemic-predicted-effects-of-opening-and-quarantining-strategies,think tank,consultancy,USA,Medicine; COVID-19 pandemic; Infection,education>school; education; health>diseases and conditions
https://dx.doi.org/10.1093/aje/kwt196,4.0,mathematicaus-9a5f23a3eae5cd1e0a090b0bbad033a0,Mathematica,Early Insights and Recommendations for Implementing a COVID-19 Antigen Testing Program in K-12 Schools: Lessons Learned from Six Pilot Sites,2021-02-03,https://mathematica.org/publications/early-insights-and-recommendations-for-implementing-a-covid-19-antigen-testing-program-in-k-12,think tank,consultancy,USA,Infection; Social distancing; Agent-based model,education>school; education; health>diseases and conditions
https://dx.doi.org/10.1093/infdis/jiv534,13.0,aspeninstitute-3237bfbd0dea11493cd9baf437eed90d,The Aspen Institute,Accelerating the Development of a Universal Influenza Vaccine - The Aspen Institute,2019-07-25,https://www.aspeninstitute.org/publications/accelerating-the-development-of-a-universal-influenza-vaccine/,think tank,,USA,Influenza pandemic; Influenza; Vaccine,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1093/infdis/jiv534,13.0,atlantafed-1daa922ac1ca47b2d66b790d4e32f2a9,Federal Reserve Bank of Atlanta,Economic Uncertainty before and during the COVID-19 Pandemic,2020-07-01,https://www.atlantafed.org/research/publications/wp/2020/07/10/09-economic-uncertainty-before-during-covid-19-pandemic.aspx,government,bank,USA,VIX; Spanish flu; S&P 500,"economy, business and finance>economy; science and technology; health"
https://dx.doi.org/10.1093/infdis/jiv534,13.0,bankofengland-27465db9fd96e443d14ca5d1db1ae191,Bank of England,Economic uncertainty before and during the Covid-19 pandemic,2020-06-26,https://www.bankofengland.co.uk/working-paper/2020/economic-uncertainty-before-and-during-the-covid-19-pandemic,government,bank,UK,Spanish flu; VIX; Influenza,"economy, business and finance>economy; health>diseases and conditions; health"
https://dx.doi.org/10.1093/infdis/jiv534,13.0,catoinstitute-c32fd387bfec395d8665efa531f1a99f,Cato Institute,Incorporating Scenario Analysis into the Federal Reserve’s Policy Strategy & Communications,2020-06-10,https://www.cato.org/working-paper/incorporating-scenario-analysis-federal-reserves-policy-strategy-communications,think tank,,USA,Federal Reserve; Inflation; Federal Open Market Committee,"economy, business and finance>economy>macro economics>recession; economy, business and finance>economy>macro economics>inflation; economy, business and finance>economy>macro economics>deflation"
https://dx.doi.org/10.1093/infdis/jiv534,13.0,cgdev-bb44a32a8e6f5e35efc30ed330cd35d9,Center for Global Development,Global Mobility and the Threat of Pandemics: Evidence from Three Centuries,2020-12-10,https://www.cgdev.org/publication/global-mobility-and-threat-pandemics-evidence-three-centuries,think tank,,USA,Influenza pandemic; Influenza; Spanish flu,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1093/infdis/jiv534,13.0,hooverinstitution-7c0ab4127e5bfa45e9ab23d5c55d9f85,Hoover Institution,"Black Swans, Dragon Kings And Gray Rhinos: The World War Of 1914-1918 And The Pandemic of 2020-?",2020-05-18,https://www.hoover.org/research/black-swans-dragon-kings-and-gray-rhinos-world-war-1914-1918-and-pandemic-2020,think tank,,USA,War; Pound sterling; Inflationism,"health>diseases and conditions; health; economy, business and finance>economy"
https://dx.doi.org/10.1093/infdis/jiv534,13.0,hooverinstitution-d4c88f68351a63496eb24fb3bc731918,Hoover Institution,Economic Uncertainty Before and During the COVID-19 Pandemic,2020-09-22,https://www.hoover.org/research/economic-uncertainty-and-during-covid-19-pandemic,think tank,,USA,Spanish flu; VIX; Influenza,"economy, business and finance>economy; health>diseases and conditions; science and technology"
https://dx.doi.org/10.1093/infdis/jiv534,13.0,hooverinstitution-f48e5c5a87b9b0adf912183d2f2f1946,Hoover Institution,Incorporating Scenario Analysis into the Federal Reserve’s Policy Strategy and Communications,2020-07-12,https://www.hoover.org/research/incorporating-scenario-analysis-federal-reserves-policy-strategy-and-communications,think tank,,USA,Federal Reserve; Inflation; Asset-backed security,"economy, business and finance>economy; health; health>diseases and conditions"
https://dx.doi.org/10.1093/infdis/jiv534,13.0,izade-99fd15015fdc1f04d362976f29f58df6,IZA Institute of Labor Economics,Global Mobility and the Threat of Pandemics: Evidence from Three Centuries,2020-12-10,https://www.iza.org/publications/dp/13947/global-mobility-and-the-threat-of-pandemics-evidence-from-three-centuries,think tank,,Germany,Spanish flu; Centrality; Influenza pandemic,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1093/infdis/jiv534,13.0,nber-f4f9c46745033dcc01e96af4db761914,NBER,Economic Uncertainty Before and During the COVID-19 Pandemic,2020-06-18,https://www.nber.org/papers/w27418,think tank,,USA,VIX; Spanish flu; Influenza,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1093/infdis/jiv534,13.0,worldbank-657f69cc3f9ff5d9d3ca7c3fd5e791bd,World Bank,"Global Economic Prospects, June 2020",2020-05-14,https://openknowledge.worldbank.org/handle/10986/33748,igo,development bank,IGO,Recession; Great Recession; Economic growth,"health; economy, business and finance>economy; health>diseases and conditions"
https://dx.doi.org/10.1093/infdis/jiv534,13.0,worldbank-7368bff30224eb7c11fea81e290ce7e9,World Bank,"Global Economic Prospects, June 2020",2020-06-08,https://hdl.handle.net/10986/33748,igo,development bank,IGO,Recession; Economy; Economic growth,"economy, business and finance>economy; economy, business and finance>economy>macro economics>recession; health"
https://dx.doi.org/10.1093/infdis/jiv534,13.0,worldbank-e8de803f1b0dd18c050a36133afbee80,World Bank,"Disease Control Priorities, Third Edition : Volume 9. Improving Health and Reducing Poverty",2017-11-15,https://openknowledge.worldbank.org/handle/10986/28877,igo,development bank,IGO,Sustainable Development Goals; Infection; Tobacco smoking,health; environment; society
https://dx.doi.org/10.1093/aje/kws259,12.0,epaireland-8679cbbcfd896b23358333dbbfead302,Irish Environmental Protection Agency,Ireland’s Climate Change Assessment Volume 3.,2023-12-18,https://www.epa.ie/publications/monitoring--assessment/climate-change/ICCA_Volume-3.pdf,government,agency,Ireland,Climate resilience; Climate change; Nature-based solutions,"environment; environment>natural resources>water; disaster, accident and emergency incident>disaster"
https://dx.doi.org/10.1093/aje/kws259,12.0,govuk-c90e7cdce038b4309c81718bae38cdd1,The UK Government,Climate change: health effects in the UK,2023-12-11,https://www.gov.uk/government/publications/climate-change-health-effects-in-the-uk,government,,UK,Infection; Pathogen transmission; Cryptosporidium,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1093/aje/kws259,12.0,izade-37f743c64033e453bce5c9a61a655378,IZA Institute of Labor Economics,The Lasting Legacy of Seasonal Influenza: In-Utero Exposure and Labor Market Outcomes,2017-03-04,https://www.iza.org/publications/dp/10589/the-lasting-legacy-of-seasonal-influenza-in-utero-exposure-and-labor-market-outcomes,think tank,,Germany,Pregnancy; Childbirth; Miscarriage,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1093/aje/kws259,12.0,izade-5228c38c6c81a09bc3005a44122a988f,IZA Institute of Labor Economics,The Value of Health Insurance during a Crisis: Effects of Medicaid Implementation on Pandemic Influenza Mortality,2020-04-30,https://www.iza.org/publications/dp/13200/the-value-of-health-insurance-during-a-crisis-effects-of-medicaid-implementation-on-pandemic-influenza-mortality,think tank,,Germany,Influenza pandemic; Infant mortality; Medicaid,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1093/aje/kws259,12.0,izade-700493fce3d6e1f6b229d0d6a1453490,IZA Institute of Labor Economics,"Maybe Next Month? Temperature Shocks, Climate Change, and Dynamic Adjustments in Birth Rates",2015-10-20,https://www.iza.org/publications/dp/9480/maybe-next-month-temperature-shocks-climate-change-and-dynamic-adjustments-in-birth-rates,think tank,,Germany,Low birth weight; Statistical hypothesis testing; Statistical significance,science and technology; weather; science and technology>social sciences
https://dx.doi.org/10.1093/aje/kws259,12.0,izade-946a88001d67dbbb843d712a2a6eba06,IZA Institute of Labor Economics,Temperature and Fertility: Evidence from Spanish Register Data,2023-05-02,https://www.iza.org/publications/dp/16110/temperature-and-fertility-evidence-from-spanish-register-data,think tank,,Germany,Meteorology; Total fertility rate; Effect size,society; science and technology; weather
https://dx.doi.org/10.1093/aje/kws259,12.0,izade-b4e05b1f2a14015c9413e288ed1ad74d,IZA Institute of Labor Economics,Measuring Social and Externality Benefits of in Influenza Vaccination,2019-06-25,https://www.iza.org/publications/dp/12525/measuring-social-and-externality-benefits-of-in-influenza-vaccination,think tank,,Germany,Health; Vaccination; IZA Institute of Labor Economics,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1093/aje/kws259,12.0,izade-ffa0554940a202ffda27a776df205e72,IZA Institute of Labor Economics,Sunlight and Protection Against Influenza,2020-07-07,https://www.iza.org/publications/dp/13469/sunlight-and-protection-against-influenza,think tank,,Germany,Meta-analysis; Vitamin; Herd immunity,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1093/aje/kws259,12.0,nber-ef43e10240822b45da49b904fd8d4710,NBER,"Maybe Next Month? Temperature Shocks, Climate Change, and Dynamic Adjustments in Birth Rates",2015-10-29,https://www.nber.org/papers/w21681,think tank,,USA,Causality; Fahrenheit; Intergovernmental Panel on Climate Change,science and technology; weather; science and technology>social sciences
https://dx.doi.org/10.1093/aje/kws259,12.0,oecddiscovery-54a50b3a591411801ff20ba0aa65d15b,OECD,Integrated Assessment of Climate Change Impacts,2014-06-11,https://dx.doi.org/https://doi.org/10.1787/5jz2qcjsrvzx-en,igo,,IGO,Natural environment; Physical geography; Earth sciences,"environment; environment>natural resources>water; economy, business and finance>economic sector>energy and resource"
https://dx.doi.org/10.1093/aje/kws259,12.0,umweltbundesamt-9b93a423d7ff74b6fff91d6c2b4b6863,Umwelt Bundesamt,Einfluss des Klimawandels auf die Morbidität und Mortalität von Atemwegserkrankungen,2021-10-05,https://www.umweltbundesamt.de/publikationen/einfluss-des-klimawandels-auf-die-morbiditaet,government,agency,Germany,Health; Chronic obstructive pulmonary disease; Cough,weather; health>diseases and conditions; environment
https://dx.doi.org/10.1093/aje/kws259,12.0,worldbank-fb2feb7d1db1cfbbdc13300fa1ade95f,World Bank,Argentina Country Climate and Development Report,2022-11-01,https://hdl.handle.net/10986/38252,igo,development bank,IGO,Semi-arid climate; Climate change; Oceanic climate,weather; environment; science and technology
https://dx.doi.org/10.1136/bmj.g5725,10.0,ecdc-3506ce47af346351d8a5a2a77a4b97e4,European Centre for Disease Prevention and Control,Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA,2017-12-06,https://www.ecdc.europa.eu/en/publications-data/expert-opinion-introduction-meningococcal-b-4cmenb-vaccine-eueea,government,agency,EU,Vaccine; Neisseria meningitidis; Vaccination schedule,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1136/bmj.g5725,10.0,europa-772b95fee57b066e2aaa0033355b439d,Publications Office of the European Union,Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA.,2018-12-10,https://op.europa.eu/en/publication-detail/-/publication/4c663b6e-fcf7-11e8-a96d-01aa75ed71a1/language-en/format-PDF,government,,EU,Meningococcal vaccine; Vaccine; Neisseria meningitidis,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment>preventative medicine
https://dx.doi.org/10.1136/bmj.g5725,10.0,gezondheidsraad-92c5b4053a44fdf14d5fdaf34eda25f9,Gezondheidsraad,Vaccinatie tegen meningokokken,2018-12-19,https://www.gezondheidsraad.nl/documenten/adviezen/2018/12/19/vaccinatie-tegen-meningokokken,government,healthcare agency,Netherlands,Clinical medicine; Immunology; Health,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease>epidemic
https://dx.doi.org/10.1136/bmj.g5725,10.0,governmentofcanada-0150c125efeb184bb3ab35257eaa56a0,Government of Canada,The use of bivalent factor H binding protein Meningococcal Serogroup B (MenB-fHBP) vaccine for the prevention of meningococcal B disease.,2019-01-01,http://publications.gc.ca/site/eng/9.881875/publication.html,government,,Canada,Neisseria meningitidis; DPT vaccine; Meningococcal vaccine,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1136/bmj.g5725,10.0,governmentofcanada-45e682217e20e3531015d7bd5832cad2,Government of Canada,Recommendations on the use of conjugate pneumococcal vaccine - 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults : economic evidence supplementary appendix.: HP5-154/2023E-PDF Publications - Canada.ca,2023-02-01,http://publications.gc.ca/site/eng/9.919396/publication.html,government,,Canada,Quality-adjusted life year; Incremental cost-effectiveness ratio; Pneumococcal conjugate vaccine,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1136/bmj.g5725,10.0,governmentofcanada-580a6ed6480a8f08901f68982fd026f2,Government of Canada,"Recommendations for public health programs on the use of pneumococcal vaccines in children, including the use of 15-valent and 20-valent conjugate vaccines : economic evidence supplementary appendix.: HP5-239/3-2024E-PDF Publications - Canada.ca",2024-03-01,http://publications.gc.ca/site/eng/9.934200/publication.html,government,,Canada,Quality-adjusted life year; Incremental cost-effectiveness ratio; Cost-effectiveness analysis,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1136/bmj.g5725,10.0,has-2d0db88873a764a14504958fdfe87059,Haute Autorité de Santé,Stratégie de vaccination pour la prévention des infections invasives à méningocoques : Le sérogroupe B et la place de BEXSERO®,2021-06-18,https://www.has-sante.fr/jcms/p_3066921/fr/strategie-de-vaccination-pour-la-prevention-des-infections-invasives-a-meningocoques-le-serogroupe-b-et-la-place-de-bexsero,government,healthcare agency,France,Vaccination; Vaccine; Neisseria meningitidis,health>diseases and conditions; science and technology>natural science>biology; health
https://dx.doi.org/10.1136/bmj.g5725,10.0,has-a5b9c5612a76393e3b843a7db0177449,Haute Autorité de Santé,Stratégie de vaccination pour la prévention des infections invasives à méningocoques : Le sérogroupe B et la place de TRUMENBA®,2021-06-22,https://www.has-sante.fr/jcms/p_3066917/fr/strategie-de-vaccination-pour-la-prevention-des-infections-invasives-a-meningocoques-le-serogroupe-b-et-la-place-de-trumenba,government,healthcare agency,France,Biology; Vaccination; Vaccine,science and technology>natural science>biology; health>diseases and conditions; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1136/bmj.g5725,10.0,has-b5dcd5badc5f1ab2a77de93421e645bd,Haute Autorité de Santé,Recommandation vaccinale contre les infections invasives à méningocoque B : Place du vaccin Bexsero® - Feuille de route,2019-07-02,https://www.has-sante.fr/portail/jcms/c_2977554/fr/recommandation-vaccinale-contre-les-infections-invasives-a-meningocoque-b-place-du-vaccin-bexsero-feuille-de-route,government,healthcare agency,France,Vaccination; Fever; Antigen,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1136/bmj.g5725,10.0,inspq_canada-5a14f0c2a8d900d8342763716523a97c,Institut national de santé publique du Québec,Avis sur la pertinence d’un programme de vaccination universelle avec le vaccin méningococcique protéinique à quatre composantes au Québec,2016-10-12,https://www.inspq.qc.ca/publications/2169,government,healthcare agency,Canada,Antigen; Infection; Vaccination,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.jhin.2009.10.007,7.0,europa-a39a42252094bb8c69509507fdbe3121,Publications Office of the European Union,Eurosurveillance : special edition : Influenza. December 2010 - June 2011.,2011-08-02,https://op.europa.eu/en/publication-detail/-/publication/805568b1-5755-440f-901e-e44e2d413c4b/language-en/format-PDF,government,,EU,2009 flu pandemic; Influenza; Influenza-like illness,health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.jhin.2009.10.007,7.0,foodgovuk-030e143c99753f13c460fdb9a734c3f9,Food Standards Agency,Review of approaches for establishing exclusion zones for shellfish harvesting around sewage discharge points | Food Standards Agency,2015-05-01,https://www.food.gov.uk/research/foodborne-disease/review-of-approaches-for-establishing-exclusion-zones-for-shellfish-harvesting-around-sewage-discharge-points,government,food and drug safety,UK,Sewage treatment; Membrane bioreactor; Secondary treatment,environment>natural resources>water; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.jhin.2009.10.007,7.0,govuk-5000ddd4078ae8da66ec9a3153a0d292,The UK Government,Flooding: surveillance of health effects,2014-08-01,https://www.gov.uk/government/publications/flooding-surveillance-of-health-effects,government,,UK,Medication; Health; Disease,health; health>diseases and conditions>communicable disease>virus disease; environment
https://dx.doi.org/10.1016/j.jhin.2009.10.007,7.0,govuk-d60c244d0e8babf5cd231841a6623624,The UK Government,Norovirus: managing outbreaks in acute and community health and social care settings,2012-03-08,https://www.gov.uk/government/publications/norovirus-managing-outbreaks-in-acute-and-community-health-and-social-care-settings,government,,UK,Norovirus; Hospital; Health care,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.jhin.2009.10.007,7.0,govuk-d911eac3e8778ae6bef0f3f3eb234895,The UK Government,Global Health Security Agenda: pilot assessment of the UK,2015-08-27,https://www.gov.uk/government/publications/global-health-security-agenda-pilot-assessment-of-the-uk,government,,UK,Zoonosis; Antimicrobial resistance; Biosafety,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.jhin.2009.10.007,7.0,livsmedelsverket-ddc66fe292eb67320848f457c31875ee,Livsmedelsverket,2012 - Early Warning Systems (EWS),2012-02-14,https://www.livsmedelsverket.se/om-oss/publikationer/sok-publikationer/artiklar/2012/2013-early-warning-systems-ews,government,agency,Sweden,Vårdguiden 1177; Information system; Early warning score,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.jhin.2009.10.007,7.0,nhsenglandccg-ab6d58d9a332ef4fc48c93909d5d91da,NHS Clinical Commissioning Groups,Guidelines for the management of norovirus outbreaks in acute and community health and social care settings,2012-03-07,https://www.coventryrugbyccg.nhs.uk/mf.ashx?ID=427915d5-7c00-4484-a005-d8b2af300689,government,healthcare agency,UK,Patient; Diarrhea; Norovirus,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.mayocp.2016.06.024,4.0,governmentofsouthafrica-9b26d20cffee78c723ab9c2bcda58b76,Government of South Africa,"South African National Essential Medicine List Primary Healthcare and Adult Hospital Level of Care Medication Review Process Component : Critical care, Antibiotics",2024-03-25,https://knowledgehub.health.gov.za/system/files/elibdownloads/2024-04/AHL_Ch23_Adult%20CriticalCare_Cef-Avi%20Review_17October2023__0.pdf,government,,South Africa,Carbapenem; Klebsiella pneumoniae; Beta-lactamase,science and technology; health; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1016/j.mayocp.2016.06.024,4.0,governmentofsouthafrica-d7d830ac8a9858256c3724fc8ca5c703,Government of South Africa,Chapter 23 Adult Critical Care,2024-03-26,https://knowledgehub.health.gov.za/system/files/elibdownloads/2024-04/Adult%20Hospital%20Chapter%2023%20-Critical%20Care_with%20supporting%20NEMLC%20report_2020-3%20review.pdf,government,,South Africa,Myocardial infarction; Shock (circulatory); Thromboelastography,science and technology>biomedical science>pharmacology; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1016/j.mayocp.2016.06.024,4.0,stateofqueensland-c0d60b75df39c5288f93cad37bfa21fc,State of Queensland,2016,2017-08-18,https://metronorth.health.qld.gov.au/wp-content/uploads/2018/01/rbwh-research-report-2016-full.pdf,government,,Australia,Clinical psychology; Nursing; University of Queensland,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.mayocp.2016.06.024,4.0,stateofvalencia-54964e78e7a64904a44cb1f3a7f837e3,Generalitat Valenciana,Articles,2017-04-21,https://sagunto.san.gva.es/documents/d/sagunto/27-Diciembre-2022-Estudio-de-cohortes-retrospectivas-Estudio-INCREMENT,government,,Spain,Health; Health sciences; Health care,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1016/j.mbs.2004.10.013,4.0,econrsa-1df4dda9ffa8bc402a2373bdde4e17c7,Economic Research Southern Africa,Optimal Targeted Lockdowns in a Multi-Group SIR Model,2020-06-04,https://econrsa.org/publications/optimal-targeted-lockdowns-in-a-multi-group-sir-model/,think tank,,South Africa,Herd immunity; Mathematical optimization; Coronavirus disease 2019,health>diseases and conditions; science and technology; science and technology>mathematics
https://dx.doi.org/10.1016/j.mbs.2004.10.013,4.0,ifs-a44221b80974bfae86d11242c8930168,Institute for Fiscal Studies,A Multi-Risk SIR Model with Optimally Targeted Lockdown,2020-05-04,https://ifs.org.uk/publications/multi-risk-sir-model-optimally-targeted-lockdown,think tank,,UK,Infection; Compartmental models in epidemiology; COVID-19 pandemic,science and technology; science and technology; health
https://dx.doi.org/10.1016/j.mbs.2004.10.013,4.0,iiasaat-7d25ca0cd350e6f427e54ad1657c122f,IIASA,"A Simple Fitness Proxy for Structured Populations with Continuous Traits, with Case Studies on the Evolution of Haplodiploids and Genetic Dimorphisms",2011-06-01,https://pure.iiasa.ac.at/id/eprint/9820/?template=default_internal,think tank,research center,Austria,Genotype; Evolutionarily stable strategy; Evolution,science and technology>mathematics; science and technology>natural science>biology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1016/j.mbs.2004.10.013,4.0,nber-e254b16d89858235e0abbec78d3039e8,NBER,A Multi-Risk SIR Model with Optimally Targeted Lockdown,2020-05-01,https://www.nber.org/papers/w27102,think tank,,USA,Infection; Herd immunity; Compartmental models in epidemiology,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.13181/mji.v27i2.2200,2.0,paho-06b3e149a5915601249322dc62c2c0fa,Pan American Health Organization (PAHO),"Guidelines for the Clinical Diagnosis and Treatment of Dengue, Chikungunya, and Zika",2022-03-24,https://iris.paho.org/handle/10665.2/55867,igo,,IGO,Platelet transfusion; Fluid replacement; Dengue fever,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.13181/mji.v27i2.2200,2.0,paho-bdd67c78eda176c2a0dac6393cb65e65,Pan American Health Organization (PAHO),"Directrices para el diagnóstico clínico y el tratamiento del dengue, el chikunguña y el zika",2022-01-01,https://iris.paho.org/handle/10665.2/55125,igo,,IGO,Condom; Medical diagnosis; Clinical trial,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1371/journal.pmed.1003614,1.0,cgdev-e9b663ae00bd1f6cd61e97dff6dd330b,Center for Global Development,Understanding the Costs and Benefits of Investing in Laboratory Systems in African Countries,2022-11-10,https://www.cgdev.org/publication/understanding-costs-and-benefits-investing-laboratory-systems-african-countries,think tank,,USA,Antimicrobial resistance; Health; Tuberculosis,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1371/journal.pone.0250711,1.0,europa-90c931e11225a4ff052048a3a920ddc5,Publications Office of the European Union,Managing antimicrobial resistance across the health system : opinion of the Expert Panel on effective ways of investing in health (EXPH).,2022-11-17,https://op.europa.eu/en/publication-detail/-/publication/8b50751a-6700-11ed-b14f-01aa75ed71a1/language-en/format-PDF,government,,EU,Antimicrobial resistance; Antibiotic; Infection,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1093/aje/kwk059,9.0,ecdc-728bad5607ceb9fd8c0ca36035f74b65,European Centre for Disease Prevention and Control,Expert opinion on the Introduction of HPV Vaccines in EU Countries,2008-03-12,https://www.ecdc.europa.eu/en/publications-data/expert-opinion-introduction-hpv-vaccines-eu-countries,government,agency,EU,Gardasil; Cervical cancer; Cervarix,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1093/aje/kwk059,9.0,folkhalsomyndigheten-64136d9e80d4ee667da378d881243d39,Folkhälsomyndigheten,Human papilloma virusvaccination of boys in the Swedish national vaccination programme,2017-10-02,https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/h/human-papilloma-virusvaccination-of-boys-in-the-swedish-national-vaccination-programme/,government,healthcare agency,Sweden,Genital wart; Human papillomavirus infection; Cervical cancer,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1093/aje/kwk059,9.0,governmentofcanada-eefe3a18b764d20fc7010d0e881e23aa,Government of Canada,Guidelines for the economic evaluation of vaccination programs in Canada.: HP5-147/2023E-PDF Publications - Canada.ca,2023-04-01,http://publications.gc.ca/site/eng/9.916479/publication.html,government,,Canada,Quality-adjusted life year; Vaccination; Health,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1093/aje/kwk059,9.0,inspq_canada-155626e1629ce8fdf21e087547fdb7fe,Institut national de santé publique du Québec,Prévention par la vaccination des maladies attribuables aux virus du papillome humain au Québec,2007-11-29,https://www.inspq.qc.ca/publications/714,government,healthcare agency,Canada,Human papillomavirus infection; Cancer; Gardasil,science and technology>natural science>biology; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1093/aje/kwk059,9.0,inspq_canada-7be5e92c2fd468cd9218bd11ed836ed2,Institut national de santé publique du Québec,Advice of the Institut national de santé publique du Québec on human papillomavirus vaccines,2008-07-09,https://www.inspq.qc.ca/en/publications/797,government,healthcare agency,Canada,Vaccination; Preventive medicine; Papillomavirus,health>health treatment>preventative medicine>vaccines; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1093/aje/kwk059,9.0,inspq_canada-d0e89426b8cc11d48881f91823a9b0d6,Institut national de santé publique du Québec,Avis de l'Institut national de santé publique du Québec : les vaccins contre le virus du papillome humain,2008-07-01,https://www.inspq.qc.ca/publications/795,government,healthcare agency,Canada,Biology; Diseases and disorders; Clinical medicine,health; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1093/aje/kwk059,9.0,inspq_canada-f03528bcfb88c218bae244d8b48ec1e0,Institut national de santé publique du Québec,Prevention by vaccination of diseases attributable to the Human Papilloma Virus in Québec,2008-07-30,https://www.inspq.qc.ca/en/publications/783,government,healthcare agency,Canada,Cervical intraepithelial neoplasia; Cervical cancer; Gardasil,science and technology>natural science>biology; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1093/aje/kwk059,9.0,stateofvirginia-00b8e02b9cb6f365c9dec88c91e1017f,Commonwealth of Virginia,Evaluation of HB 2877,2007-09-17,https://jlarc.virginia.gov/pdfs/reports/Rpt356.pdf,government,,USA,Health; Health care; Clinical medicine,health>diseases and conditions; health; health>health treatment
https://dx.doi.org/10.1093/aje/kwk059,9.0,stateofvirginia-47b1fd65bb47b9cc05736e970e32b0c1,Commonwealth of Virginia,Evaluation of HB 2877,2007-09-17,http://jlarc.virginia.gov/pdfs/reports/Rpt356.pdf,government,,USA,Health; Health care; Clinical medicine,health>diseases and conditions; health; health>health treatment
https://dx.doi.org/10.1038/srep25265,4.0,aspehhsgovus-b98addf66aa97abab0eca756195ba6ba,ASPE,Training Data for Machine Learning to Enhance Patient-Centered Outcomes Research (PCOR) Data Infrastructure — A Case Study in Tuberculosis Drug Resistance,2023-03-07,https://aspe.hhs.gov/reports/training-data-pcor-nlm,government,,USA,Multidrug-resistant tuberculosis; Extensively drug-resistant tuberculosis; Antimicrobial resistance,"economy, business and finance>economic sector>computing and information technology; health; science and technology"
https://dx.doi.org/10.1038/srep25265,4.0,stateofwesterncape-3252e195896e38691eeb48acc9070bdb,Western Cape Provincial Government,Western Cape Government,2018-02-21,https://www.westerncape.gov.za/sites/www.westerncape.gov.za/files/tygerberg_hospital_annual_report_2016_web.pdf,government,,South Africa,Nephrology; Waste; Patient,health>diseases and conditions; health; education
https://dx.doi.org/10.1038/srep25265,4.0,worldbank-3ca4b9bdf65f9e06946fca06ae0ba6aa,World Bank,"Disease Control Priorities, Third Edition",2017-11-06,https://hdl.handle.net/10986/28659,igo,development bank,IGO,Neglected tropical diseases; Sexually transmitted infection; Hepatitis B,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1038/srep25265,4.0,worldbank-3d8c68294d397bcaa1eccd55bd20f403,World Bank,"Disease Control Priorities, Third Edition : Volume 6. Major Infectious Diseases",2017-11-06,https://openknowledge.worldbank.org/handle/10986/28659,igo,development bank,IGO,Neglected tropical diseases; Sexually transmitted infection; HIV/AIDS,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease>epidemic; health
https://dx.doi.org/10.1093/infdis/167.1.180,1.0,who-014a836454d1ef964cdd32d9f62c3135,World Health Organization,"Review of the safety of chlorproguanil-dapsone in the treatment of uncomplicated falciparum malaria in Africa : report of a technical consultation convened by WHO, Geneva, 1-2 July 2004",2012-06-17,https://apps.who.int/iris/handle/10665/69128,igo,healthcare agency,IGO,Dapsone; Antimalarial medication; Malaria,science and technology>biomedical science>pharmacology; science and technology; health>diseases and conditions
https://dx.doi.org/10.1371/journal.pcbi.1004803,3.0,stateofmichigan-b14f4ede4752ef8fbca1f1e64303750f,State of Michigan,MI Flu Focus,2016-03-31,https://www.michigan.gov/documents/mdhhs/MIFF_3-30-16_519539_7.pdf,government,,USA,Influenza A virus subtype H3N2; Avian influenza; Influenza A virus subtype H5N1,health>diseases and conditions>illness; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1371/journal.pcbi.1004803,3.0,thlfi-b13bc2b14dede62a56c80912e37d06b4,Terveyden ja hyvinvoinnin laitos,Bayesian Inference for Spatio-Temporal Models,2016-06-13,http://www.julkari.fi/handle/10024/131432,government,healthcare agency,Finland,Prior probability; Statistical inference; Markov chain Monte Carlo,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1371/journal.pcbi.1004803,3.0,who-c7de059c3569edc7ec0880c62ba9ec28,World Health Organization,2017 update,2018-01-22,https://apps.who.int/iris/handle/10665/259888,igo,healthcare agency,IGO,Influenza pandemic; Public health; Health,health>diseases and conditions>communicable disease>virus disease; health; health>diseases and conditions>communicable disease>epidemic
https://dx.doi.org/10.1371/journal.pntd.0006504,2.0,pubmedcentral-4549856c94bff4f60a6c8effd8549c8e,Guidelines in PubMed Central,Chemotherapy for second‐stage human African trypanosomiasis: drugs in use,2021-12-09,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656462/pdf,other,aggregator,USA,Study heterogeneity; Systematic review; Eflornithine,science and technology>biomedical science>pharmacology; science and technology; health>diseases and conditions
https://dx.doi.org/10.1371/journal.pntd.0006504,2.0,who-e46c0cb67bf92a072ecbf32f00aef0c7,World Health Organization,Web annex A: evidence summary: systematic review of oral fexinidazole as first line treatment for rhodesiense human African trypanosomiasis,2024-01-01,https://apps.who.int/iris/handle/10665/378082,igo,healthcare agency,IGO,Health care; Medical specialties; Medicine,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.3389/fneur.2022.998758,1.0,rivmnl-f53ca30985fbff033adbbd8dc118c443,Rijksinstituut voor Volksgezondheid en Milieu,De gevolgen van de coronapandemie voor de gezondheid en het welzijn van de bevolking: deel 3. Een systematische literatuurstudie,2024-02-16,https://www.rivm.nl/publicaties/gevolgen-van-coronapandemie-voor-gezondheid-en-welzijn-van-bevolking-deel-3,government,research center,Netherlands,Major depressive disorder; COVID-19 pandemic; National Institute for Public Health and the Environment,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.5365/wpsar.2021.12.3.831,1.0,who-f8161b0cf754182d965ccaa6ff8e0096,World Health Organization,Борьба с инфодемиями как аспект коммуникации по вопросам рисков и взаимодействия с местным населением в Европейском регионе ВОЗ: практические рекомендации,2023-08-24,https://apps.who.int/iris/handle/10665/372480,igo,healthcare agency,IGO,World Health Organization; COVID-19; Health,"health; science and technology; economy, business and finance>economic sector>computing and information technology"
https://dx.doi.org/10.1016/j.jinf.2015.11.007,1.0,stateofvalencia-3d37384d1d6f6f8cd9acfdefe08566d6,Generalitat Valenciana,Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio),2018-02-14,https://fisabio.san.gva.es/media/upload/arxius/investigacion/memoria-cientifica/memoria-cientifica-fisabio-2016.pdf,government,,Spain,Biobank; Virus; Metagenomics,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health>diseases and conditions
https://dx.doi.org/10.1371/journal.pone.0160919,1.0,efsaeu-760ebe3b3ab45ae2f7587dd734a6b251,EFSA,"Database on the taxonomical characterisation and potential toxigenic capacities of microorganisms used for the industrial production of food enzymes and feed additives, which do not have a recommendation for Qualified Presumption of Safety",2017-08-03,https://www.efsa.europa.eu/en/supporting/pub/en-1274,government,agency,EU,Taxonomy (biology); 16S ribosomal RNA; Cyclopiazonic acid,"science and technology>natural science>biology; science and technology>natural science>biology>genetics; economy, business and finance>economic sector>chemicals"
https://dx.doi.org/10.3201/eid2811.220547,1.0,stateofcatalunya-56a2382edbeaed10d3169f83739efce2,Generalitat de Catalunya,Fitxes interpretatives. Atenció hospitalària. Central de Resultats,2023-11-26,https://aquas.gencat.cat/web/.content/minisite/aquas/publicacions/2023/fitxes-interpretatives-atencio-hospitalaria-cdr-aquas2023.pdf,government,,Spain,,
https://dx.doi.org/10.1038/srep15818,1.0,idrc-447dc0f928a1085eda1d29c44b24bc7b,International Development Research Centre,Modelling and controlling infectious diseases,2019-02-28,https://idl-bnc-idrc.dspacedirect.org/handle/10625/57464,think tank,,Canada,HIV/AIDS; Management of HIV/AIDS; Public health,science and technology>natural science>biology>genetics; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1080/21645515.2016.1219809,3.0,ahrq-6ea471795968c7481058aac90d20bcd4,AHRQ,Safety of Vaccines Used for Routine Immunization in the United States: An Update,2021-05-21,https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research,government,healthcare agency,USA,Vaccine; Pneumococcal conjugate vaccine; Hib vaccine,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1080/21645515.2016.1219809,3.0,ecdc-7109b2d86e0d50b766a562dfdbb4f516,European Centre for Disease Prevention and Control,"Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines",2020-10-01,https://www.ecdc.europa.eu/en/publications-data/seasonal-influenza-systematic-review-efficacy-vaccines,government,agency,EU,Vaccine efficacy; Influenza A virus subtype H3N2; Influenza vaccine,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1080/21645515.2016.1219809,3.0,europa-d56f4bf322f89f8eec32ed6e4cf100ab,Publications Office of the European Union,"Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals aged 18 years and over.",2020-10-08,https://op.europa.eu/en/publication-detail/-/publication/faa39733-0d03-11eb-bc07-01aa75ed71a1/language-en/format-PDF,government,,EU,Influenza vaccine; Vaccine efficacy; Influenza,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1089/apc.2007.0049,1.0,who-33673d2563561dc6ec1230ec280ddb4f,World Health Organization,Pharmacology and immuno-virologic efficacy of once-a-day HAART in African HIV-infected children: ANRS 12103 phase II trial,2018-03-26,https://apps.who.int/iris/handle/10665/270917,igo,healthcare agency,IGO,Management of HIV/AIDS; HIV; Lamivudine,science and technology>biomedical science>pharmacology; health>diseases and conditions; science and technology
https://dx.doi.org/10.1002/sim.2566,2.0,europa-7057b7032ef877bc1884cf52e48860a6,Publications Office of the European Union,Operations research in disaster preparedness and response : the public health perspective.,2013-01-22,https://op.europa.eu/en/publication-detail/-/publication/8579c689-ff66-4c6e-b394-b9e57a4ae8dc/language-en/format-PDF,government,,EU,Influenza; Logistics; Emergency management,health>diseases and conditions>communicable disease>epidemic; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1002/sim.2566,2.0,jointresearcheu-8ef101aacb33d74948ccec75253a119f,Joint Research Centre,Operations research in disaster preparedness and response: The public health perspective,2013-01-17,https://publications.jrc.ec.europa.eu/repository/handle/JRC78818,government,agency,EU,Mathematical optimization; Quality-adjusted life year; Humanitarian Logistics,"disaster, accident and emergency incident>disaster; health>diseases and conditions>illness; health>diseases and conditions"
https://dx.doi.org/10.1164/ajrccm/148.3.650,1.0,pubmedcentral-7c56a7c569f43e72a27493c2b8bbd876,Guidelines in PubMed Central,"Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children - Recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics",2014-06-18,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169043/pdf,other,aggregator,USA,Pneumococcal conjugate vaccine; Candidiasis; Candida (fungus),health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>illness
https://dx.doi.org/10.1021/acs.jmedchem.1c00313,1.0,gpogov-692e10ec8388c10455b5279ee2a0b56e,Government Publishing Office (GPO),Design of materials with AlchemiteTM /,2022-07-13,https://purl.fdlp.gov/GPO/gpo186526,government,,USA,"Random forest; Decision tree learning; Training, validation, and test data sets","economy, business and finance>economic sector>computing and information technology; science and technology; science and technology>mathematics"
https://dx.doi.org/10.1080/09603123.2020.1793919,1.0,governmentofthailand-771fbf91c977597fed59493093b24dc2,Government of Thailand,UounUA. UAUISAN > ovMQUASSNeAUn,2021-01-26,http://odpc9.ddc.moph.go.th/Research/Journal27-1-64.pdf,government,,Thailand,,
https://dx.doi.org/10.1111/j.1523-5378.2005.00333.x,1.0,governmentoftunisia-fd2185ba3a3d60335ea76989248decd4,Government of Tunisia,Traitement De La Maladie Ulcereuse Duodenale Non Compliquee,2007-08-20,http://www.santetunisie.rns.tn:80/images/articles/ULCEREUSE.pdf,government,,Tunisia,Peptic ulcer disease; Helicobacter pylori; Gastroenterology,science and technology>biomedical science>pharmacology; health>diseases and conditions; health
https://dx.doi.org/10.1016/j.jtbi.2013.12.024,1.0,efsaeu-6febe44429c6ed39d83ff80d1e8261bb,EFSA,MAPRA: Modelling Animal Pathogens: Review and Adaptation,2016-12-21,https://www.efsa.europa.eu/en/supporting/pub/en-1112,government,agency,EU,Parameter; Database; Research,"economy, business and finance>economic sector>computing and information technology; science and technology; science and technology>mathematics"
https://dx.doi.org/10.1017/s0950268804003024,2.0,governmentofuganda-a52a7a821a2b041b99067548e5b5f1ad,Government of Uganda,Neglected Tropical Diseases And Their Control In Uganda,2016-09-20,http://library.health.go.ug/sites/default/files/resources/Neglected%20Diseases%20and%20their%20Control%20in%20Uganda%20%29%281%29.pdf,government,,Uganda,Neglected tropical diseases; Podoconiosis; Schistosomiasis,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1017/s0950268804003024,2.0,who-c756c265fadaefc29a5fd27caca72529,World Health Organization,Research priorities for helminth infections: technical report of the TDR disease reference group on helminth infections,2012-10-15,https://apps.who.int/iris/handle/10665/75922,igo,healthcare agency,IGO,Antimicrobial resistance; Onchocerciasis; Helminthiasis,health; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1093/aje/kws583,9.0,cdc-521b38623cb638a8ebc328d644b46b75,Centers for Disease Control and Prevention (CDC),Sexually transmitted disease surveillance 2016 : high burden of STDs threaten millions of Americans,2017-09-15,https://stacks.cdc.gov/view/cdc/48600,government,healthcare agency,USA,Gonorrhea; Human papillomavirus infection; Neisseria gonorrhoeae,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1093/aje/kws583,9.0,cdc-eca0784ba9af4dc162d33a4b907e96d4,Centers for Disease Control and Prevention (CDC),Sexually transmitted disease surveillance 2017,2018-09-01,https://stacks.cdc.gov/view/cdc/59237,government,healthcare agency,USA,Sexually transmitted infection; Human papillomavirus infection; Neisseria gonorrhoeae,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1093/aje/kws583,9.0,cdc-fcfa0d3d9658f0e7a1eb233ffa4dbe05,Centers for Disease Control and Prevention (CDC),Sexually transmitted disease surveillance 2018,2019-10-01,https://stacks.cdc.gov/view/cdc/79370,government,healthcare agency,USA,Sexually transmitted infection; Human papillomavirus infection; HPV vaccine,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1093/aje/kws583,9.0,govuk-1d66f9348c688661698652f750c9796d,The UK Government,Health Protection Report volume 8 (2014),2014-12-23,https://www.gov.uk/government/publications/health-protection-report-volume-8-2014,government,,UK,MMR vaccine; Pelvic inflammatory disease; Measles,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1093/aje/kws583,9.0,govuk-6f40da17dd5354d51b9d2debaee24edc,The UK Government,Pelvic inflammatory disease in England,2015-06-23,https://www.gov.uk/government/publications/pelvic-inflammatory-disease-in-england,government,,UK,Pelvic inflammatory disease; Chlamydia trachomatis; Medical diagnosis,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1093/aje/kws583,9.0,govuk-7cf7f5f8c1c9d8471a2858c7d0e15a8b,The UK Government,Chlamydia screening: evidence summary and briefing,2014-04-01,https://www.gov.uk/government/publications/chlamydia-screening-evidence-summary-and-briefing,government,,UK,Chlamydia infection; Pelvic inflammatory disease; Sexually transmitted infection,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1093/aje/kws583,9.0,govuk-80310e9286d87777e3031b8ae48b2d5d,The UK Government,Health Protection Report volume 9 (2015),2015-12-29,https://www.gov.uk/government/publications/health-protection-report-volume-9-2015,government,,UK,Sexual health; Sexually transmitted infection; Pelvic inflammatory disease,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1093/aje/kws583,9.0,healthnz-f683bc4d11cd30fee762232cf9d91c35,New Zealand Ministry of Health,Sexually Transmitted Infections: Findings from the 2014/15 New Zealand Health Survey,2019-11-11,https://www.health.govt.nz/publication/sexually-transmitted-infections-findings-2014-15-new-zealand-health-survey,government,,New Zealand,Human papillomavirus infection; Chlamydia; Gonorrhea,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1093/aje/kws583,9.0,nice-f545e15c59495b5ab9f59a0987b42ae9,NICE,Reducing sexually transmitted infections,2022-06-15,https://www.nice.org.uk/guidance/ng221,government,healthcare agency,UK,Health; Health sciences; Health care,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1016/j.cmi.2014.07.002,1.0,pubmedcentral-b41f2bded0315fd5b68ff6e8f5c65744,Guidelines in PubMed Central,Diagnostic stewardship and the 2017 update of the IDSA-SHEA Clinical Practice Guidelines for Infection,2020-03-02,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066535/pdf,other,aggregator,USA,Clostridioides difficile infection; Medical diagnosis; Infection,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1099/jmm.0.062000-0,1.0,pubmedcentral-b3f55f866f70ce369a204c04f49c36cf,Guidelines in PubMed Central,Symptomatic treatment of the cough in whooping cough,2014-09-22,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154224/pdf,other,aggregator,USA,Whooping cough; Blinded experiment; Cold medicine,science and technology>biomedical science>pharmacology; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1111/j.1537-2995.2012.03637.x,1.0,agenasit-e41251e8b1c29148a965d581a1f1fd5f,AGENAS,HTA Report Adaptation : Filtrazione dei prioni nei concentrati eritrocitari per ridurre il rischio della malattia di Creutzfeldt-Jacob variante (MCJ variante) in Italia *,2013-08-06,https://www.agenas.gov.it/images/agenas/hta/report_hta/filtrazioneprioni.pdf,government,healthcare agency,Italy,Bovine spongiform encephalopathy; Medicine; Medical specialties,health>diseases and conditions; science and technology>natural science>biology; health
https://dx.doi.org/10.3390/ijerph18030963,2.0,oecddiscovery-293348e01d2e2a0bdf33bd314d8090de,OECD,"Tackling the Impact of Cancer on Health, the Economy and Society",2024-11-21,https://dx.doi.org/https://doi.org/10.1787/85e7c3ba-en,igo,,IGO,Preventive healthcare; Obesity; Non-communicable disease,health>diseases and conditions; health; health>diseases and conditions>cancer
https://dx.doi.org/10.3390/ijerph18030963,2.0,stateofvalencia-9ab9f9d888110878177696744b0465a3,Generalitat Valenciana,Memoria Científica,2022-10-27,https://fisabio.san.gva.es/media/upload/arxius/investigacion/memoria-cientifica/memoria-cientifica-fisabio-2021.pdf,government,,Spain,Hospital; Health sciences; Medicine,health>diseases and conditions; science and technology>natural science>biology; health
https://dx.doi.org/10.1016/j.diagmicrobio.2012.12.002,2.0,nice-f84d614a858da53365f8e596ee8fbc1f,NICE,Pneumonia (community-acquired): antimicrobial prescribing,2019-09-16,https://www.nice.org.uk/guidance/ng138,government,healthcare agency,UK,Health care; Randomized controlled trial; Community-acquired pneumonia,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1016/j.diagmicrobio.2012.12.002,2.0,pubmedcentral-b78f9b9868fd4a13d4e2e5b42d42289f,Guidelines in PubMed Central,Antibiotics for community‐acquired pneumonia in adult outpatients,2014-10-09,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078574/pdf,other,aggregator,USA,Pneumonia; Randomized controlled trial; Blinded experiment,science and technology>biomedical science>pharmacology; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1186/1478-7954-9-49,1.0,who-aabdcfa53253232d72aaa9beaff51522,World Health Organization,Validation study on assigning causes of death,2023-04-04,https://apps.who.int/iris/handle/10665/366702,igo,healthcare agency,IGO,Maternal death; Respiratory disease; Childbirth,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1186/s12879-016-1784-8,2.0,primarynz-beab23bd54775dce03b38ac040e6540d,New Zealand Ministry for Primary Industries,Foodborne disease in New Zealand 2016,2017-08-22,https://www.mpi.govt.nz/dmsdocument/19700-Foodborne-disease-in-New-Zealand-2016,government,,New Zealand,Campylobacter jejuni; Ciguatera fish poisoning; Listeria monocytogenes,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1186/s12879-016-1784-8,2.0,primarynz-ffa4a3216885c6d9b84b610fb845627b,New Zealand Ministry for Primary Industries,Annual report concerning foodborne disease in New Zealand 2016,2017-08-22,https://www.mpi.govt.nz/dmsdocument/19700-Annual-report-concerning-foodborne-disease-in-New-Zealand-2016,government,,New Zealand,Salmonella; Salmonella enterica subsp. enterica; Foodborne illness,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1098/rstb.1993.0143,4.0,odi-53b3995b98ec96ec4ebb051417531a8e,Overseas Development Institute (ODI),Estimating the Economic Impact of HIV/AIDs on the Countries of the Former Soviet Union,2003-12-01,https://odi.org/en/publications/estimating-the-economic-impact-of-hivaids-on-the-countries-of-the-former-soviet-union/,think tank,,UK,Economic growth; Poverty; Gini coefficient,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1098/rstb.1993.0143,4.0,unitednations-27c745e8f4670dae75796bc4afccfde3,United Nations,"Population bulletin of the United Nations. Special issues nos. 48/49, 2002 :completing the fertility transition",2009-02-01,https://digitallibrary.un.org/record/665330?ln=en,igo,,IGO,World population; HIV/AIDS; Total fertility rate,education; science and technology; science and technology
https://dx.doi.org/10.1098/rstb.1993.0143,4.0,who-ce45130335b03306e94eba545f7f1d70,World Health Organization,An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection,2018-03-26,https://apps.who.int/iris/handle/10665/270291,igo,healthcare agency,IGO,Herpes simplex; Herpes simplex virus; Virus latency,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1098/rstb.1993.0143,4.0,worldbank-3a3487d520055245246035aaa76b769a,World Bank,The Epidemiological Impact of an HIV/AIDS Vaccine in Developing Countries,2007-12-12,http://hdl.handle.net/10986/14818,igo,development bank,IGO,HIV/AIDS; Vaccine; Sexually transmitted infection,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1111/j.0272-4332.2004.00410.x,6.0,feemit-6eddb33a98c99daab2a3c0a710efc601,Fondazione Eni Enrico Mattei,Was It Something I Ate? Implementation of the FDA Seafood HACCP Program,2005-09-26,https://www.feem.it/en/publications/feem-working-papers-note-di-lavoro-series/was-it-something-i-ate-implementation-of-the-fda-seafood-haccp-program/,think tank,,Italy,Food safety; Food and Drug Administration; Vector autoregression,science and technology; health; science and technology>social sciences
https://dx.doi.org/10.1111/j.0272-4332.2004.00410.x,6.0,foodgovuk-9d93331e61533d498e85daafaaa32821,Food Standards Agency,Quantitative microbiological risk assessment on Salmonella in slaughter and breeder pigs | Food Standards Agency,2010-04-13,https://www.food.gov.uk/research/meat-hygiene-research-programme/quantitative-microbiological-risk-assessment-on-salmonella-in-slaughter-and-breeder-pigs,government,food and drug safety,UK,Salmonella; Salmonellosis; Pork,lifestyle and leisure>lifestyle>food and drink; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1111/j.0272-4332.2004.00410.x,6.0,primarynz-104dfbe7ff3026cfd2dd1a9a5243284a,New Zealand Ministry for Primary Industries,Risk profile: Salmonella (non-typhoidal) in pork and pork products,2010-05-17,https://www.mpi.govt.nz/dmsdocument/26186-risk-profile-salmonella-non-typhoidal-in-pork-and-pork-products,government,,New Zealand,Salmonella; Salmonellosis; Pork,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1111/j.0272-4332.2004.00410.x,6.0,primarynz-1e3f7a3b48e60e05c23394d43340f74e,New Zealand Ministry for Primary Industries,"Salmonella (non typhoidal) in high lipid foods made from sesame seeds, peanuts or cocoa beans",2022-01-25,https://www.mpi.govt.nz/dmsdocument/24248-Salmonella-non-typhoidal-in-high-lipid-foods-made-from-sesame-seeds-peanuts-or-cocoa-beans,government,,New Zealand,Salmonellosis; Chocolate; Tahini,"lifestyle and leisure>lifestyle>food and drink; economy, business and finance>economic sector>consumer goods>food; health>diseases and conditions"
https://dx.doi.org/10.1111/j.0272-4332.2004.00410.x,6.0,rivmnl-d7c82d6f9392f45f820df6e8bbb0da9e,Rijksinstituut voor Volksgezondheid en Milieu,Generic Guidance to Quantitative Microbial Risk Assessment for Food and Water,2019-04-04,https://www.rivm.nl/publicaties/generic-guidance-to-quantitative-microbial-risk-assessment-for-food-and-water,government,research center,Netherlands,Data analysis; Sampling (statistics); Dose–response relationship,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1111/j.0272-4332.2004.00410.x,6.0,vkmno-bab6841a9c2621beb9268feee4135348,Norwegian Scientific Committee for Food and Environment,Risikovurdering av import og spredning av tarmpatogene bakterier med friske krydderurter og bladgrønnsaker fra Asia,2017-07-18,https://vkm.no/risikovurderinger/allevurderinger/risikovurderingavimportogspredningavtarmpatogenebakteriermedfriskekrydderurterogbladgronnsakerfraasia.4.2994e95b15cc545071681e35.html,government,food and drug safety,Norway,Health; Confidence interval; Risk,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/0030-4220(91)90159-a,1.0,pubmedcentral-66a3f25aeaf0137b9b2da9eee07ec385,Guidelines in PubMed Central,Antibiotic prophylaxis is not indicated prior to dental procedures for prevention of periprosthetic joint infections - A systematic review and new guidelines from the Dutch Orthopaedic and Dental Societies,2017-10-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560223/pdf,other,aggregator,USA,Preventive healthcare; Bacteremia; Antibiotic,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1002/jia2.25246,4.0,marylandgov-35789fd11b1e2f4b2f9c47e57ffd814d,State of Maryland,The BESURE study,2019-07-31,https://health.maryland.gov/phpa/OIDEOR/CHSE/SiteAssets/Pages/behavioral-surveillance/BESURE%20Community%20Presentation%2006282019.pdf,government,,USA,Naloxone; Sexually transmitted infection; Drug overdose,health; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1002/jia2.25246,4.0,marylandgov-7e1dc7708ed0c21be4526f42dbcf3993,State of Maryland,Publications,2021-11-16,https://test-health.maryland.gov/phpa/OIDEOR/CHSE/SiteAssets/Pages/behavioral-surveillance/Behavioral-Surveillance-National-Publications-List-2021.pdf,government,,USA,Health sciences; Clinical medicine; Infectious diseases,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1002/jia2.25246,4.0,marylandgov-b8c45f1d429d03566c572a132a16700c,State of Maryland,The BESURE study,2019-07-31,https://test-health.maryland.gov/phpa/OIDEOR/CHSE/SiteAssets/Pages/behavioral-surveillance/BESURE%20Community%20Presentation%2006282019.pdf,government,,USA,Naloxone; Sexually transmitted infection; Drug overdose,health; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1002/jia2.25246,4.0,marylandgov-c6735ae5e00d610c9453788e17e20c09,State of Maryland,Publications,2022-07-01,https://health.maryland.gov/phpa/OIDEOR/CHSE/SiteAssets/Pages/behavioral-surveillance/BESURE-Publications-National-List-2022.pdf,government,,USA,Men who have sex with men; HIV/AIDS; HIV,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.3201/eid1004.030241,1.0,who-65829c998a68268bd66591f32cfea017,World Health Organization,"Report of the Scientific Working Group meeting on Leishmaniasis, Geneva, 2-4 February, 2004",2012-06-17,https://apps.who.int/iris/handle/10665/68897,igo,healthcare agency,IGO,T helper cell; Leishmaniasis; Visceral leishmaniasis,science and technology>natural science>biology; health>diseases and conditions; science and technology
https://dx.doi.org/10.1111/jvh.12253,4.0,parliamentofaustraliacc-4e74bcc33c96074ad74812144fd0122c,Parliament of Australia,Inquiry into Hepatitis C in Australia,2015-02-05,https://www.aph.gov.au/DocumentStore.ashx?id=6f3ebc88-2444-4673-b0cc-62e9e6b4502e&subId=303199,government,,Australia,Hepatitis C; Hepatitis; Cirrhosis,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1111/jvh.12253,4.0,who-68f001b20e2ffc2446a3371f84f2e125,World Health Organization,"First Strategic Technical Advisory Committee for Viral Hepatitis in the Western Pacific, Manila, Philippines, 27 April 2015 : meeting report",2016-06-01,https://apps.who.int/iris/handle/10665/208773,igo,healthcare agency,IGO,Hepatitis C; Hepatitis; Hepatitis B,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1111/jvh.12253,4.0,who-71f9e521af60bcd3f099086d5aabe377,World Health Organization,WHO guidelines on hepatitis B and C testing,2017-02-16,https://apps.who.int/iris/handle/10665/254621,igo,healthcare agency,IGO,Hepatitis; HIV/AIDS; Hepatitis C,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease>virus disease>retrovirus
https://dx.doi.org/10.1111/jvh.12253,4.0,who-8f41cfeaa1a66ea2efbcbc40749bf9cc,World Health Organization,"Initial Member State Consultation on the Draft Regional Action Plan For Viral Hepatitis in the Western Pacific, Manila, Philippines, 28-29 April 2015 : meeting report",2016-06-01,https://apps.who.int/iris/handle/10665/208791,igo,healthcare agency,IGO,Hepatitis B; Hepatitis C; Hepatitis,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.epidem.2021.100459,4.0,anses-f0f085ba7419f9254f2634a06e046f04,ANSES,NOTE AST de l'Anses relative à la viabilité dans l’air et la dose infectante du virus SARS-COV-2,2021-07-08,https://www.anses.fr/fr/system/files/AIR2021SA0018.pdf,government,food and drug safety,France,Interferon; Severe acute respiratory syndrome coronavirus 2; COVID-19 pandemic,health>diseases and conditions; science and technology>natural science>biology; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.epidem.2021.100459,4.0,dhsgov-07fb0e77b88ab97750003d3d688bed00,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-11-04,https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf,government,,USA,Surgical mask; Remdesivir; COVID-19 pandemic,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.epidem.2021.100459,4.0,dhsgov-6d422045165469a763b7c31921bd52c8,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-07-15,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf,government,,USA,Variants of SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; COVID-19 vaccine,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.1016/j.epidem.2021.100459,4.0,dhsgov-eeb18fe8690357c6b05b850ab4cf6b68,Department of Homeland Security,Master Question List fgor COVID-19 (caused by SARS-CoV-2),2023-02-21,https://www.dhs.gov/sites/default/files/2023-02/23_0131_st_mql_sars_cov-2.pdf,government,,USA,SARS-CoV-2 Omicron variant; Variants of SARS-CoV-2; COVID-19 testing,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1016/j.idm.2018.03.006,4.0,apo-8e3f9159cdfc01f8dc8b356ad5b78af8,Analysis & Policy Observatory,Time to act: protecting our children from RSV,2023-06-04,https://apo.org.au/node/323013,other,aggregator,Australia,Respiratory syncytial virus; Bronchiolitis; COVID-19 pandemic,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/j.idm.2018.03.006,4.0,govuk-9c68a5d82ceb3dd1fc9bd477f514d53a,The UK Government,"Respiratory syncytial virus: the green book, chapter 27a",2024-07-22,https://www.gov.uk/government/publications/respiratory-syncytial-virus-the-green-book-chapter-27a,government,,UK,Intramuscular injection; Vaccine; Health,health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.idm.2018.03.006,4.0,idrc-606f6f0c739fedfa26de0d962d51adaf,International Development Research Centre,Identifying the panorama of potential pandemic pathogens and their key characteristics : a systematic scoping review,2024-07-30,https://idrc-crdi.ca/en/node/126840,think tank,,Canada,Pandemic; Infection; Antimicrobial resistance,health>diseases and conditions>illness; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1016/j.idm.2018.03.006,4.0,provinceofquebec-867ea270a1bd9e86c4c4b8b1c24adf46,Province of Québec,Mémoire Prébudgétaire 2024-2025,2024-02-02,https://www.finances.gouv.qc.ca/ministere/outils_services/consultations_publiques/consultations_prebudgetaires/2024-2025/memoires/memoire_gsk.pdf,government,,Canada,Respiratory syncytial virus; Shingles; Vaccination,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/j.imu.2020.100508,1.0,unescap-cb815bbdd32be1b89be9dafb29ceb3b5,United Nations ESCAP,Asia-Pacific digital transformation report 2022 : shaping our digital future,2022-09-05,https://www.unescap.org/kp/2022/asia-pacific-digital-transformation-report-2022-shaping-our-digital-future,igo,,IGO,Air pollution; Education; Digital divide,"economy, business and finance>economic sector>computing and information technology; science and technology; disaster, accident and emergency incident>emergency incident>transport incident"
https://dx.doi.org/10.1086/524041,7.0,cadth-111a2ff24bb7d6ef6099f66a1e946ded,Canadian Agency for Drugs and Technologies in Health,"Quadrivalent Meningococcal Vaccination Programs for Children and Adolescents: Clinical Evidence, Risks, and Cost-Effectiveness",2012-04-12,https://cadth.ca/quadrivalent-meningococcal-vaccination-programs-children-and-adolescents-clinical-evidence-risks-and,government,healthcare agency,Canada,Meningococcal vaccine; Systematic review; Quality-adjusted life year,health; health>diseases and conditions>communicable disease>virus disease; health>health treatment>preventative medicine
https://dx.doi.org/10.1086/524041,7.0,cdc-97d96040e898286a641830b541acfe28,Centers for Disease Control and Prevention (CDC),Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP),2013-07-13,https://stacks.cdc.gov/view/cdc/13320,government,healthcare agency,USA,Meningococcal vaccine; Meningococcal disease; Advisory Committee on Immunization Practices,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease>virus disease>retrovirus
https://dx.doi.org/10.1086/524041,7.0,governmentofargentina-0707aab496b24c9c8b819619eab3f192,Government of Argentina,Vacuna Tetravalente (acyw),2016-09-09,http://www.msal.gob.ar/images/stories/bes/graficos/0000000927cnt-2016-12_lineamientos-meningo.pdf,government,,Argentina,Anaphylaxis; Meningitis; Health,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1086/524041,7.0,governmentofargentina-ba360ac33130343145a2edde6fc87b8b,Government of Argentina,Fundamentos De La Introducción V >,2017-04-12,http://www.msal.gob.ar/images/stories/bes/graficos/0000000927cnt-2017-04_lineamientos-meningo.pdf,government,,Argentina,Neisseria meningitidis; Anaphylaxis; Meningitis,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1086/524041,7.0,ifode-d2c0c3a1007524f061c3e9c2a2c75454,Ifo Institute,Mistrust and Missed Shots: Trust and Covid-19 Vaccination Decisions,2024-06-04,https://www.cesifo.org/en/publications/2024/working-paper/mistrust-and-missed-shots-trust-and-covid-19-vaccination-decisions,think tank,,Germany,Regression analysis; Dependent and independent variables; Errors and residuals,health; science and technology; health>health treatment>medicine
https://dx.doi.org/10.1086/524041,7.0,who-034c783b89a91b0977e0a905596eddc0,World Health Organization,"Weekly Epidemiological Record, 2011, vol. 86, 47 [‎full issue]‎",2016-06-16,https://apps.who.int/iris/handle/10665/241847,igo,healthcare agency,IGO,Immunology; Neisseria meningitidis; Meningococcal vaccine,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1086/524041,7.0,who-38afbbc3d97c1359946dc9c85707d54b,World Health Organization,"Meningococcal vaccines : WHO position paper, November 2011 = Note de synthèse : position de l’OMS sur les vaccins antiméningococciques, novembre 2011",2016-06-16,https://apps.who.int/iris/handle/10665/241846,igo,healthcare agency,IGO,Meningococcal vaccine; Neisseria meningitidis; Meningococcal disease,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease>virus disease>retrovirus
https://dx.doi.org/10.1016/j.scitotenv.2020.144832,3.0,anses-48b53eec19e169bdf1bcc6ee93970b2c,ANSES,AVIS et RAPPORT de l'Anses relatif au rapport « Intégration de l’exposome dans les activités de l’Anses »,2023-03-02,https://www.anses.fr/fr/system/files/AUTRE2022METH0197Ra.pdf,government,food and drug safety,France,Environmental factor; Health; Risk,science and technology>natural science>biology; environment; health>diseases and conditions
https://dx.doi.org/10.1016/j.scitotenv.2020.144832,3.0,cdc-164c146ae169efd13cf9d28437bcb7fb,Centers for Disease Control and Prevention (CDC),COVID-19 science update ; Edition 2021-01-29 (74),2021-01-29,https://stacks.cdc.gov/view/cdc/101656,government,healthcare agency,USA,Diseases and disorders; Public health; Health,health>diseases and conditions>illness; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.scitotenv.2020.144832,3.0,stateofeuskadi-ea812eab2893bb248919d6ae09697f43,Euskal Autonomia Erkidegoa,Exposómica y Salud Laboral con visión de género,2022-06-20,https://www.osalan.euskadi.eus/contenidos/informacion/ponencias_220616_curso_verano/es_def/adjuntos/Teofila-Vicente.-exposomica-y-salud-laboral-osalan-junio-2022.pdf,government,,Spain,Medical specialties; Pregnancy; Immune system,science and technology>natural science>biology; health>diseases and conditions; health
https://dx.doi.org/10.1016/j.prevetmed.2006.05.011,2.0,vkmno-4ba519baeb6e92763b2ee853fe60b7f4,Norwegian Scientific Committee for Food and Environment,"Salmonella diarizonae under norske forhold, konsekvenser for dyr og mennesker som en del av matkjeden",2008-09-09,https://vkm.no/risikovurderinger/allevurderinger/salmonelladiarizonaeundernorskeforholdkonsekvenserfordyrogmenneskersomendelavmatkjeden.4.2994e95b15cc545071681f8d.html,government,food and drug safety,Norway,Salmonella; Carbon dioxide; Food safety,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.prevetmed.2006.05.011,2.0,vkmno-a036eeb014d80ee41599d7930edf9ffa,Norwegian Scientific Committee for Food and Environment,Risikovurdering av E-coli i den norske kjøttkjeden,2007-03-06,https://vkm.no/risikovurderinger/allevurderinger/risikovurderingavecoliidennorskekjottkjeden.4.13735ab315cffecbb51ff11.html,government,food and drug safety,Norway,Pathogenic Escherichia coli; Infection; Meat,health>diseases and conditions>illness; health>diseases and conditions; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1098/rspb.2014.2509,1.0,nber-eb3824d2098ede23684a0f995c969e6b,NBER,Effects of Restrictive Abortion Legislation on Cohort Mortality Evidence from 19th Century Law Variation,2022-07-04,https://www.nber.org/papers/w30201,think tank,,USA,Socioeconomic status; Cohort study; Abortion,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1111/j.1468-1293.2011.00958.x,10.0,ecdc-061b79bc44d10c838b9795b97b51faec,European Centre for Disease Prevention and Control,"Thematic report: HIV treatment, care and support - Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 progress",2013-05-27,https://www.ecdc.europa.eu/en/publications-data/thematic-report-hiv-treatment-care-and-support-monitoring-implementation-dublin,government,agency,EU,Post-exposure prophylaxis; Management of HIV/AIDS; Pre-exposure prophylaxis,health; health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1111/j.1468-1293.2011.00958.x,10.0,europa-20124f0fab3dd98a0e49f6fa371bc4d7,Publications Office of the European Union,Eurosurveillance : special edition : HIV in MSM. June 2015.,2015-08-05,https://op.europa.eu/en/publication-detail/-/publication/0ffb69dc-6e91-46cd-9fca-8f07905f6f9a/language-en/format-PDF,government,,EU,Sexually transmitted infection; HIV/AIDS; Men who have sex with men,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1111/j.1468-1293.2011.00958.x,10.0,europa-d63dea5735ab6fb45a1cd07d48ee44c4,Publications Office of the European Union,"HIV treatment, care and support : monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia : 2012 progress report.",2013-11-12,https://op.europa.eu/en/publication-detail/-/publication/82da0220-35be-4d7d-ab4c-0e7e45107619/language-en/format-PDF,government,,EU,Pre-exposure prophylaxis; Treatment as prevention; Health insurance,health>diseases and conditions; health; health>health treatment
https://dx.doi.org/10.1111/j.1468-1293.2011.00958.x,10.0,provinceofbc-e25876a68e216bac152aa6f586762e02,Province of British Columbia,"PHO Annual Report - HIV, Stigma and Society - Download Edition",2014-07-08,https://www.health.gov.bc.ca/pho/pdf/hiv-stigma-and-society.pdf,government,,Canada,HIV/AIDS; Management of HIV/AIDS; Diagnosis of HIV/AIDS,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1111/j.1468-1293.2011.00958.x,10.0,provinceofnovascotia-bc6a5f6d0291c309e5c42902efdd9be4,Province of Nova Scotia,Surveillance Report On Hiv/aids In Nova Scotia: 1983 To 2011,2012-10-22,https://novascotia.ca/aids/documents/Surveillance-Report-HIV-AIDS-Nova-Scotia%20-1983-to-2011.pdf,government,,Canada,HIV/AIDS; Management of HIV/AIDS; Reverse-transcriptase inhibitor,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1111/j.1468-1293.2011.00958.x,10.0,robertkochde-1bad0c4a9a8d0f9329e2f9e7f8a67691,Robert Koch Institut,Epidemiologisches Bulletin 48/2020,2020-11-25,https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2020/Ausgaben/48_20.pdf?__blob=publicationFile,government,healthcare agency,Germany,HIV; HIV/AIDS; Medical humanities,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1111/j.1468-1293.2011.00958.x,10.0,robertkochde-877053f4f5979eb855fe1f991068f6ef,Robert Koch Institut,"Infektionsepidemiologisches Jahrbuch für 2012 (PDF, 6 MB, Datei ist nicht barrierefrei)",2013-06-03,https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2012.pdf?__blob=publicationFile,government,healthcare agency,Germany,Notifiable disease; Epidemiology; Veterinary medicine,health>diseases and conditions; health>diseases and conditions>illness; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1111/j.1468-1293.2011.00958.x,10.0,robertkochde-9dd31a4680e66467ce63f9a24cb6db08,Robert Koch Institut,"Infektionsepidemiologisches Jahrbuch für 2013 (PDF, 5 MB, Datei ist nicht barrierefrei)",2014-07-07,https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2013.pdf?__blob=publicationFile,government,healthcare agency,Germany,Notifiable disease; Shigatoxigenic and verotoxigenic Escherichia coli; Medical specialties,health>diseases and conditions>illness; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1111/j.1468-1293.2011.00958.x,10.0,who-040d5b9a4e5d3f48944a2d35194369d0,World Health Organization,Compendium of good practices in the health sector response to HIV in the WHO European Region,2021-07-01,https://apps.who.int/iris/handle/10665/342219,igo,healthcare agency,IGO,Pre-exposure prophylaxis; HIV/AIDS; Harm reduction,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1111/j.1468-1293.2011.00958.x,10.0,who-eae0d5cf1820cadda50e196d8b7a94cd,World Health Organization,Сборник примеров передовой практики здравоохранения в сфере противодействия ВИЧ-инфекции в Европейском регионе ВОЗ,2021-07-09,https://apps.who.int/iris/handle/10665/342565,igo,healthcare agency,IGO,HIV/AIDS; World Health Organization; HIV,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1016/j.epidem.2019.03.003,1.0,rivmnl-fc4440e867c83647eeb96c13324c79be,Rijksinstituut voor Volksgezondheid en Milieu,Sexually transmitted infections in the Netherlands in 2019,2020-06-26,https://www.rivm.nl/publicaties/sexually-transmitted-infections-in-netherlands-in-2019,government,research center,Netherlands,Gonorrhea; Sexually transmitted infection; Men who have sex with men,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.epidem.2019.100359,4.0,euparl_library-8b8331b89cafbfe2694749191e380c6b,European Parliamentary Research Service,Pollution and the spread of Covid-19,2021-12-09,https://www.europarl.europa.eu/thinktank/en/document/EPRS_STU(2021)697192,government,legislative research,EU,Airborne transmission; Pathogen transmission; Severe acute respiratory syndrome coronavirus 2,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/j.epidem.2019.100359,4.0,europa-b42beadb5f531493cd4bfdd8c9d05fe0,Publications Office of the European Union,Pollution and the spread of COVID-19.,2022-02-02,https://op.europa.eu/en/publication-detail/-/publication/d4089312-8a24-11ec-8c40-01aa75ed71a1/language-en/format-PDF,government,,EU,Airborne transmission; Severe acute respiratory syndrome coronavirus 2; Air pollution,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/j.epidem.2019.100359,4.0,stoa-691cf9c37fa4795c72f3a9daffc85a2a,Panel for the Future of Science and Technology (STOA) for the European Parliament,Pollution and the spread of Covid-19 | Panel for the Future of Science and Technology (STOA) | European Parliament,2021-12-09,https://www.europarl.europa.eu/stoa/en/document/EPRS_STU(2021)697192,government,legislative research,Belgium,Airborne transmission; SARS-CoV-2; Pathogen transmission,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/j.epidem.2019.100359,4.0,wmo-c08e22cb95f861b174edd45faa2c6547,World Meteorological Organization,Review on Meteorological and Air Quality Factors Affecting the COVID-19 Pandemic,2021-02-25,https://library.wmo.int/records/item/57336-first-report-of-the-wmo-covid-19-task-team-review-on-meteorological-and-air-quality-factors-affecting-the-covid-19-pandemic,igo,,IGO,Innate immune system; Respiratory droplet; SARS-CoV-2,weather; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.jpeds.2013.03.031,4.0,who-46bd1c9b77b79e93cceace47a6eae904,World Health Organization,Haemophilus influenzae type b (‎Hib)‎ Vaccination Position Paper — July 2013 : Introduction = Note de synthèse : Position de l’OMS sur la vaccination anti-Haemophilus influenzae type b (‎Hib)‎ — Juillet 2013 : Introduction,2016-06-16,https://apps.who.int/iris/handle/10665/242126,igo,healthcare agency,IGO,Haemophilus influenzae; Vaccine; Meningitis,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease>virus disease>retrovirus
https://dx.doi.org/10.1016/j.jpeds.2013.03.031,4.0,who-b7dce3a7c69e34f05b27101d477e71e8,World Health Organization,"Weekly Epidemiological Record, 2013, vol. 88, 39 [‎full issue]‎",2016-06-16,https://apps.who.int/iris/handle/10665/242127,igo,healthcare agency,IGO,Hib vaccine; Haemophilus influenzae; Vaccine,health; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease
https://dx.doi.org/10.1016/j.jpeds.2013.03.031,4.0,worldbank-3ca4b9bdf65f9e06946fca06ae0ba6aa,World Bank,"Disease Control Priorities, Third Edition",2017-11-06,https://hdl.handle.net/10986/28659,igo,development bank,IGO,Infection; Malaria; Safe sex,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/j.jpeds.2013.03.031,4.0,worldbank-3d8c68294d397bcaa1eccd55bd20f403,World Bank,"Disease Control Priorities, Third Edition : Volume 6. Major Infectious Diseases",2017-11-06,https://openknowledge.worldbank.org/handle/10986/28659,igo,development bank,IGO,Safe sex; Neglected tropical diseases; Sexually transmitted infection,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease>epidemic; health
https://dx.doi.org/10.1093/ofid/ofu031,1.0,cdc-3ac59c618343e7daf01b7cb7c278b202,Centers for Disease Control and Prevention (CDC),Lower respiratory tract infection hospitalizations among American Indian/Alaska Native children and the general United States child population,2015-11-05,https://stacks.cdc.gov/view/cdc/36155,government,healthcare agency,USA,Pneumonia; Influenza; Bronchiolitis,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1258/ijsa.2008.008217,2.0,unaids-b70e88432a14a1d04e442f5ce6e578f2,UNAIDS,AIDS Epidemic Update 2009,2009-11-25,https://www.unaids.org/en/resources/documents/2009/20091124_jc1700_epi_update_2009_en.pdf,igo,,IGO,Epidemiology of HIV/AIDS; HIV/AIDS in Africa; Harm reduction,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1258/ijsa.2008.008217,2.0,unitednations-d9f3e946258195d09d6dab14fc924a36,United Nations,AIDS epidemic update.,2009-01-01,https://digitallibrary.un.org/record/3942742?ln=en,igo,,IGO,HIV; Diseases and disorders; Clinical medicine,health; health; health
https://dx.doi.org/10.4269/ajtmh.1980.29.260,1.0,cdc-ae75950af183278fb6f563fb358aa695,Centers for Disease Control and Prevention (CDC),Viral hemorrhagic fever : initial management of suspected and confirmed cases,2015-11-21,https://stacks.cdc.gov/view/cdc/35794,government,healthcare agency,USA,Crimean–Congo hemorrhagic fever; Lassa fever; Ebola virus disease,health>diseases and conditions>communicable disease>virus disease; health; health>diseases and conditions>communicable disease>epidemic
https://dx.doi.org/10.1002/hep.21363,1.0,pubmedcentral-b5dbb51e5e354dd92746c630b915221f,Guidelines in PubMed Central,"APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing",2016-05-26,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003900/pdf,other,aggregator,USA,Hepatitis C; Hepatocellular carcinoma; Cirrhosis,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1186/1475-9276-6-5,2.0,gpogov-a973c2690f2e1d8ae98ba5e68e369d16,Government Publishing Office (GPO),Increasing equity of insecticide-treated net ownership in Sub-Saharan Africa from 2003 to 2014 /,2015-09-04,https://purl.fdlp.gov/GPO/gpo116480,government,,USA,Malaria; Mosquito net; Household income in the United States,health; science and technology; science and technology>social sciences
https://dx.doi.org/10.1186/1475-9276-6-5,2.0,who-6afb8506c6035710dfbaf728f549a419,World Health Organization,Equity trends in ownership of insecticide-treated nets in 19 sub-Saharan African countries,2018-03-26,https://apps.who.int/iris/handle/10665/272094,igo,healthcare agency,IGO,Malaria Atlas Project; Malaria; Surveying,science and technology; health; science and technology>social sciences
https://dx.doi.org/10.1371/journal.pcbi.1002855,4.0,fao-6f0b7748f3ce12d054597734ced235a4,Food and Agriculture Organization of the United Nations,Bulletin d'information sur les glossines et les trypanosomoses - PLTA 35.2,2013-06-04,http://www.fao.org/3/a-i3310f.pdf,igo,,IGO,African trypanosomiasis; Neglected tropical diseases; Health,health>diseases and conditions>illness; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.1371/journal.pcbi.1002855,4.0,fao-7a5f5c7d13880fd1aea0477e9263e3df,Food and Agriculture Organization of the United Nations,Tsetse and Trypanosomosis Information - PAAT 35.2,2013-05-31,http://www.fao.org/3/a-i3310e.pdf,igo,,IGO,Tsetse fly; Neglected tropical diseases; African trypanosomiasis,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health>diseases and conditions
https://dx.doi.org/10.1371/journal.pcbi.1002855,4.0,who-ae87635dc7c4ed4671b95453f0b4625d,World Health Organization,Control and surveillance of human African trypanosomiasis: report of a WHO expert committee,2013-11-27,https://apps.who.int/iris/handle/10665/95732,igo,healthcare agency,IGO,Trypanosoma brucei; Trypanosoma; Natural reservoir,science and technology>natural science>biology; health; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1371/journal.pcbi.1002855,4.0,who-f0385565be0a0300eab5eb1b10e6ff2b,World Health Organization,Trypanosomiase humaine africaine : lutte et surveillance : rapport d’un comité d’experts de l’OMS,2015-01-14,https://apps.who.int/iris/handle/10665/148113,igo,healthcare agency,IGO,Medical specialties; Organisms; Biology,health>diseases and conditions; science and technology>natural science>biology; science and technology
https://dx.doi.org/10.3802/jgo.2010.21.2.87,1.0,who-274880d48778cbea8f6683a2c7f53700,World Health Organization,"WHO guidelines for treatment of cervical intraepithelial neoplasia 2-3 and adenocarcinoma in situ: cryotherapy, large loop excision of the transformation zone, and cold knife conization",2014-02-26,https://apps.who.int/iris/handle/10665/104174,igo,healthcare agency,IGO,Cervical cancer; Cervical intraepithelial neoplasia; Colposcopy,health; health>diseases and conditions>cancer; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1371/journal.pone.0003154,2.0,rtiinternational-0687ac9644f9040ac9f94e855557715d,RTI International,Assessing network structure with practical sampling methods,2018-05-15,https://www.rti.org/rti-press-publication/assessing-network-structure,think tank,,USA,Centrality; Sampling (statistics); Degree distribution,"science and technology; science and technology>mathematics; economy, business and finance>economic sector>computing and information technology"
https://dx.doi.org/10.1371/journal.pone.0003154,2.0,rtiinternational-74f42da5c5b6869677228577fdb7471c,RTI International,Assessing network structure with practical sampling methods: An example of the Global Airport Network,2018-05-11,https://www.rti.org/rti-press-publication/assessing-network-structure-practical-sampling-methods-example-global-airport-network,think tank,,USA,Centrality; Sampling (statistics); Degree distribution,"science and technology; science and technology>mathematics; economy, business and finance>economic sector>computing and information technology"
https://dx.doi.org/10.1371/journal.pone.0084511,4.0,emcdda-3954cfc4dd79a8fda0a819e88802c1bd,EMCDDA,"Hepatitis C among drug users in Europe: epidemiology, treatment and prevention",2016-07-01,https://www.emcdda.europa.eu/publications/insights/hepatitis-c-among-drug-users-in-europe_en,government,agency,EU,Hepatocellular carcinoma; Hepatitis; Harm reduction,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1371/journal.pone.0084511,4.0,europa-847a9f7e839e41246a9bfa413ee461ea,Publications Office of the European Union,"Hepatitis C among drug users in Europe : epidemiology, treatment and prevention.",2016-08-02,https://op.europa.eu/en/publication-detail/-/publication/a33add41-b9ca-4b84-996b-8291fea801fa/language-en/format-PDF,government,,EU,Hepatitis C; Hepatocellular carcinoma; Hepatitis,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1371/journal.pone.0084511,4.0,governmentofecuador-8814c22fcc7c5226ead8294819c7c850,Government of Ecuador,"Prevención, diagnóstico y tratamiento de la infección por el virus de inmunodeficiencia humana (VIH) en embarazadas, niños, adolescentes y adultos",2019-07-05,https://www.salud.gob.ec/wp-content/uploads/2019/06/gpc_VIH_acuerdo_ministerial05-07-2019.pdf,government,,Ecuador,HIV; Management of HIV/AIDS; HIV/AIDS,health>diseases and conditions; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1371/journal.pone.0084511,4.0,stateofwesterncape-bafd42b807ce6e6cebc800254a2c339a,Western Cape Provincial Government,Health,2015-11-04,https://www.westerncape.gov.za/sites/www.westerncape.gov.za/files/tygerberg_annual_report_2014.pdf,government,,South Africa,Nursing; Health care; Health,health>diseases and conditions; health; education
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,africacdc-fdd371dfc2bf691065d99fa5a1008f09,Africa CDC,Tackling the twin threats of pandemics and climate change: an agenda for action,2023-12-06,https://africacdc.org/download/tackling-the-twin-threats-of-pandemics-and-climate-change-an-agenda-for-action/,igo,healthcare agency,IGO,Climate resilience; Zoonosis; Pandemic,health>diseases and conditions; environment; health
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,apo-2549b4b962d6908707486cad9f3b7194,Analysis & Policy Observatory,Science or stagnation? Next steps for life sciences policy in England,2022-10-27,https://apo.org.au/node/320466,other,aggregator,Australia,Cost of living; National Health Service; Innovation,"health>diseases and conditions; health; economy, business and finance>economy"
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,apo-2a9b55bd8b1318771827a88ad40f5d75,Analysis & Policy Observatory,European Climate Risk Assessment (2024),2024-03-11,https://apo.org.au/node/326004,other,aggregator,Australia,Cost of living; Climate change adaptation; Mire,weather; environment>natural resources>water; environment
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,ceprorg-71c68afc86868cc391f23a2d8441889d,Centre for Economic Policy Research,Disasters and (Bank) Financing,2024-03-20,https://cepr.org/publications/books-and-reports/disasters-and-bank-financing,think tank,,UK,Loan; Bank; Credit,"economy, business and finance>economy; health; politics>government"
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,cgdev-eb2126baa2e660af3e113186e3581d4b,Center for Global Development,Estimated Future Mortality from Pathogens of Epidemic and Pandemic Potential,2023-02-28,https://www.cgdev.org/publication/estimated-future-mortality-pathogens-epidemic-and-pandemic-potential,think tank,,USA,Pandemic; Infection; Epidemic,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,councilonforeignrelations-94d9f627bef0d8f635dbb9baa9b5931b,Council on Foreign Relations,How Will Global Health Survive Climate Change?,2022-12-01,http://live-cfr-org.pantheonsite.io/report/how-will-global-health-survive-climate-change,think tank,,USA,Health sciences; Natural environment; Politics of climate change,health; health>diseases and conditions; environment
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,cset-bc6403dd59cce649d187f0f5cbcd3771,Center for Security and Emerging Technology (CSET),Viral Families and Disease X: A Framework for U.S. Pandemic Preparedness Policy,2023-04-01,https://cset.georgetown.edu/publication/viral-families-and-disease-x-a-framework-for-u-s-pandemic-preparedness-policy/,think tank,university affiliated,USA,Smallpox; Influenza A virus; Influenza,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,europa-22f0ff2b7a7ce8397e8333c782e44125,Publications Office of the European Union,European climate risk assessment - Publications Office of the EU,2024-09-25,https://op.europa.eu/en/publication-detail/-/publication/8e234e44-7bb5-11ef-bbbe-01aa75ed71a1/language-en,government,,EU,Environmental science; Environment; Nature,"environment; disaster, accident and emergency incident>disaster; weather"
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,europa-e532167e9aeedb7ce4d9d206b40c365c,Publications Office of the European Union,Adapting postharvest activities in the value chain of fisheries and aquaculture to the effects of climate change and mitigating their climate footprint through the reduction of greenhouse gas emissions : annexes.,2023-03-30,https://op.europa.eu/en/publication-detail/-/publication/33a0a7ea-d1d1-11ed-a05c-01aa75ed71a1/language-en/format-PDF,government,,EU,Greenhouse gas emissions; Climate change; Overfishing,lifestyle and leisure>leisure>recreational activities>fishing; lifestyle and leisure>lifestyle>food and drink; environment>natural resources>water
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,forestagencysweden-461bfcbdea6042c86ebfd513a3252c1b,Skogsstyrelsen,Rapport 2023-14 Omvärldsanalys 2023,2023-09-28,https://www.skogsstyrelsen.se/globalassets/om-oss/rapporter/rapporter-2023/rapport-2023-14-omvarldsanalys-2023.pdf,government,agency,Sweden,Human migration; European Union; United States,environment; politics>government>parliament; politics
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,gbif-7db0da364bf24569f544c8116c2053dc,Global Biodiversity Information Facility,GBIF Science Review No. 11,2024-09-02,https://www.gbif.org/document/5N9YVBkTP3y7kqhFQviowM/gbif-science-review-no-11,igo,research center,IGO,Tinamou; Natural environment; Ecology,science and technology>natural science>biology; science and technology>natural science>biology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,govdeptsfrance-b248e27d403d455ef5cb3049ca67cc97,French Government Ministries,Avis du Comité de Veille et d’Anticipation des Risques,2023-06-08,https://www.enseignementsup-recherche.gouv.fr/sites/default/files/2023-06/avis-du-covars-du-8-juin-2023---risque-sanitaire-li-l-iahp-et-la-grippe-aviaire-28112.pdf,government,,France,Vaccination; Influenza A virus subtype H5N8; Influenza A virus subtype H5N1,health>diseases and conditions>illness; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,iadb-c34a58799e47eb252ccee80b7c326d67,Inter-American Development Bank,Heat and High Water: Nine Pathways to Climate Resilient Development,2023-12-01,https://publications.iadb.org/en/heat-and-high-water-nine-pathways-climate-resilient-development,igo,development bank,IGO,Effects of climate change; Natural environment; Nature,"economy, business and finance>economic sector>agriculture; environment>natural resources>water; weather"
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,iadb-c3d13cd0707e097fba62149087c93230,Inter-American Development Bank,Con el calor y el agua al cuello: nueve caminos hacia un desarrollo resiliente al cambio climático,2023-12-01,https://publications.iadb.org/es/con-el-calor-y-el-agua-al-cuello-nueve-caminos-hacia-un-desarrollo-resiliente-al-cambio-climatico,igo,development bank,IGO,Natural environment; Earth sciences; Nature,"environment; economy, business and finance>economic sector>agriculture; environment>nature"
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,idrc-6e1ccad7b6c9e76c66e31e4f97e01953,International Development Research Centre,Regulation for innovation : conceptualising a development research agenda for inclusive and sustainable economies in lower-income countries,2024-06-25,https://idrc-crdi.ca/en/node/126099,think tank,,Canada,Economy; European Union; Gig worker,science and technology; health; education
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,idsssingapore-38c4b624cb54d50995d9746a6e78f0c0,RSIS,Facing Up to Climate Change-Induced Biosecurity Threats,2024-01-09,https://www.rsis.edu.sg/rsis-publication/rsis/facing-up-to-climate-change-induced-biosecurity-threats/,think tank,university affiliated,Singapore,Health; Natural environment; Environmental social science,health>diseases and conditions; environment; health>diseases and conditions>illness
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,ifode-fb6a7c0b1484482c8ed70c0f97ca1061,Ifo Institute,How to Start a Grassroots Movement,2022-09-19,https://www.cesifo.org/en/publications/2022/working-paper/how-start-grassroots-movement,think tank,,Germany,Nudge theory; Social norm; COVID-19 pandemic,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,iiasaat-ca4691bd544bcd67487219b560388a62,IIASA,Effective Health Care and Global Pandemic Preparedness. Policy paper for G20,2023-01-01,https://pure.iiasa.ac.at/id/eprint/19119/?template=default_internal,think tank,research center,Austria,World Health Organization; International Institute for Applied Systems Analysis; Health,health; education; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,intwhalingcomm-8ec7c26bf2b0987795d14260719abf8e,International Whaling Commission (IWC),Progress report IWC 2024 IWC SC Intersessional Correspondence Group on...,2024-01-01,https://archive.iwc.int/pages/download.php?direct=1&noattach=true&ref=22067&ext=pdf&k=,igo,research center,IGO,Cetology; Marine mammals; Cetaceans,health>diseases and conditions>illness; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,ippr-cb510afdefe5483618b122b0f6e10ed7,Institute for Public Policy Research,Science or stagnation?: Next steps for life sciences policy in England,2022-10-27,https://www.ippr.org/research/publications/science-or-stagnation,think tank,,UK,Cost of living; National Health Service; Innovation,"health>diseases and conditions; health; economy, business and finance>economy"
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,izade-313c90ed2bf13165786fffed70805644,IZA Institute of Labor Economics,The Unequal Impact of the COVID Pandemic: Theory and Evidence on Health and Economic Outcomes for Different Income Groups,2022-06-30,https://www.iza.org/publications/dp/15396/the-unequal-impact-of-the-covid-pandemic-theory-and-evidence-on-health-and-economic-outcomes-for-different-income-groups,think tank,,Germany,Compartmental models in epidemiology; Health; Labour economics,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,nber-233df9a7e3de2ec13c3969b0199606a8,NBER,Long Social Distancing,2022-10-17,https://www.nber.org/papers/w30568,think tank,,USA,Standard error; Production function; Remote work,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,observerresearchfoundation-f4b3378b000192b3a47e976d13ecc95c,Observer Research Foundation,Converging Paths: Global Governance for Climate Justice and Health Equity,2023-10-12,https://www.orfonline.org/research/converging-paths,think tank,,India,Natural environment; Public health; Governance,health; environment; health>diseases and conditions
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,oecddiscovery-e7d0b6fd4cbb23683e9265c927890ba7,OECD,COVID-19 and policy for science,2023-07-03,https://dx.doi.org/https://doi.org/10.1787/8f86e60b-en,igo,,IGO,Science; Governance; COVID-19 pandemic,"economy, business and finance>economic sector>computing and information technology; science and technology; health>diseases and conditions"
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,randcorporation-9528b18dddbae0028543790ac9330f60,RAND Corporation,Lessons Learned from the COVID-19 Outbreak,2022-11-01,https://www.rand.org/pubs/perspectives/PEA1481-2.html,think tank,research center,USA,Gain-of-function research; Biosafety; Biosafety level,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,sespases-c6d1c420e0cfab0de34d5cf77c534210,SESPAS,Climate change and health : an Ibero-American vision,2023-04-12,https://sespas.es/wp-content/uploads/2022/12/CAMBIO-CLIMAiTICO-Y-SALUD_Final_EN_MGT_v2.pdf,government,healthcare agency,Spain,Nature; Environment; Natural environment,health>diseases and conditions; environment>environmental pollution; health
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,stateofnewjersey-576fb9161538cfc903d169fe56966f8d,State of New Jersey,Human Health,2022-09-15,https://dep.nj.gov/wp-content/uploads/climatechange/nj-scientific-report-human-health-addendum.pdf,government,,USA,Air pollution; Particulates; Tick,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,ukparliament_select-1761e0ee6a998e188244987059ddf12e,UK Parliament Select Committee Publications,DCC0015 - Defence and Climate Change,2022-09-08,https://committees.parliament.uk/writtenevidence/109627/default/,government,,UK,Low-carbon economy; Climate change; Greenhouse gas emissions,"economy, business and finance>economic sector>energy and resource; environment; conflicts, war and peace"
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,ukparliament_select-fe6bd57f5b7689d53c91c6da0cec17dc,UK Parliament Select Committee Publications,1Day Sooner (EMD0047),2023-05-02,https://committees.parliament.uk/writtenevidence/119786/pdf/,government,,UK,Human challenge study; COVID-19 pandemic; COVID-19 vaccine,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,unctad-2f2fb327bc32cb54bb23bf1746900289,UNCTAD,COVID-19 and International Sale of Goods: Contractual devices for commercial risk allocation and loss prevention,2023-01-11,https://unctad.org/system/files/official-document/dtltlb2023d1_en.pdf,igo,,IGO,Incoterms; Charterparty; Contract,"economy, business and finance>economic sector>transport; economy, business and finance>business information>human resources>management; science and technology>social sciences>economics"
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,undp-bde29faf4ad3f3405bc03adebed84d51,United Nations Development Programme,Human Development Report 2021-22,2022-09-08,https://hdr.undp.org/content/human-development-report-2021-22,igo,,IGO,Economics; Artificial intelligence; Media (communication),"health>diseases and conditions; environment>natural resources>water; economy, business and finance>economy"
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,unfccc-718cbcdeceef81076ef3b1f8b981015d,United Nations Framework Convention on Climate Change,"Submission to the UNFCCC First Global Stocktake, Second Technical Call, August 2022",2022-08-08,https://unfccc.int/documents/574284,igo,,IGO,Co-benefits of climate change mitigation; Climate change mitigation; Climate and Clean Air Coalition to Reduce Short-Lived Climate Pollutants,health; environment; environment>environmental pollution
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,unhabitat-5241f8bd40c703c81760d59ab67c2b25,United Nations Human Settlement Programme,World Cities Report 2022: Envisaging the Future of Cities,2022-06-27,https://unhabitat.org/sites/default/files/2022/06/wcr_2022.pdf,igo,,IGO,City; Cost of living; Governance,health>diseases and conditions; environment; health
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,unitednations-4ef4f4a10eb8320183a773cb930870a9,United Nations,"Human development report. 2021/2022 : uncertain times, unsettled lives: shaping our future in a transforming world",2022-01-01,https://digitallibrary.un.org/record/3986309?ln=en,igo,,IGO,Greenhouse gas emissions; Climate change; Human Development Index,"environment; economy, business and finance>economic sector>energy and resource; environment>natural resources>water"
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,unitednations-6626090136420c1e330aaec29957557e,United Nations,World cities report 2022 : envisaging the future of cities,2022-01-01,https://digitallibrary.un.org/record/3984713?ln=en,igo,,IGO,City; Cost of living; Governance,health>diseases and conditions; environment; health
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,vrse-1be17ab34b9388f0fa3230708f08180f,Vetenskapsrådet,Strategisk forskningsagenda: Nationellt forskningsprogram om virus och pandemier,2023-05-15,https://www.vr.se/analys/rapporter/vara-rapporter/2023-06-30-strategisk-forskningsagenda-nationellt-forskningsprogram-om-virus-och-pandemier.html,government,agency,Sweden,Zoonosis; Pathogen transmission; COVID-19 pandemic,health>diseases and conditions; science and technology>natural science>biology; health
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,whitehouse-44205588bcba70e656b203e6eb0f7e4d,Whitehouse.gov,2023 Economic Report of the President,2023-03-14,https://www.whitehouse.gov/wp-content/uploads/2023/03/ERP-2023.pdf,government,,USA,Macroeconomics; Economics; Economy,"economy, business and finance>economy; economy, business and finance>economy>macro economics>inflation; science and technology>social sciences>economics"
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,who-8cb9976f3a381335bdac2f4a073bc9c2,World Health Organization,"WHO South-East Asia Regional Strategy for the prevention and control of Nipah virus infection, 2023–2030",2023-01-01,https://apps.who.int/iris/handle/10665/373438,igo,healthcare agency,IGO,One Health; Nipah virus infection; Henipavirus,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,worldbank-1abb6cdb04f23f5ee76d9481ab5ed3fb,World Bank,Putting Pandemics Behind Us : Investing in One Health to Reduce Risks of Emerging Infectious Diseases,2022-10-24,https://openknowledge.worldbank.org/handle/10986/38200,igo,development bank,IGO,One Health; Preventive healthcare; Health,environment>nature; health>diseases and conditions; environment
https://dx.doi.org/10.1038/s41586-022-04788-w,40.0,worldbank-db4ad704b76122dba58dd540243d4e45,World Bank,Putting Pandemics Behind Us,2022-10-01,https://hdl.handle.net/10986/38200,igo,development bank,IGO,Pandemic prevention; Zoonosis; Deforestation,environment>nature; health>diseases and conditions; environment
https://dx.doi.org/10.1086/341897,1.0,marylandgov-3d3d698aaf58da9730a37c75067c98cb,State of Maryland,About Active Bacterial Core Surveillance,2012-03-19,https://test-health.maryland.gov/phpa/OIDEOR/EIP/Documents/ABCs%20Publications%20List.pdf,government,,USA,Streptococcus pneumoniae; Haemophilus influenzae; Streptococcus pyogenes,health>diseases and conditions; science and technology>natural science>biology; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1038/ki.2008.580,1.0,pubmedcentral-46d936ede12e4676f67f2b6dfb369621,Guidelines in PubMed Central,Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients,2015-12-03,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10986644/pdf,other,aggregator,USA,Mycophenolic acid; Immunosuppressive drug; Kidney transplantation,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/s41598-020-78505-w,1.0,stateofnsw-f749a2595d03d5e1afb70281196e7205,State of New South Wales,Daily evidence digest,2020-12-09,https://ciap.health.nsw.gov.au/assets/docs/covid-19/daily-evidence-digest/2020/20201209-daily-evidence-digest.pdf,government,,Australia,COVID-19 pandemic; Long COVID; National Health Service,health; health>health treatment>preventative medicine>vaccines; health>health treatment>medicine
https://dx.doi.org/10.1016/j.hlpt.2021.100583,1.0,nber-a8259275b81d227d968841297d523eb5,NBER,The Repeated Setbacks of HIV Vaccine Development Laid the Groundwork for SARS-CoV-2 Vaccines,2021-03-22,https://www.nber.org/papers/w28587,think tank,,USA,Virus; MRNA vaccine; Adenoviridae,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology>genetics; science and technology>natural science>biology
https://dx.doi.org/10.1371/journal.pone.0123482,1.0,nice-eca1723ed17559ddf0d6be29d6507833,NICE,Cabotegravir with rilpivirine for treating HIV-1,2022-01-05,https://www.nice.org.uk/guidance/ta757,government,healthcare agency,UK,Rilpivirine; Management of HIV/AIDS; Cabotegravir,science and technology>biomedical science>pharmacology; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1371/journal.pone.0204609,2.0,epagov-429e0ef00c8ebc095a57dd4da22ef3a8,EPA,Climate Change and Children's Health and Well-Being in the United States,2023-06-12,https://www.epa.gov/system/files/documents/2023-04/CLiME_Final%20Report.pdf,government,agency,USA,Pregnancy; Particulates; Climate change,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1371/journal.pone.0204609,2.0,nrdc-b5dfcf073a92ea663fdf61537f74677c,Natural Resources Defense Council,Climate Change and State-Level Health Impacts,2019-02-01,https://www.nrdc.org/resources/climate-change-and-state-level-health-impacts,think tank,,USA,Smog; Rain; Precipitation,health>diseases and conditions; health>diseases and conditions; health
https://dx.doi.org/10.1038/s41598-021-04108-8,1.0,cdc-cf0ac7c0b7daf455a35fcc68af3b091a,Centers for Disease Control and Prevention (CDC),COVID-19 weekly update : up to date genomics and precision health information on COVID-19 : published on 01/06/2022,2022-01-11,https://stacks.cdc.gov/view/cdc/113121,government,healthcare agency,USA,Severe acute respiratory syndrome coronavirus 2; COVID-19 vaccine; SARS-CoV-2 Omicron variant,science and technology>natural science>biology>genetics; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.vaccine.2021.04.008,4.0,rijksoverheid-c3890a8ecc6d04afab27802e54311d32,Rijksoverheid,Kamerbrief over het verzoek om reactie Petitie 'Op naar 0 slachtoffers in 2030!' door Alliantie Nederland Hepatitis Vrij,2022-02-25,https://www.rijksoverheid.nl/documenten/kamerstukken/2022/02/25/kamerbrief-over-het-verzoek-om-reactie-petitie-op-naar-0-slachtoffers-in-2030-door-alliantie-nederland-hepatitis-vrij,government,,Netherlands,Vaccination schedule; Clinical medicine; Immunology,health; health>health treatment>medicine; health>diseases and conditions
https://dx.doi.org/10.1016/j.vaccine.2021.04.008,4.0,rivmnl-ae0d940c7ea812af2e3e70e0b7ec3269,Rijksinstituut voor Volksgezondheid en Milieu,Sexually transmitted infections in the Netherlands in 2021,2022-06-23,https://www.rivm.nl/publicaties/sexually-transmitted-infections-in-netherlands-in-2021,government,research center,Netherlands,Epidemiology; Sexually transmitted infection; Pre-exposure prophylaxis,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1016/j.vaccine.2021.04.008,4.0,rivmnl-b6ef706e54b0c8fd9bc2650dc3d18c00,Rijksinstituut voor Volksgezondheid en Milieu,Optimalisation of the schedule of the National Immunisation Programme. Background information for the advice of the Health Council of The Netherlands on the vaccination schedule of the National Immunisation Programme,2022-06-07,https://www.rivm.nl/publicaties/optimalisation-of-schedule-of-national-immunisation-programme-background-information,government,research center,Netherlands,Infectious diseases; Clinical medicine; Medicine,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1016/j.vaccine.2021.04.008,4.0,rivmnl-c69fa3093fa222a942fba7cc93eb874d,Rijksinstituut voor Volksgezondheid en Milieu,The National Immunisation Programme in the Netherlands. Surveillance and developments in 2020-2021,2021-11-24,https://www.rivm.nl/rvp-2021,government,research center,Netherlands,Infection; Immunization; Vaccination schedule,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/s0025-5564(02)00129-3,2.0,nber-3e3f9f1b960762a40425e3ac9bfc7dbb,NBER,"Vaccination Planning under Uncertainty, with Application to Covid-19",2021-02-08,https://www.nber.org/papers/w28446,think tank,,USA,Parameter; Infection; Randomized controlled trial,health>diseases and conditions; science and technology; science and technology>mathematics
https://dx.doi.org/10.1016/s0025-5564(02)00129-3,2.0,nber-61ac83172ada03bf80f3c293c0e9b4ca,NBER,Vaccine Approvals and Mandates Under Uncertainty: Some Simple Analytics,2014-08-28,https://www.nber.org/papers/w20432,think tank,,USA,Risk; Health; Health sciences,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1371/journal.pone.0029640,1.0,who-4d8dd6ab0d35b3102328e2f6993bc3ec,World Health Organization,Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza: annex: report of systematic literature reviews,2019-10-24,https://apps.who.int/iris/handle/10665/329439,igo,healthcare agency,IGO,Influenza; Social distancing; Hand washing,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1002/ajim.23199,6.0,committee_house-0a11e28d920e5232d4d063a6ccfe3373,House Committees,"""Protecting Transportation Workers and Passengers from COVID: Gaps in Safety, Lessons Learned and Next Steps.""",2021-02-04,https://www.congress.gov/event/117th-congress/house-event/111128,government,,USA,HEPA; Cruise ship; COVID-19 pandemic,"economy, business and finance>economic sector>transport; economy, business and finance>economic sector>transport>road transport; disaster, accident and emergency incident>emergency incident>transport incident"
https://dx.doi.org/10.1002/ajim.23199,6.0,committee_house-f68c7868ffbc9bf78490d2691e379ac9,House Committees,"PROTECTING TRANSPORTATION WORKERS AND PASSENGERS FROM COVID: GAPS IN SAFETY, LESSONS LEARNED, AND NEXT STEPS",2021-04-01,https://www.congress.gov/event/117th-congress/house-event/LC67948/text,government,,USA,COVID-19 pandemic; COVID-19; Face masks during the COVID-19 pandemic,"economy, business and finance>economic sector>transport; economy, business and finance>economic sector>transport>road transport; health>diseases and conditions"
https://dx.doi.org/10.1002/ajim.23199,6.0,federalregister-ddbc65bf431c855ea6e85f734bc8505b,Federal Register,Occupational Exposure to COVID-19; Emergency Temporary Standard,2021-06-21,https://www.federalregister.gov/documents/2021/06/21/2021-12428/occupational-exposure-to-covid-19-emergency-temporary-standard,government,,USA,Severe acute respiratory syndrome coronavirus 2; Infection; Mental disorder,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1002/ajim.23199,6.0,gpogov-84c5a35f46254c14f23a40127cd377f2,Government Publishing Office (GPO),"Protecting transportation workers and passengers from COVID : gaps in safety, lessons learned, and next steps : remote hearing before the Committee on Transportation and Infrastructure, House of Representatives, One Hundred Seventeenth Congress, first session, February 4, 2021.",2022-03-08,https://purl.fdlp.gov/GPO/gpo176333,government,,USA,COVID-19 pandemic; Occupational Safety and Health Administration; Face masks during the COVID-19 pandemic,"economy, business and finance>economic sector>transport; disaster, accident and emergency incident>emergency incident>transport incident; economy, business and finance>economic sector>transport>road transport"
https://dx.doi.org/10.1002/ajim.23199,6.0,stateofalaska-b5effeadeb307ab89c51f488e6d7a3f8,State of Alaska,"Post Office Box 111149 Juneau, AK 99811 Main : 907.465.4855",2021-07-13,https://labor.alaska.gov/lss/program_directives/PD_21-05.pdf,government,,USA,Airborne transmission; Medicine; Diseases and disorders,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1002/ajim.23199,6.0,thlfi-22a1655c74e4caf363d88997ce4e2872,Terveyden ja hyvinvoinnin laitos,Koronavirusinfektiot (COVID-19) terveyden- ja sosiaalihuollon työntekijöillä Suomessa 1.2.2020-30.6.2021 : Rekisteripohjainen kohorttitutkimus,2022-05-10,http://www.julkari.fi/handle/10024/144427,government,healthcare agency,Finland,Medical specialties; Medicine; Health care,health; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,anses-351b69d924bdd84ad4b994b77229cb19,ANSES,"Avis de l’Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail relatif aux contaminations microbiologiques des viandes à l'abattoir",2010-12-10,https://www.anses.fr/fr/system/files/MIC2008sa0308.pdf,government,food and drug safety,France,Immune system; Bacteria; Epithelium,health; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,anses-5dec5e8a0a80a038fe684b7f0f14217c,ANSES,Bilan des connaissances relatives aux Escherichia coli producteurs de shigatoxines (STEC),2003-05-01,https://www.anses.fr/fr/system/files/MIC-Ra-STEC.pdf,government,food and drug safety,France,Escherichia coli; Antibiotic; Foodborne illness,health>diseases and conditions; science and technology>natural science>biology; health
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,anses-9a90c6292f9022a09b2a49d3629134b8,ANSES,AVIS de l’Anses relatif à « la définition d’un plan d’échantillonnage pour la détection d’E. coli O157 : H7 dans le cadre des autocontrôles en filière viande hachée bovine »,2014-05-06,https://www.anses.fr/fr/system/files/BIORISK2013sa0223.pdf,government,food and drug safety,France,"Meat; Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail; Probability distribution","science and technology; health; economy, business and finance>economic sector>consumer goods>food"
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,anses-9b09ad86edbb4b82fecf56ab1059a662,ANSES,AVIS de l'Anses relatif à la détection d'E. coli producteurs de shigatoxines (STEC) considérés comme hautement pathogènes en filière viande hachée bovine,2017-05-18,https://www.anses.fr/fr/system/files/BIORISK2016SA0121.pdf,government,food and drug safety,France,Escherichia coli; Microbiology; Medical specialties,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,anses-cc8592832a86a7a3a0d1f57e59a0a5f2,ANSES,AVIS et rapport de l'Anses relatifs à l'information des consommateurs en matière de prévention des risques microbiologiques liés aux aliments - Tome 2 : Évaluation de l’efficacité des stratégies de communication,2015-10-14,https://www.anses.fr/fr/system/files/BIORISK2012sa0118Ra-02.pdf,government,food and drug safety,France,,
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,cdc-e75c394397cee68655e3d9b56bffc7e6,Centers for Disease Control and Prevention (CDC),"Conference on foodborne pathogens; pathogen emergence, host susceptibility, chronic sequelae, risk assessment, consumer concern : National Conference on Emerging Foodborne Pathogens: Implications and Control, March 24-26, 1997, Alexandria, Virginia, USA",1997-10-14,https://stacks.cdc.gov/view/cdc/13345,government,healthcare agency,USA,Infection; Foodborne illness; Reactive arthritis,health>diseases and conditions>illness; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,efsaeu-0c8222602792f3f99b68efb0737ee36d,EFSA,Scientific Opinion on the development of a risk ranking framework on biological hazards,2012-06-14,https://www.efsa.europa.eu/en/efsajournal/pub/2724,government,agency,EU,Disability-adjusted life year; Quality-adjusted life year; Risk,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,efsaeu-de1c4b97de6a5e075a799a657bf52e3d,EFSA,Guidance on date marking and related food information: part 1 (date marking),2020-12-02,https://www.efsa.europa.eu/en/efsajournal/pub/6306,government,agency,EU,Pasteurization; Shelf life; Food preservation,"lifestyle and leisure>lifestyle>food and drink; economy, business and finance>economic sector>consumer goods>food; politics>government policy>regulatory of industry>food and drink regulations"
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,epagov-42aeaaadf2945a6ccbffd5de1944ef99,EPA,Microbial Risk Assessment Guideline,2012-07-24,https://www.epa.gov/sites/default/files/2013-09/documents/mra-guideline-final.pdf,government,agency,USA,Epidemiology; Genetics; Disease,science and technology>natural science>biology; health>diseases and conditions; science and technology>natural science>biology>genetics
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,epaireland-4d40043ca96c14c0de262f5bfc534591,Irish Environmental Protection Agency,Health and Water Quality Impacts Arising from Land Spreading of Biosolids,2017-01-18,https://www.epa.ie/publications/research/land-use-soils-and-transport/EPA-RR-200_web-Essentra.pdf,government,agency,Ireland,Sewage sludge; Sewage treatment; Biosolids,"economy, business and finance>economic sector>chemicals; economy, business and finance>economic sector>chemicals>organic chemical; environment>environmental pollution"
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,fao-1290dacb43b38bbb980b26ce07282130,Food and Agriculture Organization of the United Nations,Risk Assessments of Salmonella in Eggs and Broiler Chickens. Microbiological Risk Assessment Series (MRA) 2,2003-09-15,http://www.fao.org/3/y4392e/Y4392E.pdf,igo,,IGO,Risk management; Health sciences; Medicine,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,fao-38ea4f896b1589fae6c0f0d3df753928,Food and Agriculture Organization of the United Nations,Enterohaemorrhagic Escherichia coli in raw beef and beef products: approaches for the provision of scientific advice,2011-10-10,http://www.fao.org/3/at661e/at661e.pdf,igo,,IGO,Risk; Risk assessment; Shigatoxigenic and verotoxigenic Escherichia coli,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,fao-47f250c8fbc2840b6db6159042b752b4,Food and Agriculture Organization of the United Nations,"Principles and guidelines for incorporating microbiological risk assessment in the development of food safety standards, guidelines and related texts",2004-06-23,http://www.fao.org/3/a-y4302e.pdf,igo,,IGO,Hazard; Hazard analysis and critical control points; Branches of science,health>diseases and conditions; politics; health
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,fao-4d1dfe89a2adb6740023272c18e64a96,Food and Agriculture Organization of the United Nations,Rapport,2003-12-15,http://www.fao.org/3/a-y4302f.pdf,igo,,IGO,Risk; Risk management; Safety,lifestyle and leisure>lifestyle>food and drink; science and technology; politics
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,fao-8a31e1769a1a9f4798599c38cae2592b,Food and Agriculture Organization of the United Nations,Informe,2005-02-28,http://www.fao.org/3/a-y4302s.pdf,igo,,IGO,Food safety; Hazard analysis and critical control points; Food,health; politics; science and technology
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,fao-8cfa8afe141ff16b7263ee87cdf45a66,Food and Agriculture Organization of the United Nations,Microbiological Risk Assessment – Guidelines for food,2021-06-04,http://www.fao.org/3/cb5006en/cb5006en.pdf,igo,,IGO,Risk assessment; Risk management; Risk,"lifestyle and leisure>lifestyle>food and drink; economy, business and finance>economic sector>consumer goods>food; health>diseases and conditions"
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,fao-8de9bcf33bd654f3fcc32240e698d045,Food and Agriculture Organization of the United Nations,Buenas prácticas para la industria de la carne,2008-03-06,http://www.fao.org/3/y5454s/Y5454S.pdf,igo,,IGO,Hazard analysis and critical control points; Food; Meat,lifestyle and leisure>lifestyle>food and drink; health>diseases and conditions; health
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,fao-e1b8ef9b3648b583891f0c94eeb0e453,Food and Agriculture Organization of the United Nations,Case study: Escherichia coli O157:H7 in fresh raw ground beef,2008-08-29,http://www.fao.org/3/a-au624e.pdf,igo,,IGO,Beef; Hemolytic–uremic syndrome; Medical specialties,health>diseases and conditions; health; lifestyle and leisure>lifestyle>food and drink
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,foodgovuk-2d7ed7d266ffee2ffcc7a7a53b7c7115,Food Standards Agency,Safety implications of the manufacture of minced meat from aged meat | Food Standards Agency,2014-07-15,https://www.food.gov.uk/research/foodborne-disease/safety-implications-of-the-manufacture-of-minced-meat-from-aged-meat,government,food and drug safety,UK,Beef; Ground beef; Escherichia coli,"health; lifestyle and leisure>lifestyle>food and drink; economy, business and finance>economic sector>consumer goods>food"
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,foodgovuk-33e6c290ae92a60142fa229cb8d42945,Food Standards Agency,Quantification of the controls that should be placed on meat prior to mincing | Food Standards Agency,2014-07-15,https://www.food.gov.uk/research/foodborne-disease/quantification-of-the-controls-that-should-be-placed-on-meat-prior-to-mincing,government,food and drug safety,UK,Beef; Coliform bacteria; Ground beef,"health; lifestyle and leisure>lifestyle>food and drink; economy, business and finance>economic sector>consumer goods>food"
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,foodgovuk-887142693f04b36df2a92b6daa1ac47f,Food Standards Agency,Risk to human health from consumption of VTEC O157 in beef burgers | Food Standards Agency,2015-09-10,https://www.food.gov.uk/research/foodborne-disease/risk-to-human-health-from-consumption-of-vtec-o157-in-beef-burgers,government,food and drug safety,UK,Escherichia coli O157:H7; Beef; Meat,"economy, business and finance>economic sector>consumer goods>food; lifestyle and leisure>lifestyle>food and drink; science and technology"
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,foodgovuk-dbe569c21d747c0aaa0de3434e9e1ae6,Food Standards Agency,Application of the thermal inactivation model to model risk to human health from consumption of VTEC O157 in beef burgers | Food Standards Agency,2015-05-18,https://www.food.gov.uk/research/foodborne-disease/application-of-the-thermal-inactivation-model-to-model-risk-to-human-health-from-consumption-of-vtec-o157-in-beef-burgers,government,food and drug safety,UK,Temperature; R-value (insulation); Thermal conduction,"science and technology; science and technology>mathematics; economy, business and finance>economic sector>consumer goods>food"
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,governmentofcanada-195ad19295ede1f5375d2ef74a791021,Government of Canada,Canadian guidelines for domestic reclaimed water for use in toilet and urinal flushing : H128-1/10-602E-PDF Publications - Canada.ca,2010-01-01,http://publications.gc.ca/site/eng/9.697421/publication.html,government,,Canada,Public health; Environmental science; Medical specialties,"economy, business and finance>economic sector>chemicals; health>diseases and conditions; environment>environmental pollution"
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,governmentofestonia-9bab9542945164660a1bcfa352fc8005,Government of Estonia,Suunised säilimisaja märgistuse ja sellega seotud toidualase teabe kohta :,2021-03-15,https://labris.agri.ee/sites/default/files/RISKIHINDAMINE/Suunised%20s%C3%A4ilimisaja%20m%C3%A4rgistuse%20ja%20toidualase%20teabe%20kohta%201.%20osa%20(s%C3%A4ilimisaja%20m%C3%A4rgistus).pdf,government,,Estonia,,
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,nijzslovenia-b002dc913d1076379b7a3d0b360322c6,NIJZ,Navodila za izdelavo ocene tveganja za zdravje ljudi zaradi izpostavljenosti kemijskim in mikrobiološkim dejavnikom iz okolja z izbranimi poglavji in praktičnimi primeri I. del,2020-07-28,https://www.nijz.si/sl/publikacije/navodila-za-izdelavo-ocene-tveganja-za-zdravje-ljudi-zaradi-izpostavljenosti-kemijskim,government,healthcare agency,Slovenia,,
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,oieint-a31445ca656a2096397089dcb9181e55,World Organization for Animal Health,"2nd OIE international conference on antimicrobial resistance. Use of antimicrobials and protection of public health - Problems and perceptions, progress in science, reviews of actions taken. 2-4 october 2001, OIE Headquarters, 12 rue de Prony, 75017, Paris, France",2001-01-01,https://doc.oie.int/dyn/portal/index.xhtml?page=alo&aloId=17829&req=89,igo,,IGO,Minimum inhibitory concentration; Antimicrobial resistance; Disk diffusion test,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,primarynz-367071c17bea36ae271b2272942e0ad9,New Zealand Ministry for Primary Industries,Risk Profile: Shiga Toxin-producing Escherichia Coli in red meat and meat products,2003-05-01,https://www.mpi.govt.nz/dmsdocument/26042-risk-profile-shiga-toxin-producing-escherichia-coli-in-red-meat-and-meat-products,government,,New Zealand,Escherichia coli; Foodborne illness; Beef,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,who-2f999fe3b8e2f904cd991444e885ee7e,World Health Organization,Microbiological risk assessment: guidance for food,2021-06-04,https://apps.who.int/iris/handle/10665/341630,igo,healthcare agency,IGO,Risk assessment; Risk management; Risk,"lifestyle and leisure>lifestyle>food and drink; economy, business and finance>economic sector>consumer goods>food; health>diseases and conditions"
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,who-442ec300216fb05c91047fb9b5a1181e,World Health Organization,Risk assessments of Salmonella in eggs and broiler chickens,2021-07-02,https://apps.who.int/iris/handle/10665/342257,igo,healthcare agency,IGO,Salmonellosis; Salmonella; Egg as food,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,who-50657099bbd6b9dc9b6725d42a977cf1,World Health Organization,Enterohaemorrhagic Escherichia coli in raw beef and beef products: approaches for the provision of scientific advice: meeting report,2012-06-16,http://apps.who.int/iris/handle/10665/44659,igo,healthcare agency,IGO,Risk management; Shigatoxigenic and verotoxigenic Escherichia coli; Escherichia coli O157:H7,"health; health>diseases and conditions>communicable disease>virus disease; economy, business and finance>economic sector>consumer goods>food"
https://dx.doi.org/10.1016/s0168-1605(98)00028-2,31.0,who-b7d0bb3f2d309a29c270a34b4e5fc370,World Health Organization,Risk assessment of Listeria monocytogenes in ready-to-eat foods: technical report,2012-06-16,http://apps.who.int/iris/handle/10665/42875,igo,healthcare agency,IGO,Listeriosis; Listeria monocytogenes; Listeria,health; health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology
https://dx.doi.org/10.1371/journal.pone.0234763,2.0,instituteofdevelopmentstudies-4e0407cf4a17d84347a0b0a70770fab8,Institute of Development Studies,COVID-19 Health Evidence Summary No.82,2020-07-07,https://opendocs.ids.ac.uk/opendocs/handle/20.500.12413/15513,think tank,,UK,World Health Organization; Malaria; Intensive care unit,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1371/journal.pone.0234763,2.0,instituteofdevelopmentstudies-c8d8c1788e9fe5f71e3559efbb4eac34,Institute of Development Studies,COVID-19 Health Evidence Summary No.83,2020-07-09,https://opendocs.ids.ac.uk/opendocs/handle/20.500.12413/15520,think tank,,UK,Health sciences; Health care; COVID-19 pandemic,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.2166/wh.2009.133,4.0,governmentofcanada-035d4cd76118dde7c7f9b837d412516d,Government of Canada,Guidance on the use of quantitative microbial risk assessment in drinking water.,2019-01-01,http://publications.gc.ca/site/eng/9.870075/publication.html,government,,Canada,Risk assessment; Disability-adjusted life year; Risk management,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.2166/wh.2009.133,4.0,governmentofcanada-4dfab838c8911b1a5590108649012364,Government of Canada,Guidelines for Canadian drinking water quality : guideline technical document - enteric protozoa : Giardia and Cryptosporidium.,2019-04-01,http://publications.gc.ca/site/eng/9.858761/publication.html,government,,Canada,Real-time polymerase chain reaction; Giardia lamblia; Cryptosporidiosis,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology
https://dx.doi.org/10.2166/wh.2009.133,4.0,governmentofcanada-ae4f2eec399d0e7e33641baa9dc49807,Government of Canada,Guidelines for Canadian drinking water quality - guideline technical document : Enteric Protozoa: Giardia and Cryptosporidium / prepared by the Federal-Provincial-Territorial Committee on Drinking Water of the Federal-Provincial-Territorial Committee on Health and the Environment. : H129-23/2013E-PDF Publications - Canada.ca,an unknown date,http://publications.gc.ca/site/eng/9.697188/publication.html,government,,Canada,Giardiasis; Water purification; Cryptosporidiosis,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health>diseases and conditions
https://dx.doi.org/10.2166/wh.2009.133,4.0,who-26e21b229192eb81f63fc427fed09f60,World Health Organization,Quantitative Microbial Risk Assessment: Application for Water Safety Management,2016-07-11,https://apps.who.int/iris/handle/10665/246195,igo,healthcare agency,IGO,Risk; Risk assessment; Sensitivity analysis,health; environment; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.4161/hv.2.2.2611,4.0,governmentofcanada-2827d930785bef37c033ae61c1f20914,Government of Canada,The recommended use of the multicomponent meningococcal B (4CMenB) vaccine in Canada : common guidance statement / prepared by: Meningococcal B Pilot Project Task Group. : HP40-103/2014E-PDF Publications - Canada.ca,2014-03-26,http://publications.gc.ca/site/eng/9.699194/publication.html,government,,Canada,Vaccine; Pneumococcal conjugate vaccine; Meningococcal vaccine,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.4161/hv.2.2.2611,4.0,hcspfr-415e8666c1d913efd9712b50a76adead,Haut Conseil de la santé publique,Vaccination par le vaccin méningococcique conjugué de sérogroupe C,2009-04-24,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=71,government,agency,France,Biology; Public health; Clinical medicine,science and technology>natural science>biology; health; health>diseases and conditions
https://dx.doi.org/10.4161/hv.2.2.2611,4.0,hcspfr-abc804a8cb4eddfba40248be0c114472,Haut Conseil de la santé publique,Vaccination par le vaccin méningococcique conjugué de sérogroupe C,2009-04-24,https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=72,government,agency,France,Vaccination; Influenza; Medical specialties,science and technology>natural science>biology; health; health>diseases and conditions
https://dx.doi.org/10.4161/hv.2.2.2611,4.0,inspq_canada-bf29cb4923a05698ecc1e04700f51062,Institut national de santé publique du Québec,Avis du Comité sur l'immunisation du Québec concernant l'utilité d'une dose de rappel de vaccin contre le méningocoque chez les adolescents au Québec,2011-01-03,https://www.inspq.qc.ca/publications/1178,government,healthcare agency,Canada,Vaccine; Vaccination; COVID-19 vaccine,health; health>health treatment>preventative medicine>vaccines; health>diseases and conditions
https://dx.doi.org/10.4161/hv.7.5.14620,3.0,ahrq-6ea471795968c7481058aac90d20bcd4,AHRQ,Safety of Vaccines Used for Routine Immunization in the United States: An Update,2021-05-21,https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research,government,healthcare agency,USA,Hepatitis B vaccine; Vaccine; Pneumococcal conjugate vaccine,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.4161/hv.7.5.14620,3.0,pubmedcentral-2629cce4ee4e6fca487514d995ac3844,Guidelines in PubMed Central,Vaccines for preventing rotavirus diarrhoea: vaccines in use,2019-03-26,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434239/pdf,other,aggregator,USA,Public health; Medicine; Health sciences,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; health
https://dx.doi.org/10.4161/hv.7.5.14620,3.0,pubmedcentral-6368c329275a2daf676e49ad461f0bd7,Guidelines in PubMed Central,Vaccines for preventing rotavirus diarrhoea: vaccines in use,2019-10-28,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816010/pdf,other,aggregator,USA,Health care; Immunology; Clinical medicine,health>diseases and conditions>communicable disease>virus disease; health; science and technology>natural science>biology
https://dx.doi.org/10.1002/sim.4780080112,1.0,iiasaat-226ff0bf4afcb05dd5619b31d7870e4f,IIASA,Projections of the HIV/AIDS Epidemic for Homosexual/Bisexual Men and Intravenous Drug Users in Five European Countries,1989-10-01,https://pure.iiasa.ac.at/id/eprint/3276/?template=default_internal,think tank,research center,Austria,HIV/AIDS; Drug injection; Variance,health>diseases and conditions; science and technology; health
https://dx.doi.org/10.1002/hep.510310131,7.0,cadth-0c8fbaad9e1bd0642843705240ffad0c,Canadian Agency for Drugs and Technologies in Health,Pegylated Interferon Combined With Ribavirin for Chronic Hepatitis C Virus Infection: An Economic Evaluation,2007-03-21,https://cadth.ca/pegylated-interferon-combined-ribavirin-chronic-hepatitis-c-virus-infection-economic-evaluation-0,government,healthcare agency,Canada,Interferon; Quality-adjusted life year; Hepatitis,health; health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology
https://dx.doi.org/10.1002/hep.510310131,7.0,cadth-2e19a5c960b63e3ac6e43842017709bb,Canadian Agency for Drugs and Technologies in Health,Clinical and Cost-effectiveness of Interferon-based Therapies for Chronic Hepatitis C Virus Infection,2007-03-21,https://cadth.ca/clinical-and-cost-effectiveness-interferon-based-therapies-chronic-hepatitis-c-virus-infection-0,government,healthcare agency,Canada,Hepatitis C; Interferon; Quality-adjusted life year,health; health>diseases and conditions>communicable disease>virus disease; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1002/hep.510310131,7.0,cadth-f99e4c7f44ae73282449621f5d0aa017,Canadian Agency for Drugs and Technologies in Health,Inteferon-based therapies for chronic Hepatitis C virus infection: an assessment of clinical outcomes,2004-05-13,https://cadth.ca/inteferon-based-therapies-chronic-hepatitis-c-virus-infection-assessment-clinical-outcomes-0,government,healthcare agency,Canada,Randomized controlled trial; Hepatitis C; Interferon,health; health>diseases and conditions>communicable disease>virus disease; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1002/hep.510310131,7.0,itaost-d7df827d1edad190611410bb44fae0cb,Institut für Technikfolgen-Abschätzung,Antivirale Kombinationstherapie bei Patienten mit chronischer Hepatitis C in Österreich. Gesundheitsökonomische Evaluation der Kombinationstherapie mit Interferon/Peginterferon und Ribavirin. Institut für Technikfolgen-Abschätzung:.,2006-06-01,http://epub.oeaw.ac.at/ita/ita-projektberichte/d2-2b29.pdf,government,technology assessment,Austria,Hepatitis C; Cirrhosis; Evidence-based medicine,health; health>health treatment; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1002/hep.510310131,7.0,opensocietyfoundations-96cfe2a17caac854ffa0b80de41be332,Open Society Foundations,Delivering HIV Care and Treatment for People Who Use Drugs,2006-07-01,https://www.opensocietyfoundations.org/publications/delivering-hiv-care-and-treatment-people-who-use-drugs,think tank,,USA,Preventive healthcare; Medication; Prison,health; health>diseases and conditions; health>diseases and conditions
https://dx.doi.org/10.1002/hep.510310131,7.0,pubmedcentral-2f334bc06712ca7ee0554042dd652f3d,Guidelines in PubMed Central,Interferon for acute hepatitis C,2001-10-23,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061490/pdf,other,aggregator,USA,Hepatitis; Hepatitis C; Medical specialties,health>diseases and conditions; health>health treatment; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1002/hep.510310131,7.0,pubmedcentral-4ff5a381c3e8e3f5c8eaefe36ef6ca9d,Guidelines in PubMed Central,Interferon for interferon naive patients with chronic hepatitis C,2002-04-22,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061493/pdf,other,aggregator,USA,Health sciences; Health care; Clinical medicine,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1002/sim.2174,1.0,bankofbrazil-a37ffc71dd1c90c1fe966114c61af96f,Banco Central do Brasil,Investigação dos fatores relacionados à saída de famílias do Cadastro Único,2020-06-19,https://www.bcb.gov.br/conteudo/relatorioinflacao/EstudosEspeciais/EE081_Investigacao_dos_fatores_relacionados_a_saida_de_familias_do_Cadastro_Unico.pdf,government,bank,Brazil,Bolsa Família; Credit; Transaction account,"science and technology; economy, business and finance>economy; labour"
https://dx.doi.org/10.1007/s00285-007-0074-x,2.0,who-36db8c1d01645851c7c6a48dea366edf,World Health Organization,"Dengue bulletin, 2008, Vol. 32",2016-04-07,https://apps.who.int/iris/handle/10665/204938,igo,healthcare agency,IGO,Vaccine; Dengue virus; Linear regression,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1007/s00285-007-0074-x,2.0,who-5bba32b0d4bcfdb46b25f008d99144da,World Health Organization,Applied informatics manipulation for fight against dengue.,2015-05-13,https://apps.who.int/iris/handle/10665/170478,igo,healthcare agency,IGO,Medical specialties; Medicine; Life sciences,health>diseases and conditions; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1007/s00285-009-0313-4,1.0,efsaeu-6febe44429c6ed39d83ff80d1e8261bb,EFSA,MAPRA: Modelling Animal Pathogens: Review and Adaptation,2016-12-21,https://www.efsa.europa.eu/en/supporting/pub/en-1112,government,agency,EU,Parameter; Database; Research,"economy, business and finance>economic sector>computing and information technology; science and technology; science and technology>mathematics"
https://dx.doi.org/10.1177/095632020701800605,2.0,ahrq-72e6e2631c884d7791bc896aae8b9f8e,AHRQ,Decision and Simulation Modeling in Systematic Reviews,2013-02-21,https://effectivehealthcare.ahrq.gov/products/methods-decision-simulation-modeling/research,government,healthcare agency,USA,Evidence-based medicine; Sensitivity analysis; Screening (medicine),health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1177/095632020701800605,2.0,stateofkwazulunatal-81057a31cb0e4b8b9f8a3bddd25f443c,KwaZulu-Natal Provincial Government,"Evalution of the antiretroviral therapy in KwaZulu-Natal, South Africa",2008-11-25,http://www.kznhealth.gov.za/italian/arv.pdf,government,,South Africa,Body mass index; Clinical medicine; Health care,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1186/s12936-015-0695-2,1.0,who-db6b6d986e10c1ff538ff1b0ac268510,World Health Organization,Safety of artemisinin and non-artemisinin antimalarials in the first trimester of pregnancy: review of evidence,2024-01-01,https://apps.who.int/iris/handle/10665/376478,igo,healthcare agency,IGO,Malaria; Antimalarial medication; Artesunate,science and technology>biomedical science>pharmacology; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.1002/(sici)1097-0258(19980530)17:10<1121::aid-sim824>3.0.co;2-e,1.0,who-7cc2c0b546c2b2da081cb9a9f546d49f,World Health Organization,2nd ed,2019-10-17,https://apps.who.int/iris/handle/10665/329389,igo,healthcare agency,IGO,Purchasing power parity; Randomized controlled trial; Cost-effectiveness analysis,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1186/s13613-022-00996-9,1.0,cityofmadrid-39852d219810da736534345f2381ec09,Comunidad de Madrid,Memoria Científica 2022,2023-12-07,https://www.comunidad.madrid/hospital/getafe/file/4081/download?token=zQDLUnt3,government,city,Spain,Sexual harassment; Hospital; Biobank,science and technology>biomedical science>pharmacology; science and technology>natural science>biology; science and technology>natural science>biology>physiology
https://dx.doi.org/10.1371/journal.pone.0219190,1.0,oecddiscovery-0ab6672d1cc1e4c3205271b577604614,OECD,Embracing a One Health Framework to Fight Antimicrobial Resistance,2023-09-14,https://dx.doi.org/https://doi.org/10.1787/ce44c755-en,igo,,IGO,Antimicrobial resistance; Antibiotic; Health,health>health treatment; health>diseases and conditions; health
https://dx.doi.org/10.1016/j.epidem.2017.02.003,1.0,pubmedcentral-03444662e2431dade5d33fa4962eb987,Guidelines in PubMed Central,Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?,2018-06-15,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982704/pdf,other,aggregator,USA,Schistosomiasis; Neglected tropical diseases; World Health Organization,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/j.epidem.2020.100430,5.0,dhsgov-07fb0e77b88ab97750003d3d688bed00,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-11-04,https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf,government,,USA,Severe acute respiratory syndrome coronavirus 2; Infection; COVID-19 vaccine,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.epidem.2020.100430,5.0,dhsgov-38fd23e57dd8ec707294d25fb8fb9019,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-01-28,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210126.pdf,government,,USA,SARS-CoV-2; Variants of SARS-CoV-2; COVID-19 testing,science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions
https://dx.doi.org/10.1016/j.epidem.2020.100430,5.0,dhsgov-6d422045165469a763b7c31921bd52c8,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-07-15,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf,government,,USA,Medicine; Cloth face mask; Casirivimab/imdevimab,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions; science and technology>natural science>biology
https://dx.doi.org/10.1016/j.epidem.2020.100430,5.0,dhsgov-d03d62734a42fe925cf1a6d5dd96f67c,Department of Homeland Security,Master Question List for COVID-19 (caused by SARS-CoV-2),2021-01-07,https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf,government,,USA,Epidemiology; Public health; Diseases and disorders,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.1016/j.epidem.2020.100430,5.0,dhsgov-eeb18fe8690357c6b05b850ab4cf6b68,Department of Homeland Security,Master Question List fgor COVID-19 (caused by SARS-CoV-2),2023-02-21,https://www.dhs.gov/sites/default/files/2023-02/23_0131_st_mql_sars_cov-2.pdf,government,,USA,Public health; Health; Immunology,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; health>diseases and conditions
https://dx.doi.org/10.2337/dc12-0759,5.0,cdc-125315c8933b49b9d80b60869ce4d1a2,Centers for Disease Control and Prevention (CDC),Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines,2018-01-26,https://stacks.cdc.gov/view/cdc/55095,government,healthcare agency,USA,Postherpetic neuralgia; Zoster vaccine; Advisory Committee on Immunization Practices,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.2337/dc12-0759,5.0,cdc-f46e48df784c7d707efc48e559210a84,Centers for Disease Control and Prevention (CDC),Prevention of Hepatitis B virus infection in the United States : recommendations of the Advisory Committee on Immunization Practices,2018-01-12,https://stacks.cdc.gov/view/cdc/50791,government,healthcare agency,USA,Hepatitis B; Hepatitis; Hepatitis B vaccine,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.2337/dc12-0759,5.0,nber-657a2be9c6244e9b09ae6fa09b32b004,NBER,Optimal Vaccine Subsidies for Endemic and Epidemic Diseases,2020-11-16,https://www.nber.org/papers/w28085,think tank,,USA,Compartmental models in epidemiology; Market (economics); Monopoly,science and technology>mathematics; science and technology; health>diseases and conditions
https://dx.doi.org/10.2337/dc12-0759,5.0,pubmedcentral-27fcccaa541aef57412749f8f000cebe,Guidelines in PubMed Central,Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines,2018-01-26,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812314/pdf,other,aggregator,USA,Zoster vaccine; Shingles; Postherpetic neuralgia,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.2337/dc12-0759,5.0,pubmedcentral-d520064af050dde92873a4d914a659b2,Guidelines in PubMed Central,Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices,2018-01-12,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837403/pdf,other,aggregator,USA,Post-exposure prophylaxis; Medicine; Immunology,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1016/j.rmed.2015.01.017,2.0,awmf-bc7805ef2c06f12b1512d4d0579f49d9,Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF),Tuberkulose im Erwachsenenalter,2023-09-21,https://register.awmf.org/de/leitlinien/detail/020-019,government,healthcare agency,Germany,Notifiable disease; Tuberculosis; Mycobacterium bovis,health>diseases and conditions; health>diseases and conditions>illness; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.1016/j.rmed.2015.01.017,2.0,awmf-d57e0afb2368148dfa5c77c4a81159e8,Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF),Tuberkulose im Erwachsenenalter,2017-06-30,https://www.awmf.org/leitlinien/detail/ll/020-019.html,government,healthcare agency,Germany,Elderly care; Medical specialties; Medicine,health; science and technology>biomedical science>pharmacology; science and technology>natural science>biology
https://dx.doi.org/10.1016/s0169-4758(00)01691-4,5.0,who-4c595f4fba14f6f81505d0cef238e050,World Health Organization,Integrating neglected tropical diseases into global health and development: fourth WHO report on neglected tropical diseases,2017-04-13,https://apps.who.int/iris/handle/10665/255011,igo,healthcare agency,IGO,WASH; Zika fever; Zoonosis,health; health>diseases and conditions>communicable disease>epidemic; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/s0169-4758(00)01691-4,5.0,who-7d3e9aad01eeb8af1cbf384753bd859b,World Health Organization,"Report of the Scientific Working Group meeting on lymphatic filariasis, Geneva, 10-12 May, 2005",2012-06-17,https://apps.who.int/iris/handle/10665/69484,igo,healthcare agency,IGO,Filariasis; Wuchereria bancrofti; Lymphatic filariasis,health; science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/s0169-4758(00)01691-4,5.0,who-8006645ea66fdf8d5ea767fc3159fef3,World Health Organization,Intégrer les maladies tropicales négligées dans l’action pour la santé mondiale et le développement : quatrième rapport de l’OMS sur les maladies tropicales négligées,2018-02-22,https://apps.who.int/iris/handle/10665/260289,igo,healthcare agency,IGO,Sustainable Development Goals; Zoonosis; Mosquito,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/s0169-4758(00)01691-4,5.0,who-a9f45be3a721f3813d47da0af62a5f06,World Health Organization,"Regional Health Forum, Vol. 6, No. 2",2016-05-03,https://apps.who.int/iris/handle/10665/205792,igo,healthcare agency,IGO,Hepatitis B; Maternal death; Childbirth,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/s0169-4758(00)01691-4,5.0,who-b0f80e8f13dc195056593345f6bc26cd,World Health Organization,Tropical Disease Research : results portfolio 3 : a collection of final reports from projects selected by independent scientific experts,2012-06-17,https://apps.who.int/iris/handle/10665/70698,igo,healthcare agency,IGO,Dihydrofolate reductase; Malaria; Anopheles,health>diseases and conditions; science and technology>natural science>biology; health
https://dx.doi.org/10.1017/s095026880005158x,2.0,who-f225b1efeb3de3c9a0b9e7ac73152363,World Health Organization,"Control of rubella and congenital rubella syndrome (‎CRS)‎ in developing countries, Part 2: Vaccination against rubella.",2018-03-25,https://apps.who.int/iris/handle/10665/264259,igo,healthcare agency,IGO,Children's health; Vaccine; MMR vaccine,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1017/s095026880005158x,2.0,who-fde9478456155e5f27cb9556101c51f2,World Health Organization,"Control of rubella and congenital rubella syndrome (‎CRS)‎ in developing countries, part 2 : vaccination against rubella / S. E. Robertson ... [‎et al.]‎",2012-06-16,https://apps.who.int/iris/handle/10665/54483,igo,healthcare agency,IGO,World Health Organization; Medical humanities; Immunology,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1046/j.1365-2702.2003.00749.x,3.0,helsedirektoratet-b1fe17f3411996d6b17be71e86168bd7,Norwegian Directorate for Health and Social Affairs,Langtids mekanisk ventilasjon (LTMV) Nasjonal faglig retningslinje,2012-06-29,https://www.helsedirektoratet.no/retningslinjer/langtids-mekanisk-ventilasjon-ltmv,government,healthcare agency,Norway,Spirometry; Election; Clinical medicine,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1046/j.1365-2702.2003.00749.x,3.0,provinceofquebec-dac40313d710941e9cb541796fc80527,Province of Québec,Endotracheal Suctioning of Mechanically Ventilated Patients With Artificial Airways 2010,2010-05-21,https://www.cisss-bsl.gouv.qc.ca/sites/default/files/fichier/succion_endotracheale_-_guide_anglais_.pdf,government,,Canada,Respiratory arrest; Mechanical ventilation; Airway management,health; health>diseases and conditions; health>health treatment>medical procedure/test
https://dx.doi.org/10.1046/j.1365-2702.2003.00749.x,3.0,pubmedcentral-3dc4703d317d1e9e64590793a07ae6bc,Guidelines in PubMed Central,Closed tracheal suction systems versus open tracheal suction systems for mechanically ventilated adult patients,2007-10-17,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517217/pdf,other,aggregator,USA,Acute respiratory distress syndrome; Systematic review; Health,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.3201/eid2201.151410,2.0,governmentofcanada-aca43e862267b3350777ecaecefdbffe,Government of Canada,Interim statement on the use of the rVSVΔG-ZEBOV-GP vaccine for the prevention of Ebola virus disease.: HP40-261/2019E-PDF Publications - Canada.ca,2020-01-01,http://publications.gc.ca/site/eng/9.881612/publication.html,government,,Canada,Medicine; Ebola virus disease; Needlestick injury,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.3201/eid2201.151410,2.0,who-5b135bb23d4aa5ada178b122f4087080,World Health Organization,A polio transition investment case for the WHO Eastern Mediterranean Region,2024-02-01,https://apps.who.int/iris/handle/10665/377317,igo,healthcare agency,IGO,Vaccine; Vaccination; Basic reproduction number,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1098/rspb.2015.0347,2.0,ifode-ee700e9ef6ff4c25eb645550b7d0779b,Ifo Institute,Policy Implications of Models of the Spread of Coronavirus: Perspectives and Opportunities for Economists,2020-05-12,https://www.cesifo.org/en/publikationen/2020/working-paper/policy-implications-models-spread-coronavirus-perspectives-and,think tank,,Germany,Compartmental models in epidemiology; Infection; Social distancing,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1098/rspb.2015.0347,2.0,nber-05b0053a9a880e53df5e61ebaa50be76,NBER,Policy Implications of Models of the Spread of Coronavirus: Perspectives and Opportunities for Economists,2020-04-16,https://www.nber.org/papers/w27007,think tank,,USA,Compartmental models in epidemiology; Health; Health sciences,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1111/1469-0691.12182,7.0,cdc-9ba0b65f4f7c3e6fe943e7a693b1cea0,Centers for Disease Control and Prevention (CDC),"Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023",2023-01-01,https://stacks.cdc.gov/view/cdc/133328,government,healthcare agency,USA,Pneumococcal polysaccharide vaccine; Pneumococcal vaccine; Advisory Committee on Immunization Practices,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1111/1469-0691.12182,7.0,deptofhealthau-b9347a6ce007a826cbd33364a577aadd,Australian Government Department of Health,Revised use of pneumococcal vaccines,2020-06-05,https://www.health.gov.au/resources/publications/revised-use-of-pneumococcal-vaccines,government,,Australia,Medical specialties; Health sciences; Health,health>diseases and conditions; health>diseases and conditions; health
https://dx.doi.org/10.1111/1469-0691.12182,7.0,folkhalsomyndigheten-36291ad769d46e0d0a5fcba4c786dc53,Folkhälsomyndigheten,Pneumokockvaccination till riskgrupper – Kunskapsunderlag,2016-02-05,https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/p/pneumokockvaccination-till-riskgrupper/,government,healthcare agency,Sweden,Pneumonia; Cancer; Vaccination,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1111/1469-0691.12182,7.0,govdeptsspain-6a1434b5eec58c3c98e5b877f8999aa3,Government of Spain,50 (Supl 1,2015-07-17,https://www.mscbs.gob.es/organizacion/sns/planCalidadSNS/pdf/Guia_Espanola_EPOC_gesEPOC_Actualizacion_2014.pdf,government,,Spain,Nicotine; Chronic obstructive pulmonary disease; Tiotropium bromide,health>diseases and conditions; science and technology>biomedical science>pharmacology; health
https://dx.doi.org/10.1111/1469-0691.12182,7.0,governmentofandorra-68b260c55526dc479d8c96e771315528,Government of Andorra,Vacunació adult Pneumo actualització 2018,2018-04-20,https://www.salut.ad/images/stories/Salut/pdfs/temes_interes/VacunacioAdult_Pneumo_2018.pdf,government,,Andorra,Antigen; Immune system; Chronic lymphocytic leukemia,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1111/1469-0691.12182,7.0,pubmedcentral-9e4749c57786755405d04955545f6e92,Guidelines in PubMed Central,2020 Brazilian Thoracic Association recommendations for the management of asthma,2020-01-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462684/pdf,other,aggregator,USA,Long-acting beta-adrenoceptor agonist; Asthma; Omalizumab,science and technology>biomedical science>pharmacology; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1111/1469-0691.12182,7.0,pubmedcentral-bd4f611b029305523cc6a76932bd823a,Guidelines in PubMed Central,"Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023",2023-09-08,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495181/pdf,other,aggregator,USA,Pneumococcal conjugate vaccine; Pneumococcal polysaccharide vaccine; Pneumococcal vaccine,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1007/s10096-019-03503-4,2.0,nice-4803315a99b52a47003135c06cd2c35e,NICE,Clostridioides difficile infection: antimicrobial prescribing,2021-07-23,https://www.nice.org.uk/guidance/ng199,government,healthcare agency,UK,Bezlotoxumab; Fidaxomicin; Clostridioides difficile (bacteria),health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1007/s10096-019-03503-4,2.0,pubmedcentral-153622113d8b7027abbbdb1c8cae98c5,Guidelines in PubMed Central,"Recommendations for the diagnosis and treatment of infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR)",2020-02-20,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111242/pdf,other,aggregator,USA,Health; Ridinilazole; Bezlotoxumab,health>diseases and conditions>illness; science and technology>biomedical science>pharmacology; health>diseases and conditions
https://dx.doi.org/10.1016/j.ijid.2012.11.018,1.0,governmentofindonesia-f8f379500697803866530e8bfb766966,Government of Indonesia,Antimicrobial Resistance,2018-09-12,http://repository.pertanian.go.id/bitstream/handle/123456789/8912/BOOKLET%20ANTIMICROBIAL%20RESISTANCE%20In%20INDONESIA.pdf?sequence=1&isAllowed=y,government,,Indonesia,,
https://dx.doi.org/10.1016/j.jhep.2022.09.011,2.0,kirbyinstitute-6fbeb57c5e52ac223ab417551848a18d,Kirby Institute,Australia’s progress towards hepatitis C elimination – Annual Report 2023,2023-11-24,https://www.kirby.unsw.edu.au/research/reports/australias-progress-towards-hepatitis-c-elimination-annual-report-2023,think tank,university affiliated,Australia,Hepatitis; Hepatocellular carcinoma; Cirrhosis,health>diseases and conditions; health; health>health treatment>medicine
https://dx.doi.org/10.1016/j.jhep.2022.09.011,2.0,kirbyinstitute-fd5a481fcafe23d05eca85668482c024,Kirby Institute,"Monitoring hepatitis C treatment uptake in Australia Issue 13, July 2023",2023-07-28,https://www.kirby.unsw.edu.au/research/reports/monitoring-hepatitis-c-treatment-uptake-australia-issue-13-july-2023,think tank,university affiliated,Australia,Drugs; Hepatitis; General practitioner,health; health>health treatment; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.jtbi.2013.09.026,1.0,efsaeu-6febe44429c6ed39d83ff80d1e8261bb,EFSA,MAPRA: Modelling Animal Pathogens: Review and Adaptation,2016-12-21,https://www.efsa.europa.eu/en/supporting/pub/en-1112,government,agency,EU,Parameter; Database; Research,"economy, business and finance>economic sector>computing and information technology; science and technology; science and technology>mathematics"
https://dx.doi.org/10.1016/s0001-706x(02)00017-7,4.0,who-048097d3945b413ea19db793094729fa,World Health Organization,"Prevalence, intensity and associated morbidity of Schistosoma japonicum infection in the Dongting Lake region, China",2018-03-26,https://apps.who.int/iris/handle/10665/269979,igo,healthcare agency,IGO,Schistosomiasis; Schistosoma japonicum; Medicine,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1016/s0001-706x(02)00017-7,4.0,who-3c8ed84f5696cf6f88b9e13a12f22976,World Health Organization,"Expert Consultation to Accelerate Elimination of Asian Schistosomiasis, Shanghai, China, 22-23 May 2017 : meeting report",2017-12-07,https://apps.who.int/iris/handle/10665/259630,igo,healthcare agency,IGO,Schistosomiasis; Schistosoma mekongi; Schistosoma japonicum,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1016/s0001-706x(02)00017-7,4.0,who-4dea1b6586569bdde8d9982d58085c19,World Health Organization,Is mass treatment the appropriate schistosomiasis elimination strategy?,2018-03-26,https://apps.who.int/iris/handle/10665/270292,igo,healthcare agency,IGO,Schistosomiasis; Confidence interval; Health,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1016/s0001-706x(02)00017-7,4.0,who-9daefc69428e6026152c452847f7185b,World Health Organization,Research priorities for zoonoses and marginalized infections,2012-09-10,https://apps.who.int/iris/handle/10665/75350,igo,healthcare agency,IGO,Cryptosporidium; Echinococcus multilocularis; Infection,health>diseases and conditions>communicable disease>virus disease; health; health>diseases and conditions>communicable disease>epidemic
https://dx.doi.org/10.1016/j.jtbi.2016.08.009,1.0,bundestag-94511d999081d6ad867d2d3e568f0d84,Deutscher Bundestag,WD 9 - 055/20 Zum Umgang mit der SARS-CoV-2-Pandemie in Taiwan und SÃ¼dkorea auf Grund der Erfahrungen mit frÃ¼heren Pandemien. (Stand: 17. Juli 2020),2020-07-28,https://www.bundestag.de/resource/blob/798254/eeba41ad98e2f4d540c576c053521706/WD-9-055-20-pdf-data.pdf,government,,Germany,COVID-19 pandemic; Severe acute respiratory syndrome; Middle East respiratory syndrome–related coronavirus,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1016/j.vaccine.2015.09.025,1.0,inspq_canada-bb2653bb99bb9f6e1d33531ff085d2c8,Institut national de santé publique du Québec,Stratégie optimale de vaccination contre la coqueluche au Québec,2018-03-28,https://www.inspq.qc.ca/publications/2369,government,healthcare agency,Canada,Whooping cough; Pertussis vaccine; Vaccination,health; health>diseases and conditions>illness; health>health treatment>medicine
https://dx.doi.org/10.1016/s0277-9536(00)00282-3,12.0,adminch-1a164b51b9ebe9839dec145e46274de9,Government of Switzerland,Feasibility study for an economic evaluation of the prevention measures in the field of HIV and other sexually transmitted diseases (STI),2013-06-03,https://www.bag.admin.ch/dam/bag/fr/dokumente/e-f/evalber-mt/2013-machbarkeitsstudie-oekonomische-evaluation-hiv-sti-schlussbericht.pdf.download.pdf/2013-feasibility-study-economic-eval-sti-e.pdf,government,,Switzerland,Sexually transmitted infection; Evaluation; Men who have sex with men,health>diseases and conditions; health; education
https://dx.doi.org/10.1016/s0277-9536(00)00282-3,12.0,iom-90ff51e5c7a2d7a56fdf5e91f18940ca,International Organization for Migration,Mobile Populations and HIV/AIDS in the Southern African Region: Desk Review and Bibliography on HIV/AIDS and Mobile Populations -,2003-05-22,http://publications.iom.int/books/mobile-populations-and-hivaids-southern-african-region-desk-review-and-bibliography-hivaids,igo,,IGO,HIV/AIDS; Sexually transmitted infection; Preventive healthcare,"health; conflicts, war and peace; conflicts, war and peace>armed conflict"
https://dx.doi.org/10.1016/s0277-9536(00)00282-3,12.0,unaids-90976a56debe03b792365c96aebd2c31,UNAIDS,Together we will end AIDS,2017-10-19,https://www.unaids.org/en/resources/documents/2012/JC2296_together-we-will-end-AIDS,igo,,IGO,HIV/AIDS; Management of HIV/AIDS; Pre-exposure prophylaxis,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/s0277-9536(00)00282-3,12.0,unitednations-44a1950dbbe59e6394c1b4b9bf1f80b6,United Nations,Together we will end AIDS,2012-01-01,https://digitallibrary.un.org/record/3951088?ln=en,igo,,IGO,HIV/AIDS; Management of HIV/AIDS; Pre-exposure prophylaxis,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1016/s0277-9536(00)00282-3,12.0,unitednations-beeb3e2288662f421cf30aed25e2534c,United Nations,Mobile populations and HIV/AIDS in the southern African region :recommendations for action : desk review and bibliography on HIV/AIDS and mobile populations,2003-05-01,https://digitallibrary.un.org/record/506329?ln=en,igo,,IGO,Sexually transmitted infection; HIV/AIDS; Migrant worker,"labour; health; economy, business and finance>economic sector>transport"
https://dx.doi.org/10.1016/s0277-9536(00)00282-3,12.0,unpopulation-4bc2ce230d562f9631bafc171532f7a5,United Nations Population Fund,Female Condom: A Powerful Tool for Protection,an unknown date,https://www.unfpa.org/publications/female-condom-powerful-tool-protection,igo,,IGO,Sexually transmitted infection; Condom; Female condom,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/s0277-9536(00)00282-3,12.0,worldbank-3ca4b9bdf65f9e06946fca06ae0ba6aa,World Bank,"Disease Control Priorities, Third Edition",2017-11-06,https://hdl.handle.net/10986/28659,igo,development bank,IGO,Neglected tropical diseases; Sexually transmitted infection; Hepatitis B,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1016/s0277-9536(00)00282-3,12.0,worldbank-3d8c68294d397bcaa1eccd55bd20f403,World Bank,"Disease Control Priorities, Third Edition : Volume 6. Major Infectious Diseases",2017-11-06,https://openknowledge.worldbank.org/handle/10986/28659,igo,development bank,IGO,Neglected tropical diseases; Sexually transmitted infection; HIV/AIDS,health>diseases and conditions>communicable disease>virus disease; health>diseases and conditions>communicable disease>epidemic; health
https://dx.doi.org/10.1016/s0277-9536(00)00282-3,12.0,worldbank-73b7e12270be50ebdebadfbd5a4a2fda,World Bank,The Global HIV Epidemics among Men Who Have Sex with Men,2011-05-27,https://hdl.handle.net/10986/2308,igo,development bank,IGO,Men who have sex with men; Epidemiology of HIV/AIDS; Sexually transmitted infection,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1016/s0277-9536(00)00282-3,12.0,worldbank-8f3a5ebf1c9996a90cb260b36a12e8da,World Bank,The Global HIV Epidemics among Men Who Have Sex with Men,2012-03-19,https://openknowledge.worldbank.org/handle/10986/2308,igo,development bank,IGO,Men who have sex with men; Health; Public health,health; health>diseases and conditions>communicable disease>virus disease; society
https://dx.doi.org/10.1016/s0277-9536(00)00282-3,12.0,worldbank-94ae74e6b1b3c28857c9b076c8a22cd3,World Bank,"Disease Control Priorities in Developing Countries, Second Edition",2012-06-06,https://openknowledge.worldbank.org/handle/10986/7242,igo,development bank,IGO,Health; Health sciences; Disease,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/s0277-9536(00)00282-3,12.0,worldbank-abf2b3789348f2d1e1b1ffcad34868ec,World Bank,"Disease Control Priorities in Developing Countries, Second Edition",2006-01-01,https://hdl.handle.net/10986/7242,igo,development bank,IGO,HIV/AIDS; Medical specialties; Medicine,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.3201/eid1306.061264,1.0,healthprotectionscotland-1598959b7cd6635c6680f2a508613b07,Health Protection Scotland,"VTEC/E. coli O157 Action Plan for Scotland, 2013-2017. Online Appendix (i)",2013-11-12,https://hps.scot.nhs.uk/web-resources-container/vtece-coli-o157-action-plan-for-scotland-2013-2017-online-appendix-i/,government,healthcare agency,UK,Escherichia coli O157:H7; Escherichia coli; Hemolytic–uremic syndrome,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1023/b:ejep.0000024752.48929.bd,9.0,ecdc-83348634943d552c06705e54cc34ccbb,European Centre for Disease Prevention and Control,Use of pneumococcal polysaccharide vaccine for subjects over 65 years of age during an inter-pandemic period,2007-01-17,https://www.ecdc.europa.eu/en/publications-data/use-pneumococcal-polysaccharide-vaccine-subjects-over-65-years-age-during-inter,government,agency,EU,Pneumonia; Vaccine; Medical specialties,health>diseases and conditions; health; health>health treatment>preventative medicine>vaccines
https://dx.doi.org/10.1023/b:ejep.0000024752.48929.bd,9.0,govdeptsjapan-1416cbdd20d9152aed6245597b18a67a,Government of Japan,肺炎球菌ポリサッカライドワクチン (成人用) 作業チーム報告書 (案),2011-01-18,https://www.mhlw.go.jp/stf/shingi/2r98520000010kk8-att/2r98520000010kyr.pdf,government,,Japan,Pneumonia; Vaccine; Influenza vaccine,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1023/b:ejep.0000024752.48929.bd,9.0,govdeptsjapan-22bba8bf4132db069e2834fe372f4ad4,Government of Japan,肺炎球菌ポリサッカライドワクチン (成人用) 作業チーム報告書,2011-03-28,https://www.mhlw.go.jp/stf/shingi/2r98520000014wdd-att/2r98520000016rq9.pdf,government,,Japan,Vaccine; Pneumonia; Influenza vaccine,health; health>diseases and conditions; health>health treatment
https://dx.doi.org/10.1023/b:ejep.0000024752.48929.bd,9.0,govdeptsjapan-dcf26d03fa5d05974c2f92e8f6a0eeef,Government of Japan,肺炎球菌ポリサッカライドワクチン (成人用) 作業チーム報告書,2011-03-28,https://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000207087.pdf,government,,Japan,Vaccine; Pneumonia; Influenza vaccine,health; health>diseases and conditions; health>health treatment
https://dx.doi.org/10.1023/b:ejep.0000024752.48929.bd,9.0,governmentofandorra-68b260c55526dc479d8c96e771315528,Government of Andorra,Vacunació adult Pneumo actualització 2018,2018-04-20,https://www.salut.ad/images/stories/Salut/pdfs/temes_interes/VacunacioAdult_Pneumo_2018.pdf,government,,Andorra,Antigen; Immune system; Chronic lymphocytic leukemia,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1023/b:ejep.0000024752.48929.bd,9.0,ilcuk-d50b67326131a294a1f77d005d6722ef,International Longevity Centre,Adult vaccination - a key component of healthy ageing - ILCUK,2013-11-13,https://ilcuk.org.uk/adult-vaccination-a-key-component-of-healthy-ageing/,think tank,,UK,Chickenpox; Diseases and disorders; Health care,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1023/b:ejep.0000024752.48929.bd,9.0,ilcuk-e7351a2c706b526394f948a15c0a211e,International Longevity Centre,Generation Vax: Leveraging intergenerational relations to increase routine vaccination uptake - ILCUK,2022-03-15,https://ilcuk.org.uk/generation-vax-report/,think tank,,UK,Health; Health sciences; Human activities,"health; health>diseases and conditions; economy, business and finance>economic sector>media"
https://dx.doi.org/10.1023/b:ejep.0000024752.48929.bd,9.0,paho-c43edfff644dcdac34c7b4530dda89c9,Pan American Health Organization (PAHO),Avances recientes en inmunización. 2.ed.,2007-11-13,https://iris.paho.org/handle/10665.2/34890,igo,,IGO,Medical specialties; Clinical medicine; Immunology,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1023/b:ejep.0000024752.48929.bd,9.0,thlfi-08e9fbb798210255869def2d0e914239,Terveyden ja hyvinvoinnin laitos,Invasive pneumococcal infections in Finland before routine use of conjugate vaccines: opportunities for prevention,2009-02-09,http://www.julkari.fi/handle/10024/79995,government,healthcare agency,Finland,Epidemiology; Diseases and disorders; Medical specialties,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1016/j.mbs.2016.03.013,3.0,fgvbr-665c3119c0f7f1a10d4b6020bfd1be6e,Fundação Getulio Vargas,Utilização de indicadores ambientais e epidemiológicos no estudo da dinâmica da malária,2023-12-12,https://repositorio.fgv.br/items/a6efe2fc-90c7-4a0d-b9f5-ebc2d152cdd8/full,think tank,research center,Brazil,Deforestation; Malaria; Habitat,science and technology; health; health>diseases and conditions
https://dx.doi.org/10.1016/j.mbs.2016.03.013,3.0,idrc-f64a4e54f2f3baf7225e149cd9825276,International Development Research Centre,Age-structured model for transmission dynamics of malaria with infected immigrants and asymptomatic carriers,2021-08-12,https://idrc-crdi.ca/en/node/123289,think tank,,Canada,Basic reproduction number; Malaria; Asymptomatic carrier,science and technology; health; science and technology>mathematics
https://dx.doi.org/10.1016/j.mbs.2016.03.013,3.0,priono-8b3d7658773f109f7dc357eb6447a301,Peace Research Insitute Oslo,"Rainfall Variability and Violent, State-Based Conflict: A Machine Learning Approach to Estimate Context Specificity",2020-01-01,https://www.prio.org/Publications/Publication/?x=12564,think tank,,Norway,Estimator; Regression analysis; Dependent and independent variables,"science and technology; conflicts, war and peace; weather"
https://dx.doi.org/10.1016/j.vaccine.2013.03.049,2.0,governmentofcanada-2356036ad0e5820512f9022916609e94,Government of Canada,Update on the use of pneumococcal vaccines in adults 65 years of age and older : a public health perspective.,2018-11-01,http://publications.gc.ca/site/eng/9.859249/publication.html,government,,Canada,Pneumococcal conjugate vaccine; Pneumococcal vaccine; Pneumonia,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1016/j.vaccine.2013.03.049,2.0,governmentofmalaysia-e71764d653c5f472ff3be05eb26dff90,Government of Malaysia,Ee Uaas,2014-12-08,https://www.moh.gov.my/moh/resources/auto%20download%20images/587f11568fcaa.pdf,government,,Malaysia,Pneumococcal conjugate vaccine; Pneumococcal vaccine; Streptococcus pneumoniae,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1016/s0022-5193(05)80549-1,1.0,santafeinstitute-a41f3695ad4059e8f6674355c10e542e,Santa Fe Institute,Modeling Plasma Virus Concentration and CD4+ T Cell Kinetics during Primary HIV Infection,1999-01-01,https://sfi-edu.s3.amazonaws.com/sfi-edu/production/uploads/sfi-com/dev/uploads/filer/38/31/383132ad-76ab-4e20-95e8-b94f2f96ffd2/99-05-036.pdf,think tank,,USA,HIV; Cytotoxic T cell; Virus,science and technology>natural science>biology; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1002/ijc.23633,2.0,folkhalsomyndigheten-64136d9e80d4ee667da378d881243d39,Folkhälsomyndigheten,Human papilloma virusvaccination of boys in the Swedish national vaccination programme,2017-10-02,https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/h/human-papilloma-virusvaccination-of-boys-in-the-swedish-national-vaccination-programme/,government,healthcare agency,Sweden,Cervarix; Human papillomavirus infection; Cervical cancer,health>diseases and conditions; health; health>diseases and conditions>communicable disease>virus disease
https://dx.doi.org/10.1002/ijc.23633,2.0,publichealthinformationdevelopmentunit-a0570bf0af0f598b524aba0dc6486bad,Public Health Information Development Unit,Advocacy and action in public health: Lessons from Australia over the 20th century - Phidu,2017-03-28,https://phidu.torrens.edu.au/publications-2010-to-2014/advocacy-and-action-in-public-health-lessons-from-australia-over-the-20th-century,think tank,university affiliated,Australia,Human papillomavirus infection; HPV vaccine; Cervical cancer,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1002/msj.20137,1.0,nber-c5687264364045780d121ffaf0fa32f8,NBER,Urban Resilience,2021-09-20,https://www.nber.org/papers/w29261,think tank,,USA,Black Death; Pericles; Economic growth,"disaster, accident and emergency incident>disaster; economy, business and finance>economy; science and technology"
https://dx.doi.org/10.1007/s10654-020-00676-7,1.0,governmentofsrilanka-343b3ff3302e3c72b519fa17477e7122,Government of Sri Lanka,| cei ee,2023-12-20,https://www.health.gov.lk/wp-content/uploads/2022/08/Sri-Lanka-Journal-of-Health-Research-Vo.02-Iss.-01-December-2022-1.pdf,government,,Sri Lanka,Coronary artery bypass surgery; Tax; Cardiovascular disease,health>diseases and conditions; health; science and technology>biomedical science>pharmacology
https://dx.doi.org/10.3201/eid1508.081061,4.0,federalregister-e597836fb44981a0dcaaa9c4b94940c9,Federal Register,Control of Communicable Diseases; Foreign Quarantine: Importation of Dogs and Cats,2023-07-10,https://www.federalregister.gov/documents/2023/07/10/2023-14343/control-of-communicable-diseases-foreign-quarantine-importation-of-dogs-and-cats,government,,USA,Rabies; Centers for Disease Control and Prevention; Rabies in animals,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.3201/eid1508.081061,4.0,federalregister-e60074e472032d365fedcf219616c099,Federal Register,Control of Communicable Diseases; Foreign Quarantine: Importation of Dogs and Cats,2024-05-13,https://www.federalregister.gov/documents/2024/05/13/2024-09676/control-of-communicable-diseases-foreign-quarantine-importation-of-dogs-and-cats,government,,USA,Centers for Disease Control and Prevention; U.S. Customs and Border Protection; United States Department of Homeland Security,health>diseases and conditions; health; health>health treatment>medicine
https://dx.doi.org/10.3201/eid1508.081061,4.0,govdeptsbrazil-5337ffdaacfd69c49904367636056de4,Government of Brazil,Bovine rabies : economic loss and its mitigation through antirabies vaccination 1,2019-03-28,https://www.agraer.ms.gov.br/wp-content/uploads/2023/12/Bovine-rabies-economic-loss-and-its-mitigation-through-antirabies-vaccination.pdf,government,,Brazil,Rabies; Cattle; Vaccination,health; health>diseases and conditions; health>health treatment>medicine
https://dx.doi.org/10.3201/eid1508.081061,4.0,who-1db895e2fcbef8cc8f81281f458404e1,World Health Organization,WHO Expert Consultation on Rabies: second report,2013-07-03,https://apps.who.int/iris/handle/10665/85346,igo,healthcare agency,IGO,Lyssavirus; Rabies; Vaccine,health>diseases and conditions>communicable disease>virus disease; science and technology>natural science>biology; health
https://dx.doi.org/10.2166/wh.2006.024,16.0,california_state_agencies-2aa30f3781bff207f8c6e1c7aea2ea0d,State of California,Bacteria Indicators Fact Sheet,2024-01-26,https://www.waterboards.ca.gov/gama/docs/coc_bacteria_indicators.pdf,government,,USA,Water purification; Fecal coliform; Drinking water,health>diseases and conditions>illness; health>diseases and conditions; environment>environmental pollution
https://dx.doi.org/10.2166/wh.2006.024,16.0,california_state_agencies-6dcbad0739d94f31c0a1d08dbf35e866,State of California,"Groundwater Information Sheet, Bacteria Indicators",2019-10-29,https://www.waterboards.ca.gov/water_issues/programs/gama/docs/coc_bacteria_indicators.pdf,government,,USA,Coliform bacteria; Water purification; Drinking water,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.2166/wh.2006.024,16.0,cdc-151251fa57525eed0a2471cc7742e4a2,Centers for Disease Control and Prevention (CDC),"Surveillance for waterborne disease and outbreaks associated with recreational water use and other aquatic facility-associated health events-- United States, 2005-2006; and, Surveillance for waterborne disease and outbreaks associated with drinking water and water not intended for drinking-- United States, 2005-2006",2008-08-28,https://stacks.cdc.gov/view/cdc/7036,government,healthcare agency,USA,Cryptosporidiosis; Legionnaires' disease; Vibrio,health; health>diseases and conditions>communicable disease>virus disease; environment
https://dx.doi.org/10.2166/wh.2006.024,16.0,cdc-720cfda619c2230b35ea464fb7ffa2a5,Centers for Disease Control and Prevention (CDC),The Surgeon General’s call to action to promote healthy homes,2009-05-28,https://stacks.cdc.gov/view/cdc/21123,government,healthcare agency,USA,Health; Air pollution; Preventive healthcare,health; environment; environment>natural resources
https://dx.doi.org/10.2166/wh.2006.024,16.0,cdc-775073673516eea0712c9b8b142a1640,Centers for Disease Control and Prevention (CDC),"Surveillance for waterborne disease and outbreaks associated with recreational water-- United States, 2003-2004; Surveillance for waterborne disease and outbreaks associated with drinking water and water not intended for drinking-- United States, 2003-2004",2006-12-22,https://stacks.cdc.gov/view/cdc/26707,government,healthcare agency,USA,Safe Drinking Water Act; Legionnaires' disease; Legionella,health>diseases and conditions>communicable disease>virus disease; health; health>diseases and conditions>communicable disease>epidemic
https://dx.doi.org/10.2166/wh.2006.024,16.0,fairus-d2fdd0f238522db783ce890a68e37ea2,Federation for American Immigration Reform,Running Dry: Looming Water Shortages in The United States (2012),2012-10-03,https://www.fairus.org/issue/publications-resources/running-dry-looming-water-shortages-united-states-2012,think tank,,USA,Ogallala Aquifer; Groundwater; Water scarcity,environment; environment>natural resources; environment>natural resources>water
https://dx.doi.org/10.2166/wh.2006.024,16.0,governmentofcanada-2922e2415b7de24e2bfa06573e69a98b,Government of Canada,Guidelines for Canadian drinking water quality : guideline technical document - enteric viruses.,2019-01-01,http://publications.gc.ca/site/eng/9.867654/publication.html,government,,Canada,Norovirus; Astrovirus; Aquifer,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.2166/wh.2006.024,16.0,governmentofcanada-2eb87e4aa4a8191b993f7d46fb2543cb,Government of Canada,Guidelines for Canadian drinking water quality : guideline technical document : total coliforms.: H144-8/2020E-PDF Publications - Canada.ca,2020-01-01,http://publications.gc.ca/site/eng/9.885293/publication.html,government,,Canada,Water purification; Drinking water; Water quality,health>diseases and conditions>communicable disease>virus disease; environment; health
https://dx.doi.org/10.2166/wh.2006.024,16.0,gpogov-15f5258261ce008032012c9d1709dbb8,Government Publishing Office (GPO),The impacts of climate change on human health in the United States : a scientific assessment /,2016-04-22,https://purl.fdlp.gov/GPO/gpo68498,government,,USA,Effects of global warming; Public health; Air pollution,health; environment; weather
https://dx.doi.org/10.2166/wh.2006.024,16.0,healthnz-1c4728eb9e639a842593a818e32660c4,New Zealand Ministry of Health,Drinking-water Cost-Benefit Analysis,2010-05-20,https://www.health.govt.nz/publication/drinking-water-cost-benefit-analysis,government,,New Zealand,Drinking water; Cost–benefit analysis; Disease,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.2166/wh.2006.024,16.0,nicholasinstitute-e82247d16af7e80b6dbae81e8f5ab045,Nicholas Institute,USFS Predictive Model Library: Fire and Timber Management,2020-04-15,https://nicholasinstitute.duke.edu/publications/usfs-predictive-model-library-fire-and-timber-management,think tank,university affiliated,USA,HAZUS; Geographic information system; Air pollution,"environment; economy, business and finance>economic sector>computing and information technology; economy, business and finance>economic sector>computing and information technology>software"
https://dx.doi.org/10.2166/wh.2006.024,16.0,nrdc-6fa895e57a435c98db2c1130774f35c4,Natural Resources Defense Council,Rising Tide of Illness: How Global Warming Could Increase the Threat of Waterborne Diseases,2010-07-21,https://www.nrdc.org/resources/rising-tide-illness-how-global-warming-could-increase-threat-waterborne-diseases,think tank,,USA,Drinking water; Waterborne diseases; Pollution,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.2166/wh.2006.024,16.0,stateofvirginia-01e11abcb625ad7e9fe39de0cf51e78e,Commonwealth of Virginia,Water safety in buildings,2011-02-16,https://www.vdh.virginia.gov/content/uploads/sites/14/2020/06/WHO-Water-Safety-in-Buildings.pdf,government,,USA,Water; Water heating; Infection prevention and control,"economy, business and finance>economic sector>energy and resource>water supply; health>diseases and conditions; environment>natural resources>water"
https://dx.doi.org/10.2166/wh.2006.024,16.0,surgeongeneral-19778238514ea030a27ea90fb3e314bf,Office of the Surgeon General,The Surgeon General's Call to Action to Promote Healthy Homes,2009-01-01,https://www.ncbi.nlm.nih.gov/books/n/ctahome/,government,healthcare agency,USA,Health; Preventive healthcare; Air pollution,"health>diseases and conditions; health; economy, business and finance>economic sector>chemicals"
https://dx.doi.org/10.2166/wh.2006.024,16.0,who-1a5ec414d1492245b404e96ee1423daa,World Health Organization,Securité sanitaire de l'eau dans les bâtiments,2014-01-03,https://apps.who.int/iris/handle/10665/97941,igo,healthcare agency,IGO,Safety; Risk; Plumbing,health; health>diseases and conditions; environment
https://dx.doi.org/10.2166/wh.2006.024,16.0,who-d42e1fd25929e8f095a5d1141ef5cdd3,World Health Organization,Water safety in buildings,2012-10-23,https://apps.who.int/iris/handle/10665/76145,igo,healthcare agency,IGO,Legionella; Water; Management,"health; environment; economy, business and finance>economic sector>chemicals"
https://dx.doi.org/10.4269/ajtmh.18-0372,2.0,paho-1029437e2134f50931b25c1d16c6dd1b,Pan American Health Organization (PAHO),Pautas operativas para la eliminación de la fascioliasis humana como problema de salud pública en las Américas,2023-12-18,https://iris.paho.org/handle/10665.2/58950,igo,,IGO,Trematoda; Fasciolosis; Health,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.4269/ajtmh.18-0372,2.0,paho-e6b91ba15736b6ecfa9693b6f93fe1c0,Pan American Health Organization (PAHO),Operational guidelines for the elimination of human fascioliasis as a public health problem in the Americas,2024-06-03,https://iris.paho.org/handle/10665.2/60164,igo,,IGO,Health; Medical specialties; Health sciences,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1186/1475-2891-10-25,5.0,fao-653a5c99e0b34c744b5fe0fcf2da0e60,Food and Agriculture Organization of the United Nations,"Livestock programming for nutritional improvements in children under five years of age, pregnant and lactating mothers",2022-02-10,http://www.fao.org/3/cb8625en/cb8625en.pdf,igo,,IGO,Stunted growth; Human nutrition; Pastoralism,health; science and technology; lifestyle and leisure>lifestyle>food and drink
https://dx.doi.org/10.1186/1475-2891-10-25,5.0,governmentofperu-67412c9a2253bce6290211d4b44f95f9,Government of Peru,Ministerio de Salud,2018-02-16,http://www.minsa.gob.pe/presupuestales2017/doc2018/pp/anexo/1/ANEXO2.pdf,government,,Peru,Breastfeeding; Malnutrition; Emaciation,health; health>diseases and conditions; health>health treatment>diet
https://dx.doi.org/10.1186/1475-2891-10-25,5.0,governmentofperu-d7a658354a5d06784ab727a0c8edf12d,Government of Peru,Ministerio de Salud,2019-01-30,https://www.minsa.gob.pe/presupuestales/doc2019/pp/anexo/ANEXO2_1.pdf,government,,Peru,Dieting; Childbirth; Diarrhea,health; health>diseases and conditions; science and technology
https://dx.doi.org/10.1186/1475-2891-10-25,5.0,izade-e870aebee39775b9e696a5f12b53e584,IZA Institute of Labor Economics,Urban-Rural Disparities of Child Health and Nutritional Status in China from 1989 to 2006,2012-04-26,https://www.iza.org/publications/dp/6528/urban-rural-disparities-of-child-health-and-nutritional-status-in-china-from-1989-to-2006,think tank,,Germany,Health; Nutrition; Malnutrition,science and technology; health; science and technology>social sciences
https://dx.doi.org/10.1186/1475-2891-10-25,5.0,pubmedcentral-8b88c08985b13dac71e3026261daf149,Guidelines in PubMed Central,Lay health workers in primary and community health care for maternal and child health: identification and treatment of wasting in children,2023-08-30,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467022/pdf,other,aggregator,USA,Health care; Stunted growth; Health professional,health; science and technology; health>health treatment>medicine
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,africacdc-c3914a29d2a4eb32da05392fbf73c13e,Africa CDC,COVID-19 Scientific and Public Health Policy Update – 9 June 2020,2020-06-09,https://africacdc.org/download/covid-19-scientific-and-public-health-policy-update-9-june-2020/,igo,healthcare agency,IGO,Coronavirus disease 2019; Clinical trial; Nitazoxanide,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,boe-9b3c529e53464b9c94635a00f68194d9,Boletín Oficial del Estado,"Efectividad de las medidas de distanciamiento social, en el contexto de la pandemia por COVID-19",2022-06-15,https://cpage.mpr.gob.es/producto/efectividad-de-las-medidas-de-distanciamiento-social-en-el-contexto-de-la-pandemia-por-covid-19-3/,government,,Spain,COVID-19 pandemic; Infectious diseases; Medicine,health; science and technology; health>diseases and conditions
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,britishacademy-532124799434214a896d23c7155bdd9d,British Academy,What factors make a community more vulnerable to COVID-19?,2020-11-02,https://www.thebritishacademy.ac.uk/publications/covid-19-shape-the-future-what-factors-make-community-more-vulnerable/,government,academy,UK,Social inequality; Homelessness; Health,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,britishacademy-5b5ea7322bfe83c89d3d58cc9ea4e534,British Academy,Health and inequality: the implications of the COVID-19 pandemic,2020-11-27,https://www.thebritishacademy.ac.uk/publications/covid-decade-health-inequality-implications-pandemic/,government,academy,UK,Loneliness; Unemployment; Immune system,health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,ecdc-20812da853a5139ca143439f63424c3a,European Centre for Disease Prevention and Control,Rapid Risk Assessment: Risk of COVID-19 transmission related to the end-of-year festive season,2020-12-04,https://www.ecdc.europa.eu/en/publications-data/risk-assessment-covid-19-festive-season,government,agency,EU,COVID-19 pandemic; Coronavirus disease 2019; Risk,health>diseases and conditions; health; health>diseases and conditions>illness
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,ecdc-469dbbe08d10cee3ee244e450fc958a4,European Centre for Disease Prevention and Control,Guidelines for the implementation of non-pharmaceutical interventions against COVID-19,2020-09-23,https://www.ecdc.europa.eu/en/publications-data/covid-19-guidelines-non-pharmaceutical-interventions,government,agency,EU,Coronavirus disease 2019; Respirator; Transmission (medicine),health>diseases and conditions>illness; health>diseases and conditions; health
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,ecdc-c3cb5bb43516149fe329e0b3735bd0b3,European Centre for Disease Prevention and Control,Rapid Risk Assessment: Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – eleventh update: resurgence of cases,2020-08-10,https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-coronavirus-disease-2019-covid-19-eueea-and-uk-eleventh,government,agency,EU,Coronavirus disease 2019; COVID-19 pandemic; Health,health>diseases and conditions; health; science and technology
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,europa-419ef4e9bb94722ec466f4e8e2bc7e76,Publications Office of the European Union,"A new era for Europe : how the European Union can make the most of its pandemic recovery, pursue sustainable growth, and promote global stability.",2022-03-04,https://op.europa.eu/en/publication-detail/-/publication/66e98136-a4d9-11ec-83e1-01aa75ed71a1/language-en/format-PDF,government,,EU,Next Generation EU; Tax; European Union,"politics>government; economy, business and finance>economy; science and technology"
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,europa-e47b4e0d1629509aa0075090020e03ba,Publications Office of the European Union,"A new era for Europe : how the European Union can make the most of its pandemic recovery, pursue sustainable growth, and promote global stability.",2022-09-26,https://op.europa.eu/en/publication-detail/-/publication/cb52073e-3ed5-11ed-92ed-01aa75ed71a1/language-en/format-PDF,government,,EU,Next Generation EU; Tax; European Union,"politics>government; economy, business and finance>economy; politics"
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,govuk-5999000816602e947c6c74ba85c9bddd,The UK Government,"SPI-B, SPI-M and EMG: Considerations for potential impact of Plan B measures, 13 October 2021",2021-10-22,https://www.gov.uk/government/publications/spi-b-spi-m-and-emg-considerations-for-potential-impact-of-plan-b-measures-13-october-2021,government,,UK,Face masks during the COVID-19 pandemic; Surgical mask; Airborne transmission,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,instituteofdevelopmentstudies-0b602240dbf6d0625c2ed00a82098c11,Institute of Development Studies,COVID-19 Demography Evidence Summary No.8,2020-07-02,https://opendocs.ids.ac.uk/opendocs/handle/20.500.12413/15495,think tank,,UK,COVID-19 pandemic; Risk; Infection,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,instituteofdevelopmentstudies-2378aff3faa851a468cfe305f4bdc6de,Institute of Development Studies,COVID-19 Health Evidence Summary No.56,2020-06-05,https://opendocs.ids.ac.uk/opendocs/handle/20.500.12413/15386,think tank,,UK,COVID-19 pandemic; World Health Organization; Face masks during the COVID-19 pandemic,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,instituteofdevelopmentstudies-a3552bfef2ffc4c031206514b817d7fe,Institute of Development Studies,COVID-19 Health Evidence Summary No.54,2020-06-04,https://opendocs.ids.ac.uk/opendocs/handle/20.500.12413/15378,think tank,,UK,Severe acute respiratory syndrome coronavirus 2; World Health Organization; COVID-19 pandemic,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1038/s41562-020-0898-6,14.0,populationeurope-2903113d04133f801bcfa1e1105a693d,Population Europe,Demography and the Coronavirus Pandemic,2020-05-04,https://population-europe.eu/research/policy-briefs/demography-and-coronavirus-pandemic,think tank,research center,Germany,COVID-19; Human migration; Pandemic,health; science and technology; health>diseases and conditions>communicable disease>epidemic
https://dx.doi.org/10.1086/432010,1.0,governmentofportugal-67fe95a6b2f77883989583c392b3aef5,Government of Portugal,"Clinical, laboratorial and immunological aspects of severe malaria in children from Guinea-Bissau",2018-05-08,http://repositorio.chlc.min-saude.pt/bitstream/10400.17/2965/1/Acta%20Tropica%202018_46.pdf,government,,Portugal,Immunoglobulin G; Serology; Antibody,science and technology>natural science>biology; science and technology>natural science>biology>genetics; health
https://dx.doi.org/10.2989/16085906.2014.927780,1.0,sidase-d96e546394cf341fb3496903be95390d,Sida,Evaluation of the Health Economics and HIV and AIDS Research Division (HEARD),2017-05-08,https://www.sida.se/en/publications/evaluation-of-the-health-economics-and-hiv-and-aids-research-division-heard,think tank,,Sweden,Web of Science; Research; Google Scholar,education; health; science and technology
https://dx.doi.org/10.1002/(sici)1097-0258(19980430)17:8<909::aid-sim753>3.0.co;2-o,2.0,governmentofuruguay-1115adb14733b615fcffdb2a1aa35810,Government of Uruguay,MANUAL CLINICO.p65,2013-04-15,http://dspace.mides.gub.uy:8080/xmlui/bitstream/handle/123456789/307/Organizacion_Panamericana_Salud_Manual_clinico_AIEPI_Neonatal_Uruguay_2013.pdf?sequence=1&isAllowed=y,government,,Uruguay,Pan American Health Organization; Health; Neonate,health>diseases and conditions; health>diseases and conditions>illness; health
https://dx.doi.org/10.1002/(sici)1097-0258(19980430)17:8<909::aid-sim753>3.0.co;2-o,2.0,nice-684a58626cc0bf7bed9cec74b8e9d11d,NICE,Neonatal infection: antibiotics for prevention and treatment,2021-04-20,https://www.nice.org.uk/guidance/ng195,government,healthcare agency,UK,Medical specialties; Neonatal intensive care unit; Infection,health>diseases and conditions; health>diseases and conditions>illness; health>diseases and conditions
https://dx.doi.org/10.1002/hep.23192,1.0,pubmedcentral-51d9a10a521ba4b1bcd36f5c98b7c771,Guidelines in PubMed Central,An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver,2015-01-01,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334064/pdf,other,aggregator,USA,Simeprevir; Hepatitis C; Sofosbuvir,health>diseases and conditions; health>diseases and conditions>communicable disease>virus disease; health
